Query 012021
Match_columns 472
No_of_seqs 429 out of 2598
Neff 8.1
Searched_HMMs 46136
Date Fri Mar 29 07:47:10 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/012021.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/012021hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0583 Serine/threonine prote 100.0 1.1E-62 2.3E-67 499.5 29.3 340 6-348 13-368 (370)
2 KOG0575 Polo-like serine/threo 100.0 6.5E-61 1.4E-65 487.9 25.3 263 11-276 19-282 (592)
3 KOG0615 Serine/threonine prote 100.0 1.7E-61 3.7E-66 471.0 17.5 259 8-269 170-443 (475)
4 KOG0588 Serine/threonine prote 100.0 2.6E-60 5.6E-65 485.1 20.4 259 9-270 11-270 (786)
5 KOG0598 Ribosomal protein S6 k 100.0 6.2E-58 1.3E-62 443.0 21.3 259 7-268 22-286 (357)
6 KOG0616 cAMP-dependent protein 100.0 7.1E-58 1.5E-62 429.3 19.5 256 7-268 41-302 (355)
7 KOG0592 3-phosphoinositide-dep 100.0 2.6E-57 5.6E-62 454.8 20.9 260 8-268 71-343 (604)
8 KOG0581 Mitogen-activated prot 100.0 3.4E-55 7.3E-60 424.1 21.9 257 7-270 76-342 (364)
9 KOG0595 Serine/threonine-prote 100.0 2.8E-54 6.1E-59 421.0 22.1 259 7-270 7-275 (429)
10 KOG0585 Ca2+/calmodulin-depend 100.0 5.3E-54 1.2E-58 424.6 21.4 269 4-272 91-381 (576)
11 KOG0605 NDR and related serine 100.0 4.8E-54 1E-58 431.6 21.2 260 7-268 138-450 (550)
12 KOG0611 Predicted serine/threo 100.0 7.6E-55 1.6E-59 422.4 14.6 264 7-274 50-314 (668)
13 KOG0694 Serine/threonine prote 100.0 3.8E-53 8.3E-58 435.6 25.6 261 5-268 363-629 (694)
14 KOG0033 Ca2+/calmodulin-depend 100.0 1.8E-54 3.8E-59 396.5 6.0 260 5-269 6-273 (355)
15 KOG0591 NIMA (never in mitosis 100.0 6.1E-54 1.3E-58 400.0 6.9 248 6-257 15-275 (375)
16 KOG0661 MAPK related serine/th 100.0 2.7E-52 5.8E-57 413.0 15.0 263 3-271 3-299 (538)
17 KOG0580 Serine/threonine prote 100.0 1.4E-52 3.1E-57 383.2 12.0 259 5-268 17-278 (281)
18 KOG0198 MEKK and related serin 100.0 1.4E-51 3E-56 404.1 18.8 259 10-271 17-284 (313)
19 KOG0593 Predicted protein kina 100.0 3E-52 6.6E-57 392.1 13.4 256 9-267 1-288 (396)
20 KOG0597 Serine-threonine prote 100.0 4.1E-52 8.9E-57 417.6 14.7 257 9-270 1-258 (808)
21 PTZ00263 protein kinase A cata 100.0 1.4E-50 3.1E-55 407.4 24.9 256 7-268 15-276 (329)
22 cd05612 STKc_PRKX_like Catalyt 100.0 2.4E-50 5.2E-55 398.5 22.3 253 10-268 1-259 (291)
23 KOG0032 Ca2+/calmodulin-depend 100.0 5.5E-50 1.2E-54 406.7 24.9 259 7-269 32-299 (382)
24 cd05571 STKc_PKB Catalytic dom 100.0 1.1E-49 2.5E-54 399.7 26.6 250 16-268 1-256 (323)
25 KOG4717 Serine/threonine prote 100.0 5.3E-51 1.2E-55 405.3 16.2 261 8-272 16-279 (864)
26 KOG0600 Cdc2-related protein k 100.0 4.7E-50 1E-54 399.6 19.8 258 8-268 115-405 (560)
27 PTZ00426 cAMP-dependent protei 100.0 2.1E-49 4.4E-54 400.9 24.7 258 5-268 25-289 (340)
28 KOG0610 Putative serine/threon 100.0 8E-50 1.7E-54 390.0 18.2 264 5-269 72-398 (459)
29 cd05585 STKc_YPK1_like Catalyt 100.0 6.5E-49 1.4E-53 392.2 24.2 249 18-269 1-253 (312)
30 cd05589 STKc_PKN Catalytic dom 100.0 1.6E-48 3.5E-53 391.4 27.1 254 12-268 1-262 (324)
31 cd05593 STKc_PKB_gamma Catalyt 100.0 2E-48 4.3E-53 391.7 27.4 250 16-268 1-256 (328)
32 KOG0578 p21-activated serine/t 100.0 1.1E-49 2.4E-54 402.9 18.1 254 9-268 272-528 (550)
33 KOG0582 Ste20-like serine/thre 100.0 9.1E-49 2E-53 385.3 23.9 262 6-270 22-300 (516)
34 cd05595 STKc_PKB_beta Catalyti 100.0 1.7E-48 3.7E-53 391.3 26.5 250 16-268 1-256 (323)
35 KOG0599 Phosphorylase kinase g 100.0 2.2E-50 4.7E-55 374.6 10.6 257 8-268 15-288 (411)
36 cd05628 STKc_NDR1 Catalytic do 100.0 1.8E-48 3.8E-53 397.4 25.7 257 10-268 1-298 (363)
37 KOG0586 Serine/threonine prote 100.0 1.7E-49 3.6E-54 404.8 17.7 261 7-271 53-314 (596)
38 KOG0659 Cdk activating kinase 100.0 8E-49 1.7E-53 363.4 19.3 255 10-268 2-286 (318)
39 KOG0690 Serine/threonine prote 100.0 8.5E-50 1.8E-54 378.3 12.6 262 4-268 162-429 (516)
40 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 3E-48 6.4E-53 390.8 24.7 253 10-268 1-262 (333)
41 cd05598 STKc_LATS Catalytic do 100.0 5.4E-48 1.2E-52 395.4 26.9 257 10-268 1-306 (376)
42 cd05599 STKc_NDR_like Catalyti 100.0 2.9E-48 6.3E-53 395.5 24.6 257 10-268 1-301 (364)
43 cd05631 STKc_GRK4 Catalytic do 100.0 3.1E-48 6.8E-53 382.1 23.9 254 11-268 1-266 (285)
44 cd05626 STKc_LATS2 Catalytic d 100.0 5.8E-48 1.3E-52 396.1 26.4 258 11-269 2-311 (381)
45 cd05620 STKc_nPKC_delta Cataly 100.0 4.4E-48 9.4E-53 387.1 24.8 251 16-269 1-254 (316)
46 cd05587 STKc_cPKC Catalytic do 100.0 5.2E-48 1.1E-52 387.7 25.4 255 11-268 1-262 (324)
47 cd05590 STKc_nPKC_eta Catalyti 100.0 3.4E-48 7.4E-53 388.6 23.5 250 16-268 1-258 (320)
48 cd05596 STKc_ROCK Catalytic do 100.0 5.3E-48 1.1E-52 395.0 25.3 262 7-269 40-310 (370)
49 cd05629 STKc_NDR_like_fungal C 100.0 4.4E-48 9.6E-53 396.3 24.5 257 10-268 1-310 (377)
50 cd05621 STKc_ROCK2 Catalytic d 100.0 6.6E-48 1.4E-52 394.3 25.2 263 6-269 39-310 (370)
51 cd05625 STKc_LATS1 Catalytic d 100.0 7.4E-48 1.6E-52 395.3 25.6 257 10-268 1-310 (382)
52 cd05591 STKc_nPKC_epsilon Cata 100.0 5E-48 1.1E-52 387.3 23.8 250 16-268 1-259 (321)
53 cd05594 STKc_PKB_alpha Catalyt 100.0 3.7E-48 8E-53 389.0 22.4 250 16-268 1-257 (325)
54 cd05573 STKc_ROCK_NDR_like Cat 100.0 4.1E-48 8.9E-53 391.7 22.8 257 10-268 1-290 (350)
55 cd05614 STKc_MSK2_N N-terminal 100.0 1.7E-47 3.7E-52 385.0 26.8 258 11-269 1-273 (332)
56 cd05584 STKc_p70S6K Catalytic 100.0 1.6E-47 3.6E-52 384.0 26.3 251 15-268 1-261 (323)
57 cd05592 STKc_nPKC_theta_delta 100.0 1.7E-47 3.6E-52 383.0 25.7 250 16-268 1-253 (316)
58 cd05616 STKc_cPKC_beta Catalyt 100.0 1.6E-47 3.5E-52 384.0 25.2 255 11-268 1-262 (323)
59 cd07848 STKc_CDKL5 Catalytic d 100.0 1.5E-47 3.2E-52 376.6 24.1 254 10-266 1-287 (287)
60 cd07871 STKc_PCTAIRE3 Catalyti 100.0 1.7E-47 3.7E-52 377.4 24.2 253 9-266 4-288 (288)
61 cd05601 STKc_CRIK Catalytic do 100.0 2.4E-47 5.1E-52 383.6 25.2 257 10-268 1-268 (330)
62 cd05588 STKc_aPKC Catalytic do 100.0 1.9E-47 4E-52 384.7 24.3 250 16-268 1-267 (329)
63 cd05570 STKc_PKC Catalytic dom 100.0 3.1E-47 6.8E-52 381.2 25.2 251 16-269 1-258 (318)
64 cd05627 STKc_NDR2 Catalytic do 100.0 2.1E-47 4.6E-52 388.9 23.8 257 10-268 1-298 (360)
65 cd05619 STKc_nPKC_theta Cataly 100.0 3.6E-47 7.9E-52 380.5 25.1 251 16-269 1-254 (316)
66 KOG0660 Mitogen-activated prot 100.0 4.2E-48 9.2E-53 373.3 17.3 260 8-269 20-316 (359)
67 cd05575 STKc_SGK Catalytic dom 100.0 5.4E-47 1.2E-51 380.2 26.1 250 16-268 1-256 (323)
68 cd05618 STKc_aPKC_iota Catalyt 100.0 4.1E-47 8.9E-52 382.3 24.6 250 16-268 1-267 (329)
69 cd07869 STKc_PFTAIRE1 Catalyti 100.0 4.1E-47 9E-52 377.2 24.1 256 9-269 4-294 (303)
70 cd05604 STKc_SGK3 Catalytic do 100.0 6.6E-47 1.4E-51 379.9 25.8 250 16-268 1-256 (325)
71 cd05622 STKc_ROCK1 Catalytic d 100.0 6.8E-47 1.5E-51 387.0 25.5 263 6-269 39-310 (371)
72 cd05603 STKc_SGK2 Catalytic do 100.0 1.1E-46 2.4E-51 377.5 26.4 250 16-268 1-256 (321)
73 cd05615 STKc_cPKC_alpha Cataly 100.0 7.3E-47 1.6E-51 379.4 24.9 255 11-268 1-262 (323)
74 cd05582 STKc_RSK_N N-terminal 100.0 4E-47 8.6E-52 380.2 22.0 251 15-269 1-260 (318)
75 KOG0192 Tyrosine kinase specif 100.0 9.7E-47 2.1E-51 380.0 23.4 250 7-262 38-298 (362)
76 cd05586 STKc_Sck1_like Catalyt 100.0 4.5E-47 9.7E-52 381.8 20.5 249 18-268 1-258 (330)
77 cd05617 STKc_aPKC_zeta Catalyt 100.0 4E-46 8.6E-51 374.7 27.3 250 16-268 1-265 (327)
78 cd05608 STKc_GRK1 Catalytic do 100.0 1.6E-46 3.4E-51 369.0 23.6 248 18-268 1-262 (280)
79 KOG0663 Protein kinase PITSLRE 100.0 4.5E-47 9.8E-52 361.4 18.5 258 8-269 74-367 (419)
80 cd05602 STKc_SGK1 Catalytic do 100.0 1.9E-46 4E-51 376.6 23.7 250 16-268 1-256 (325)
81 cd06649 PKc_MEK2 Catalytic dom 100.0 5.8E-46 1.3E-50 374.1 27.4 257 7-270 2-308 (331)
82 cd05605 STKc_GRK4_like Catalyt 100.0 3.1E-46 6.7E-51 367.9 24.8 254 11-268 1-266 (285)
83 cd07859 STKc_TDY_MAPK_plant Ca 100.0 2.7E-46 5.9E-51 376.2 24.9 256 11-268 1-295 (338)
84 cd05597 STKc_DMPK_like Catalyt 100.0 4.4E-46 9.5E-51 375.0 25.8 258 10-268 1-271 (331)
85 KOG0201 Serine/threonine prote 100.0 1.8E-48 4E-53 383.0 7.4 255 10-269 13-269 (467)
86 cd05624 STKc_MRCK_beta Catalyt 100.0 1.7E-45 3.8E-50 370.7 28.1 258 10-268 1-271 (331)
87 KOG0594 Protein kinase PCTAIRE 100.0 2E-46 4.3E-51 362.6 20.0 257 9-269 10-308 (323)
88 PTZ00036 glycogen synthase kin 100.0 5.5E-46 1.2E-50 388.4 24.2 251 8-269 64-357 (440)
89 cd05623 STKc_MRCK_alpha Cataly 100.0 1.4E-45 3E-50 371.5 25.7 258 10-268 1-271 (332)
90 PTZ00283 serine/threonine prot 100.0 9.8E-46 2.1E-50 391.6 25.8 259 8-268 30-302 (496)
91 cd07862 STKc_CDK6 Catalytic do 100.0 9.6E-46 2.1E-50 364.3 23.5 251 10-266 1-290 (290)
92 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1.7E-45 3.8E-50 366.5 24.4 257 8-269 4-292 (309)
93 cd05580 STKc_PKA Catalytic dom 100.0 3.2E-45 7E-50 361.1 25.8 253 10-268 1-259 (290)
94 PLN00034 mitogen-activated pro 100.0 2.2E-45 4.7E-50 373.1 25.2 255 8-269 72-334 (353)
95 cd07876 STKc_JNK2 Catalytic do 100.0 2.6E-45 5.7E-50 373.3 25.7 256 7-269 18-321 (359)
96 PTZ00267 NIMA-related protein 100.0 3.4E-45 7.3E-50 386.4 27.2 256 9-268 66-328 (478)
97 KOG0589 Serine/threonine prote 100.0 1.6E-46 3.5E-51 377.6 16.3 258 9-270 3-265 (426)
98 cd06650 PKc_MEK1 Catalytic dom 100.0 4E-45 8.8E-50 368.4 25.8 257 7-270 2-306 (333)
99 PF00069 Pkinase: Protein kina 100.0 1.1E-45 2.4E-50 356.7 20.8 252 12-266 1-260 (260)
100 KOG0604 MAP kinase-activated p 100.0 9.6E-47 2.1E-51 354.4 12.6 255 5-271 56-330 (400)
101 PHA03212 serine/threonine kina 100.0 2.8E-45 6.1E-50 377.4 24.6 250 7-268 89-381 (391)
102 cd07878 STKc_p38beta_MAPK11 Ca 100.0 1.7E-45 3.7E-50 372.1 22.0 256 7-269 12-304 (343)
103 KOG0667 Dual-specificity tyros 100.0 9.5E-46 2.1E-50 380.8 20.1 253 5-268 181-507 (586)
104 cd07853 STKc_NLK Catalytic dom 100.0 2.7E-45 5.9E-50 375.1 23.1 257 11-270 1-295 (372)
105 cd05630 STKc_GRK6 Catalytic do 100.0 6.8E-45 1.5E-49 358.4 25.0 254 11-268 1-266 (285)
106 cd06625 STKc_MEKK3_like Cataly 100.0 8.1E-45 1.8E-49 351.8 24.6 256 10-266 2-263 (263)
107 cd07863 STKc_CDK4 Catalytic do 100.0 6.9E-45 1.5E-49 357.6 23.7 250 11-266 1-288 (288)
108 cd05102 PTKc_VEGFR3 Catalytic 100.0 5.1E-45 1.1E-49 367.7 22.4 254 6-262 3-329 (338)
109 cd07874 STKc_JNK3 Catalytic do 100.0 7E-45 1.5E-49 369.5 23.5 256 7-269 14-317 (355)
110 KOG0986 G protein-coupled rece 100.0 9.1E-46 2E-50 364.1 16.2 258 7-268 182-451 (591)
111 cd05607 STKc_GRK7 Catalytic do 100.0 1.3E-44 2.8E-49 354.9 24.0 247 18-268 1-259 (277)
112 cd05632 STKc_GRK5 Catalytic do 100.0 2.1E-44 4.7E-49 354.7 25.6 255 11-269 1-267 (285)
113 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.8E-44 3.9E-49 357.7 25.2 256 8-268 4-291 (301)
114 PTZ00284 protein kinase; Provi 100.0 6.8E-45 1.5E-49 383.2 23.4 252 8-270 127-445 (467)
115 KOG0658 Glycogen synthase kina 100.0 1.4E-45 2.9E-50 356.6 16.5 251 8-269 22-312 (364)
116 cd07875 STKc_JNK1 Catalytic do 100.0 1.3E-44 2.9E-49 368.8 24.6 255 7-268 21-323 (364)
117 cd08223 STKc_Nek4 Catalytic do 100.0 7.1E-44 1.5E-48 344.0 26.0 252 11-266 1-257 (257)
118 cd06628 STKc_MAPKKK_Byr2_like 100.0 5.4E-44 1.2E-48 347.1 25.0 255 11-266 1-267 (267)
119 KOG0612 Rho-associated, coiled 100.0 8.9E-46 1.9E-50 396.5 13.1 259 9-269 74-344 (1317)
120 cd05574 STKc_phototropin_like 100.0 7.7E-44 1.7E-48 355.4 26.2 258 10-268 1-294 (316)
121 cd06654 STKc_PAK1 Catalytic do 100.0 8.7E-44 1.9E-48 352.5 26.2 255 9-269 19-276 (296)
122 cd07861 STKc_CDK1_euk Catalyti 100.0 6.4E-44 1.4E-48 349.9 24.7 252 11-266 1-285 (285)
123 PHA03207 serine/threonine kina 100.0 4.2E-44 9.1E-49 369.0 24.1 254 5-268 87-380 (392)
124 cd06615 PKc_MEK Catalytic doma 100.0 9.5E-44 2.1E-48 354.2 25.8 253 10-269 1-293 (308)
125 cd05578 STKc_Yank1 Catalytic d 100.0 4.2E-44 9E-49 346.4 21.6 252 11-266 1-258 (258)
126 cd06655 STKc_PAK2 Catalytic do 100.0 1.7E-43 3.7E-48 350.5 26.3 255 10-270 19-276 (296)
127 KOG0607 MAP kinase-interacting 100.0 3.4E-45 7.3E-50 346.4 13.1 256 12-270 79-368 (463)
128 cd06610 STKc_OSR1_SPAK Catalyt 100.0 2.3E-43 5E-48 341.8 26.3 255 10-266 1-267 (267)
129 cd06656 STKc_PAK3 Catalytic do 100.0 1E-43 2.2E-48 352.2 23.6 257 9-271 18-277 (297)
130 cd07847 STKc_CDKL1_4 Catalytic 100.0 2.4E-43 5.2E-48 345.7 25.8 254 10-266 1-286 (286)
131 cd07868 STKc_CDK8 Catalytic do 100.0 7.6E-44 1.6E-48 355.7 22.7 246 15-266 6-317 (317)
132 cd06609 STKc_MST3_like Catalyt 100.0 1.4E-43 3.1E-48 345.9 23.7 256 10-270 1-258 (274)
133 cd06611 STKc_SLK_like Catalyti 100.0 9.4E-44 2E-48 348.3 22.5 256 9-269 4-268 (280)
134 cd05609 STKc_MAST Catalytic do 100.0 2.4E-43 5.3E-48 350.4 25.6 258 10-268 1-278 (305)
135 cd08529 STKc_FA2-like Catalyti 100.0 3.6E-43 7.9E-48 338.6 26.0 252 11-266 1-256 (256)
136 cd06631 STKc_YSK4 Catalytic do 100.0 2.4E-43 5.2E-48 342.4 24.9 254 11-266 1-265 (265)
137 cd07839 STKc_CDK5 Catalytic do 100.0 5.7E-44 1.2E-48 350.3 20.7 252 11-266 1-284 (284)
138 cd08227 PK_STRAD_alpha Pseudok 100.0 1.1E-43 2.3E-48 356.7 23.1 255 13-268 1-312 (327)
139 PHA03211 serine/threonine kina 100.0 1.5E-43 3.3E-48 370.4 25.0 250 8-268 167-460 (461)
140 cd08218 STKc_Nek1 Catalytic do 100.0 3.3E-43 7E-48 339.5 25.0 252 11-266 1-256 (256)
141 cd07832 STKc_CCRK Catalytic do 100.0 2.1E-43 4.5E-48 346.2 23.9 254 11-267 1-286 (286)
142 PTZ00266 NIMA-related protein 100.0 1.8E-43 3.9E-48 388.6 26.0 262 3-269 6-301 (1021)
143 cd06619 PKc_MKK5 Catalytic dom 100.0 2.9E-43 6.4E-48 345.3 24.9 250 10-269 1-259 (279)
144 cd06644 STKc_STK10_LOK Catalyt 100.0 3.3E-43 7E-48 347.0 25.2 261 4-269 6-275 (292)
145 cd06643 STKc_SLK Catalytic dom 100.0 4E-43 8.6E-48 344.5 25.2 255 11-270 6-269 (282)
146 cd06637 STKc_TNIK Catalytic do 100.0 2.2E-43 4.7E-48 343.8 23.0 253 8-266 4-272 (272)
147 cd06646 STKc_MAP4K5 Catalytic 100.0 1.9E-43 4E-48 343.6 22.4 253 8-265 7-267 (267)
148 cd06629 STKc_MAPKKK_Bck1_like 100.0 4.6E-43 9.9E-48 341.8 25.0 256 11-266 2-272 (272)
149 PHA02988 hypothetical protein; 100.0 3.6E-43 7.8E-48 346.2 24.4 245 11-263 19-275 (283)
150 cd05572 STKc_cGK_PKG Catalytic 100.0 3.5E-43 7.6E-48 340.7 23.9 247 18-268 1-257 (262)
151 cd05633 STKc_GRK3 Catalytic do 100.0 3.4E-43 7.3E-48 345.3 24.0 248 17-268 1-260 (279)
152 cd06645 STKc_MAP4K3 Catalytic 100.0 1.6E-43 3.6E-48 344.0 21.5 252 9-265 8-267 (267)
153 cd07846 STKc_CDKL2_3 Catalytic 100.0 1.5E-43 3.2E-48 347.5 21.2 254 10-266 1-286 (286)
154 KOG0696 Serine/threonine prote 100.0 9E-45 1.9E-49 353.0 12.0 261 5-268 344-611 (683)
155 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 2E-43 4.3E-48 347.1 21.8 255 10-270 1-269 (286)
156 cd07841 STKc_CDK7 Catalytic do 100.0 3.8E-43 8.2E-48 347.1 23.9 258 11-271 1-290 (298)
157 cd06630 STKc_MEKK1 Catalytic d 100.0 3.1E-43 6.8E-48 341.7 22.5 256 11-267 1-268 (268)
158 cd06651 STKc_MEKK3 Catalytic d 100.0 7.8E-43 1.7E-47 339.5 25.2 256 10-267 2-265 (266)
159 KOG0579 Ste20-like serine/thre 100.0 3E-45 6.4E-50 371.2 8.2 254 10-269 32-295 (1187)
160 cd05096 PTKc_DDR1 Catalytic do 100.0 5.4E-43 1.2E-47 347.6 24.3 253 7-262 2-300 (304)
161 cd05581 STKc_PDK1 Catalytic do 100.0 2.3E-43 4.9E-48 344.3 21.1 256 10-266 1-280 (280)
162 cd05106 PTKc_CSF-1R Catalytic 100.0 2.3E-43 4.9E-48 361.4 21.7 254 7-263 35-368 (374)
163 cd08221 STKc_Nek9 Catalytic do 100.0 1.5E-42 3.3E-47 334.8 26.3 252 11-266 1-256 (256)
164 cd06639 STKc_myosinIIIB Cataly 100.0 2E-42 4.3E-47 341.0 27.5 254 8-267 20-291 (291)
165 cd06917 STKc_NAK1_like Catalyt 100.0 6.9E-43 1.5E-47 341.4 23.8 256 11-270 2-262 (277)
166 cd05606 STKc_beta_ARK Catalyti 100.0 8.3E-43 1.8E-47 342.2 24.2 249 17-269 1-261 (278)
167 cd05048 PTKc_Ror Catalytic Dom 100.0 4.9E-43 1.1E-47 343.6 22.3 253 8-263 3-279 (283)
168 cd06640 STKc_MST4 Catalytic do 100.0 5.5E-43 1.2E-47 342.8 22.6 257 9-270 3-260 (277)
169 PHA03209 serine/threonine kina 100.0 3.2E-43 6.9E-48 358.0 21.6 246 9-268 65-356 (357)
170 cd08220 STKc_Nek8 Catalytic do 100.0 1.3E-42 2.8E-47 334.8 24.6 251 11-266 1-256 (256)
171 cd06652 STKc_MEKK2 Catalytic d 100.0 1.9E-42 4.2E-47 336.3 25.8 256 10-267 2-265 (265)
172 cd06613 STKc_MAP4K3_like Catal 100.0 1.6E-42 3.5E-47 335.3 25.1 251 9-265 2-262 (262)
173 cd08219 STKc_Nek3 Catalytic do 100.0 1.7E-42 3.7E-47 334.6 25.1 248 11-263 1-252 (255)
174 cd05577 STKc_GRK Catalytic dom 100.0 8.2E-43 1.8E-47 341.6 23.1 247 18-268 1-259 (277)
175 cd06632 STKc_MEKK1_plant Catal 100.0 1.5E-42 3.2E-47 334.4 24.4 253 11-266 1-258 (258)
176 cd07845 STKc_CDK10 Catalytic d 100.0 9.9E-43 2.1E-47 346.5 23.9 258 8-269 5-296 (309)
177 cd05104 PTKc_Kit Catalytic dom 100.0 5E-43 1.1E-47 359.0 22.3 254 7-263 32-370 (375)
178 cd07833 STKc_CDKL Catalytic do 100.0 1E-42 2.3E-47 341.6 23.4 255 10-266 1-288 (288)
179 cd07860 STKc_CDK2_3 Catalytic 100.0 6.4E-43 1.4E-47 342.9 21.9 252 11-266 1-284 (284)
180 cd06636 STKc_MAP4K4_6 Catalyti 100.0 1.2E-42 2.6E-47 340.8 23.7 252 8-266 14-282 (282)
181 cd06608 STKc_myosinIII_like Ca 100.0 1.2E-42 2.5E-47 338.1 23.3 252 9-266 5-275 (275)
182 cd07849 STKc_ERK1_2_like Catal 100.0 1E-42 2.2E-47 351.0 23.7 260 8-270 3-299 (336)
183 cd05579 STKc_MAST_like Catalyt 100.0 7.1E-43 1.5E-47 337.4 21.6 250 18-268 1-262 (265)
184 KOG4236 Serine/threonine prote 100.0 3.8E-44 8.3E-49 357.2 12.9 249 16-271 570-827 (888)
185 cd05064 PTKc_EphR_A10 Catalyti 100.0 1.7E-42 3.6E-47 337.5 24.2 251 8-262 3-260 (266)
186 cd06658 STKc_PAK5 Catalytic do 100.0 6.1E-43 1.3E-47 345.9 21.3 255 10-270 22-279 (292)
187 cd07865 STKc_CDK9 Catalytic do 100.0 1.5E-42 3.3E-47 344.0 24.1 257 8-266 10-310 (310)
188 cd06638 STKc_myosinIIIA Cataly 100.0 2.3E-42 4.9E-47 339.3 24.7 253 8-266 16-286 (286)
189 cd07844 STKc_PCTAIRE_like Cata 100.0 1.9E-42 4.1E-47 340.9 24.2 253 9-266 4-291 (291)
190 cd07850 STKc_JNK Catalytic dom 100.0 2.3E-42 5E-47 350.9 25.2 257 7-270 13-318 (353)
191 cd06641 STKc_MST3 Catalytic do 100.0 2.7E-42 5.9E-47 337.9 24.7 255 11-270 5-260 (277)
192 cd06612 STKc_MST1_2 Catalytic 100.0 1.6E-42 3.5E-47 334.1 22.6 250 9-266 2-256 (256)
193 KOG0614 cGMP-dependent protein 100.0 1.2E-44 2.7E-49 359.8 7.9 258 7-268 417-682 (732)
194 KOG0197 Tyrosine kinases [Sign 100.0 4E-43 8.6E-48 354.3 18.9 241 11-261 207-455 (468)
195 cd08217 STKc_Nek2 Catalytic do 100.0 3.4E-42 7.3E-47 332.7 24.4 252 11-266 1-265 (265)
196 cd06626 STKc_MEKK4 Catalytic d 100.0 5.1E-42 1.1E-46 332.1 25.8 255 11-266 1-264 (264)
197 cd07867 STKc_CDC2L6 Catalytic 100.0 1.3E-42 2.8E-47 346.4 22.1 247 14-266 5-317 (317)
198 cd07880 STKc_p38gamma_MAPK12 C 100.0 3.2E-42 6.9E-47 348.7 25.2 256 8-270 13-305 (343)
199 KOG4279 Serine/threonine prote 100.0 3.3E-43 7.1E-48 359.5 17.7 249 17-271 582-840 (1226)
200 cd07837 STKc_CdkB_plant Cataly 100.0 3.6E-42 7.7E-47 339.4 24.3 254 10-267 1-295 (295)
201 cd06605 PKc_MAPKK Catalytic do 100.0 1.4E-42 3E-47 336.6 20.9 252 10-268 1-262 (265)
202 cd07836 STKc_Pho85 Catalytic d 100.0 3.6E-42 7.7E-47 337.4 24.0 251 11-266 1-284 (284)
203 cd06642 STKc_STK25-YSK1 Cataly 100.0 5.6E-43 1.2E-47 342.5 18.1 255 10-269 4-259 (277)
204 cd07831 STKc_MOK Catalytic dom 100.0 3.4E-42 7.4E-47 336.9 23.7 248 12-266 1-282 (282)
205 cd06647 STKc_PAK_I Catalytic d 100.0 2.7E-42 5.8E-47 341.3 22.7 256 9-270 18-276 (293)
206 cd08228 STKc_Nek6 Catalytic do 100.0 6.8E-42 1.5E-46 332.3 25.1 251 10-263 2-261 (267)
207 cd07854 STKc_MAPK4_6 Catalytic 100.0 4.1E-42 8.8E-47 347.6 24.4 257 8-268 3-305 (342)
208 cd05062 PTKc_IGF-1R Catalytic 100.0 4.7E-42 1E-46 336.0 23.4 255 6-263 2-274 (277)
209 cd07870 STKc_PFTAIRE2 Catalyti 100.0 7.3E-42 1.6E-46 337.0 25.0 252 10-266 5-291 (291)
210 cd07843 STKc_CDC2L1 Catalytic 100.0 2.5E-42 5.3E-47 340.7 21.6 254 9-266 4-293 (293)
211 cd06659 STKc_PAK6 Catalytic do 100.0 3.1E-42 6.7E-47 341.7 22.4 255 11-271 22-279 (297)
212 cd05611 STKc_Rim15_like Cataly 100.0 4.4E-42 9.5E-47 332.6 22.9 246 16-268 2-256 (260)
213 cd06648 STKc_PAK_II Catalytic 100.0 1.2E-41 2.6E-46 335.2 26.2 254 11-270 20-276 (285)
214 cd05061 PTKc_InsR Catalytic do 100.0 7.3E-42 1.6E-46 336.9 24.4 259 6-267 2-284 (288)
215 PLN00009 cyclin-dependent kina 100.0 1E-41 2.2E-46 336.5 25.2 257 9-269 1-290 (294)
216 cd08225 STKc_Nek5 Catalytic do 100.0 6.2E-42 1.3E-46 330.2 23.1 252 11-266 1-257 (257)
217 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 4.1E-42 8.9E-47 337.8 22.2 255 9-270 4-273 (284)
218 cd05090 PTKc_Ror1 Catalytic do 100.0 8.1E-42 1.8E-46 335.3 24.2 252 9-263 4-279 (283)
219 cd05093 PTKc_TrkB Catalytic do 100.0 8E-42 1.7E-46 336.6 24.1 250 9-262 4-274 (288)
220 cd05052 PTKc_Abl Catalytic dom 100.0 1.1E-41 2.4E-46 330.9 24.7 251 7-263 3-258 (263)
221 cd05032 PTKc_InsR_like Catalyt 100.0 1.1E-41 2.3E-46 332.8 24.7 254 7-263 3-274 (277)
222 cd05049 PTKc_Trk Catalytic dom 100.0 3.9E-42 8.4E-47 336.4 21.6 251 9-262 4-276 (280)
223 cd06617 PKc_MKK3_6 Catalytic d 100.0 1.1E-41 2.4E-46 333.7 24.7 255 10-270 1-268 (283)
224 cd08215 STKc_Nek Catalytic dom 100.0 1.6E-41 3.6E-46 326.2 25.3 252 11-266 1-258 (258)
225 cd07851 STKc_p38 Catalytic dom 100.0 4.5E-42 9.8E-47 347.4 22.5 256 7-269 12-304 (343)
226 cd07835 STKc_CDK1_like Catalyt 100.0 4.9E-42 1.1E-46 336.5 21.8 251 12-266 1-283 (283)
227 cd07842 STKc_CDK8_like Catalyt 100.0 5.9E-42 1.3E-46 341.0 22.7 255 11-266 1-316 (316)
228 cd06623 PKc_MAPKK_plant_like C 100.0 1.5E-41 3.3E-46 328.5 24.9 254 10-268 1-261 (264)
229 cd06606 STKc_MAPKKK Catalytic 100.0 2E-41 4.4E-46 325.2 25.6 254 11-266 1-260 (260)
230 cd05108 PTKc_EGFR Catalytic do 100.0 8.1E-42 1.8E-46 341.4 23.6 251 9-263 6-264 (316)
231 KOG0574 STE20-like serine/thre 100.0 5.2E-45 1.1E-49 342.6 0.3 251 11-269 34-289 (502)
232 KOG4645 MAPKKK (MAP kinase kin 100.0 2E-44 4.4E-49 390.4 4.7 259 9-268 1234-1499(1509)
233 cd06627 STKc_Cdc7_like Catalyt 100.0 2.5E-41 5.4E-46 324.8 25.7 252 11-266 1-254 (254)
234 cd06607 STKc_TAO Catalytic dom 100.0 1.5E-41 3.4E-46 337.8 25.1 257 6-269 11-273 (307)
235 cd05033 PTKc_EphR Catalytic do 100.0 1.9E-41 4.1E-46 329.5 25.1 252 9-263 3-261 (266)
236 cd05035 PTKc_Axl_like Catalyti 100.0 1.3E-41 2.9E-46 330.9 23.8 250 12-263 1-268 (273)
237 cd05084 PTKc_Fes Catalytic dom 100.0 1E-41 2.2E-46 328.5 22.7 244 16-262 1-248 (252)
238 cd07858 STKc_TEY_MAPK_plant Ca 100.0 7.3E-42 1.6E-46 345.0 22.6 257 8-268 3-296 (337)
239 cd07864 STKc_CDK12 Catalytic d 100.0 9.4E-42 2E-46 337.6 23.0 259 5-266 2-302 (302)
240 cd05088 PTKc_Tie2 Catalytic do 100.0 1E-41 2.3E-46 338.7 23.3 251 7-263 4-276 (303)
241 cd05054 PTKc_VEGFR Catalytic d 100.0 4.2E-42 9.1E-47 347.1 20.6 255 6-263 3-329 (337)
242 cd07855 STKc_ERK5 Catalytic do 100.0 6E-42 1.3E-46 345.1 21.4 260 8-269 3-300 (334)
243 cd07877 STKc_p38alpha_MAPK14 C 100.0 1.6E-41 3.5E-46 343.7 24.6 256 8-270 15-307 (345)
244 cd06653 STKc_MEKK3_like_1 Cata 100.0 4.2E-41 9.2E-46 326.9 26.4 255 10-266 2-264 (264)
245 cd05036 PTKc_ALK_LTK Catalytic 100.0 1.6E-41 3.4E-46 332.5 23.5 253 8-263 4-274 (277)
246 cd05098 PTKc_FGFR1 Catalytic d 100.0 1.8E-41 3.9E-46 337.3 24.1 255 6-263 14-295 (307)
247 cd05091 PTKc_Ror2 Catalytic do 100.0 6.5E-42 1.4E-46 335.8 20.6 253 8-263 3-279 (283)
248 cd06624 STKc_ASK Catalytic dom 100.0 2.8E-41 6.1E-46 328.7 24.8 248 14-266 12-268 (268)
249 PHA03390 pk1 serine/threonine- 100.0 1.3E-41 2.9E-46 331.9 22.6 244 9-267 13-266 (267)
250 cd00192 PTKc Catalytic domain 100.0 2.4E-41 5.3E-46 325.8 24.1 245 16-263 1-260 (262)
251 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 4.6E-41 1E-45 331.0 26.5 254 10-270 1-273 (287)
252 cd05053 PTKc_FGFR Catalytic do 100.0 2.2E-41 4.8E-46 333.7 24.1 254 7-263 9-287 (293)
253 cd05114 PTKc_Tec_Rlk Catalytic 100.0 2.3E-41 5E-46 327.1 23.7 246 10-262 4-253 (256)
254 cd07852 STKc_MAPK15 Catalytic 100.0 8.1E-42 1.7E-46 344.4 21.2 262 6-269 3-301 (337)
255 KOG0577 Serine/threonine prote 100.0 4.8E-43 1E-47 353.4 12.1 252 11-270 27-285 (948)
256 cd05075 PTKc_Axl Catalytic dom 100.0 1.9E-41 4.1E-46 330.1 23.1 250 12-263 1-267 (272)
257 cd08229 STKc_Nek7 Catalytic do 100.0 1.3E-41 2.9E-46 330.3 22.0 250 10-262 2-260 (267)
258 KOG0596 Dual specificity; seri 100.0 1.3E-42 2.8E-47 349.0 15.0 256 9-268 360-632 (677)
259 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 3.8E-41 8.2E-46 338.8 25.6 258 8-272 8-297 (328)
260 cd05123 STKc_AGC Catalytic dom 100.0 1.8E-41 3.9E-46 325.6 22.3 246 18-266 1-250 (250)
261 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 5.8E-41 1.3E-45 325.3 26.0 250 10-262 2-260 (267)
262 PRK13184 pknD serine/threonine 100.0 2E-41 4.4E-46 371.0 25.2 253 9-262 1-284 (932)
263 KOG0603 Ribosomal protein S6 k 100.0 1.4E-42 3E-47 355.9 14.8 244 8-266 320-566 (612)
264 cd05051 PTKc_DDR Catalytic dom 100.0 2.7E-41 5.9E-46 333.3 23.4 252 8-262 3-292 (296)
265 PHA03210 serine/threonine kina 100.0 6.3E-42 1.4E-46 363.3 20.2 262 5-269 143-460 (501)
266 cd05105 PTKc_PDGFR_alpha Catal 100.0 1.9E-41 4.2E-46 349.7 23.2 254 7-263 34-393 (400)
267 KOG0608 Warts/lats-like serine 100.0 4.8E-42 1E-46 348.3 18.2 256 11-268 630-933 (1034)
268 cd07866 STKc_BUR1 Catalytic do 100.0 2.5E-41 5.4E-46 335.4 23.1 260 5-266 3-311 (311)
269 cd05613 STKc_MSK1_N N-terminal 100.0 4.6E-41 9.9E-46 331.2 24.1 258 11-269 1-274 (290)
270 cd05059 PTKc_Tec_like Catalyti 100.0 3.3E-41 7.2E-46 326.2 22.4 247 10-263 4-254 (256)
271 cd07840 STKc_CDK9_like Catalyt 100.0 3.6E-41 7.9E-46 329.9 22.9 252 12-266 1-287 (287)
272 cd05055 PTKc_PDGFR Catalytic d 100.0 4.2E-41 9.2E-46 334.3 23.6 257 4-263 29-297 (302)
273 PTZ00024 cyclin-dependent prot 100.0 2.5E-41 5.5E-46 340.4 22.3 261 8-269 6-319 (335)
274 cd05072 PTKc_Lyn Catalytic dom 100.0 5.4E-41 1.2E-45 325.2 23.7 249 7-262 3-256 (261)
275 cd05109 PTKc_HER2 Catalytic do 100.0 6.5E-41 1.4E-45 328.2 24.5 253 7-263 4-264 (279)
276 cd05148 PTKc_Srm_Brk Catalytic 100.0 2E-41 4.4E-46 327.9 20.6 247 9-262 5-256 (261)
277 cd06657 STKc_PAK4 Catalytic do 100.0 3.7E-41 8E-46 333.3 22.8 254 12-271 22-278 (292)
278 cd05094 PTKc_TrkC Catalytic do 100.0 4.9E-41 1.1E-45 331.5 23.5 251 9-263 4-278 (291)
279 cd05071 PTKc_Src Catalytic dom 100.0 5.4E-41 1.2E-45 326.2 23.4 248 7-262 3-255 (262)
280 cd05089 PTKc_Tie1 Catalytic do 100.0 5.5E-41 1.2E-45 332.3 23.8 248 10-263 2-271 (297)
281 cd05092 PTKc_TrkA Catalytic do 100.0 4.3E-41 9.3E-46 330.1 22.7 252 7-262 2-276 (280)
282 cd05099 PTKc_FGFR4 Catalytic d 100.0 9.4E-41 2E-45 333.4 25.4 255 6-263 8-289 (314)
283 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 5.3E-41 1.1E-45 325.3 22.9 249 6-262 2-255 (260)
284 cd05045 PTKc_RET Catalytic dom 100.0 5.7E-41 1.2E-45 330.7 23.5 250 11-263 1-282 (290)
285 cd05122 PKc_STE Catalytic doma 100.0 1.6E-40 3.4E-45 317.7 25.8 248 11-265 1-253 (253)
286 cd08530 STKc_CNK2-like Catalyt 100.0 6.6E-41 1.4E-45 322.6 23.4 250 11-266 1-256 (256)
287 cd05068 PTKc_Frk_like Catalyti 100.0 8.8E-41 1.9E-45 323.9 24.2 249 7-262 3-256 (261)
288 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 9.3E-41 2E-45 327.8 24.5 251 9-262 2-276 (283)
289 KOG1989 ARK protein kinase fam 100.0 8.2E-42 1.8E-46 361.7 18.0 246 10-263 37-307 (738)
290 cd05113 PTKc_Btk_Bmx Catalytic 100.0 7.4E-41 1.6E-45 324.1 23.2 248 9-263 3-254 (256)
291 cd05101 PTKc_FGFR2 Catalytic d 100.0 6.6E-41 1.4E-45 332.6 23.4 255 6-263 11-292 (304)
292 cd06616 PKc_MKK4 Catalytic dom 100.0 4.3E-41 9.3E-46 330.8 21.8 254 10-268 4-272 (288)
293 cd06614 STKc_PAK Catalytic dom 100.0 1.1E-40 2.5E-45 327.7 24.5 254 8-268 17-275 (286)
294 cd07834 STKc_MAPK Catalytic do 100.0 3.2E-41 7E-46 338.6 20.9 257 11-269 1-295 (330)
295 cd08226 PK_STRAD_beta Pseudoki 100.0 5E-41 1.1E-45 337.5 22.2 254 16-270 4-315 (328)
296 cd05100 PTKc_FGFR3 Catalytic d 100.0 9.8E-41 2.1E-45 336.2 24.0 256 5-263 7-289 (334)
297 cd05111 PTK_HER3 Pseudokinase 100.0 1.2E-40 2.6E-45 326.9 24.0 252 8-263 5-264 (279)
298 cd05116 PTKc_Syk Catalytic dom 100.0 9.3E-41 2E-45 323.2 22.9 245 16-263 1-251 (257)
299 cd06635 STKc_TAO1 Catalytic do 100.0 2E-40 4.4E-45 331.5 26.0 256 9-271 24-285 (317)
300 cd07879 STKc_p38delta_MAPK13 C 100.0 7.3E-41 1.6E-45 338.5 22.9 254 8-269 13-303 (342)
301 cd05103 PTKc_VEGFR2 Catalytic 100.0 4.3E-41 9.4E-46 340.4 21.3 255 6-263 3-335 (343)
302 cd05610 STKc_MASTL Catalytic d 100.0 1.2E-40 2.7E-45 364.3 26.4 149 9-157 3-152 (669)
303 KOG2345 Serine/threonine prote 100.0 1.9E-42 4.1E-47 318.2 10.1 253 8-263 19-296 (302)
304 cd05065 PTKc_EphR_B Catalytic 100.0 1.5E-40 3.4E-45 323.6 24.2 252 9-263 3-264 (269)
305 KOG0695 Serine/threonine prote 100.0 1.7E-41 3.6E-46 322.9 16.8 259 7-268 247-521 (593)
306 cd05069 PTKc_Yes Catalytic dom 100.0 1.5E-40 3.3E-45 322.3 24.1 248 7-262 3-255 (260)
307 cd05097 PTKc_DDR_like Catalyti 100.0 7.6E-41 1.6E-45 330.8 22.2 251 9-262 4-291 (295)
308 cd05067 PTKc_Lck_Blk Catalytic 100.0 1.5E-40 3.2E-45 322.1 23.8 249 6-262 2-255 (260)
309 cd06633 STKc_TAO3 Catalytic do 100.0 2.8E-40 6.1E-45 330.0 26.4 255 9-270 20-280 (313)
310 cd05066 PTKc_EphR_A Catalytic 100.0 1.5E-40 3.3E-45 323.5 23.5 251 9-262 3-261 (267)
311 cd05050 PTKc_Musk Catalytic do 100.0 1.2E-40 2.6E-45 327.9 22.8 252 8-262 3-284 (288)
312 cd05095 PTKc_DDR2 Catalytic do 100.0 1.6E-40 3.5E-45 328.6 23.7 252 8-262 3-292 (296)
313 cd05057 PTKc_EGFR_like Catalyt 100.0 2.7E-40 5.8E-45 323.9 25.0 251 8-262 5-263 (279)
314 cd05583 STKc_MSK_N N-terminal 100.0 1.9E-40 4E-45 326.5 23.5 257 11-268 1-271 (288)
315 cd05034 PTKc_Src_like Catalyti 100.0 3.1E-40 6.6E-45 319.7 24.5 249 7-262 3-256 (261)
316 cd05118 STKc_CMGC Catalytic do 100.0 6.6E-41 1.4E-45 327.7 20.0 251 12-266 1-283 (283)
317 PF07714 Pkinase_Tyr: Protein 100.0 6.3E-41 1.4E-45 325.6 19.4 247 13-262 2-257 (259)
318 KOG0983 Mitogen-activated prot 100.0 8.9E-42 1.9E-46 317.4 12.4 253 11-270 93-356 (391)
319 cd05039 PTKc_Csk_like Catalyti 100.0 3.3E-40 7.3E-45 318.7 23.7 244 8-263 4-252 (256)
320 cd05107 PTKc_PDGFR_beta Cataly 100.0 1.6E-40 3.5E-45 342.8 22.7 255 6-263 33-395 (401)
321 cd05082 PTKc_Csk Catalytic dom 100.0 3.7E-40 7.9E-45 318.7 23.8 243 7-262 3-251 (256)
322 KOG0193 Serine/threonine prote 100.0 1.2E-41 2.6E-46 345.8 13.8 253 5-262 387-648 (678)
323 cd05060 PTKc_Syk_like Catalyti 100.0 4.6E-40 9.9E-45 318.2 24.3 243 16-262 1-250 (257)
324 cd05063 PTKc_EphR_A2 Catalytic 100.0 5.5E-40 1.2E-44 319.4 24.4 254 7-263 2-263 (268)
325 cd06634 STKc_TAO2 Catalytic do 100.0 3E-40 6.6E-45 328.9 22.9 255 8-269 13-273 (308)
326 KOG0662 Cyclin-dependent kinas 100.0 1.1E-41 2.5E-46 299.4 11.1 255 10-268 2-288 (292)
327 cd05115 PTKc_Zap-70 Catalytic 100.0 6.4E-40 1.4E-44 317.9 24.4 243 17-263 2-251 (257)
328 cd07838 STKc_CDK4_6_like Catal 100.0 4.3E-40 9.3E-45 322.6 23.3 249 12-266 1-287 (287)
329 cd07829 STKc_CDK_like Catalyti 100.0 1.7E-40 3.7E-45 324.6 20.3 251 12-266 1-282 (282)
330 cd07857 STKc_MPK1 Catalytic do 100.0 4.8E-40 1E-44 330.9 24.1 257 11-269 1-298 (332)
331 cd05043 PTK_Ryk Pseudokinase d 100.0 5.3E-40 1.1E-44 321.8 23.7 253 7-262 3-271 (280)
332 cd08222 STKc_Nek11 Catalytic d 100.0 1.5E-40 3.3E-45 321.8 19.6 252 11-266 1-260 (260)
333 cd05041 PTKc_Fes_like Catalyti 100.0 5.7E-40 1.2E-44 315.9 23.2 244 16-263 1-248 (251)
334 cd05047 PTKc_Tie Catalytic dom 100.0 6.2E-40 1.3E-44 320.0 23.6 242 16-263 1-264 (270)
335 cd05112 PTKc_Itk Catalytic dom 100.0 9.6E-40 2.1E-44 315.3 24.1 247 10-263 4-254 (256)
336 cd06618 PKc_MKK7 Catalytic dom 100.0 7.9E-40 1.7E-44 323.7 23.8 259 4-268 9-278 (296)
337 cd07830 STKc_MAK_like Catalyti 100.0 3.5E-40 7.6E-45 323.1 21.0 249 12-266 1-283 (283)
338 cd05040 PTKc_Ack_like Catalyti 100.0 8.2E-40 1.8E-44 315.9 23.3 243 16-262 1-253 (257)
339 KOG4721 Serine/threonine prote 100.0 2E-41 4.4E-46 340.4 12.3 241 7-263 121-364 (904)
340 cd08216 PK_STRAD Pseudokinase 100.0 3.2E-40 7E-45 328.8 20.9 247 22-270 12-302 (314)
341 cd05073 PTKc_Hck Catalytic dom 100.0 1.6E-39 3.5E-44 315.1 24.9 249 6-262 2-255 (260)
342 cd05046 PTK_CCK4 Pseudokinase 100.0 7.8E-40 1.7E-44 319.5 22.9 251 9-263 4-272 (275)
343 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.8E-40 3.9E-45 321.6 18.0 238 16-263 1-256 (258)
344 smart00219 TyrKc Tyrosine kina 100.0 1.2E-39 2.6E-44 313.9 23.6 247 12-262 1-256 (258)
345 KOG0584 Serine/threonine prote 100.0 4.9E-41 1.1E-45 343.3 14.3 254 9-269 38-302 (632)
346 cd05085 PTKc_Fer Catalytic dom 100.0 2E-39 4.3E-44 312.0 24.4 243 16-263 1-247 (250)
347 KOG1035 eIF-2alpha kinase GCN2 100.0 5.8E-41 1.3E-45 362.1 14.5 255 8-267 477-875 (1351)
348 cd05056 PTKc_FAK Catalytic dom 100.0 1.9E-39 4.1E-44 316.2 23.7 251 8-263 4-261 (270)
349 cd05576 STKc_RPK118_like Catal 100.0 4.1E-40 9E-45 315.6 18.3 228 21-266 4-237 (237)
350 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.5E-39 3.3E-44 316.3 22.1 238 16-263 1-260 (262)
351 cd05042 PTKc_Aatyk Catalytic d 100.0 1.7E-39 3.6E-44 316.4 22.4 244 16-262 1-265 (269)
352 cd05044 PTKc_c-ros Catalytic d 100.0 1.6E-39 3.4E-44 316.1 21.2 244 16-262 1-265 (269)
353 cd05110 PTKc_HER4 Catalytic do 100.0 2.5E-39 5.5E-44 321.5 22.9 251 9-263 6-264 (303)
354 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 2.7E-39 5.8E-44 317.8 22.9 250 11-263 5-279 (284)
355 KOG0671 LAMMER dual specificit 100.0 5.4E-41 1.2E-45 325.2 10.4 254 4-268 83-411 (415)
356 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 1.7E-39 3.8E-44 318.1 21.0 237 17-263 2-272 (274)
357 KOG0194 Protein tyrosine kinas 100.0 7.1E-40 1.5E-44 335.3 18.5 252 7-262 154-415 (474)
358 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 5.1E-39 1.1E-43 315.4 23.7 251 9-263 3-279 (284)
359 cd05083 PTKc_Chk Catalytic dom 100.0 3.3E-39 7.2E-44 311.6 22.0 241 9-263 5-250 (254)
360 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 4.7E-39 1E-43 313.4 23.2 244 16-262 1-265 (269)
361 KOG0666 Cyclin C-dependent kin 100.0 5.3E-41 1.2E-45 317.0 8.9 262 9-272 23-346 (438)
362 cd05058 PTKc_Met_Ron Catalytic 100.0 5.2E-39 1.1E-43 311.2 23.0 245 16-263 1-255 (262)
363 PHA02882 putative serine/threo 100.0 6.3E-39 1.4E-43 317.5 23.6 255 5-262 7-291 (294)
364 cd05074 PTKc_Tyro3 Catalytic d 100.0 4.2E-39 9E-44 313.8 21.8 250 12-263 1-268 (273)
365 cd08528 STKc_Nek10 Catalytic d 100.0 8E-39 1.7E-43 311.3 23.2 249 11-263 1-266 (269)
366 KOG1187 Serine/threonine prote 100.0 5.5E-39 1.2E-43 325.3 20.8 246 10-262 75-347 (361)
367 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 6.7E-39 1.5E-43 309.4 20.4 235 16-262 1-256 (259)
368 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1.1E-38 2.5E-43 312.0 21.7 250 10-262 4-278 (284)
369 cd05086 PTKc_Aatyk2 Catalytic 100.0 3.2E-38 6.9E-43 307.7 22.6 244 16-262 1-264 (268)
370 KOG1026 Nerve growth factor re 100.0 4.6E-39 9.9E-44 339.5 15.9 250 9-261 485-756 (774)
371 KOG0669 Cyclin T-dependent kin 100.0 1.1E-40 2.3E-45 307.0 2.8 268 1-270 8-322 (376)
372 KOG1151 Tousled-like protein k 100.0 2E-39 4.4E-44 318.0 11.3 264 7-270 460-748 (775)
373 KOG4250 TANK binding protein k 100.0 4.1E-39 8.9E-44 332.9 13.1 241 10-255 13-296 (732)
374 PLN03225 Serine/threonine-prot 100.0 1E-37 2.2E-42 334.0 20.5 254 7-269 129-456 (566)
375 KOG0587 Traf2- and Nck-interac 100.0 1.1E-37 2.3E-42 327.9 18.7 254 9-269 18-288 (953)
376 KOG1095 Protein tyrosine kinas 100.0 3.2E-37 7E-42 336.1 21.8 251 9-262 691-956 (1025)
377 smart00220 S_TKc Serine/Threon 100.0 1.2E-36 2.5E-41 288.6 21.7 239 22-266 1-244 (244)
378 KOG0670 U4/U6-associated splic 100.0 1.6E-38 3.5E-43 316.9 8.4 255 4-268 426-751 (752)
379 KOG0668 Casein kinase II, alph 100.0 5.1E-38 1.1E-42 285.7 8.4 251 8-269 36-328 (338)
380 KOG1006 Mitogen-activated prot 100.0 3.3E-38 7.1E-43 292.6 5.5 252 12-270 66-334 (361)
381 PLN03224 probable serine/threo 100.0 1.4E-35 3.1E-40 311.0 23.1 261 7-268 142-505 (507)
382 KOG1290 Serine/threonine prote 100.0 3.9E-35 8.5E-40 291.5 17.9 134 4-142 71-221 (590)
383 KOG0199 ACK and related non-re 100.0 6.8E-36 1.5E-40 306.7 12.9 255 9-267 109-372 (1039)
384 KOG0665 Jun-N-terminal kinase 100.0 3.1E-36 6.7E-41 286.2 9.3 253 7-267 14-314 (369)
385 KOG1152 Signal transduction se 100.0 7.8E-36 1.7E-40 301.1 11.1 201 10-214 561-771 (772)
386 KOG4278 Protein tyrosine kinas 100.0 4.7E-35 1E-39 296.8 15.4 241 12-261 269-517 (1157)
387 PLN00113 leucine-rich repeat r 100.0 8.2E-35 1.8E-39 332.2 17.1 237 10-263 690-947 (968)
388 KOG1094 Discoidin domain recep 100.0 6.5E-35 1.4E-39 294.7 14.2 255 8-268 536-803 (807)
389 KOG0196 Tyrosine kinase, EPH ( 100.0 3.4E-35 7.3E-40 305.2 12.2 250 10-263 629-887 (996)
390 KOG0664 Nemo-like MAPK-related 100.0 3.6E-36 7.8E-41 279.8 4.1 257 12-271 55-351 (449)
391 KOG4257 Focal adhesion tyrosin 100.0 7.8E-35 1.7E-39 295.7 13.4 244 12-262 391-644 (974)
392 KOG0576 Mitogen-activated prot 100.0 4.9E-35 1.1E-39 299.7 8.9 255 9-269 14-277 (829)
393 KOG1027 Serine/threonine prote 100.0 8.7E-35 1.9E-39 304.8 10.1 244 14-269 513-773 (903)
394 KOG3653 Transforming growth fa 100.0 2.9E-34 6.2E-39 284.8 11.5 244 10-261 210-497 (534)
395 KOG2052 Activin A type IB rece 100.0 1.4E-33 3.1E-38 278.0 15.3 248 7-262 208-498 (513)
396 KOG1345 Serine/threonine kinas 100.0 3.8E-34 8.2E-39 266.3 9.7 255 7-270 21-294 (378)
397 KOG0200 Fibroblast/platelet-de 100.0 2.3E-32 5E-37 295.4 21.2 252 7-262 293-574 (609)
398 KOG1167 Serine/threonine prote 100.0 2.9E-33 6.3E-38 274.8 11.7 256 6-268 32-386 (418)
399 cd00180 PKc Catalytic domain o 100.0 2E-31 4.3E-36 246.1 20.9 212 18-264 1-215 (215)
400 KOG0984 Mitogen-activated prot 100.0 2.1E-32 4.5E-37 245.8 11.2 211 11-228 47-269 (282)
401 smart00221 STYKc Protein kinas 100.0 5.9E-31 1.3E-35 247.5 20.9 218 12-233 1-223 (225)
402 KOG1025 Epidermal growth facto 100.0 3.9E-32 8.5E-37 283.3 13.7 247 12-262 698-952 (1177)
403 KOG0590 Checkpoint kinase and 100.0 1.2E-31 2.6E-36 287.0 5.2 260 9-269 316-591 (601)
404 PLN00181 protein SPA1-RELATED; 100.0 1.3E-30 2.9E-35 291.2 9.3 199 66-268 28-270 (793)
405 COG0515 SPS1 Serine/threonine 100.0 3.7E-27 7.9E-32 230.3 24.0 255 12-269 2-281 (384)
406 PRK09188 serine/threonine prot 100.0 8.1E-28 1.8E-32 242.7 17.0 172 5-186 13-195 (365)
407 KOG1024 Receptor-like protein 100.0 3.2E-28 7E-33 236.5 12.4 253 7-262 281-550 (563)
408 smart00750 KIND kinase non-cat 99.9 3.8E-28 8.1E-33 221.5 10.3 158 95-268 1-170 (176)
409 KOG1164 Casein kinase (serine/ 99.9 1.1E-26 2.3E-31 233.3 20.8 248 11-263 19-293 (322)
410 KOG0603 Ribosomal protein S6 k 99.9 9.4E-29 2E-33 254.3 4.2 238 17-268 1-248 (612)
411 KOG1163 Casein kinase (serine/ 99.9 6.1E-27 1.3E-31 215.1 15.3 250 4-260 9-277 (341)
412 KOG1165 Casein kinase (serine/ 99.9 1.8E-26 4E-31 220.5 16.3 247 7-260 25-292 (449)
413 PRK10359 lipopolysaccharide co 99.9 5.3E-25 1.2E-29 207.8 12.5 176 6-206 27-216 (232)
414 cd05147 RIO1_euk RIO kinase fa 99.9 3.2E-24 7E-29 198.9 13.7 142 15-160 2-168 (190)
415 KOG0606 Microtubule-associated 99.9 1.1E-24 2.3E-29 234.2 9.8 220 8-268 81-320 (1205)
416 KOG0590 Checkpoint kinase and 99.9 3.9E-25 8.4E-30 237.0 6.1 259 9-268 19-291 (601)
417 cd05145 RIO1_like RIO kinase f 99.9 2.2E-23 4.7E-28 193.5 15.0 143 14-160 1-168 (190)
418 PF14531 Kinase-like: Kinase-l 99.9 1.5E-23 3.2E-28 203.7 10.0 234 11-254 13-288 (288)
419 PRK12274 serine/threonine prot 99.9 7E-23 1.5E-27 189.8 13.0 192 12-215 4-210 (218)
420 PRK10345 hypothetical protein; 99.9 7.4E-22 1.6E-26 185.4 14.3 132 15-154 7-154 (210)
421 KOG4158 BRPK/PTEN-induced prot 99.9 1.7E-22 3.6E-27 197.4 7.8 250 8-258 155-505 (598)
422 KOG1240 Protein kinase contain 99.9 2.7E-23 5.8E-28 223.7 2.2 248 11-263 24-291 (1431)
423 smart00090 RIO RIO-like kinase 99.8 8.6E-21 1.9E-25 182.0 13.7 143 12-159 30-198 (237)
424 KOG0195 Integrin-linked kinase 99.8 1.1E-21 2.5E-26 183.2 5.7 242 8-261 188-440 (448)
425 KOG1166 Mitotic checkpoint ser 99.8 1.7E-20 3.7E-25 205.6 11.7 236 9-260 697-946 (974)
426 PRK14879 serine/threonine prot 99.8 1.6E-19 3.4E-24 169.8 15.6 137 16-158 2-143 (211)
427 cd05144 RIO2_C RIO kinase fami 99.8 2E-19 4.4E-24 167.8 11.4 139 12-160 17-176 (198)
428 TIGR03724 arch_bud32 Kae1-asso 99.8 6.1E-19 1.3E-23 164.3 12.3 133 17-158 1-138 (199)
429 PRK09605 bifunctional UGMP fam 99.8 1.9E-18 4E-23 185.2 14.2 140 10-159 333-477 (535)
430 cd05119 RIO RIO kinase family, 99.8 2.4E-18 5.2E-23 158.6 11.5 139 14-159 1-164 (187)
431 KOG1033 eIF-2alpha kinase PEK/ 99.8 2.2E-19 4.8E-24 182.2 2.5 248 9-266 243-515 (516)
432 PF03822 NAF: NAF domain; Int 99.7 7.8E-19 1.7E-23 129.6 4.3 60 310-369 1-63 (63)
433 PRK01723 3-deoxy-D-manno-octul 99.7 1.7E-17 3.7E-22 159.4 13.8 137 16-158 37-191 (239)
434 KOG1023 Natriuretic peptide re 99.7 1.1E-17 2.3E-22 172.6 11.4 199 64-262 1-219 (484)
435 cd05120 APH_ChoK_like Aminogly 99.7 1.8E-16 4E-21 139.0 12.8 132 14-158 2-138 (155)
436 KOG0606 Microtubule-associated 99.7 2.1E-17 4.6E-22 178.6 2.6 261 8-269 802-1098(1205)
437 KOG0601 Cyclin-dependent kinas 99.6 3.5E-16 7.6E-21 161.7 5.0 257 7-268 111-384 (524)
438 TIGR01982 UbiB 2-polyprenylphe 99.6 1.2E-14 2.5E-19 151.5 10.9 141 16-160 123-308 (437)
439 PRK04750 ubiB putative ubiquin 99.5 2.8E-15 6.1E-20 158.3 4.3 144 9-160 119-315 (537)
440 cd05146 RIO3_euk RIO kinase fa 99.5 4E-13 8.7E-18 124.4 13.4 141 15-160 2-175 (197)
441 cd05151 ChoK Choline Kinase (C 99.5 2.4E-13 5.2E-18 122.9 11.1 127 15-157 3-135 (170)
442 KOG1243 Protein kinase [Genera 99.5 6.5E-13 1.4E-17 138.9 13.7 171 28-210 30-201 (690)
443 KOG0601 Cyclin-dependent kinas 99.4 6.9E-14 1.5E-18 144.8 5.1 253 5-267 260-518 (524)
444 KOG1266 Protein kinase [Signal 99.3 1.2E-12 2.6E-17 126.2 5.5 201 64-268 121-336 (458)
445 cd05154 ACAD10_11_like Acyl-Co 99.3 2.5E-11 5.4E-16 114.3 13.0 139 16-157 4-205 (223)
446 COG3642 Mn2+-dependent serine/ 99.3 6.3E-11 1.4E-15 106.8 11.9 134 16-158 2-140 (204)
447 KOG3087 Serine/threonine prote 99.2 2E-10 4.3E-15 103.2 12.1 144 14-159 11-166 (229)
448 KOG3741 Poly(A) ribonuclease s 99.2 4.8E-10 1E-14 114.4 14.2 210 23-263 289-521 (655)
449 PF01163 RIO1: RIO1 family; I 99.1 2.8E-10 6.1E-15 104.9 10.7 128 25-159 1-156 (188)
450 KOG2137 Protein kinase [Signal 99.1 4.5E-11 9.8E-16 125.8 4.2 153 117-270 107-272 (700)
451 PRK15123 lipopolysaccharide co 99.0 4.1E-09 8.8E-14 102.8 14.5 131 25-157 37-193 (268)
452 COG0478 RIO-like serine/threon 99.0 2.7E-09 5.8E-14 101.7 11.3 137 12-157 93-250 (304)
453 COG4248 Uncharacterized protei 98.8 4.5E-08 9.9E-13 98.0 13.7 232 13-259 14-292 (637)
454 PF06293 Kdo: Lipopolysacchari 98.8 8.5E-08 1.9E-12 90.1 13.3 104 55-158 56-170 (206)
455 PF06176 WaaY: Lipopolysacchar 98.8 1.3E-07 2.8E-12 88.5 14.1 141 7-157 28-182 (229)
456 PRK09902 hypothetical protein; 98.7 2E-07 4.2E-12 87.0 12.7 137 19-157 27-178 (216)
457 COG1718 RIO1 Serine/threonine 98.6 9.8E-07 2.1E-11 83.6 13.8 138 17-160 55-217 (268)
458 TIGR02172 Fb_sc_TIGR02172 Fibr 98.6 8.4E-07 1.8E-11 84.6 13.2 132 16-157 7-181 (226)
459 PF01636 APH: Phosphotransfera 98.6 8.5E-07 1.8E-11 83.7 12.9 136 15-157 2-196 (239)
460 COG0661 AarF Predicted unusual 98.5 4.7E-07 1E-11 95.7 11.4 143 16-161 131-317 (517)
461 KOG0576 Mitogen-activated prot 98.4 5.1E-08 1.1E-12 102.1 0.4 237 12-268 244-489 (829)
462 cd05150 APH Aminoglycoside 3'- 98.3 6E-06 1.3E-10 79.3 11.8 74 17-98 5-80 (244)
463 PLN02876 acyl-CoA dehydrogenas 98.3 1.1E-05 2.5E-10 91.0 15.4 82 14-97 42-131 (822)
464 PF10707 YrbL-PhoP_reg: PhoP r 98.2 2.1E-05 4.6E-10 73.2 13.5 130 16-152 7-165 (199)
465 KOG1035 eIF-2alpha kinase GCN2 98.2 5.8E-06 1.2E-10 92.3 10.1 202 56-269 228-440 (1351)
466 COG2112 Predicted Ser/Thr prot 98.2 1.2E-05 2.6E-10 72.5 9.6 129 13-158 25-155 (201)
467 PF13095 FTA2: Kinetochore Sim 98.2 3.7E-05 8.1E-10 71.3 13.1 128 10-156 37-206 (207)
468 cd05155 APH_ChoK_like_1 Unchar 98.1 2.8E-05 6E-10 74.4 10.6 73 16-98 3-82 (235)
469 KOG1235 Predicted unusual prot 98.1 2.3E-05 5.1E-10 82.8 10.8 141 16-161 167-357 (538)
470 PF12260 PIP49_C: Protein-kina 97.9 5.5E-05 1.2E-09 70.0 9.3 99 58-160 7-113 (188)
471 PRK10593 hypothetical protein; 97.8 0.00041 8.9E-09 68.9 14.8 78 13-97 17-100 (297)
472 PRK09550 mtnK methylthioribose 97.8 0.0003 6.4E-09 72.5 13.9 79 15-95 31-116 (401)
473 cd05157 ETNK_euk Ethanolamine 97.8 0.00021 4.6E-09 68.1 11.8 75 15-97 3-79 (235)
474 KOG1826 Ras GTPase activating 97.8 8.5E-07 1.8E-11 100.5 -5.7 208 58-268 1277-1497(2724)
475 TIGR02721 ycfN_thiK thiamine k 97.8 0.00015 3.2E-09 70.3 10.2 131 17-157 3-174 (256)
476 cd05153 HomoserineK_II Homoser 97.8 0.00026 5.7E-09 69.9 12.2 135 15-157 19-204 (296)
477 KOG2268 Serine/threonine prote 97.8 2.6E-05 5.6E-10 76.6 4.7 134 12-155 94-248 (465)
478 PF02149 KA1: Kinase associate 97.8 6.3E-05 1.4E-09 52.7 5.4 42 386-428 3-45 (47)
479 TIGR00938 thrB_alt homoserine 97.7 0.00042 9.2E-09 69.1 12.0 136 15-157 27-216 (307)
480 COG3173 Predicted aminoglycosi 97.6 0.00068 1.5E-08 67.5 12.1 139 13-159 28-229 (321)
481 cd05156 ChoK_euk Choline Kinas 97.5 0.001 2.2E-08 66.0 11.5 75 15-97 3-84 (302)
482 PRK05231 homoserine kinase; Pr 97.5 0.0025 5.5E-08 63.7 14.4 135 15-157 27-216 (319)
483 PLN02756 S-methyl-5-thioribose 97.3 0.003 6.5E-08 65.0 12.8 77 14-94 36-119 (418)
484 KOG2270 Serine/threonine prote 97.2 0.0035 7.7E-08 62.9 11.0 141 14-158 148-313 (520)
485 cd05152 MPH2' Macrolide 2'-Pho 97.1 0.0061 1.3E-07 59.9 12.2 30 129-158 186-216 (276)
486 KOG1093 Predicted protein kina 97.1 0.0012 2.6E-08 68.7 7.0 163 55-271 27-202 (725)
487 TIGR01767 MTRK 5-methylthiorib 97.1 0.0037 8.1E-08 63.3 10.3 77 17-95 2-85 (370)
488 TIGR02906 spore_CotS spore coa 96.8 0.014 3E-07 57.9 12.2 29 128-157 187-215 (313)
489 PRK12396 5-methylribose kinase 96.8 0.0057 1.2E-07 62.7 8.8 79 15-95 34-118 (409)
490 PLN02236 choline kinase 96.7 0.014 3E-07 59.2 11.5 136 14-157 40-230 (344)
491 PLN02421 phosphotransferase, a 96.4 0.034 7.3E-07 56.1 11.6 135 15-157 19-212 (330)
492 PF03881 Fructosamin_kin: Fruc 96.2 0.063 1.4E-06 53.0 12.3 75 13-95 20-97 (288)
493 PF01633 Choline_kinase: Choli 96.2 0.015 3.3E-07 54.5 7.4 29 129-157 144-173 (211)
494 COG5072 ALK1 Serine/threonine 96.1 0.024 5.2E-07 57.0 8.2 86 69-159 284-371 (488)
495 TIGR02904 spore_ysxE spore coa 96.0 0.12 2.5E-06 51.6 13.1 29 129-157 197-225 (309)
496 COG2334 Putative homoserine ki 95.9 0.093 2E-06 52.8 11.7 133 17-157 33-227 (331)
497 PRK11768 serine/threonine prot 95.6 0.34 7.3E-06 48.7 14.6 71 21-96 36-113 (325)
498 PF07387 Seadorna_VP7: Seadorn 95.4 0.058 1.3E-06 50.8 7.6 84 55-154 103-188 (308)
499 PTZ00384 choline kinase; Provi 95.2 0.12 2.6E-06 53.2 10.1 76 14-97 54-136 (383)
500 PRK06148 hypothetical protein; 94.6 0.28 6E-06 57.0 12.0 135 16-157 31-235 (1013)
No 1
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-62 Score=499.49 Aligned_cols=340 Identities=53% Similarity=0.893 Sum_probs=278.5
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK--VGMIDQIKREISVMRLVR-HPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (472)
....++|++++.||+|+||+|++|.+..+|+.||+|+++++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 367889999999999999999999999999999999888764331 135678889999999999 99999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCEEEeeccchhhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~-g~vkl~DFGla~~~~ 160 (472)
+++|+||||+.||+|++++.. +++.|.+++++|+||++|++|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999977 899999999999999999999999999999999999999999 999999999999774
Q ss_pred cccCCCccccccCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCC-CHH
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF-APE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 238 (472)
..+..+.+.||||.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3456689999999999999999998 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc-CCCCCCCCcccccc-c--CCCCCCcccCCCC--CCccccccccccCCCC
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK-GLVKPSISETEEKE-W--APVDADAVFSPSG--STSTVAESKNELAKPC 312 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h~~f~~-~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 312 (472)
+++||++||.+||.+|+|+.+|++||||+. .............. . .+...+....... .......... ...+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 329 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTP-ESLPL 329 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999999999999999999999998 43322111000000 0 0000000000000 0000000000 00356
Q ss_pred CCCchhhhc-cCCCC--CCCCchhhhhhcccceeeccCC
Q 012021 313 NLNAFDIIS-FSAGF--DLSGLFEEREKRKEVRFTSNKP 348 (472)
Q Consensus 313 ~~~~f~~~~-~s~~~--~ls~l~~~~~~~~~~rf~~~~~ 348 (472)
.++++++++ ++.+. +++++++....++..+|.+..+
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (370)
T KOG0583|consen 330 SLNAYDLGSSLSTGINEALSGLFENEKEKEEPRFASLTS 368 (370)
T ss_pred ccChhhhcccccccccccccccccccccchhhhhhhccc
Confidence 788888887 88888 8999987654456677776654
No 2
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=6.5e-61 Score=487.92 Aligned_cols=263 Identities=37% Similarity=0.716 Sum_probs=248.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|..++.||+|||++||.+++..+|+.||+|++.+....+....+.+.+||+|++.|+|||||+++++|++.+++|+|+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 79999999999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+|..++|..++++ +.++|.+++.+++||+.||.|||++||+|||||..||||+++-++||+|||||+....... .-.
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~ 176 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKK 176 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--ccc
Confidence 9999999999875 6899999999999999999999999999999999999999999999999999998775432 246
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
+.||||.|+|||++.+.++. ..+||||+||+||.||.|++||...+..+.|.+|...++.+|..+|.++++||.+||++
T Consensus 177 TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred eecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcC
Confidence 88999999999999988875 89999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCChhhhhcCcccccCCCCCCCC
Q 012021 250 NPNTRISMTKIMENSWFRKGLVKPSIS 276 (472)
Q Consensus 250 dP~~Rpt~~eil~h~~f~~~~~~~~~~ 276 (472)
||.+|||+++||.|+||+.+..+...+
T Consensus 256 ~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 999999999999999998877654443
No 3
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.7e-61 Score=471.02 Aligned_cols=259 Identities=39% Similarity=0.733 Sum_probs=232.5
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh----hHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG----MIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+.+.|.+.+.||+|+||.|.+|.++.||+.||||++++.+..... ....+.+|++||+.|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567899999999999999999999999999999999988765422 2345789999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCEEEeeccchhhh
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~---g~vkl~DFGla~~~ 159 (472)
..|+||||+.||+|++++.. +.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999865 789999999999999999999999999999999999999766 67999999999987
Q ss_pred hcccCCCccccccCCCcccChhhhcccCCC--CCcccchhhhHHHHHHhcCCCCCCCCcHHH-HHHHHhccCCCCC--CC
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYD--GSKADIWSCGVILYVLLAGYLPFHDSNLME-MYRKIGKAEFKFP--NW 234 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlGvil~~lltG~~Pf~~~~~~~-~~~~i~~~~~~~~--~~ 234 (472)
. ....+.+.||||.|+|||++...++. ..+.|+|||||+||.+++|++||.+..... ++++|.++.+.+- .|
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 5 34567899999999999999877643 457899999999999999999998866554 8899999987764 34
Q ss_pred --CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 235 --FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 --~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
++.++.+||.+||..||+.|||++|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 79999999999999999999999999999999853
No 4
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.6e-60 Score=485.12 Aligned_cols=259 Identities=44% Similarity=0.838 Sum_probs=245.5
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.|-|+++++||.|+-|.|.+|++..||+.+|||++.+...........+.+||.||+.+.|||++++|++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 56899999999999999999999999999999999888544445567799999999999999999999999999999999
Q ss_pred EEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
.||++||+||+++. +|+++|.++.++|+||+.|+.|||..+|+||||||+|+|||..+++||+|||+|.+-. .+..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---CCcc
Confidence 99999999999985 5899999999999999999999999999999999999999999999999999998643 4567
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L 247 (472)
+.+.||+|.|.|||++.+.+|+|.++||||||||||.||||++||++.+...++.++.++.+.+|..+++++++||++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012021 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+.||.+|+|++||++|||+....
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999998654
No 5
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=6.2e-58 Score=442.98 Aligned_cols=259 Identities=36% Similarity=0.715 Sum_probs=241.0
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.+.|++++.||+|+||+||.++.+.|++.+|+|+++|..+.+....+..+.|..||..++||.||+++..|++.+++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999999999999999999999888778899999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|+||+.||+|+..+.+ +.++|..++.|+..|+.||.|||++||+||||||||||||.+|+++|+||||++......
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-- 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-- 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--
Confidence 99999999999999975 899999999999999999999999999999999999999999999999999998654322
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHh
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~ 244 (472)
....+.|||+.|||||++.+.+|+ ..+|.||||+++|+|++|.+||.+.+...++++|.++.. ..|..++++++++|+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 235678999999999999999987 889999999999999999999999999999999999994 445559999999999
Q ss_pred cccCCCCCCcC----ChhhhhcCccccc
Q 012021 245 KILDPNPNTRI----SMTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rp----t~~eil~h~~f~~ 268 (472)
++|..||.+|. ++.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999996 6889999999985
No 6
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=7.1e-58 Score=429.28 Aligned_cols=256 Identities=40% Similarity=0.786 Sum_probs=244.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.-.++|+++++||.|+||+|.+++++.+|..+|+|++++..+.+....+...+|..+|+.+.||.++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55678999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||++||+|+.++++ ++++|..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 99999999999999987 8999999999999999999999999999999999999999999999999999986543
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
...+.||||.|+|||++..++|. .++|.|||||++|||++|++||.+.+...+|++|..++..+|..+++++++||++
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 25788999999999999999986 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcC-----ChhhhhcCccccc
Q 012021 246 ILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
+|+.|-.+|. ...+|.+||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 5779999999985
No 7
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-57 Score=454.84 Aligned_cols=260 Identities=34% Similarity=0.700 Sum_probs=242.5
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (472)
-..+|.+++.||+|+|++|++|+++.+++.||||+++|+.+.++...+.+.+|-.+|.+| +||.|++||..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 345899999999999999999999999999999999999998888889999999999999 7999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|+||+++|+|.++|.+ |.|+|..++.|+.||++||+|||++|||||||||||||||.||+++|+|||.|+.+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999999876532211
Q ss_pred -----------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC
Q 012021 166 -----------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW 234 (472)
Q Consensus 166 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 234 (472)
..-.+.+||..|++||++.... .++.+|||+||||||.|++|.+||.+.+...++++|....+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 1114578999999999997664 4689999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+++.+++||+++|..||++|+|+++|.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999986
No 8
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-55 Score=424.11 Aligned_cols=257 Identities=31% Similarity=0.548 Sum_probs=232.9
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-EE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-KI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 85 (472)
+..+..+.+..||+|+.|+||+++++.|++.+|+|++... .+....+++.+|++|++..+||+||++|+.|..+. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3445778899999999999999999999999999999433 23466789999999999999999999999999999 59
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+++||||+||+|.+.+.. |+++|....+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.+......
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999999998876 899999999999999999999995 99999999999999999999999999999876543
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-----cHHHHHHHHhcc-CCCCCCC-CC
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKA-EFKFPNW-FA 236 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s 236 (472)
...+.+||..|||||.+.+..|. .++||||||++++|+++|+.||... +..+++..|..+ .+.+|.. +|
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred ---hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 45788999999999999988876 8899999999999999999999874 677888888885 4667876 99
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+++++||..||++||.+|||+.|+++|||+++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999999998744
No 9
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-54 Score=421.04 Aligned_cols=259 Identities=38% Similarity=0.679 Sum_probs=235.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-..++|.+.+.||+|+||+||+|+++.++..||||.+.+.+.. ....+.+..||.||+.++|||||++++++.+++.+|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4567899999999999999999999999999999999988753 356788999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC------CCEEEeeccchhhh
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH------GNLKVSDFGLSALA 159 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~------g~vkl~DFGla~~~ 159 (472)
+|||||+||+|.+++.+ +.++|..++.+++||+.||++||+++|+||||||+||||+.+ -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999976 699999999999999999999999999999999999999865 35899999999987
Q ss_pred hcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCC
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFA 236 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s 236 (472)
.. .....+.||+|.|||||++....|+ .|+|+||+|+|+|++++|+.||+..+..+++..+.++.. .++.+++
T Consensus 166 ~~---~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 166 QP---GSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred Cc---hhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 63 3456889999999999999888887 799999999999999999999999999999888877653 3456688
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+...+|+...|..+|..|.+..+-+.|+++....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8889999999999999999999999999987643
No 10
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.3e-54 Score=424.57 Aligned_cols=269 Identities=36% Similarity=0.657 Sum_probs=238.3
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHHhcCCCCe
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----------GMIDQIKREISVMRLVRHPNV 72 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnI 72 (472)
.+....+.|++++.||+|.||+|.+|++..+++.||||++++...... .-.+.+.+||.||+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 355678899999999999999999999999999999999987543321 124689999999999999999
Q ss_pred eeEEEEEEeC--CEEEEEEEecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEE
Q 012021 73 VELYEVMASK--TKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 73 v~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vk 149 (472)
|+|+++..+. +++|||+|||..|.+...-..+. +++.+++.|+++++.||+|||.+||+||||||.|+||+++|.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999999764 68999999999998865555566 99999999999999999999999999999999999999999999
Q ss_pred Eeeccchhhhhcc---cCCCccccccCCCcccChhhhcc---cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHH
Q 012021 150 VSDFGLSALAESK---HQDGLLHTTCGTPAYVAPEVINR---RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK 223 (472)
Q Consensus 150 l~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~ 223 (472)
|+|||.+..+... ..+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|++||.+....+++.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998866332 22234566899999999999977 55778999999999999999999999999999999999
Q ss_pred HhccCCCCCCC--CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCCC
Q 012021 224 IGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK 272 (472)
Q Consensus 224 i~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~~ 272 (472)
|......+|.. +.+++++||.+||++||.+|+++.+|..|||.......
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 99999988876 78999999999999999999999999999999876543
No 11
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=4.8e-54 Score=431.55 Aligned_cols=260 Identities=37% Similarity=0.690 Sum_probs=234.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.+.|++++.||+|+||.||+|+.+.||+.+|+|+++|+.....+.++.++.|-+||....+|.||+||..|.+..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34678999999999999999999999999999999999988777788899999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc---
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK--- 162 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~--- 162 (472)
|||||++||++..++.+ +.|+|+.++.|+.+++.|++.+|+.|+|||||||+|+|||..|++||+||||+.-....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999998865 89999999999999999999999999999999999999999999999999998633210
Q ss_pred -----------------cCCC-------------------------ccccccCCCcccChhhhcccCCCCCcccchhhhH
Q 012021 163 -----------------HQDG-------------------------LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGV 200 (472)
Q Consensus 163 -----------------~~~~-------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv 200 (472)
..+. .....+|||.|+|||++.+.+|. ..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence 0000 11234699999999999999986 8999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCCC--CCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 201 ILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPNW--FAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 201 il~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~l~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
|+||||.|++||...++.+.+++|.... +.+|.. +++++++||.+||. ||.+|.. ++||.+||||+.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999999999998765 555544 78999999999999 9999985 899999999986
No 12
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.6e-55 Score=422.42 Aligned_cols=264 Identities=41% Similarity=0.754 Sum_probs=248.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-+..||++.++||.|+||+|.+|.+...|+.||||.|.++++.....+-.+++||+||..|+||||+.+|++|++.+++.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 35679999999999999999999999999999999999999988888889999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||..+|+|++++.. +.|+|.+++++|+||++|+.|||.++++|||||.+|||||.|+++||+||||+.++.. .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---K 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---c
Confidence 99999999999999975 7999999999999999999999999999999999999999999999999999988754 4
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
..+.++||+|.|.+||++.+.+|.++..|-|||||+||.|+.|..||++.+...+.++|.++.+.-|. -+.++.-||+.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRW 285 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHH
Confidence 56899999999999999999999999999999999999999999999999999999999999988776 56678999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCCCCCC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKGLVKPS 274 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~~~~~~ 274 (472)
||-.||.+|.|+.+|-.|=|..=++.-+.
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred HHhcCcccchhHHHHhhhheeeccccccc
Confidence 99999999999999999988877665443
No 13
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-53 Score=435.62 Aligned_cols=261 Identities=33% Similarity=0.641 Sum_probs=245.9
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (472)
+.+-.+.|.+++.||+|+||+|++|..+.+++.+|||+++|..+.....++..+.|.+|+...+ ||.+++++.+|.+++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3566789999999999999999999999999999999999999988888999999999998885 999999999999999
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|+||||+.||++..++..+.++|..++.|+..++.||.|||++||||||||.+|||||.+|.+||+|||+++....
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-- 520 (694)
T ss_pred eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC--
Confidence 999999999999988888889999999999999999999999999999999999999999999999999999985442
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
.+....|.||||.|+|||++.+..|. .+.|.|||||+||+||.|..||.+.+..+++..|...++.+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 33457899999999999999998886 89999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCcCCh-----hhhhcCccccc
Q 012021 244 SKILDPNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~-----~eil~h~~f~~ 268 (472)
+++|..||++|..+ .+|..||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999999999975 68999999986
No 14
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-54 Score=396.48 Aligned_cols=260 Identities=36% Similarity=0.738 Sum_probs=235.3
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...+.+.|++-+.||+|.|+.||.+.+..||+.+|+|+++..+... ...+.+.+|+.|-+.|+||||++|++.+.+.+.
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 4567789999999999999999999999999999999998776544 356889999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCEEEeeccchhhhh
Q 012021 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSDFGLSALAE 160 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~---g~vkl~DFGla~~~~ 160 (472)
.|+|+|++.|++|+.-|.. --++|..+-.+++||+++|.|||.+||+|||+||+|+||-.. .-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999776654 578999999999999999999999999999999999999543 359999999998766
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--C--CC
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s 236 (472)
. ........|||.|||||++...+|. ..+|||++|||||-|+.|++||.+.+...+|+.|..+.+.+|. | ++
T Consensus 165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 D---GEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred C---ccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 2 2335677899999999999888875 7899999999999999999999999999999999999887765 3 89
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
+++++||++||..||.+|+|+.|.|+|||+.+.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999863
No 15
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=6.1e-54 Score=399.98 Aligned_cols=248 Identities=32% Similarity=0.595 Sum_probs=223.1
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEE-EEEeCC-
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE-VMASKT- 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~- 83 (472)
..-...|+|++.||+|+||+||++.+..+|..||.|.+.-... +....+.+..|+.+|++|+|||||++++ .+..++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3445569999999999999999999999999999999985543 3456678899999999999999999999 454444
Q ss_pred EEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEcCCCCEEEeecc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHS--RG--VCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~--~g--iiHrDlKp~NILld~~g~vkl~DFG 154 (472)
.+++|||||.+|+|...|+. ..++|..+|+++.||+.||..||+ .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 49999999999999998853 469999999999999999999999 45 9999999999999999999999999
Q ss_pred chhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CC-
Q 012021 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FP- 232 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~- 232 (472)
|++.+..... ..++.+|||.||+||++...+|+ +++||||+||++|||+.-..||.+.+...+..+|..++++ +|
T Consensus 174 L~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 174 LGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 9998876543 35778999999999999999997 9999999999999999999999999999999999999876 67
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCCh
Q 012021 233 NWFAPEVRRLLSKILDPNPNTRISM 257 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~ 257 (472)
..+|.++..+|..|+..||..||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 5689999999999999999999997
No 16
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-52 Score=413.00 Aligned_cols=263 Identities=31% Similarity=0.525 Sum_probs=230.9
Q ss_pred CcCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012021 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
..-.++++||.++++||.|+||.||+|....+|+.||||.+.+.... .+..-.+ ||+..|++|+ ||||++|.+++.+
T Consensus 3 ~~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nL-REvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 3 LTQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNL-REVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred ceehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHH-HHHHHHHhcCCCCcchhhHHHhhc
Confidence 44567899999999999999999999999999999999999765533 3333333 8999999999 9999999999987
Q ss_pred CC-EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhh
Q 012021 82 KT-KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 82 ~~-~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~ 158 (472)
.+ .+|+||||++ .+|+++++. ..|+|..++.|+.||+.||+|+|.+|++|||+||||||+..+..+||+|||||+.
T Consensus 81 ~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 81 NDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred cCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 77 9999999995 589999965 4799999999999999999999999999999999999999999999999999998
Q ss_pred hhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc------------
Q 012021 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------ 226 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~------------ 226 (472)
..+... .+..+.|.+|+|||++...++++.+.|+||+|||++|+.+-++.|.+.+..+...+|..
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 776543 57789999999999999999999999999999999999999999999988877777642
Q ss_pred -------cCCCCCC-----------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 227 -------AEFKFPN-----------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 227 -------~~~~~~~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
-++.+|. ..++++.++|.+||.+||.+|||+.|+++||||+....
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1233332 25789999999999999999999999999999997654
No 17
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.4e-52 Score=383.22 Aligned_cols=259 Identities=38% Similarity=0.722 Sum_probs=243.6
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.+.-.++|++++.||.|-||.||+|+.+.++-.||+|++.++.+...+...++.+|++|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34567899999999999999999999999999999999999988887888899999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+++||...|+|+..+.. .+++|..+..|+.|++.|+.|||.++|+||||||+|+|++.+|.+||+|||-+.....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999999973 4699999999999999999999999999999999999999999999999998876542
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHH
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~ 241 (472)
+.-.+.|||..|.+||...+.+++ ...|+|++|++.||++.|.+||...+..+.|++|.+..+.+|..++.++++
T Consensus 177 ----~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 177 ----NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred ----CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 223688999999999999999887 789999999999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+|.+||..+|.+|.+..|+++|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999975
No 18
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-51 Score=404.15 Aligned_cols=259 Identities=32% Similarity=0.608 Sum_probs=222.9
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--EEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT--KIYF 87 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~l 87 (472)
.+|..++.||+|+||.||++.+..+|+..|||.+...... ..+.+.+|+.+|+.++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4689999999999999999999999999999999776322 2677999999999999999999999854444 7999
Q ss_pred EEEecCCCcccchhcc-C-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEeeccchhhhhc-cc
Q 012021 88 VMEYVKGGELFGKVAK-G-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAES-KH 163 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~DFGla~~~~~-~~ 163 (472)
+|||++||+|.+++.+ + +++|..++++.+||+.||.|||++||+||||||+|||++. ++.+||+|||++..... ..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999999986 4 6999999999999999999999999999999999999999 79999999999887663 11
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccC--CCCCCCCCHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE--FKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~s~~l~ 240 (472)
.........|||.|||||++........++|||||||++.||+||..||.. .......-.+.... +.+|.++|++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 112234578999999999998633344589999999999999999999987 44444444554443 678999999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
+||.+||..||++|||++++|+|||.+....
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999999987543
No 19
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=3e-52 Score=392.11 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=219.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
|++|+.+.++|+|+||.||+++++.||+.||||.+-.+. .+....+-..|||.+|++++|||+|.++++|..+.++++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 578999999999999999999999999999999986543 2233445678999999999999999999999999999999
Q ss_pred EEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+|||+..-|..+-+ .+++++..++.|++|++.|+.|||+++++|||||||||||+.+|.+||||||+|+..... ...
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cch
Confidence 99997754443333 267999999999999999999999999999999999999999999999999999987642 234
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------- 228 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------- 228 (472)
.+..+.|.+|+|||.+.+...++.+.||||+||++.||++|.+.|++.+..+....|.+.-
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 6778899999999999987667899999999999999999999999987766655553210
Q ss_pred CCCC------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 229 FKFP------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 229 ~~~~------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
..+| +.++.-+.+|+.+||..||.+|++.++++.||+|.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 0111 12456788999999999999999999999999994
No 20
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=4.1e-52 Score=417.60 Aligned_cols=257 Identities=33% Similarity=0.628 Sum_probs=240.7
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.++|..... .....+.+|++|++.++|||||.++++|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 578999999999999999999999999999999999876543 5678899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||+.| +|+.++.. +.++|+.++.++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+....+ ...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC--cee
Confidence 999987 99999976 78999999999999999999999999999999999999999999999999999977653 234
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L 247 (472)
+....|||.|||||++.+..|+ ..+|+||||||+||+++|++||...+...+...|.......|...+..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6677899999999999988887 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012021 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
.+||.+|.|-.+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999998644
No 21
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=1.4e-50 Score=407.38 Aligned_cols=256 Identities=37% Similarity=0.750 Sum_probs=233.9
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34678999999999999999999999999999999998765444455677899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999998865 67999999999999999999999999999999999999999999999999998755321
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
..+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.++++.+++||.+
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2356899999999999877764 8999999999999999999999998888889999989999999999999999999
Q ss_pred ccCCCCCCcCC-----hhhhhcCccccc
Q 012021 246 ILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rpt-----~~eil~h~~f~~ 268 (472)
||+.||.+|++ ++++++||||+.
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999997 799999999976
No 22
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=2.4e-50 Score=398.47 Aligned_cols=253 Identities=32% Similarity=0.670 Sum_probs=230.6
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----c
Confidence 99999999999865 67999999999999999999999999999999999999999999999999998765321 2
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999877764 8999999999999999999999999888889999988899999999999999999999
Q ss_pred CCCCCcCC-----hhhhhcCccccc
Q 012021 249 PNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt-----~~eil~h~~f~~ 268 (472)
.||.+|++ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
No 23
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-50 Score=406.73 Aligned_cols=259 Identities=39% Similarity=0.741 Sum_probs=236.6
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (472)
-+..+|++++.||+|.||.||.++++.||+.+|+|++.+.........+.+.+|+.||+++. |||||.++++|++.+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34568999999999999999999999999999999999887765555678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CCEEEeeccchhhhhc
Q 012021 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH----GNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~----g~vkl~DFGla~~~~~ 161 (472)
|+|||++.||+|++.+....++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999976569999999999999999999999999999999999999543 4799999999987765
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC--CC--CCH
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP--NW--FAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~ 237 (472)
....++.||||.|+|||++...+|. ..+||||+|+++|.|++|..||.+.+....+.++..+.+.++ .| ++.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 3457889999999999999877775 899999999999999999999999999888889999887654 33 789
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.++++|++||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998753
No 24
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=1.1e-49 Score=399.66 Aligned_cols=250 Identities=38% Similarity=0.677 Sum_probs=225.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567789999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCC
Q 012021 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecC
Confidence 99988865 67999999999999999999999999999999999999999999999999998743221 1223456899
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012021 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999877765 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 012021 255 I-----SMTKIMENSWFRK 268 (472)
Q Consensus 255 p-----t~~eil~h~~f~~ 268 (472)
| ++.++++||||+.
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999976
No 25
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.3e-51 Score=405.27 Aligned_cols=261 Identities=41% Similarity=0.736 Sum_probs=242.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.|=|.+.+.||+|-|+.|.+|++.-||+.||||++++.+... -....+.+|+.-|+.++|||||+||++..+.+++|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 4556999999999999999999999999999999999988654 334678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCCEEEeeccchhhhhcccC
Q 012021 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL-DEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILl-d~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+|+-.+|+|+++|.+ ..+.|+.+++||.||+.|+.|||+..++||||||+|+.+ ..-|-+||.|||++..+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 9999999999999965 579999999999999999999999999999999999865 56789999999998876543
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
..+.+.||+..|.|||++.+..|+.++.||||||||||-|++|++||...+..+....|....+..|..++.+.++||.
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ 251 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence 3478999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCChhhhhcCcccccCCCC
Q 012021 245 KILDPNPNTRISMTKIMENSWFRKGLVK 272 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h~~f~~~~~~ 272 (472)
.||..||++|.+.++|..++|++.+...
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999999999999999999999976543
No 26
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.7e-50 Score=399.62 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=227.0
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (472)
..+.|+.+++||+|+||.||+|++..+|+.||+|.+..+.. +.+......|||.||++|+||||++|.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 35679999999999999999999999999999999987653 345667788999999999999999999998776 789
Q ss_pred EEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+|+||++. +|.-++... +|++.+++.|+.||+.||+|||++||+|||||..|||||.+|++||+|||||+++....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999965 788888774 79999999999999999999999999999999999999999999999999999876644
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------CCCCC-
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA----------EFKFP- 232 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------~~~~~- 232 (472)
. ..++..+-|.+|+|||.+.+...++.+.|+||+||||.||++|++.|.+.+..+...+|.+. ...+|
T Consensus 273 ~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 S-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred C-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 33667788999999999999887789999999999999999999999999988888777431 01111
Q ss_pred ------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 233 ------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
..+++.+.+|+..||..||.+|.|+.++|+++||..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 125778999999999999999999999999999954
No 27
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=2.1e-49 Score=400.93 Aligned_cols=258 Identities=31% Similarity=0.621 Sum_probs=232.9
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTG-MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..+-.++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456778999999999999999999976654 789999997765444455677889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
..|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999999865 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|..+++++.++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 12456899999999999876664 8999999999999999999999999888889999998888999999999999
Q ss_pred HhcccCCCCCCcC-----ChhhhhcCccccc
Q 012021 243 LSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
|++||+.||.+|+ |++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
No 28
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8e-50 Score=389.96 Aligned_cols=264 Identities=32% Similarity=0.537 Sum_probs=236.8
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+.+-.+.|++++.||.|.-|+||+|+.+.++..+|+|+++++.........++..|..||+.++||.++.||..|+++..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 45566789999999999999999999999999999999999988776777889999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.|++||||+||+|..+.++ +.+++..++.|+..++.||+|||..|||+||||||||||-++|+|.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999888765 4699999999999999999999999999999999999999999999999998753210
Q ss_pred ---------------------------------ccCC---------------------CccccccCCCcccChhhhcccC
Q 012021 162 ---------------------------------KHQD---------------------GLLHTTCGTPAYVAPEVINRRG 187 (472)
Q Consensus 162 ---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~ 187 (472)
.... ......+||-.|+|||++.+.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0000 0112346999999999999999
Q ss_pred CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC--CCHHHHHHHhcccCCCCCCcCC----hhhhh
Q 012021 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRIS----MTKIM 261 (472)
Q Consensus 188 ~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt----~~eil 261 (472)
.. .++|.|+|||++||||.|..||.+.+..+.+.+|......+|.. ++..+++||+++|.+||++|.. +.||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 85 89999999999999999999999999999999999988888764 6789999999999999999998 99999
Q ss_pred cCcccccC
Q 012021 262 ENSWFRKG 269 (472)
Q Consensus 262 ~h~~f~~~ 269 (472)
+||||+..
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999863
No 29
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=6.5e-49 Score=392.20 Aligned_cols=249 Identities=36% Similarity=0.642 Sum_probs=224.2
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765544444566788999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCc
Q 012021 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcc
Confidence 998865 689999999999999999999999999999999999999999999999999987543221 22345689999
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcC-
Q 012021 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRI- 255 (472)
Q Consensus 177 y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp- 255 (472)
|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.++|.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887765 78999999999999999999999998888889998888899999999999999999999999997
Q ss_pred --ChhhhhcCcccccC
Q 012021 256 --SMTKIMENSWFRKG 269 (472)
Q Consensus 256 --t~~eil~h~~f~~~ 269 (472)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57899999999863
No 30
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.6e-48 Score=391.41 Aligned_cols=254 Identities=31% Similarity=0.580 Sum_probs=227.0
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR---LVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++. .++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999998765443445567778877664 56799999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||+.|++|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998643221 1223
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.++|.+||.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999877664 7899999999999999999999998888888888888888899999999999999999
Q ss_pred CCCCCcC-----ChhhhhcCccccc
Q 012021 249 PNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
.||.+|| ++.++++||||+.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 6899999999976
No 31
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=2e-48 Score=391.68 Aligned_cols=250 Identities=37% Similarity=0.674 Sum_probs=224.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444455667889999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCC
Q 012021 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCC
Confidence 99988865 57999999999999999999999999999999999999999999999999998753221 1223456899
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012021 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999877664 8999999999999999999999988888888888888888999999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 012021 255 I-----SMTKIMENSWFRK 268 (472)
Q Consensus 255 p-----t~~eil~h~~f~~ 268 (472)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
No 32
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-49 Score=402.95 Aligned_cols=254 Identities=31% Similarity=0.567 Sum_probs=229.5
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|...+.||+|+-|.||.|+...+++.||||.++.....+ .+.+.+|+.+|+..+|+|||++++.|--++.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 347999999999999999999999999999999999877543 46789999999999999999999999888999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||++||+|.+.+....++|.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+...... -
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--R 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999877654432 3
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh-cc--CCCCCCCCCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG-KA--EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-~~--~~~~~~~~s~~l~~li~~ 245 (472)
.+.+|||+|||||+...+.|. ++.||||||++++||+-|++||-..++......|. .+ .+..|..+|+++++|+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 577899999999999988885 99999999999999999999998766654444443 33 456678899999999999
Q ss_pred ccCCCCCCcCChhhhhcCccccc
Q 012021 246 ILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
||+.||.+|+++.|+|+||||+.
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999964
No 33
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.1e-49 Score=385.32 Aligned_cols=262 Identities=32% Similarity=0.541 Sum_probs=229.8
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+-.+.|++...||.|.-+.||+|+.+.+++.||||+++.++... .++.+.+|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 345678999999999999999999999999999999999988654 378999999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|+||.|+.+|++.+++.. ..++|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+......
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999999975 57999999999999999999999999999999999999999999999999987755443
Q ss_pred cCCC--ccccccCCCcccChhhhc--ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC------
Q 012021 163 HQDG--LLHTTCGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP------ 232 (472)
Q Consensus 163 ~~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~------ 232 (472)
.... .+.+..|||+|||||++. ..||+ .|+||||||++..||.+|..||....++.+.-.-.++.++.+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 3211 126679999999999953 35776 899999999999999999999999888876655445544322
Q ss_pred ----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 233 ----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 233 ----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..++..++.+|..||+.||.+|||+++++.|+||++..
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12567899999999999999999999999999999753
No 34
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=1.7e-48 Score=391.27 Aligned_cols=250 Identities=37% Similarity=0.682 Sum_probs=224.2
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765443345567788999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCC
Q 012021 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCC
Confidence 99888865 57999999999999999999999999999999999999999999999999998753221 1223456799
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012021 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.++|.+||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999777664 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 012021 255 I-----SMTKIMENSWFRK 268 (472)
Q Consensus 255 p-----t~~eil~h~~f~~ 268 (472)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
No 35
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.2e-50 Score=374.57 Aligned_cols=257 Identities=37% Similarity=0.724 Sum_probs=229.8
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLV-RHPNVVELYEVMAS 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (472)
..++|+-.+.||.|..+.|..+.++.+|..+|+|+++..... ...+.+.-.+|+.||+++ .||+|+++.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 456788999999999999999999999999999999643221 123456677899999987 59999999999999
Q ss_pred CCEEEEEEEecCCCcccchhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 82 KTKIYFVMEYVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+...++|+|.++.|+|+|++... .++|.+++++++||++|++|||.++|+||||||+|||+|+|-++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999999874 79999999999999999999999999999999999999999999999999999776
Q ss_pred cccCCCccccccCCCcccChhhhcc------cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC--C
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINR------RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--P 232 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~--~ 232 (472)
... .+...||||+|.|||.+.. .+| +...|+||||||+|.|+.|.+||.....+-+.+.|..+++.+ |
T Consensus 175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred Cch---hHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 433 3677899999999999843 344 367999999999999999999999999999999999988765 5
Q ss_pred CC--CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 233 NW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ~~--~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.| +|.+.++||++||+.||.+|+|++|+|+||||.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 66 7899999999999999999999999999999965
No 36
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=1.8e-48 Score=397.38 Aligned_cols=257 Identities=32% Similarity=0.587 Sum_probs=222.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC----
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ---- 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~---- 164 (472)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999865 6899999999999999999999999999999999999999999999999999875432100
Q ss_pred -----------------------------CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC
Q 012021 165 -----------------------------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS 215 (472)
Q Consensus 165 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~ 215 (472)
.......+||+.|+|||++.+.+++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346899999999999887775 7999999999999999999999998
Q ss_pred cHHHHHHHHhcc--CCCCCCC--CCHHHHHHHhcccCCCCC---CcCChhhhhcCccccc
Q 012021 216 NLMEMYRKIGKA--EFKFPNW--FAPEVRRLLSKILDPNPN---TRISMTKIMENSWFRK 268 (472)
Q Consensus 216 ~~~~~~~~i~~~--~~~~~~~--~s~~l~~li~~~L~~dP~---~Rpt~~eil~h~~f~~ 268 (472)
+..+.+.++... ...+|+. ++++++++|.+|+. +|. .||+++||++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888887653 3445543 78999999999765 344 5689999999999975
No 37
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.7e-49 Score=404.81 Aligned_cols=261 Identities=43% Similarity=0.790 Sum_probs=245.1
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.-.+.|.+.++||.|.|++|.+|++..++..||||++++...... ....+.+|+.+|+.++|||||+++.+.++...+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 456789999999999999999999999999999999999876543 3345899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||+.+|++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+.. .
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY---G 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc---c
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999998764 3
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
..+.+.||++.|.|||++.+..|+++.+|+||+|+++|.|+.|.+||++.+..++..+...+.+.+|-.++.+..++|++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCCC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
+|.++|.+|+++++|+.|.|....+.
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhh
Confidence 99999999999999999999976543
No 38
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=8e-49 Score=363.43 Aligned_cols=255 Identities=32% Similarity=0.504 Sum_probs=223.8
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.||...+.||+|+||.||+|++..||+.||||.+...... .+......|||..|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5899999999999999999999999999999999877543 244556779999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++. +|...|+. ..++...++.|+.+++.||+|||++.|+||||||+|+|++++|.+||+|||+|+.+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99954 89888876 46999999999999999999999999999999999999999999999999999988765443
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----CCC----------
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-----KFP---------- 232 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-----~~~---------- 232 (472)
....+-|.+|+|||.+.+...++...|+||.|||+.||+-|.+-|.+.+..+....|-+.-. .+|
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 23347899999999999888778999999999999999999999999888777766643100 011
Q ss_pred -------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 233 -------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 -------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+..++++.+|+.+||..||.+|+|+.|+++|+||+.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 114678899999999999999999999999999986
No 39
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.5e-50 Score=378.25 Aligned_cols=262 Identities=36% Similarity=0.663 Sum_probs=242.7
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..+-++.|+.++.||+|+||+|-+++.+.+|+.+|||+++++.+.....+..-..|-.+|+..+||.+..|...|.+.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34578999999999999999999999999999999999999998776666667778999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
++|+||||+.||+|+-.+.+ ..++|+.++.|...|+.||.|||+++|++||||.+|+|||.+|++||+||||++.-..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999999999988866 6799999999999999999999999999999999999999999999999999875332
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
......+.||||.|.|||++....|. .+.|.|.+||++|||+||++||...+...++..|......+|..++++++.|
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred -ccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 22346789999999999999888875 8999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcC-----ChhhhhcCccccc
Q 012021 243 LSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
+..+|..||++|. .+.||++|+||..
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999998 4789999999975
No 40
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=3e-48 Score=390.82 Aligned_cols=253 Identities=32% Similarity=0.580 Sum_probs=224.5
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999965 6799999999999999999999999999999999999999999999999999875533 23
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC------CCCHHHH
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN------WFAPEVR 240 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~l~ 240 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456899999999999877665 89999999999999999999999888877776665422 22232 3589999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 241 RLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
++|.+||..+|.+||++.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999985
No 41
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=5.4e-48 Score=395.43 Aligned_cols=257 Identities=33% Similarity=0.584 Sum_probs=220.1
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655433344577889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc-----
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH----- 163 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~----- 163 (472)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999865 678999999999999999999999999999999999999999999999999975321100
Q ss_pred ------------------------------------CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc
Q 012021 164 ------------------------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA 207 (472)
Q Consensus 164 ------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt 207 (472)
........+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999887765 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcc--CCCCCC--CCCHHHHHHHhcccCCCCCCcC---ChhhhhcCccccc
Q 012021 208 GYLPFHDSNLMEMYRKIGKA--EFKFPN--WFAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFRK 268 (472)
Q Consensus 208 G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~l~~li~~~L~~dP~~Rp---t~~eil~h~~f~~ 268 (472)
|+.||.+.+..+....+... ...+|. .+++++.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988877666655433 223333 47899999999976 5999999 9999999999985
No 42
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=2.9e-48 Score=395.45 Aligned_cols=257 Identities=34% Similarity=0.664 Sum_probs=223.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC---
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD--- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~--- 165 (472)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999998865 67999999999999999999999999999999999999999999999999998654321100
Q ss_pred ---------------------------------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCC
Q 012021 166 ---------------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF 212 (472)
Q Consensus 166 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf 212 (472)
......+||+.|+|||++.+.++. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999877765 8999999999999999999999
Q ss_pred CCCcHHHHHHHHhccC--CCCCC--CCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 213 HDSNLMEMYRKIGKAE--FKFPN--WFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 213 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~l~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
...+....+..+.... ..+|. .+++++++||.+||. +|.+|++ ++++++||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777775433 33443 368999999999997 9999998 999999999975
No 43
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=3.1e-48 Score=382.05 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=219.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+++..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987654433344567899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.+|+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---Ce
Confidence 9999999877643 36899999999999999999999999999999999999999999999999998764321 12
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCCCHHHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
.....||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+. ......+......++..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2456799999999999877665 789999999999999999999987543 23333444555667778999999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCccccc
Q 012021 244 SKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~h~~f~~ 268 (472)
++||+.||.+||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999976
No 44
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=5.8e-48 Score=396.14 Aligned_cols=258 Identities=32% Similarity=0.552 Sum_probs=221.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999987665555566789999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC-----
Q 012021 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ----- 164 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~----- 164 (472)
|++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999998865 6799999999999999999999999999999999999999999999999999753311000
Q ss_pred ----------------------------------------CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHH
Q 012021 165 ----------------------------------------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYV 204 (472)
Q Consensus 165 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ 204 (472)
.....+.+||+.|+|||++.+.++. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999877765 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHhc--cCCCCCC--CCCHHHHHHHhccc--CCCCCCcCChhhhhcCcccccC
Q 012021 205 LLAGYLPFHDSNLMEMYRKIGK--AEFKFPN--WFAPEVRRLLSKIL--DPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~l~~li~~~L--~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
|++|..||...+..+...++.. ....+|. .+++++.+||.+|+ ..+|..|++++++++||||...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999998877666555543 2344444 47999999999955 5566669999999999999863
No 45
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=4.4e-48 Score=387.14 Aligned_cols=251 Identities=31% Similarity=0.616 Sum_probs=221.2
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|..++.. .+||||+++++++.+++.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999987543322344566778888875 4899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .......+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCC
Confidence 999988865 67999999999999999999999999999999999999999999999999998643221 122355789
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|.+++.+++++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877765 889999999999999999999999888888888888888889999999999999999999999
Q ss_pred cCCh-hhhhcCcccccC
Q 012021 254 RISM-TKIMENSWFRKG 269 (472)
Q Consensus 254 Rpt~-~eil~h~~f~~~ 269 (472)
||++ +++++||||+..
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999763
No 46
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=5.2e-48 Score=387.67 Aligned_cols=255 Identities=32% Similarity=0.589 Sum_probs=227.5
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP-NVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 89 (472)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444556788899999999764 6889999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--CCce
Confidence 99999999988865 67999999999999999999999999999999999999999999999999998643221 1223
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+......+|..+++++.++|++||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999877664 7899999999999999999999999888889999888888999999999999999999
Q ss_pred CCCCCcCCh-----hhhhcCccccc
Q 012021 249 PNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~-----~eil~h~~f~~ 268 (472)
.||.+|++. +++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999987 79999999975
No 47
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=3.4e-48 Score=388.59 Aligned_cols=250 Identities=32% Similarity=0.650 Sum_probs=223.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543334456677888888876 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccccccc
Confidence 999988865 68999999999999999999999999999999999999999999999999998743221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+.......|.++++++.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999876664 789999999999999999999999998889999988888999999999999999999999999
Q ss_pred cCCh------hhhhcCccccc
Q 012021 254 RISM------TKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~------~eil~h~~f~~ 268 (472)
||++ ++++.||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 89999999975
No 48
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=5.3e-48 Score=395.03 Aligned_cols=262 Identities=30% Similarity=0.548 Sum_probs=228.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44678999999999999999999999999999999997654433344566789999999999999999999999999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+||||++||+|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-V 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-c
Confidence 999999999999999888899999999999999999999999999999999999999999999999999876532211 1
Q ss_pred ccccccCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC--CCCHHH
Q 012021 167 LLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN--WFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~l 239 (472)
.....+||+.|+|||++.... ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 124568999999999986542 34589999999999999999999999988888888886543 44555 479999
Q ss_pred HHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~--Rpt~~eil~h~~f~~~ 269 (472)
.+||.+||..+|.+ |+|++++++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999998 9999999999999863
No 49
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=4.4e-48 Score=396.32 Aligned_cols=257 Identities=32% Similarity=0.611 Sum_probs=221.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC---
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD--- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~--- 165 (472)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999998865 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHH
Q 012021 166 ------------------------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203 (472)
Q Consensus 166 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 203 (472)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 000135799999999999877765 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC--CCCHHHHHHHhcccCCCCCCc---CChhhhhcCccccc
Q 012021 204 VLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN--WFAPEVRRLLSKILDPNPNTR---ISMTKIMENSWFRK 268 (472)
Q Consensus 204 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~l~~li~~~L~~dP~~R---pt~~eil~h~~f~~ 268 (472)
+|++|..||...+..+.+..+... ...+|. .+++++.+||.+||. +|.+| +|+.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988887777777642 344554 378999999999998 67765 59999999999974
No 50
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=6.6e-48 Score=394.29 Aligned_cols=263 Identities=30% Similarity=0.574 Sum_probs=227.4
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999765443334456688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~- 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM- 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999876532211
Q ss_pred CccccccCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC--CCCHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN--WFAPE 238 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~ 238 (472)
....+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||...+....+.++... ...+|. .+++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1124568999999999987643 3457999999999999999999999998888888877653 345555 36899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012021 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~h~~f~~~ 269 (472)
++++|.+||..++.+ |+|+.++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999866554 8999999999999863
No 51
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=7.4e-48 Score=395.35 Aligned_cols=257 Identities=35% Similarity=0.618 Sum_probs=221.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 37999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc-----
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH----- 163 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~----- 163 (472)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999998865 679999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHH
Q 012021 164 ----------------------------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203 (472)
Q Consensus 164 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 203 (472)
......+.+||+.|+|||++.+.++. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011245799999999999888776 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhcc--CCCCC--CCCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 204 VLLAGYLPFHDSNLMEMYRKIGKA--EFKFP--NWFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 204 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~l~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
+|++|+.||...+..+...++... ...+| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988877666666542 23344 347999999999976 59999997 999999999976
No 52
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=5e-48 Score=387.30 Aligned_cols=250 Identities=32% Similarity=0.618 Sum_probs=223.8
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556677899998865 799999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccccccc
Confidence 999988865 67999999999999999999999999999999999999999999999999998753322 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+......+|.++++++.++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999877665 789999999999999999999999999999999998888899999999999999999999999
Q ss_pred cC-------ChhhhhcCccccc
Q 012021 254 RI-------SMTKIMENSWFRK 268 (472)
Q Consensus 254 Rp-------t~~eil~h~~f~~ 268 (472)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999965
No 53
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=3.7e-48 Score=388.96 Aligned_cols=250 Identities=37% Similarity=0.678 Sum_probs=223.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567788999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|..++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++...... .......+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--CcccccccC
Confidence 99988865 579999999999999999999997 79999999999999999999999999998643221 122345679
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999877664 899999999999999999999999888888888888888899999999999999999999999
Q ss_pred cC-----ChhhhhcCccccc
Q 012021 254 RI-----SMTKIMENSWFRK 268 (472)
Q Consensus 254 Rp-----t~~eil~h~~f~~ 268 (472)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
No 54
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=4.1e-48 Score=391.72 Aligned_cols=257 Identities=33% Similarity=0.661 Sum_probs=226.8
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999999999999999998765444455677899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc-----
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH----- 163 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~----- 163 (472)
||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999866 589999999999999999999999999999999999999999999999999987654322
Q ss_pred ----------------------CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH
Q 012021 164 ----------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY 221 (472)
Q Consensus 164 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~ 221 (472)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00123345799999999999887664 8999999999999999999999998887777
Q ss_pred HHHhc--cCCCCCCC--CCHHHHHHHhcccCCCCCCcCC-hhhhhcCccccc
Q 012021 222 RKIGK--AEFKFPNW--FAPEVRRLLSKILDPNPNTRIS-MTKIMENSWFRK 268 (472)
Q Consensus 222 ~~i~~--~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt-~~eil~h~~f~~ 268 (472)
.++.. ....+|.. +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77766 44445544 59999999999997 9999999 999999999975
No 55
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.7e-47 Score=384.98 Aligned_cols=258 Identities=34% Similarity=0.622 Sum_probs=221.3
Q ss_pred CeEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (472)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999875 47899999999765432 2234567889999999994 99999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999998865 6799999999999999999999999999999999999999999999999999876433222
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCCCHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~l~ 240 (472)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 12335689999999999976654568899999999999999999999642 3344555666677778888999999
Q ss_pred HHHhcccCCCCCCcC-----ChhhhhcCcccccC
Q 012021 241 RLLSKILDPNPNTRI-----SMTKIMENSWFRKG 269 (472)
Q Consensus 241 ~li~~~L~~dP~~Rp-----t~~eil~h~~f~~~ 269 (472)
++|.+||..||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 78899999999863
No 56
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=1.6e-47 Score=384.02 Aligned_cols=251 Identities=35% Similarity=0.670 Sum_probs=222.1
Q ss_pred EeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 15 GRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLK-VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
++.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 478999999997654321 2334567899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CCccc
Confidence 9999999999865 67899999999999999999999999999999999999999999999999998643221 12234
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+..+...+|..+++++.++|.+||..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 56899999999999877664 89999999999999999999999988888888888888899999999999999999999
Q ss_pred CCCCcC-----ChhhhhcCccccc
Q 012021 250 NPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rp-----t~~eil~h~~f~~ 268 (472)
||++|| +++++++||||+.
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999 8999999999975
No 57
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=1.7e-47 Score=382.95 Aligned_cols=250 Identities=35% Similarity=0.674 Sum_probs=220.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+.........+.+..|..++.. .+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987654333444556677777765 4899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccC
Confidence 999988865 689999999999999999999999999999999999999999999999999987543221 22345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|.+++.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877664 889999999999999999999999888888888888888889999999999999999999999
Q ss_pred cCChh-hhhcCccccc
Q 012021 254 RISMT-KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~-eil~h~~f~~ 268 (472)
||++. ++++||||+.
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99875 8889999975
No 58
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=1.6e-47 Score=383.99 Aligned_cols=255 Identities=32% Similarity=0.586 Sum_probs=227.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544334455677788888777 5899999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--CCcc
Confidence 99999999988865 68999999999999999999999999999999999999999999999999998743321 1223
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+......+|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999877765 8999999999999999999999999888889999888888999999999999999999
Q ss_pred CCCCCcCCh-----hhhhcCccccc
Q 012021 249 PNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~-----~eil~h~~f~~ 268 (472)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999985 79999999975
No 59
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.5e-47 Score=376.63 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=213.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 5899999999999999999999999999999999765432 234567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.++.+..+... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccc
Confidence 99998877655543 5799999999999999999999999999999999999999999999999999886543221 122
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------C
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------F 229 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (472)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345799999999999877764 79999999999999999999998765543332221110 0
Q ss_pred CC-------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 KF-------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~-------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.. ...+++++.+||.+||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01 11267889999999999999999999999999998
No 60
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=1.7e-47 Score=377.40 Aligned_cols=253 Identities=29% Similarity=0.460 Sum_probs=212.6
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++.+.||.|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 56899999999999999999999999999999999754321 2235677999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence 999975 88887754 358999999999999999999999999999999999999999999999999987543221 2
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------------
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------ 228 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (472)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||...+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 23456789999999998765444589999999999999999999998877655444332110
Q ss_pred -CCC-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 -FKF-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 -~~~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..+ ...+++++.+||++||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 011 12367899999999999999999999999999998
No 61
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=2.4e-47 Score=383.63 Aligned_cols=257 Identities=30% Similarity=0.580 Sum_probs=223.1
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 99999999999865 5799999999999999999999999999999999999999999999999999876543221 11
Q ss_pred cccccCCCcccChhhhcc-----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC--CCCCHH
Q 012021 168 LHTTCGTPAYVAPEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP--NWFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~ 238 (472)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233578999999999999999999999888777777765432 2333 357899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+.+||.+||. +|.+|||++++++||||+.
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999986
No 62
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=1.9e-47 Score=384.71 Aligned_cols=250 Identities=31% Similarity=0.587 Sum_probs=218.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccC
Confidence 999888754 68999999999999999999999999999999999999999999999999998642211 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---------cHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---------NLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
|+.|+|||++.+..++ .++|+|||||++|+|++|+.||... .....+..+......+|..+++++.++|.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877665 7999999999999999999999631 12234566677778889999999999999
Q ss_pred cccCCCCCCcCC------hhhhhcCccccc
Q 012021 245 KILDPNPNTRIS------MTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt------~~eil~h~~f~~ 268 (472)
+||..||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999965
No 63
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=3.1e-47 Score=381.19 Aligned_cols=251 Identities=33% Similarity=0.662 Sum_probs=224.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444556778899999887 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccceec
Confidence 999988865 58999999999999999999999999999999999999999999999999998643221 122345679
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||..||++
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999877765 799999999999999999999999888888888888888889899999999999999999999
Q ss_pred cCCh-----hhhhcCcccccC
Q 012021 254 RISM-----TKIMENSWFRKG 269 (472)
Q Consensus 254 Rpt~-----~eil~h~~f~~~ 269 (472)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
No 64
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=2.1e-47 Score=388.91 Aligned_cols=257 Identities=33% Similarity=0.618 Sum_probs=223.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455678889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC----
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ---- 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~---- 164 (472)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999874422110
Q ss_pred -----------------------------CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC
Q 012021 165 -----------------------------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS 215 (472)
Q Consensus 165 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~ 215 (472)
.......+||+.|+|||++.+.++. .++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245899999999999887775 7999999999999999999999998
Q ss_pred cHHHHHHHHhcc--CCCCCCC--CCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 216 NLMEMYRKIGKA--EFKFPNW--FAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 216 ~~~~~~~~i~~~--~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
+....+.++... ...+|+. +++++++||.+|+. ||.+|++ ++++++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888877777643 3344543 78999999999874 9999984 799999999985
No 65
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=3.6e-47 Score=380.55 Aligned_cols=251 Identities=34% Similarity=0.633 Sum_probs=220.9
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987643322334556678888876 5899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCceeeecC
Confidence 999999875 57999999999999999999999999999999999999999999999999998643221 122345679
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|.+++.++.++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999877665 899999999999999999999999888888888877777888899999999999999999999
Q ss_pred cCChh-hhhcCcccccC
Q 012021 254 RISMT-KIMENSWFRKG 269 (472)
Q Consensus 254 Rpt~~-eil~h~~f~~~ 269 (472)
||++. ++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999763
No 66
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-48 Score=373.33 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=222.8
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----C
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-----K 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 82 (472)
+..+|..++.||.|+||.|+.|.++.+|+.||||.+.... ...-.+++..||+.+|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4457777899999999999999999999999999986332 233556888899999999999999999999855 4
Q ss_pred CEEEEEEEecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 83 TKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+.+|+|+|++ +.+|...++.++ +++..++.++.||+.||+|+|+.||+||||||.|+|++.++.+||+|||||+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 669999998876 99999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc---------------
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--------------- 226 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--------------- 226 (472)
...++.++..+-|.+|.|||++.....++.+.||||+|||+.||++|++.|.+.+.......|..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 44445567788999999999987665556899999999999999999999998776555544421
Q ss_pred --------cCCCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 227 --------AEFKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 --------~~~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
..+.. .+..++.+.+|+.+||..||.+|+|++|+|+||||..-
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 12468999999999999999999999999999999864
No 67
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=5.4e-47 Score=380.18 Aligned_cols=250 Identities=34% Similarity=0.620 Sum_probs=219.6
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333445555555 56889999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccC
Confidence 999988865 67999999999999999999999999999999999999999999999999998643221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.......++.+++++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999877665 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred cCCh----hhhhcCccccc
Q 012021 254 RISM----TKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~----~eil~h~~f~~ 268 (472)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9998 59999999975
No 68
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=4.1e-47 Score=382.28 Aligned_cols=250 Identities=32% Similarity=0.601 Sum_probs=217.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999998776 799999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccC
Confidence 999888765 679999999999999999999999999999999999999999999999999987532211 12345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---------CcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---------SNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. ......+..+......+|..++.++.++|.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877665 799999999999999999999952 112334556667778889999999999999
Q ss_pred cccCCCCCCcCC------hhhhhcCccccc
Q 012021 245 KILDPNPNTRIS------MTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt------~~eil~h~~f~~ 268 (472)
+||..||++||| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 579999999975
No 69
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=4.1e-47 Score=377.19 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=209.5
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999999754321 2234567899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--H 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--c
Confidence 99996 567666654 579999999999999999999999999999999999999999999999999987543221 2
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhcc--C---------------
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKA--E--------------- 228 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~--~--------------- 228 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655455789999999999999999999987433 2222222110 0
Q ss_pred ----CC--CCC---------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 229 ----FK--FPN---------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 ----~~--~~~---------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
+. .+. .+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 000 135678999999999999999999999999999863
No 70
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=6.6e-47 Score=379.85 Aligned_cols=250 Identities=34% Similarity=0.608 Sum_probs=219.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997664433333445556655 46789999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccC
Confidence 999888865 67999999999999999999999999999999999999999999999999998743221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++..+.......++..+.++.++|.+||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999877765 799999999999999999999999988888888888877777789999999999999999999
Q ss_pred cCCh----hhhhcCccccc
Q 012021 254 RISM----TKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~----~eil~h~~f~~ 268 (472)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9987 48999999975
No 71
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=6.8e-47 Score=387.00 Aligned_cols=263 Identities=32% Similarity=0.572 Sum_probs=226.5
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34567999999999999999999999999999999999765443334456688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~- 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM- 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999876532211
Q ss_pred CccccccCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC--CCCHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN--WFAPE 238 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~ 238 (472)
....+.+||+.|+|||++...+ ..+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++.+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1124568999999999987543 34579999999999999999999999998888888876543 34443 58999
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012021 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~h~~f~~~ 269 (472)
++++|.+||..++.+ |+++++|++|+||+..
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999763
No 72
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=1.1e-46 Score=377.47 Aligned_cols=250 Identities=34% Similarity=0.609 Sum_probs=219.2
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333445555554 67889999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccC
Confidence 999888865 67999999999999999999999999999999999999999999999999998743221 222345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|...+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877665 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred cCChh----hhhcCccccc
Q 012021 254 RISMT----KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~----eil~h~~f~~ 268 (472)
|++.. ++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 99764 9999999974
No 73
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=7.3e-47 Score=379.42 Aligned_cols=255 Identities=32% Similarity=0.588 Sum_probs=226.3
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+..|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444444567788999998886 577889999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccc
Confidence 99999999998866 689999999999999999999999999999999999999999999999999987532211 123
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999877664 7999999999999999999999999888888888888888999999999999999999
Q ss_pred CCCCCcCCh-----hhhhcCccccc
Q 012021 249 PNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~-----~eil~h~~f~~ 268 (472)
.+|.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999984 68999999985
No 74
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=4e-47 Score=380.18 Aligned_cols=251 Identities=36% Similarity=0.654 Sum_probs=221.9
Q ss_pred EeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 15 GRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
++.||+|+||+||++++. .+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 368999999999999874 57899999999765432 22335677899999999999999999999999999999999
Q ss_pred cCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccc
Q 012021 92 VKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
+.+++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cceec
Confidence 999999998865 579999999999999999999999999999999999999999999999999987543321 22345
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCC
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~d 250 (472)
.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+......+|..+++++.++|++||+.|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 6899999999999877664 799999999999999999999999888888888888888899999999999999999999
Q ss_pred CCCcCC-----hhhhhcCcccccC
Q 012021 251 PNTRIS-----MTKIMENSWFRKG 269 (472)
Q Consensus 251 P~~Rpt-----~~eil~h~~f~~~ 269 (472)
|.+||| +.+++.||||+..
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999 6779999999763
No 75
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=9.7e-47 Score=380.01 Aligned_cols=250 Identities=30% Similarity=0.517 Sum_probs=216.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcE-EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-E
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMS-VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-K 84 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 84 (472)
+......+.+.||+|+||+||++.. .|+. ||+|++......... .+.+.+|+.+|.+++|||||+++|++.+.. .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3445566778899999999999988 5556 999999876654433 779999999999999999999999998887 7
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCCC-CEEEeeccchhhh
Q 012021 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRG-VCHRDLKPENLLLDEHG-NLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~g-iiHrDlKp~NILld~~g-~vkl~DFGla~~~ 159 (472)
..+||||+++|+|++++.. +.++...+.+++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999954 68999999999999999999999999 99999999999999998 9999999999866
Q ss_pred hcccCCCccccccCCCcccChhhhc--ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh--ccCCCCCCCC
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG--KAEFKFPNWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~ 235 (472)
.... .......||+.|||||++. ...|+ .++||||||+++|||+||+.||.+.........+. ...+.+|..+
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 5432 1223468999999999998 44665 89999999999999999999999988755544443 3456677789
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 236 APEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+..++.+||+.||.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999999975
No 76
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=4.5e-47 Score=381.76 Aligned_cols=249 Identities=31% Similarity=0.593 Sum_probs=216.8
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
||+|+||+||+|++..+|+.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344555677777655 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCccCccC
Confidence 999988865 67999999999999999999999999999999999999999999999999998753322 122346789
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC-CCHHHHHHHhcccCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW-FAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~l~~li~~~L~~dP~ 252 (472)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+..+...+|.. +++++.++|.+||.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999998765544589999999999999999999999998888888888877777754 799999999999999999
Q ss_pred CcC----ChhhhhcCccccc
Q 012021 253 TRI----SMTKIMENSWFRK 268 (472)
Q Consensus 253 ~Rp----t~~eil~h~~f~~ 268 (472)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7899999999975
No 77
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=4e-46 Score=374.74 Aligned_cols=250 Identities=30% Similarity=0.592 Sum_probs=218.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999887 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccC
Confidence 999888865 68999999999999999999999999999999999999999999999999998743221 122346789
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-------CcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-------SNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. ......+..+......+|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999877664 899999999999999999999953 12234556666677788888999999999999
Q ss_pred cCCCCCCcCCh------hhhhcCccccc
Q 012021 247 LDPNPNTRISM------TKIMENSWFRK 268 (472)
Q Consensus 247 L~~dP~~Rpt~------~eil~h~~f~~ 268 (472)
|..||.+|+++ .++++||||+.
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99999999984 69999999976
No 78
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=1.6e-46 Score=369.05 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=213.8
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||++.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++..++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544333446678899999999999999999999999999999999999999
Q ss_pred cchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccccc
Q 012021 98 FGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 98 ~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
...+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 87662 24699999999999999999999999999999999999999999999999999875543221 233457
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ......+......+|..+++++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999877765 789999999999999999999976432 2334444555566777899999999999999
Q ss_pred CCCCCcC-----ChhhhhcCccccc
Q 012021 249 PNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 7899999999975
No 79
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=4.5e-47 Score=361.39 Aligned_cols=258 Identities=31% Similarity=0.432 Sum_probs=221.5
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (472)
..+.|+.+..|++|+||.||+|+|+.|++.||+|.++.++- +.+.-=.-.|||.+|...+|||||.+-++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 34579999999999999999999999999999999977652 22333345699999999999999999999754 4689
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+|||||+. +|..++.. .++...+++.++.|++.|++|||.+.|+||||||+|+|+...|.+||+|||||+.+.+..
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999965 78888865 589999999999999999999999999999999999999999999999999999887653
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------------
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---------------- 227 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------- 227 (472)
. .++..+-|.+|+|||.+.+...++.+.|+||+|||+.||+++++-|.+.+..+...+|-+.
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2 3566678999999999999887779999999999999999999999998887777776421
Q ss_pred ---CCCCC------------CC-CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 ---EFKFP------------NW-FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---~~~~~------------~~-~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
...++ .. ++....+|+..+|..||.+|.|+.+.|+|+||.+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 01111 11 45788899999999999999999999999999874
No 80
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=1.9e-46 Score=376.59 Aligned_cols=250 Identities=35% Similarity=0.620 Sum_probs=218.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHH-HHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI-SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865433323333444444 456889999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccC
Confidence 999998865 67999999999999999999999999999999999999999999999999998753221 222345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+......+++.+++++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877665 789999999999999999999999888888888887777888889999999999999999999
Q ss_pred cCChh----hhhcCccccc
Q 012021 254 RISMT----KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~----eil~h~~f~~ 268 (472)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
No 81
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=5.8e-46 Score=374.06 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=218.8
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||.||++++..+|..||+|++.... .....+.+.+|+.+|+.++||||+++++++..++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999997643 2234567999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999999999875 5799999999999999999999986 6999999999999999999999999998755322
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc------------------
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------------ 226 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~------------------ 226 (472)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+..++...+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 22455799999999999877664 799999999999999999999977655443322211
Q ss_pred ----------------------------c-CCCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 227 ----------------------------A-EFKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 227 ----------------------------~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
. ....+ ..+++++++||.+||..||++|||+.+|++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 01111 13678999999999999999999999999999998643
No 82
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=3.1e-46 Score=367.87 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=219.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554333334567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---c
Confidence 9999999887743 469999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH----HHHHHhccCCCCCCCCCHHHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----MYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
....+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+... ....+......++..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2345799999999999776654 78999999999999999999998765432 223344445566777999999999
Q ss_pred hcccCCCCCCcC-----ChhhhhcCccccc
Q 012021 244 SKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
.+||..||++|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
No 83
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=2.7e-46 Score=376.19 Aligned_cols=256 Identities=31% Similarity=0.502 Sum_probs=207.5
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK-----TKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 85 (472)
||++.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 79999999999999999999999999999999864322 122345688999999999999999999988543 358
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 688888765 5799999999999999999999999999999999999999999999999999875433221
Q ss_pred C-CccccccCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh-----------------
Q 012021 165 D-GLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG----------------- 225 (472)
Q Consensus 165 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~----------------- 225 (472)
. ......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 122446799999999998652 233579999999999999999999998765433221110
Q ss_pred ----------ccC-CCC---CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 226 ----------KAE-FKF---PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 226 ----------~~~-~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
... ..+ .+.+++++.++|.+||+.||++|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 000 000 1236788999999999999999999999999999975
No 84
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=4.4e-46 Score=375.04 Aligned_cols=258 Identities=30% Similarity=0.567 Sum_probs=219.6
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||++++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999865 5799999999999999999999999999999999999999999999999999865433221 11
Q ss_pred cccccCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC---CCCCHH
Q 012021 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP---NWFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 238 (472)
....+||+.|+|||++.. .+..+.++|||||||++|+|++|+.||...+..+.+..+.... +.+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2344578999999999999999999999888777777775432 3333 347899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012021 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~h~~f~~ 268 (472)
++++|++||..++++ |+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999988664443 889999999999975
No 85
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-48 Score=382.97 Aligned_cols=255 Identities=34% Similarity=0.566 Sum_probs=228.9
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..|+..+.||+|+||.||+|.+..+++.||+|+++.+... ...+.+.+|+.+|..++++||.++|+.+-.+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4688889999999999999999999999999999887643 45688999999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l-~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.||++.+.++.+.+ +|.++..++++++.|+.|||+++.+|||||+.|||+..+|.+||+|||++......... -
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--R 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--c
Confidence 99999999999998765 99999999999999999999999999999999999999999999999998866544332 2
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhccc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L 247 (472)
.+.+|||.|||||++...+|+ .++||||||++.+||++|.+||.+..++.....|.+.. +.+...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999999988887 79999999999999999999999887765444444433 3444568999999999999
Q ss_pred CCCCCCcCChhhhhcCcccccC
Q 012021 248 DPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
+.||+.||++.++|.|+|++..
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999873
No 86
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.7e-45 Score=370.68 Aligned_cols=258 Identities=29% Similarity=0.523 Sum_probs=220.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997654433344566889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 99999999999965 5799999999999999999999999999999999999999999999999999875543221 11
Q ss_pred cccccCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC---CCCHH
Q 012021 168 LHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN---WFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 238 (472)
....+||+.|+|||++.+. +..+.++|||||||++|+|++|+.||...+..+.+.++.... +.+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 233578999999999999999999999888877777776533 33443 36899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012021 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~h~~f~~ 268 (472)
++++|.+||..++.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876654 568999999999975
No 87
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=2e-46 Score=362.59 Aligned_cols=257 Identities=32% Similarity=0.497 Sum_probs=219.1
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC----
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKT---- 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 83 (472)
+..|+.+++||+|+||+||+|+++.+|+.||+|.+..+.-. ++.-....+|+.+|+.++|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 55688889999999999999999999999999999776532 233455689999999999999 999999998887
Q ss_pred --EEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 84 --KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
.+|+|+||++ -+|..++.. ..++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999995 478888764 25888899999999999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---------
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--------- 227 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--------- 227 (472)
+...... ......++|.+|+|||++.+...++...||||+|||++||++++.-|.+.+..+...+|-+.
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9655332 22567789999999999999866678999999999999999999999998887766665321
Q ss_pred ---------CCCCCCC------------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 ---------EFKFPNW------------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~~~~~~~------------~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
...++.| .+++..+++.+||+.+|.+|.|++.++.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1122322 23578899999999999999999999999999864
No 88
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=5.5e-46 Score=388.43 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=206.6
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4568999999999999999999999999999999886543 2345799999999999999999986432
Q ss_pred ---CEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CEEEeec
Q 012021 83 ---TKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDF 153 (472)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-~vkl~DF 153 (472)
..+++||||+.+ +|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999976 5655543 35799999999999999999999999999999999999999765 6999999
Q ss_pred cchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------
Q 012021 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------ 227 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------ 227 (472)
|+|....... .....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+.++...
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998654322 1235678999999999876544458999999999999999999999887665544443211
Q ss_pred -----------CC------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 -----------EF------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 -----------~~------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.. .+|...++++.+||.+||..||.+|||+.|+++||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1344567899999999999999999999999999999763
No 89
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.4e-45 Score=371.48 Aligned_cols=258 Identities=28% Similarity=0.535 Sum_probs=220.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444344566889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+|+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence 99999999999965 5799999999999999999999999999999999999999999999999999865432211 11
Q ss_pred cccccCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC---CCCHH
Q 012021 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN---WFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 238 (472)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+.+.++.... ..+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234579999999999863 2334579999999999999999999999988888888776543 33333 47899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012021 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~h~~f~~ 268 (472)
+++||++||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999665544 789999999999975
No 90
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=9.8e-46 Score=391.59 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=226.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
..++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 457999999999999999999999999999999999776543 244567889999999999999999998875432
Q ss_pred ----EEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeecc
Q 012021 84 ----KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFG 154 (472)
.+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 47899999999999988753 468999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCC
Q 012021 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPN 233 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~ 233 (472)
+++............+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+..+.+.++..+.. .+|.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 98865543333334567899999999999877665 899999999999999999999999888777777765543 4677
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.+++++.+++.+||..||.+||++.++++|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 89999999999999999999999999999999875
No 91
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=9.6e-46 Score=364.27 Aligned_cols=251 Identities=33% Similarity=0.493 Sum_probs=207.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMA----- 80 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 80 (472)
++|++++.||+|+||+||+|++.. ++..||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 489999999999999999999865 47889999987554322 2334566788887766 6999999999985
Q ss_pred eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
....+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 578877754 458999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--------
Q 012021 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-------- 229 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------- 229 (472)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+.++.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 65432 223456799999999999776665 789999999999999999999998877666655542110
Q ss_pred -------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 -------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 -------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
...+.+++.+.++|.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112467889999999999999999999999999998
No 92
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1.7e-45 Score=366.54 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=213.6
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-+++|++.+.||+|+||+||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 357899999999999999999999999999999998755422 223457789999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 9999975 77777654 458999999999999999999999999999999999999999999999999987543221
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------ 227 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (472)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12234578999999999876555568999999999999999999999877654443332210
Q ss_pred -CCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 -EFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 -~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
...++ +.+++++++||.+||..||.+|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 2368899999999999999999999999999999853
No 93
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=3.2e-45 Score=361.15 Aligned_cols=253 Identities=38% Similarity=0.794 Sum_probs=229.7
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997765544455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999865 67999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+..+...+|..+++.+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 34579999999999876654 47899999999999999999999988877778888888888898899999999999999
Q ss_pred CCCCCcC-----ChhhhhcCccccc
Q 012021 249 PNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rp-----t~~eil~h~~f~~ 268 (472)
.||.+|+ +++++++||||+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 8999999999975
No 94
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=2.2e-45 Score=373.13 Aligned_cols=255 Identities=30% Similarity=0.476 Sum_probs=213.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..+.|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567999999999999999999999999999999986543 22345678999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||||+.+++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 9999999998653 3467888899999999999999999999999999999999999999999999876543211 1
Q ss_pred cccccCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---HHHHHHHh-ccCCCCCCCCCHHH
Q 012021 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---MEMYRKIG-KAEFKFPNWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~-~~~~~~~~~~s~~l 239 (472)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..+++++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 245679999999998743 23455789999999999999999999974332 22222222 23345566789999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+||.+||..||++|||+.|+++||||...
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999999999874
No 95
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.6e-45 Score=373.27 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=209.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT--- 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (472)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 567899999999999999999999999999999999975532 2234567789999999999999999999986543
Q ss_pred ---EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 84 ---KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 4555543 458999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--------------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-------------- 226 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-------------- 226 (472)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 TN---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cC---ccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 21 223456789999999999877765 789999999999999999999987654333222110
Q ss_pred --------cCCC---------CCC-----------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 227 --------AEFK---------FPN-----------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 --------~~~~---------~~~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.... ++. ..++++++||.+||..||++|||+.|+++||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0000 111 135789999999999999999999999999999753
No 96
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=3.4e-45 Score=386.45 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=223.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+|+.++||||+++++++..++.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998887 7889999875432 2334567889999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 88 VMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
||||++||+|.+.+.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999887642 46899999999999999999999999999999999999999999999999999865443
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRR 241 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~ 241 (472)
.......+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+....+..+.. .+|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 222234566899999999999877664 889999999999999999999998888777777766554 456678999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+|.+||..||++||++++++.|+|++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999974
No 97
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.6e-46 Score=377.58 Aligned_cols=258 Identities=31% Similarity=0.532 Sum_probs=237.7
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE-EEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK-IYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 87 (472)
+++|++++.+|+|+||.+++++++..++.+++|.++...... .......+|+.++++++|||||.+.+.|..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 578999999999999999999999999999999998877544 334578899999999999999999999988887 999
Q ss_pred EEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 88 VMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||+||+||+|.+.|.+ .-++|+.+..|+.||+.|+.|||+++|+|||||+.||++..++.|||.|||+|+......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999965 259999999999999999999999999999999999999999999999999999887543
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLL 243 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li 243 (472)
....+..|||.|++||++.+.+|. .++|||||||++|||++-+++|.+.+...+..+|.++. .+.|..++.+++.+|
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 346788999999999999999986 89999999999999999999999999999999998887 678888999999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccCC
Q 012021 244 SKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+.||..+|..||++.++|.+|..+...
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999999887543
No 98
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=4e-45 Score=368.41 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=216.9
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45689999999999999999999999999999999987653 2234567899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999999999865 6799999999999999999999985 79999999999999999999999999987553321
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH--------------------
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI-------------------- 224 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i-------------------- 224 (472)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...........+
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2345799999999999776654 7899999999999999999999765443222111
Q ss_pred ------------------------hcc-CCCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 225 ------------------------GKA-EFKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 225 ------------------------~~~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
... ....+ ..+++++++||.+||+.||++|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 111 11111 13678999999999999999999999999999998643
No 99
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1.1e-45 Score=356.67 Aligned_cols=252 Identities=40% Similarity=0.685 Sum_probs=213.3
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++++.||+|+||+||++.+..+++.||+|++........ ......+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999988764332 223445699999999999999999999999999999999
Q ss_pred cCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccc
Q 012021 92 VKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 92 ~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
+.+++|.+++. .+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 99999999997 5889999999999999999999999999999999999999999999999999987531 12223456
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCC----CCCHHHHHHH
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPN----WFAPEVRRLL 243 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~s~~l~~li 243 (472)
..+|+.|+|||++......+.++||||||+++++|++|..||...+ ......+........+. ..++++.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7889999999998734445689999999999999999999999873 33333333322221111 1238999999
Q ss_pred hcccCCCCCCcCChhhhhcCccc
Q 012021 244 SKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
No 100
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=9.6e-47 Score=354.39 Aligned_cols=255 Identities=34% Similarity=0.670 Sum_probs=221.1
Q ss_pred CCcccCCeEEE-eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-
Q 012021 5 GSILMQRYELG-RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS- 81 (472)
Q Consensus 5 g~~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~- 81 (472)
..-+.+.|.+- +.||-|-.|+|-.+.++.||+.+|+|++... ...++|++..-+. .|||||.++++|++
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 34466778876 6799999999999999999999999998543 3467899887655 59999999999854
Q ss_pred ---CCEEEEEEEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCEEEee
Q 012021 82 ---KTKIYFVMEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSD 152 (472)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~---g~vkl~D 152 (472)
...+.+|||+++||+|++.|.. | .++|.++..+++||..|+.|||+.+|.||||||||+|...+ ..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 4568899999999999999975 3 59999999999999999999999999999999999999754 4699999
Q ss_pred ccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhccC
Q 012021 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAE 228 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~ 228 (472)
||+|+.... ...+.+.|-||+|+|||++....|+ ...|+||+||++|.||+|++||.... ...+..+|..+.
T Consensus 208 fGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 208 FGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred cccccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 999987653 3457899999999999999888876 78999999999999999999997643 346778899998
Q ss_pred CCCCC--C--CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 229 FKFPN--W--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 229 ~~~~~--~--~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
+.||. | +|.+++++|+.+|..+|.+|.|+.++++|||+.....
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 88874 4 7899999999999999999999999999999986543
No 101
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.8e-45 Score=377.44 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=205.6
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.+|+.++||||+++++++..+...|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 345689999999999999999999999999999997532 34678999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|||++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....... .
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 9999995 678777754 679999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-------HHHHHHHH--------------
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-------LMEMYRKI-------------- 224 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-------~~~~~~~i-------------- 224 (472)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 223456899999999999877664 89999999999999999998875321 01111111
Q ss_pred ------------hccC----CCCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 225 ------------GKAE----FKFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 225 ------------~~~~----~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.... ...|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0000 01111 14568999999999999999999999999999986
No 102
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=1.7e-45 Score=372.09 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=213.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||.|+||+||+|.+..+++.||+|.+.+.... ......+.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3567999999999999999999999999999999998754321 22345677899999999999999999987543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+++|++ +++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999988 7789888888889999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------ 228 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (472)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 12456799999999998775555689999999999999999999998766544433332110
Q ss_pred -----------CCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 229 -----------FKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 -----------~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
... ....++.+.+||.+||..||.+|||+.++++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 001 12356778999999999999999999999999999863
No 103
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=9.5e-46 Score=380.77 Aligned_cols=253 Identities=31% Similarity=0.470 Sum_probs=218.3
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-C-----CCeeeEEEE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-H-----PNVVELYEV 78 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~ 78 (472)
++++..||+|++.||+|+||.|.+|.|..|++.||||+++..+ ....+...|+.||..|+ | -|||+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 4556669999999999999999999999999999999997765 45677889999999997 4 489999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--CEEEeec
Q 012021 79 MASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG--NLKVSDF 153 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g--~vkl~DF 153 (472)
|...++.|||+|.+ +-+|+++++. .+++...++.+++||+.||.+||+.||||+|||||||||.+.+ .|||+||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 99999999999999 5689999976 4689999999999999999999999999999999999997654 6999999
Q ss_pred cchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------
Q 012021 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------ 227 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------ 227 (472)
|.|+.... ...+.+-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|...
T Consensus 336 GSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 336 GSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccccccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 99986532 23478899999999999999997 7899999999999999999999998887777666310
Q ss_pred ----------------------------------------------CCCCCCC-----------CCHHHHHHHhcccCCC
Q 012021 228 ----------------------------------------------EFKFPNW-----------FAPEVRRLLSKILDPN 250 (472)
Q Consensus 228 ----------------------------------------------~~~~~~~-----------~s~~l~~li~~~L~~d 250 (472)
....|.. -...+.+||++||+.|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0001100 0135789999999999
Q ss_pred CCCcCChhhhhcCccccc
Q 012021 251 PNTRISMTKIMENSWFRK 268 (472)
Q Consensus 251 P~~Rpt~~eil~h~~f~~ 268 (472)
|.+|+|..++|+||||..
T Consensus 490 P~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTG 507 (586)
T ss_pred chhcCCHHHHhcCccccc
Confidence 999999999999999984
No 104
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=2.7e-45 Score=375.05 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=214.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-----KI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (472)
.|++++.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999999865422 2234567889999999999999999999998776 89
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 467776654 6799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc------------------
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------------ 226 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~------------------ 226 (472)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 159 -KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred -ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2233457899999999998765556899999999999999999999988766554443321
Q ss_pred -----cCC---------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 227 -----AEF---------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 227 -----~~~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
... .+....++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234678999999999999999999999999999998753
No 105
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=6.8e-45 Score=358.45 Aligned_cols=254 Identities=27% Similarity=0.486 Sum_probs=216.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999976654443444567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence 9999999888743 369999999999999999999999999999999999999999999999999986543221 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---HHHHH-HhccCCCCCCCCCHHHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---EMYRK-IGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~---~~~~~-i~~~~~~~~~~~s~~l~~li 243 (472)
.....||+.|+|||++.+..+. .++||||||+++|+|++|..||...... ..... ........+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877664 7899999999999999999999864321 11121 22223345667899999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCccccc
Q 012021 244 SKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~h~~f~~ 268 (472)
.+||+.||.+||| ++++++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
No 106
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=8.1e-45 Score=351.83 Aligned_cols=256 Identities=30% Similarity=0.565 Sum_probs=220.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK--VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.|++.+.||+|+||.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++.++...|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1234678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|+||++|++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.+++++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998865 678999999999999999999999999999999999999999999999999987543322111
Q ss_pred -ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHH
Q 012021 167 -LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 167 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li 243 (472)
......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+......++... ...+|..+++++.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1134568899999999987664 48999999999999999999999887666555554433 3456777899999999
Q ss_pred hcccCCCCCCcCChhhhhcCccc
Q 012021 244 SKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
No 107
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=6.9e-45 Score=357.55 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=205.3
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----C
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMAS-----K 82 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 82 (472)
+|++.+.||+|+||+||+|++..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543221 2233456778777665 69999999999854 3
Q ss_pred CEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~ 159 (472)
..++++|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 78777754 35899999999999999999999999999999999999999999999999998765
Q ss_pred hcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-----------
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE----------- 228 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------- 228 (472)
.... ......||+.|+|||++.+..+. .++|||||||++|+|++|..||..........++....
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQM---ALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCcc---cCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 4322 12345789999999999776654 89999999999999999999998776655444432200
Q ss_pred C----------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 F----------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~----------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
. .+.+.++.++.++|.+||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367789999999999999999999999999998
No 108
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=5.1e-45 Score=367.73 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=206.8
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+-.++|++++.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455679999999999999999999753 3567899999865432 23446788999999999 899999999988
Q ss_pred EeC-CEEEEEEEecCCCcccchhcc-------------------------------------------------------
Q 012021 80 ASK-TKIYFVMEYVKGGELFGKVAK------------------------------------------------------- 103 (472)
Q Consensus 80 ~~~-~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------- 103 (472)
... ..+|+||||+++|+|.+++..
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 468999999999999888753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCC
Q 012021 104 --------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175 (472)
Q Consensus 104 --------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~ 175 (472)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 237788899999999999999999999999999999999999999999999987653222111122345678
Q ss_pred cccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH-HHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCC
Q 012021 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME-MYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 176 ~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~ 252 (472)
.|+|||++.+..+. .++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++++.++|.+||..||.
T Consensus 241 ~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 241 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 89999999777665 89999999999999997 999998755433 33333333 3455667899999999999999999
Q ss_pred CcCChhhhhc
Q 012021 253 TRISMTKIME 262 (472)
Q Consensus 253 ~Rpt~~eil~ 262 (472)
+|||+.++++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999986
No 109
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=7e-45 Score=369.48 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=210.1
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 567899999999999999999999999999999999875432 223456778999999999999999999998543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 5555553 358999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 171 ~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred Cc---cccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 32 123456799999999999877765 7899999999999999999999877654433222110
Q ss_pred ---------C-----CC---------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 ---------E-----FK---------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~-----~~---------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
. .. .+...+.++++||.+||..||++|||+.|+++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00 011135678999999999999999999999999999753
No 110
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.1e-46 Score=364.09 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=230.8
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.+-|+.-+.||+|+||+||-++-+.||+.+|+|.+++..+.+..-.....+|-.||.+++.+.||.+-..|++++.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567889999999999999999999999999999999888766555566789999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||..++||+|.-.|.+ | .++|..++.|+.+|+.||++||+++|++||+||+|||||+.|+++|+|+|||..+....
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999777755 4 79999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhccCCCCCCCCCHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
. ....+||.+|||||++.+..|+ ...|.|||||++|+|+.|+.||.... ..+.-+.+......+|..+|+++
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred c---cccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 2 3455999999999999888875 89999999999999999999997643 33556667777888999999999
Q ss_pred HHHHhcccCCCCCCcCC-----hhhhhcCccccc
Q 012021 240 RRLLSKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt-----~~eil~h~~f~~ 268 (472)
+++.+.+|..||++|.. ++++.+||||+.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999999985 569999999986
No 111
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=1.3e-44 Score=354.86 Aligned_cols=247 Identities=29% Similarity=0.465 Sum_probs=207.4
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443323334566799999999999999999999999999999999999999
Q ss_pred cchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCC
Q 012021 98 FGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 98 ~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
.+.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCC
Confidence 887743 358999999999999999999999999999999999999999999999999987654321 12345799
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCC-CCCCHHHHHHHhcccCC
Q 012021 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFP-NWFAPEVRRLLSKILDP 249 (472)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~l~~li~~~L~~ 249 (472)
+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..............+ ..+++++.++|++||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 4899999999999999999999976432 233333333333332 35899999999999999
Q ss_pred CCCCcCCh----hhhhcCccccc
Q 012021 250 NPNTRISM----TKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rpt~----~eil~h~~f~~ 268 (472)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 66789999975
No 112
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=2.1e-44 Score=354.75 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=219.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+|+.++|+||+.+++++..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999977654443444567889999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---S 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---c
Confidence 9999999877743 369999999999999999999999999999999999999999999999999886543211 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH----HHHHhccCCCCCCCCCHHHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM----YRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~l~~li 243 (472)
.....|++.|+|||.+.+..+. .++|+||||+++|+|++|..||........ ...+......++..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999776654 789999999999999999999987655332 23334444556677899999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCcccccC
Q 012021 244 SKILDPNPNTRIS-----MTKIMENSWFRKG 269 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~h~~f~~~ 269 (472)
.+||+.||++||| +.++++|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999863
No 113
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.8e-44 Score=357.69 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=214.3
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 467899999999999999999999999999999998754322 223457789999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 999997 478777754 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------ 227 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (472)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 12234567899999999876655568999999999999999999999887665444332210
Q ss_pred -CCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 228 -EFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 -~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
....| ..+++++++||.+||..||.+|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111 246888999999999999999999999999999975
No 114
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=6.8e-45 Score=383.24 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=203.1
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC------CCeeeEEEEEEe
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH------PNVVELYEVMAS 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~ 81 (472)
..++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999996432 223456678888877754 458999999876
Q ss_pred C-CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCC------------
Q 012021 82 K-TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHG------------ 146 (472)
Q Consensus 82 ~-~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g------------ 146 (472)
+ .++|+|||++ |++|.+++.+ +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5789999988 7788887754 689999999999999999999998 5999999999999998766
Q ss_pred ----CEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH
Q 012021 147 ----NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 147 ----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~ 222 (472)
.+||+|||++..... .....+||+.|+|||++.+..|. .++|||||||++|+|++|++||...+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998753221 12456899999999999887775 78999999999999999999998776554433
Q ss_pred HHhccCCCCC----------------------------C--------------CCCHHHHHHHhcccCCCCCCcCChhhh
Q 012021 223 KIGKAEFKFP----------------------------N--------------WFAPEVRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 223 ~i~~~~~~~~----------------------------~--------------~~s~~l~~li~~~L~~dP~~Rpt~~ei 260 (472)
.+......+| . ..++.+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 3321110000 0 013567799999999999999999999
Q ss_pred hcCcccccCC
Q 012021 261 MENSWFRKGL 270 (472)
Q Consensus 261 l~h~~f~~~~ 270 (472)
|+||||.+..
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999998743
No 115
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.4e-45 Score=356.56 Aligned_cols=251 Identities=33% Similarity=0.534 Sum_probs=213.3
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
..=+|+-.+.+|.|+||.||.|....+++.||||.+-.++..+ .+|+.+|+.++|||||+|..+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3447999999999999999999999999999999986665433 38999999999999999999984332
Q ss_pred -EEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCEEEeeccch
Q 012021 84 -KIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLS 156 (472)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~-g~vkl~DFGla 156 (472)
...+||||++. +|.+.++ +.+++.-.++-|.+||++||.|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 34589999954 8888887 4679999999999999999999999999999999999999976 89999999999
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc----------
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK---------- 226 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~---------- 226 (472)
+....+..+ .+...|..|+|||.+.+...++.+.||||.||++.||+-|++-|.+.+..++...|.+
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987655443 4567799999999998887777999999999999999999999999877665554431
Q ss_pred -------cCCC------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 227 -------AEFK------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 -------~~~~------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+.. +....++++.+|+.++|..+|.+|.++.|++.||||..-
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 0111 122368999999999999999999999999999999864
No 116
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.3e-44 Score=368.76 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=210.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||+|+||.||.|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 4578999999999999999999999999999999999754322 23446778999999999999999999987543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999965 5666554 358899999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------ 228 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (472)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+.++....
T Consensus 178 ~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred CC---CcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 32 123456799999999999887765 78999999999999999999998877655544442210
Q ss_pred ----------CC--------------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 229 ----------FK--------------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ----------~~--------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.. .....+.++++||.+||..||.+|||+.++++||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00113467899999999999999999999999999974
No 117
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=7.1e-44 Score=344.05 Aligned_cols=252 Identities=26% Similarity=0.537 Sum_probs=218.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 89 (472)
+|++++.||.|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999765432 2345678899999999999999999998864 45789999
Q ss_pred EecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 90 EYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||+++++|.+++.. ..+++.+++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--D 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--C
Confidence 99999999988864 358999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhc
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~ 245 (472)
......|++.|+|||++.+..+. .++|+||||+++++|++|..||...+.......+..+.. ..+..+++++.++|.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 23456789999999998776654 789999999999999999999988777666555555443 4566789999999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012021 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f 266 (472)
||++||.+|||+.+++.||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
No 118
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=5.4e-44 Score=347.13 Aligned_cols=255 Identities=29% Similarity=0.578 Sum_probs=219.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK------VGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+|.++..||.|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 6899999999999999999999999999999986543321 2344678899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
.++||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999876 679999999999999999999999999999999999999999999999999987665321
Q ss_pred CC----CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012021 164 QD----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 164 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.. .......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+....+.++... ...+|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 111234688999999998776654 7899999999999999999999887665555444433 34566778999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+.++|.+||++||.+||++.+|++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 119
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.9e-46 Score=396.47 Aligned_cols=259 Identities=32% Similarity=0.568 Sum_probs=230.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|+|++.||+|+||.|.+++.+.|++.||+|++++-...+......++.|-.||.--+.+=|++++..|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 46899999999999999999999999999999999874433334456789999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||++||+|..++.+ ++++|+.++.|+..|+.||+.+|+.|+|||||||+|||||.+|++||+|||.+......+. -.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EE
Confidence 999999999999987 5799999999999999999999999999999999999999999999999998776553222 22
Q ss_pred cccccCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCC--CCCCHHH
Q 012021 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFP--NWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~l 239 (472)
....+|||.|++||++.. .+.+|..+|.||+||++|||+.|..||...+..+.|.+|..- .+.|| ..+|+++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 356789999999999853 355678999999999999999999999999999999999764 67888 4589999
Q ss_pred HHHHhcccCCCCCCcCC---hhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRIS---MTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt---~~eil~h~~f~~~ 269 (472)
++||.+++. +|..|.. +++|..||||...
T Consensus 313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 999999876 5788888 9999999999863
No 120
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=7.7e-44 Score=355.43 Aligned_cols=258 Identities=34% Similarity=0.608 Sum_probs=225.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776544345677899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC-
Q 012021 90 EYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~- 165 (472)
||+.|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998864 46999999999999999999999999999999999999999999999999998754321110
Q ss_pred --------------------------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH
Q 012021 166 --------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME 219 (472)
Q Consensus 166 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~ 219 (472)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468999999999987765 479999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCC--CCHHHHHHHhcccCCCCCCcCC----hhhhhcCccccc
Q 012021 220 MYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRIS----MTKIMENSWFRK 268 (472)
Q Consensus 220 ~~~~i~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt----~~eil~h~~f~~ 268 (472)
.+..+......++.. +++++.++|.+||..||++||| ++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777776666555554 6899999999999999999999 999999999986
No 121
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=8.7e-44 Score=352.47 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=220.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|++.+.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+......|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 46999999999999999999999999999999998765432 246788999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~ 173 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987643322 112
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~ 245 (472)
....|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....+..+++.+.++|.+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred CcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 34578999999999877655 48999999999999999999999877654333223222 223455688999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
||..+|++|||+.+|++||||...
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999763
No 122
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=6.4e-44 Score=349.89 Aligned_cols=252 Identities=31% Similarity=0.475 Sum_probs=208.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654322 2334678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 91 YVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+|||++.+|.++|+|||++....... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--R 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--c
Confidence 997 477776643 468999999999999999999999999999999999999999999999999987543221 1
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------C
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------E 228 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~ 228 (472)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...........+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876554457899999999999999999999876543222211100 0
Q ss_pred -----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 -----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
......+++++.++|.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00122368899999999999999999999999999998
No 123
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4.2e-44 Score=369.01 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=208.5
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+.++..+|++++.||+|+||.||+|.... ++..||+|.+.... ...+|+.+|+.++||||+++++++...
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 45667789999999999999999997643 56889999986542 346899999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...|+|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999999995 578787754 6899999999999999999999999999999999999999999999999999876544
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---HHHHHHHhc----c-------
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---MEMYRKIGK----A------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~~----~------- 227 (472)
...........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+... ...+..+.+ .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 3222223356799999999999877765 789999999999999999999976431 111111110 0
Q ss_pred ------------------CCCCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 228 ------------------EFKFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 ------------------~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.+..|. .++.++.++|.+||..||++|||+.+++.||||.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 011111 24668899999999999999999999999999976
No 124
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=9.5e-44 Score=354.17 Aligned_cols=253 Identities=27% Similarity=0.483 Sum_probs=214.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986542 2334567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++|++|.+++.. +.+++..+..++.||+.||.|||+ .|++||||||+|||++.++.++|+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 99999999999865 679999999999999999999998 59999999999999999999999999988654322 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------------
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------- 227 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------- 227 (472)
....+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 245678999999999876655 47899999999999999999999765543333222111
Q ss_pred -----------------CCCCCC-CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 -----------------EFKFPN-WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 -----------------~~~~~~-~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
....|. .+++++.++|.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 111111 267889999999999999999999999999999763
No 125
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=4.2e-44 Score=346.40 Aligned_cols=252 Identities=30% Similarity=0.614 Sum_probs=223.3
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987665444566889999999999999999999999999999999999
Q ss_pred ecCCCcccchhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 91 YVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+.|++|.+++... .+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 99999999999764 89999999999999999999999999999999999999999999999999987654322 234
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
...|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+ ...............|..++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678999999999977664 489999999999999999999998766 334433333356677788899999999999
Q ss_pred cCCCCCCcCCh--hhhhcCccc
Q 012021 247 LDPNPNTRISM--TKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~--~eil~h~~f 266 (472)
|..||.+||+. +++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
No 126
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.7e-43 Score=350.54 Aligned_cols=255 Identities=29% Similarity=0.528 Sum_probs=221.5
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.....+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 579999999999999999999999999999999875432 23467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+.+++|..++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (296)
T ss_pred EecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence 999999999999888899999999999999999999999999999999999999999999999999875443221 123
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhcc
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~~ 246 (472)
...|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+.......+... ....+..+++.+.++|.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred CcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 45789999999998776654 7899999999999999999999887765444444322 2334556889999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCC
Q 012021 247 LDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
|..||.+|||+.+|+.||||+...
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999999998643
No 127
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-45 Score=346.41 Aligned_cols=256 Identities=31% Similarity=0.645 Sum_probs=220.3
Q ss_pred eEE-EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012021 12 YEL-GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 12 y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
|.+ .+.||+|+|+.|--+.+..+|..+|||++++.. .....++.+|++++...+ |+||++|+++|+++++.|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 444 378999999999999999999999999998874 245678999999999985 999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CEEEeeccchhhhhcc---
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSALAESK--- 162 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g---~vkl~DFGla~~~~~~--- 162 (472)
|-+.||+|...|.+ ..++|.++.++.++|+.||+|||.+||.||||||+|||-.... -+|||||.|..-....
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999999888866 6799999999999999999999999999999999999996554 4899999986543221
Q ss_pred --cCCCccccccCCCcccChhhhc----ccCCCCCcccchhhhHHHHHHhcCCCCCCCC---------------cHHHHH
Q 012021 163 --HQDGLLHTTCGTPAYVAPEVIN----RRGYDGSKADIWSCGVILYVLLAGYLPFHDS---------------NLMEMY 221 (472)
Q Consensus 163 --~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---------------~~~~~~ 221 (472)
.....+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. =...++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1223456789999999999863 2233448999999999999999999999642 134678
Q ss_pred HHHhccCCCCCCC----CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 222 RKIGKAEFKFPNW----FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 222 ~~i~~~~~~~~~~----~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..|..+.+.||.. +|.+++++|+.+|..|+..|.++.++++|||++...
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 8899999999963 899999999999999999999999999999998643
No 128
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=2.3e-43 Score=341.85 Aligned_cols=255 Identities=31% Similarity=0.533 Sum_probs=219.9
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999999999999987654322 4578899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 90 EYVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999864 45899999999999999999999999999999999999999999999999998876543322
Q ss_pred --CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCC-----CCCCH
Q 012021 166 --GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFP-----NWFAP 237 (472)
Q Consensus 166 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~s~ 237 (472)
.......|++.|+|||.+......+.++|+||||+++++|++|+.||...+....+.++..... .++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 1224457899999999987664456899999999999999999999988776665555544332 121 24678
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 238 EVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
++.+++.+||..||++|||+.+|+.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
No 129
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1e-43 Score=352.15 Aligned_cols=257 Identities=30% Similarity=0.513 Sum_probs=220.1
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 47899999999999999999999999999999998754432 236688999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||+++++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 172 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999875433221 12
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~ 245 (472)
....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..+++.+.++|.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred CcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 34578999999999977665 48899999999999999999999876553332222221 223455678899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCCC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
||..+|++|||+.++++||||+....
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 252 CLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HccCChhhCcCHHHHhcCchhccccc
Confidence 99999999999999999999986543
No 130
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=2.4e-43 Score=345.75 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=212.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|++..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5899999999999999999999999999999998654321 123356789999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++++.|..++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 99999888877654 5799999999999999999999999999999999999999999999999999886543321 12
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------CC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------EF 229 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (472)
....++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 33467889999999876554568999999999999999999999876654333222110 00
Q ss_pred CCC------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 KFP------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~~------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..| +.++..+.+||.+||+++|++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
No 131
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=7.6e-44 Score=355.65 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=193.7
Q ss_pred EeeEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEEEEEE
Q 012021 15 GRLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKIYFVME 90 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 90 (472)
+++||+|+||+||+|++. .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999976 4678999999865432 2456789999999999999999999854 567899999
Q ss_pred ecCCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCCEEEeeccch
Q 012021 91 YVKGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLS 156 (472)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILl----d~~g~vkl~DFGla 156 (472)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9854 67666531 258999999999999999999999999999999999999 45678999999999
Q ss_pred hhhhcccC-CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---------HHHHHHHhc
Q 012021 157 ALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---------MEMYRKIGK 226 (472)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---------~~~~~~i~~ 226 (472)
........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 86543221 12234568899999999998765556899999999999999999999964321 111111100
Q ss_pred ----------------------------cCCCC----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 227 ----------------------------AEFKF----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 227 ----------------------------~~~~~----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..... ....++++.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01134678899999999999999999999999998
No 132
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.4e-43 Score=345.90 Aligned_cols=256 Identities=32% Similarity=0.546 Sum_probs=223.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 589999999999999999999999999999999876532 233466889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+.+++|.+++..+++++..++.++.||+.|+.|||++|++||||+|+||++++++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999876654321 123
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCC-CCHHHHHHHhccc
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNW-FAPEVRRLLSKIL 247 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~l~~li~~~L 247 (472)
...|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.... ...+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4578899999999987765 489999999999999999999998777665555554443 334444 7899999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012021 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..+|++|||++++++||||++..
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCC
Confidence 99999999999999999998643
No 133
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=9.4e-44 Score=348.32 Aligned_cols=256 Identities=33% Similarity=0.499 Sum_probs=220.8
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||.|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 357999999999999999999998899999999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 999999999998865 4699999999999999999999999999999999999999999999999998876543221
Q ss_pred ccccccCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHHH
Q 012021 167 LLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~l 239 (472)
......||+.|+|||.+... ...+.++|+||||+++|+|++|..||...+......++..... ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 12345689999999997532 2234689999999999999999999988877666666665432 3455688999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.++|.+||+.+|.+||++.++++||||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
No 134
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=2.4e-43 Score=350.43 Aligned_cols=258 Identities=33% Similarity=0.644 Sum_probs=221.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997765433345567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC----
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ---- 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~---- 164 (472)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999998763211000
Q ss_pred ---------CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--
Q 012021 165 ---------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN-- 233 (472)
Q Consensus 165 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~-- 233 (472)
........|+..|+|||.+....+ +.++|+||||+++|+|++|..||.+....+....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001123467889999999877665 48999999999999999999999988777777777665444332
Q ss_pred -CCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 234 -WFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 234 -~~s~~l~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
.+++++.++|.+||..||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 789999999965
No 135
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=3.6e-43 Score=338.61 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=221.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998765433 2445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|++|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--F 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--h
Confidence 9999999998865 4689999999999999999999999999999999999999999999999999876543221 2
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~ 246 (472)
....+|++.|+|||++.+..++ .++|+||||+++++|++|..||...+......++..... .++..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2345789999999999877654 789999999999999999999998887777777666543 34446889999999999
Q ss_pred cCCCCCCcCChhhhhcCccc
Q 012021 247 LDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f 266 (472)
|+.+|++||++.+++.|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
No 136
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=2.4e-43 Score=342.44 Aligned_cols=254 Identities=26% Similarity=0.500 Sum_probs=216.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL---KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+|++++.||.|+||+||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 58899999998754321 12334678999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc---
Q 012021 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH--- 163 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~--- 163 (472)
+|||++|++|.+++.+ +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999876 679999999999999999999999999999999999999999999999999987653211
Q ss_pred -CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHH
Q 012021 164 -QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEV 239 (472)
Q Consensus 164 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l 239 (472)
.........|+..|+|||.+.+..+. .++|+||||+++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11122345689999999999776654 7899999999999999999999876655444333332 234666789999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.++|.+||.++|.+|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
No 137
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=5.7e-44 Score=350.34 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=208.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
||++.+.||.|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+.+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999975432 22334567789999999999999999999999999999999
Q ss_pred ecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 91 YVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|+.+ +|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++....... ...
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCc
Confidence 9975 6766664 3679999999999999999999999999999999999999999999999999987554321 122
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC-CCcHHHHHHHHhccC-------------------
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKAE------------------- 228 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~-~~~~~~~~~~i~~~~------------------- 228 (472)
....+++.|+|||++.+....+.++|||||||++|+|++|..||. ..+..+.+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 345678999999998776555689999999999999999988854 444334333332100
Q ss_pred C----------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 F----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+ ...+.++++++++|.+||..||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
No 138
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=1.1e-43 Score=356.72 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=206.8
Q ss_pred EEEeeEccc--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 13 ELGRLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 13 ~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+++++||+| +||+||++.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 7899999999999999999999765432 2445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC---
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ--- 164 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~--- 164 (472)
|+++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999998854 4599999999999999999999999999999999999999999999999986543221111
Q ss_pred --CCccccccCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-----------
Q 012021 165 --DGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK----------- 230 (472)
Q Consensus 165 --~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~----------- 230 (472)
........++..|+|||++.+. ...+.++|||||||++|+|++|..||..............+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234577889999998753 22347899999999999999999999875543332222211100
Q ss_pred -----------------------------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 231 -----------------------------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 231 -----------------------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
....+++++.+||.+||+.||++|||++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 11124678999999999999999999999999999976
No 139
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.5e-43 Score=370.43 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=204.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|||||++++++..++..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45589999999999999999999999999999996422 235689999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 578777754 46999999999999999999999999999999999999999999999999998765433222
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC--------cHHHHHHHHhccCC--------
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--------NLMEMYRKIGKAEF-------- 229 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~--------~~~~~~~~i~~~~~-------- 229 (472)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..|+... ....+.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222346799999999999877765 8999999999999999987664321 11222222222111
Q ss_pred ---------------------CCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 230 ---------------------KFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 ---------------------~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
..+. .+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1111 14568999999999999999999999999999974
No 140
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=3.3e-43 Score=339.51 Aligned_cols=252 Identities=29% Similarity=0.587 Sum_probs=220.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||+||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998765432 2344678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.+++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--L 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--h
Confidence 9999999998854 3589999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~ 246 (472)
.....|++.|+|||++.+..+ +.++|+|||||++++|++|..||...+..+....+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223468899999999876655 4789999999999999999999998888777777665554 45667899999999999
Q ss_pred cCCCCCCcCChhhhhcCccc
Q 012021 247 LDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f 266 (472)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
No 141
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=2.1e-43 Score=346.19 Aligned_cols=254 Identities=30% Similarity=0.501 Sum_probs=215.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 91 YVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|+ +++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999998854 5799999999999999999999999999999999999999999999999999886643321 223
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------CC
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------EF 229 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (472)
....|+..|+|||.+.+....+.++||||||+++|+|++|.+||........+..+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 45678999999999876655568999999999999999999888776655544433211 00
Q ss_pred C-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 230 K-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 230 ~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
. ..+..+.++.++|.+||..+|++|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 1123568899999999999999999999999999983
No 142
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.8e-43 Score=388.57 Aligned_cols=262 Identities=29% Similarity=0.508 Sum_probs=218.6
Q ss_pred CcCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q 012021 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (472)
..|.+..++|++++.||.|+||+||+|.+..++..||+|++...... ......+.+|+.+|+.++|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 45788899999999999999999999999999999999999765433 2345678899999999999999999998854
Q ss_pred -CCEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEcC----
Q 012021 82 -KTKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSR-------GVCHRDLKPENLLLDE---- 144 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~-------giiHrDlKp~NILld~---- 144 (472)
...+|+||||+.+++|.+++.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999998854 5799999999999999999999984 4999999999999964
Q ss_pred -------------CCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCC
Q 012021 145 -------------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYL 210 (472)
Q Consensus 145 -------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltG~~ 210 (472)
.+.+||+|||++...... ......+||+.|+|||++.+. ...+.++||||||||||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 234899999998765332 123456799999999998643 234578999999999999999999
Q ss_pred CCCCCcHHH-HHHHHhccCCCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 211 PFHDSNLME-MYRKIGKAEFKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 211 Pf~~~~~~~-~~~~i~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
||...+... ....+... ..+| ...++++.+||.+||..+|.+|||+.++|.|+|++..
T Consensus 242 PF~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 998765443 33333333 3333 4478999999999999999999999999999999754
No 143
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=2.9e-43 Score=345.25 Aligned_cols=250 Identities=24% Similarity=0.436 Sum_probs=210.8
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999876532 234467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence 99999988544 46889999999999999999999999999999999999999999999999998755322 224
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-------HHHHHHHhccC-CCC-CCCCCHHHH
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-------MEMYRKIGKAE-FKF-PNWFAPEVR 240 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-~~~~s~~l~ 240 (472)
..+||+.|+|||++.+..+. .++|+||||+++|+|++|..||..... ......+.... ... ....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 56899999999999877654 899999999999999999999965321 12222222221 222 234788999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 241 RLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
++|.+||+.+|.+||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999764
No 144
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=3.3e-43 Score=347.03 Aligned_cols=261 Identities=31% Similarity=0.459 Sum_probs=220.3
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
++-...++|++++.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++..++
T Consensus 6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 44455678999999999999999999999999999999986543 234567889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||++|++|..++.+ +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999999999877643 5799999999999999999999999999999999999999999999999998765332
Q ss_pred ccCCCccccccCCCcccChhhhcccC----CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCC
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRG----YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNW 234 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~ 234 (472)
... ......+++.|+|||.+.... ..+.++|+|||||++|+|++|..||...+....+.++..... ..+..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 163 TLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred ccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 211 123456889999999985321 224689999999999999999999988776665555544322 23456
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
++.++.++|.+||..||++||+++++++||||...
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 78899999999999999999999999999999753
No 145
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=4e-43 Score=344.47 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=217.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|++.+.||+|+||+||++.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 91 YVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|+.+++|...+.. +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 9999999887753 579999999999999999999999999999999999999999999999999987543221 122
Q ss_pred ccccCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHH
Q 012021 169 HTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRR 241 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~ 241 (472)
....|++.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+.... ...|..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34578999999999742 1223468999999999999999999998877666555554432 2345568899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+|.+||..||.+|||++++++||||+...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999999998643
No 146
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=2.2e-43 Score=343.82 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=211.8
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS----- 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----- 81 (472)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3578999999999999999999999999999999987543 2235788999999998 69999999999865
Q ss_pred -CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 82 -KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
...+|++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3578999999999999998864 368999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCccccccCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--CC
Q 012021 158 LAESKHQDGLLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--KF 231 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--~~ 231 (472)
...... .......|++.|+|||++... ...+.++|||||||++|+|++|..||...........+..... ..
T Consensus 160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 653321 123456799999999998532 1234789999999999999999999987665544444333221 12
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+..++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33478899999999999999999999999999997
No 147
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.9e-43 Score=343.60 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=212.1
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35689999999999999999999999999999999865432 223568899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+.+++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 9999999999998864 6799999999999999999999999999999999999999999999999999876533211
Q ss_pred ccccccCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC-----CCCCHHH
Q 012021 167 LLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-----NWFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~l 239 (472)
......|++.|+|||.+... ...+.++|+||+||++|+|++|..||...........+....+..+ ..++.++
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 12345789999999987432 2234789999999999999999999976654443333333332222 2367899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcc
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~ 265 (472)
.++|++||..+|++|||+++|++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
No 148
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=4.6e-43 Score=341.77 Aligned_cols=256 Identities=28% Similarity=0.525 Sum_probs=214.7
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-------VGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6999999999999999999999999999999986432111 123456889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+++||||+.+++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 68999999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCccccccCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC----CC
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN----WF 235 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 235 (472)
..........|+..|+|||.+.... ..+.++|+||||+++|++++|..||...+.......+... ...++. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233456899999999987654 2357899999999999999999999876655444333222 222332 35
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 236 APEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+.++.++|.+||.++|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
No 149
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=3.6e-43 Score=346.18 Aligned_cols=245 Identities=19% Similarity=0.263 Sum_probs=210.9
Q ss_pred CeEEE--eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCE
Q 012021 11 RYELG--RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----KTK 84 (472)
Q Consensus 11 ~y~i~--~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 84 (472)
.++.. ..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 19 ~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 19 DIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred HcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 34444 6799999999999987 799999999987654444446788899999999999999999999876 457
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
+++||||++||+|.+++.. +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 8999999999999999876 5799999999999999999999984 9999999999999999999999999998865332
Q ss_pred cCCCccccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPE 238 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~ 238 (472)
.....||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+.+..+... .+..|..++++
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 250 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLE 250 (283)
T ss_pred -----cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHH
Confidence 134578999999999875 344 58999999999999999999999998887777777443 45566568999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||+.||++|||++++++.
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999999999999999864
No 150
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=3.5e-43 Score=340.68 Aligned_cols=247 Identities=38% Similarity=0.720 Sum_probs=219.1
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+++..|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876654445567899999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCc
Q 012021 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999876 568999999999999999999999999999999999999999999999999987654332 1234578999
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHh--ccCCCCCCCCCHHHHHHHhcccCCCCC
Q 012021 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIG--KAEFKFPNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 177 y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~l~~li~~~L~~dP~ 252 (472)
|+|||.+....++ .++|+||||+++|+|++|..||.... ....+.++. .....+|...++++.++|.+||..+|.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776654 78999999999999999999998766 666666666 445677777899999999999999999
Q ss_pred CcCC-----hhhhhcCccccc
Q 012021 253 TRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 253 ~Rpt-----~~eil~h~~f~~ 268 (472)
+||+ ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999985
No 151
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=3.4e-43 Score=345.31 Aligned_cols=248 Identities=30% Similarity=0.515 Sum_probs=204.5
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR---LVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++++..++..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997765432222233444544444 4479999999999999999999999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccccc
Q 012021 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcC
Confidence 9999988865 679999999999999999999999999999999999999999999999999986543221 23457
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012021 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
||+.|+|||.+......+.++||||+||++|+|++|..||.... ..............+|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643334578999999999999999999997532 222222223345567778999999999999999
Q ss_pred CCCCcC-----ChhhhhcCccccc
Q 012021 250 NPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rp-----t~~eil~h~~f~~ 268 (472)
||.+|+ |++++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
No 152
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.6e-43 Score=343.97 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=212.0
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999865532 2335678899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||+.+++|.+++.. +.+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 999999999998864 689999999999999999999999999999999999999999999999999987543221 11
Q ss_pred cccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC-----CCCCHHHH
Q 012021 168 LHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-----NWFAPEVR 240 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~l~ 240 (472)
.....|++.|+|||++.. ....+.++|+|||||++|+|++|..||...........+.......+ ..++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 234578999999999742 22234789999999999999999999976654443333333332222 23678899
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcc
Q 012021 241 RLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h~~ 265 (472)
++|.+||..+|++|||+++|++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
No 153
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=1.5e-43 Score=347.50 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=214.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986644322 34567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++++.|..+... +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 99999988877654 469999999999999999999999999999999999999999999999999987654322 223
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------C
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------F 229 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (472)
....++..|+|||++.+....+.++||||||+++|+|++|..||......+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999998765555688999999999999999999998766544333322100 0
Q ss_pred ------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 ------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..++.++..+.+++.+||+.+|.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
No 154
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9e-45 Score=353.03 Aligned_cols=261 Identities=32% Similarity=0.578 Sum_probs=236.8
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (472)
..+-...|..+..||.|+||+|-+|..+.+.+.+|||++.+..+.....++--..|-.+|.... -|.+++++.+|.+-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3455668999999999999999999999999999999999988766555555567888888774 688999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+.||+|.-.|.+ |++.|..+..|+..|+-||-|||++||++||||.+|||||.+|++||+|||++..-..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 99999999999999888876 8999999999999999999999999999999999999999999999999999874332
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
.+....+.||||.|+|||++...+|. ..+|.||+||+||||++|+.||++.+..++++.|..-+..+|..+|.++.++
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 23345789999999999999988875 8899999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcCCh-----hhhhcCccccc
Q 012021 243 LSKILDPNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~-----~eil~h~~f~~ 268 (472)
++..|...|.+|... .+|.+||||+.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999999864 58999999985
No 155
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2e-43 Score=347.09 Aligned_cols=255 Identities=26% Similarity=0.488 Sum_probs=216.7
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986542 2233467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 90 EYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999998888664 79999999999999999999997 59999999999999999999999999998754322
Q ss_pred CCccccccCCCcccChhhhcccCC-----CCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHH---Hhcc-CCCCCCCC
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGY-----DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK---IGKA-EFKFPNWF 235 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~---i~~~-~~~~~~~~ 235 (472)
......|++.|+|||.+.+... .+.++|+|||||++|+|++|..||........+.. +... ...+|..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2244578999999999854432 25789999999999999999999976554443332 3222 34566678
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
++++.++|.+||..+|.+||+++++++||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997643
No 156
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=3.8e-43 Score=347.13 Aligned_cols=258 Identities=32% Similarity=0.457 Sum_probs=215.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... .......+..|+.+++.++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999765433 123345677899999999999999999999999999999
Q ss_pred EEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+ +++|.+++... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 88999998763 59999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----------------
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF----------------- 229 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (472)
......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||...+..+.+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345788999999986655556899999999999999999888887665554444422100
Q ss_pred -----------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 230 -----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 230 -----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
......+.++.++|.+||.+||++|||+.+++.||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 001224678999999999999999999999999999987554
No 157
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=3.1e-43 Score=341.68 Aligned_cols=256 Identities=26% Similarity=0.514 Sum_probs=215.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL---KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+|+.++.||+|+||.||.+.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 589999999999999999999999999999998754321 12345788999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-~vkl~DFGla~~~~~~~~~ 165 (472)
||||+.|++|.+++.. +++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998865 6799999999999999999999999999999999999998876 5999999998765432111
Q ss_pred --CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH---h--ccCCCCCCCCCHH
Q 012021 166 --GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI---G--KAEFKFPNWFAPE 238 (472)
Q Consensus 166 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~s~~ 238 (472)
.......||..|+|||.+.+..+. .++|+||||+++++|++|..||...........+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111234688999999998776654 7899999999999999999999754432222222 1 2234566678899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
No 158
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=7.8e-43 Score=339.50 Aligned_cols=256 Identities=28% Similarity=0.515 Sum_probs=215.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (472)
..|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3699999999999999999999999999999998754322 12345678899999999999999999999865 4688
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc-
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH- 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~- 163 (472)
|+++||+++++|.+++.. +.+++...+.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999998865 579999999999999999999999999999999999999999999999999987553221
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--cCCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~l~~ 241 (472)
.........++..|+|||.+.+..++ .++|||||||++|+|++|+.||...........+.. ....+|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11112335688999999999776654 789999999999999999999987765554444432 234566778899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
+| +||..+|++|||+++|++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
No 159
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3e-45 Score=371.17 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=226.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+-|+|+..||.|+||+||+|.++.++-.-|-|+|.... .+.++.+.-||.||..+.||+||+|++.|..+++++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 46889999999999999999999999999999986543 456788889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||.||-....+.. ..|+|.+++-+.+|+++||.|||+++|||||||..|||+.-+|.++|+|||.+.........
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk-- 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK-- 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh--
Confidence 99999988877754 67999999999999999999999999999999999999999999999999998754332222
Q ss_pred cccccCCCcccChhhh-----cccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC---CCCCCCHHH
Q 012021 168 LHTTCGTPAYVAPEVI-----NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK---FPNWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~-----~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~l 239 (472)
-.++.|||+|||||+. ...+|+ +++||||||++|.+|..+.+|-...+++..+-+|.+..++ -|..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 3567999999999986 345676 8999999999999999999999999999988888876653 366789999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+|+.+||..||..||++++|++||||++.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999999853
No 160
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=5.4e-43 Score=347.63 Aligned_cols=253 Identities=20% Similarity=0.321 Sum_probs=205.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLK----------------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp 70 (472)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+|+.++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCC
Confidence 346799999999999999999998532 345799999875432 23456788999999999999
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccchhccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 012021 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG--------------------KLKEDAARKYFQQLISAVDYCHSRGV 130 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~i~~ql~~aL~yLH~~gi 130 (472)
||+++++++.+.+..|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999998887432 35778899999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--C
Q 012021 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--G 208 (472)
Q Consensus 131 iHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--G 208 (472)
+||||||+|||++.++.+||+|||++................++..|+|||++....+ +.++||||||+++|+|++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999875533221111233456788999999876665 489999999999999986 6
Q ss_pred CCCCCCCcHHHHHHHHhc--------cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 209 YLPFHDSNLMEMYRKIGK--------AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..||...+.......+.. .....|+.++..+.++|.+||+.||++|||+.+|.+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 788877665544433321 112345567899999999999999999999999943
No 161
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=2.3e-43 Score=344.26 Aligned_cols=256 Identities=34% Similarity=0.704 Sum_probs=228.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 88 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++..++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544455577889999999998 99999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC--
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-- 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~-- 165 (472)
|||+.+++|.+++.+ +.+++..++.++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999976 48999999999999999999999999999999999999999999999999998765433211
Q ss_pred ----------------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC
Q 012021 166 ----------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF 229 (472)
Q Consensus 166 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~ 229 (472)
.......|+..|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11233467899999999876554 4789999999999999999999998887777777777778
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCCh----hhhhcCccc
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISM----TKIMENSWF 266 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~eil~h~~f 266 (472)
.+|..+++.+.++|.+||+.+|.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999998
No 162
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=2.3e-43 Score=361.36 Aligned_cols=254 Identities=23% Similarity=0.405 Sum_probs=208.0
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+-.++|++++.||+|+||.||+|++..+| ..||+|++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 34568999999999999999999875444 57999999765422 3356788999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc---------------------------------------------------------
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAK--------------------------------------------------------- 103 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------------------------------------------------------- 103 (472)
.....|+||||+.+|+|.+++..
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999887642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 104 --------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 104 --------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 247888999999999999999999999999999999999999999999999987553322111112
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHHhcc
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li~~~ 246 (472)
...+++.|+|||++....+. .++|||||||++|+|++ |..||........+...... ....|..+++++.++|.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 23356689999999776654 89999999999999997 99999876544333333322 3455677899999999999
Q ss_pred cCCCCCCcCChhhhhcC
Q 012021 247 LDPNPNTRISMTKIMEN 263 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h 263 (472)
|+.||.+|||+.++++.
T Consensus 352 l~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 352 WNLEPTERPTFSQISQL 368 (374)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999763
No 163
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.5e-42 Score=334.82 Aligned_cols=252 Identities=28% Similarity=0.545 Sum_probs=221.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 9999999998865 3689999999999999999999999999999999999999999999999999876543321 2
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CCCCCCHHHHHHHhcc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~l~~li~~~ 246 (472)
.....|++.|+|||.+.+..+. .++|+||||+++++|++|..||...+..+....+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999998776654 7899999999999999999999988887777777665443 3455789999999999
Q ss_pred cCCCCCCcCChhhhhcCccc
Q 012021 247 LDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f 266 (472)
|..+|.+||++.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
No 164
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=2e-42 Score=341.03 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=213.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK---- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---- 82 (472)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4678999999999999999999999999999999986543 2235678899999988 799999999998653
Q ss_pred -CEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 83 -TKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
+..|+||||++|++|.+++. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 46899999999999988774 257899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccCC----CCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---C
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGY----DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---F 229 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~ 229 (472)
......... .....|+..|+|||.+..... .+.++|||||||++|+|++|+.||...+.......+.+.. .
T Consensus 176 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 765432211 234568999999999854321 2578999999999999999999998876655555554432 2
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
..+..++.++.++|.+||+.+|++||++.+|++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445778899999999999999999999999999995
No 165
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=6.9e-43 Score=341.43 Aligned_cols=256 Identities=29% Similarity=0.577 Sum_probs=219.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (472)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58899999999999999999999999999999865432 234567889999999997 9999999999999999999
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||||++|++|.+++..+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--K 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--c
Confidence 99999999999999888899999999999999999999999999999999999999999999999999876544322 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCC-CCHHHHHHHhc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNW-FAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~l~~li~~ 245 (472)
.....|+..|+|||.+......+.++|+||||+++|+|++|..||...........+.... ..++.. ++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 2345789999999998655444689999999999999999999998876655544443332 223332 78899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
||+.||++|||+.+++.|+||++..
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999998754
No 166
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=8.3e-43 Score=342.21 Aligned_cols=249 Identities=32% Similarity=0.517 Sum_probs=207.9
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHH---HHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI---SVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
.||+|+||.||+|.+..+++.||+|.+.+..............|. ..++...||||+++++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999876443222222233343 34455679999999999999999999999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccccc
Q 012021 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
|++|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcC
Confidence 9999888865 679999999999999999999999999999999999999999999999999987543221 23457
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012021 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
|+..|+|||.+.+....+.++||||+|+++|+|++|..||... ........+......+|..+++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433457899999999999999999999876 3344444444556677777899999999999999
Q ss_pred CCCCcC-----ChhhhhcCcccccC
Q 012021 250 NPNTRI-----SMTKIMENSWFRKG 269 (472)
Q Consensus 250 dP~~Rp-----t~~eil~h~~f~~~ 269 (472)
+|.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999863
No 167
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=4.9e-43 Score=343.57 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=216.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3568999999999999999999986655 689999986543 223456789999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012021 83 TKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~ 145 (472)
...|++|||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999888753 357889999999999999999999999999999999999999
Q ss_pred CCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012021 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.++|+|||++................+++.|+|||.+....++ .++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999998754332222223345678899999998776654 89999999999999998 99999988887777777
Q ss_pred hccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 225 GKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.... ...|..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6544 34567789999999999999999999999999875
No 168
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=5.5e-43 Score=342.80 Aligned_cols=257 Identities=30% Similarity=0.504 Sum_probs=221.8
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3578899999999999999999999999999999875532 23457788999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||+.|++|.+++..+++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhccc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L 247 (472)
....++..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+... ....+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999876665 48999999999999999999999887666555444333 23344557889999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012021 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+.+|++||++.+++.|+||.+..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcc
Confidence 99999999999999999997643
No 169
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.2e-43 Score=358.00 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=199.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|++++.||+|+||.||+|.+..+++.||+|+..+.. ...|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999999999999999854332 34699999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---c
Confidence 99995 577777753 57999999999999999999999999999999999999999999999999998753321 1
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCC-CCCcH----------HHHHHHHh---ccCCCCC
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF-HDSNL----------MEMYRKIG---KAEFKFP 232 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf-~~~~~----------~~~~~~i~---~~~~~~~ 232 (472)
......||+.|+|||++.+..+. .++|||||||++|+|+++..|+ ..... ..+...+. .....++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 12345799999999999877765 8999999999999999865554 32111 01111111 0001111
Q ss_pred ------------------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 233 ------------------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ------------------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124567788999999999999999999999999975
No 170
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.3e-42 Score=334.80 Aligned_cols=251 Identities=33% Similarity=0.581 Sum_probs=219.3
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999865433 2345788999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CEEEeeccchhhhhcccCCC
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-~vkl~DFGla~~~~~~~~~~ 166 (472)
|++|++|.+++.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 9999999999865 2489999999999999999999999999999999999998655 579999999876543221
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.... ..++..+++++.++|.+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred -ccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 234568999999999876654 478999999999999999999998887776666665443 45667789999999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012021 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f 266 (472)
||.++|.+|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
No 171
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1.9e-42 Score=336.30 Aligned_cols=256 Identities=29% Similarity=0.532 Sum_probs=214.6
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (472)
..|++++.||+|+||.||.+.+..+|..||||.+..... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 122345688999999999999999999999866 3578
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999865 5789999999999999999999999999999999999999999999999999875532211
Q ss_pred -CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHH
Q 012021 165 -DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRR 241 (472)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~ 241 (472)
........|+..|+|||++.+..+ +.++||||||+++|+|++|+.||...........+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 111234568999999999977665 48899999999999999999999876655544444332 23456667888999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
+|++|+. +|++||++++|+.|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999974
No 172
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=1.6e-42 Score=335.28 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=216.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++...+.+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976532 2457889999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 999999999998864 5799999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-----CCCCCCHH
Q 012021 167 LLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-----FPNWFAPE 238 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~ 238 (472)
......++..|+|||.+... .++ .++|+||||+++|+|++|..||...+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 12345789999999998765 454 7899999999999999999999887665554444444222 22335788
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcc
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h~~ 265 (472)
+.++|.+||..+|..|||+.+|+.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
No 173
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=1.7e-42 Score=334.55 Aligned_cols=248 Identities=31% Similarity=0.582 Sum_probs=216.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+.+++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 59999999999999999999999999999999865432 2345778899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+++++|.+++.. +.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--Y 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--c
Confidence 9999999888753 4589999999999999999999999999999999999999999999999999875543221 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~ 246 (472)
.....|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+....+..+..+.. ..|..++..+.++|.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999877665 4789999999999999999999998887777766665544 35667889999999999
Q ss_pred cCCCCCCcCChhhhhcC
Q 012021 247 LDPNPNTRISMTKIMEN 263 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h 263 (472)
|+.||.+|||+.+|+.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
No 174
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=8.2e-43 Score=341.56 Aligned_cols=247 Identities=31% Similarity=0.523 Sum_probs=211.7
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765543333445667899999999999999999999999999999999999999
Q ss_pred cchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCC
Q 012021 98 FGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 98 ~~~i~~-~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
.+++.. + .+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---CccccccCC
Confidence 988854 3 6999999999999999999999999999999999999999999999999998765431 122345688
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCCCHHHHHHHhcccCCC
Q 012021 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250 (472)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~d 250 (472)
..|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ..+...+.......+..+++++.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877664 4789999999999999999999976543 333333444455667778999999999999999
Q ss_pred CCCcC-----ChhhhhcCccccc
Q 012021 251 PNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 251 P~~Rp-----t~~eil~h~~f~~ 268 (472)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999975
No 175
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=1.5e-42 Score=334.44 Aligned_cols=253 Identities=29% Similarity=0.526 Sum_probs=218.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
||+..+.||+|+||+||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999889999999998654321 123456789999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||+++++|.+++.+ +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999876 469999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--cCCCCCCCCCHHHHHHHhc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~l~~li~~ 245 (472)
.....|++.|+|||.+......+.++|+||||+++|+|++|..||..........++.. ....++..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 24567899999999987655245889999999999999999999987765554444443 2335566789999999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012021 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f 266 (472)
||..+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
No 176
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=9.9e-43 Score=346.55 Aligned_cols=258 Identities=31% Similarity=0.469 Sum_probs=213.3
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (472)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3568999999999999999999999999999999987543221 2233456899999999999999999998655 578
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 67777654 579999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------------
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---------------- 227 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------- 227 (472)
. ......+++.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+...
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1 1233356888999999876554568999999999999999999999988776665554321
Q ss_pred ---CCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 ---EFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+..+ .++++++.++|.+||++||++|||+.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 11111 2358899999999999999999999999999999853
No 177
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=5e-43 Score=358.95 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=207.6
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARN-----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+-.++|++++.||+|+||+||+|.+ ..++..||+|++..... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456899999999999999999974 34677899999865432 23346788999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhccC--------------------------------------------------------
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAKG-------------------------------------------------------- 104 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-------------------------------------------------------- 104 (472)
..+..|+||||++||+|.+++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999998877431
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 105 --------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 105 --------------------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 367888999999999999999999999999999999999999999999999876543222
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
........++..|+|||++.+..+. .++|||||||++|+|++ |..||...... ..+..+..+ ....|...+.++.+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 1111223456779999999777664 89999999999999998 89999876543 333333333 23345667899999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012021 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
||.+||++||++|||+.+|++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999865
No 178
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1e-42 Score=341.57 Aligned_cols=255 Identities=32% Similarity=0.535 Sum_probs=215.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999999999999999865432 2244578899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.++.+..+..+ ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99998777666654 5699999999999999999999999999999999999999999999999999886654332 123
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---------------------
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--------------------- 227 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--------------------- 227 (472)
....++..|+|||++.+....+.++||||||+++|+|++|..||...+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 44678899999999987734558999999999999999999999876554433322110
Q ss_pred C-----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 228 E-----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 228 ~-----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
. ..++..+++++.+||.+||..+|++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458899999999999999999999999999998
No 179
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=6.4e-43 Score=342.89 Aligned_cols=252 Identities=30% Similarity=0.487 Sum_probs=209.7
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++++.||.|+||.||+|.+..+|+.||||.+...... ......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998654322 2334578899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+. ++|..++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 996 578777643 568999999999999999999999999999999999999999999999999987554321 12
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------CC
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------EF 229 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~~ 229 (472)
.....+++.|+|||.+.+....+.++||||||+++|+|+||..||...+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467889999999876665568899999999999999999999876654333222110 00
Q ss_pred C-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 K-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
. ..+.++++++++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1 112367889999999999999999999999999998
No 180
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=1.2e-42 Score=340.83 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=210.6
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE------
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA------ 80 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------ 80 (472)
..++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3578999999999999999999999999999999986543 2335688899999988 6999999999984
Q ss_pred eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
....+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35689999999999999988854 458999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCccccccCCCcccChhhhcc-----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-C-
Q 012021 158 LAESKHQDGLLHTTCGTPAYVAPEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-K- 230 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~- 230 (472)
...... .......|++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhccc--cCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 654321 12244678999999999753 233 4689999999999999999999987665544443333221 1
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.+..+++++.++|.+||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223478999999999999999999999999999997
No 181
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=1.2e-42 Score=338.06 Aligned_cols=252 Identities=33% Similarity=0.507 Sum_probs=212.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-----
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK----- 82 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~----- 82 (472)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5799999999999999999999999999999999876542 336788999999998 699999999999654
Q ss_pred -CEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 83 -TKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
..+|+||||+.+++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 458999999999999887753 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccC----CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRG----YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--- 229 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--- 229 (472)
....... .......|++.|+|||++.... ..+.++||||||+++|+|++|..||...........+.....
T Consensus 161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 7543321 1223456899999999975432 234689999999999999999999987666555555554422
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..+..++.++.++|.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
No 182
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=1e-42 Score=350.97 Aligned_cols=260 Identities=29% Similarity=0.482 Sum_probs=211.6
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4578999999999999999999999999999999986432 223456678899999999999999999987544
Q ss_pred CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 83 TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
...|+++||+.+ +|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999964 8888888888999999999999999999999999999999999999999999999999998765332
Q ss_pred cC-CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc---------------
Q 012021 163 HQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--------------- 226 (472)
Q Consensus 163 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--------------- 226 (472)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 21 11223457899999999876544445899999999999999999999977654332221110
Q ss_pred c---------C--CC-----CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 227 A---------E--FK-----FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 227 ~---------~--~~-----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
. . .. ..+..++++.++|.+||+.+|++|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 0 00 1123578899999999999999999999999999998643
No 183
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=7.1e-43 Score=337.36 Aligned_cols=250 Identities=37% Similarity=0.693 Sum_probs=220.5
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||.|+||.||++.+..+|+.+|+|++...........+.+.+|+.+++.++||||+++++.+..+...|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776544445567899999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC------CCcccc
Q 012021 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ------DGLLHT 170 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~------~~~~~~ 170 (472)
.+++.+ +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 998876 6899999999999999999999999999999999999999999999999999876543321 012234
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCC--CHHHHHHHhcccC
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF--APEVRRLLSKILD 248 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~l~~li~~~L~ 248 (472)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+.......|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999876664 4899999999999999999999998888888888877777776665 8999999999999
Q ss_pred CCCCCcCCh---hhhhcCccccc
Q 012021 249 PNPNTRISM---TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~---~eil~h~~f~~ 268 (472)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
No 184
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-44 Score=357.19 Aligned_cols=249 Identities=33% Similarity=0.652 Sum_probs=222.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||.|-||+||-|.++.+|+.||||+|++.+... ...+++++|++||+.+.||.||.+--.|++.+++|+|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 78999999999999999999999999999987654 33488999999999999999999999999999999999999776
Q ss_pred cccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CEEEeeccchhhhhcccCCCcccc
Q 012021 96 ELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 96 ~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g---~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
-|.-.+. +|+++|...+.++.||+.||+|||-+||+|+|||||||||.+.. .+||||||+|+.+..+.- -.+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---Rrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhh
Confidence 6655554 48999999999999999999999999999999999999997665 599999999998875433 356
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--C--CCHHHHHHHhcc
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FAPEVRRLLSKI 246 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~l~~li~~~ 246 (472)
.+|||.|.|||++..++|. ..-|+||.|||+|.-+.|..||.... ++..+|.++.+.+|+ | +++++.+||..+
T Consensus 726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 7899999999999999998 78999999999999999999997654 455678888887775 3 899999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCCC
Q 012021 247 LDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
|+..-.+|+|++..+.|||++....
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred HHHHHHHhcchHhhccchhhhcchH
Confidence 9999999999999999999997543
No 185
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=1.7e-42 Score=337.54 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=211.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
-.++|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4568999999999999999999765 3567899999876532 2334678899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999998865 47999999999999999999999999999999999999999999999999986643221
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
.. .......++..|+|||.+.+..+. .++|||||||++|++++ |..||...+.......+..+ ....|..++..+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 11 011123456789999998776664 79999999999999775 99999988877777766654 3455667899999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||..+|.+|||+++|++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999975
No 186
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=6.1e-43 Score=345.89 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=218.7
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+++++|.+++..+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ...
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 999999999998888899999999999999999999999999999999999999999999999999875433221 123
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhcc
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~~ 246 (472)
...|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.......+.... ......++..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 45789999999998776654 78999999999999999999998877665555544322 222234788999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCC
Q 012021 247 LDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
|..||++|||++++++||||+...
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccC
Confidence 999999999999999999998643
No 187
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=1.5e-42 Score=344.03 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=206.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
..++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 456899999999999999999999999999999998654322 122345678999999999999999999986543
Q ss_pred ----EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 84 ----KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
..|+||||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 56999999965 77777654 379999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCC--CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------
Q 012021 158 LAESKHQD--GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------ 229 (472)
Q Consensus 158 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------ 229 (472)
........ .......++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 65432221 1223456788999999987655445789999999999999999999987765443332221100
Q ss_pred -------------CCC-------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 -------------KFP-------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 -------------~~~-------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.+| ...++.+.++|.+||..||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011 1135678899999999999999999999999998
No 188
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=2.3e-42 Score=339.34 Aligned_cols=253 Identities=27% Similarity=0.475 Sum_probs=210.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE-----e
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA-----S 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~ 81 (472)
..++|++.+.||+|+||+||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 4679999999999999999999999999999999986532 1235678899999998 6999999999873 4
Q ss_pred CCEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 82 KTKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
++..|+||||++|++|.+++. .+.+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 567999999999999988764 246899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---C
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---F 229 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~ 229 (472)
........ ......|++.|+|||++... ...+.++|||||||++|+|++|..||..........++.... .
T Consensus 172 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 172 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred eecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 75533211 12345699999999997532 123478999999999999999999998776554444433222 2
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..|..++.++.++|.+||+.||++|||+.++++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2345568899999999999999999999999999997
No 189
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=1.9e-42 Score=340.95 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=206.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999998754321 1223466899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 999975 88887754 4689999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc------------------
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA------------------ 227 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~------------------ 227 (472)
......+++.|+|||++.+....+.++||||||+++|+|++|+.||.... ..+....+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12234578899999998765444578999999999999999999997655 22222211100
Q ss_pred -CCCC-----------CCCCC--HHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 228 -EFKF-----------PNWFA--PEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 228 -~~~~-----------~~~~s--~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.... ...++ .++.++|.+||.++|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01233 788999999999999999999999999998
No 190
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=2.3e-42 Score=350.86 Aligned_cols=257 Identities=30% Similarity=0.501 Sum_probs=211.0
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999865432 223446677899999999999999999998543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 777776544 9999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
... ......||+.|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+.++...
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 TSF---MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCC---CCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 321 12345689999999999887765 8899999999999999999999876654443333110
Q ss_pred ---------CCC--------------C-------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 228 ---------EFK--------------F-------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 228 ---------~~~--------------~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
... + +...+++++++|.+||+.||++|||+.|+++||||+.-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 000 0 112356789999999999999999999999999997533
No 191
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.7e-42 Score=337.87 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=220.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
=|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 478899999999999999999999999999998654322 345678899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccc
Q 012021 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|+.+++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhcc
Confidence 99999999999888899999999999999999999999999999999999999999999999998875433211 1233
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCC
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~ 249 (472)
..|+..|+|||.+...... .++|+|||||++|+|++|..||...........+.... ..++..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 4688999999998766554 78999999999999999999998877666555554433 345566889999999999999
Q ss_pred CCCCcCChhhhhcCcccccCC
Q 012021 250 NPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 250 dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+|.+||++.+++.||||.+..
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhh
Confidence 999999999999999998743
No 192
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1.6e-42 Score=334.08 Aligned_cols=250 Identities=30% Similarity=0.526 Sum_probs=216.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999998899999999865431 57899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+||+.+++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999864 5789999999999999999999999999999999999999999999999999886644321
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHH
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li 243 (472)
......|+..|+|||++.+..++ .++||||||+++|+|++|..||...........+... ....+..++.++.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 12344588999999999877664 7899999999999999999999876655443333222 2233445788999999
Q ss_pred hcccCCCCCCcCChhhhhcCccc
Q 012021 244 SKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.+||+.||++|||+.+++.||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
No 193
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-44 Score=359.78 Aligned_cols=258 Identities=33% Similarity=0.604 Sum_probs=239.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-....+++.+||-|+||.|-++........+|+|++++..+.+....+.+..|-.||...+.|.||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34556788999999999999999876555569999999998888788889999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
++||-|-||+|...++. |.+++..++.|+..+++|++|||++||++|||||+|++||.+|-+||.|||+|+.......
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K- 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK- 575 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence 99999999999999975 7899999999999999999999999999999999999999999999999999998876443
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li 243 (472)
.-+.||||.|+|||++..++.+ .++|.||||+++|||++|.+||.+.+++..|..|.++ .+.+|..++..+.+||
T Consensus 576 --TwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred --eeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 5789999999999999999988 8999999999999999999999999999999999887 4788999999999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCccccc
Q 012021 244 SKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~h~~f~~ 268 (472)
+++...+|.+|.. +.+|..|.||..
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999996 789999999964
No 194
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4e-43 Score=354.34 Aligned_cols=241 Identities=29% Similarity=0.493 Sum_probs=210.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.+.+++.||+|-||+||++... ....||+|.+...... .+.+.+|+.+|+.|+|+|||++++++..+.-+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 3456789999999999999983 2348999999765432 2567799999999999999999999999889999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|++.|+|.+++.. +.+...+...++.||++|++||+++++|||||...|||++++..+||+|||||+......
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~---- 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE---- 357 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc----
Confidence 9999999999976 469999999999999999999999999999999999999999999999999999443211
Q ss_pred cccccC---CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012021 168 LHTTCG---TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 168 ~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
.....| ...|+|||.+....++ .+||||||||+|+||+| |+.||...+..+....+.++. .+.|..+|+++.++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 122222 3359999999888776 89999999999999999 999999999999999998874 67889999999999
Q ss_pred HhcccCCCCCCcCChhhhh
Q 012021 243 LSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil 261 (472)
+..||..+|++|||++.+.
T Consensus 437 M~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHhhCCcccCCCHHHHH
Confidence 9999999999999999664
No 195
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=3.4e-42 Score=332.66 Aligned_cols=252 Identities=32% Similarity=0.606 Sum_probs=219.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA--SKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV 88 (472)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++. .+...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 599999999999999999999999999999998765432 344567889999999999999999999875 34678999
Q ss_pred EEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEcCCCCEEEeeccchhh
Q 012021 89 MEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCH-----SRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH-----~~giiHrDlKp~NILld~~g~vkl~DFGla~~ 158 (472)
|||+++++|.+++.. +.+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999888853 57999999999999999999999 89999999999999999999999999999886
Q ss_pred hhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCH
Q 012021 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAP 237 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 237 (472)
...... ......|++.|+|||.+....+ +.++|+||||+++++|++|..||...+.......+..... .++..++.
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCcc--cccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 654321 1234578999999999877665 4789999999999999999999998877777777766554 45667889
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 238 EVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
++.+++.+||..+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
No 196
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=5.1e-42 Score=332.11 Aligned_cols=255 Identities=34% Similarity=0.614 Sum_probs=216.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
||++.+.||+|+||.||.+.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 799999999999999999999989999999999766533 3456789999999999999999999999999999999999
Q ss_pred ecCCCcccchhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC-c-
Q 012021 91 YVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-L- 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~- 167 (472)
|+.+++|.+++..+ .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999764 68999999999999999999999999999999999999999999999999988654332211 1
Q ss_pred cccccCCCcccChhhhcccC--CCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHh-ccCCCCCCCC--CHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRG--YDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIG-KAEFKFPNWF--APEVRR 241 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~-~~~~~~~~~~--s~~l~~ 241 (472)
.....+++.|+|||.+.... ..+.++||||||++++++++|..||.... .......+. .....+|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 23578999999999999999999997653 222222222 2334555554 899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
No 197
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.3e-42 Score=346.38 Aligned_cols=247 Identities=28% Similarity=0.442 Sum_probs=192.8
Q ss_pred EEeeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEEEEEE
Q 012021 14 LGRLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA--SKTKIYFVM 89 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~ 89 (472)
.+.+||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+|+||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 34789999999999999754 668999999865432 245778999999999999999999984 456889999
Q ss_pred EecCCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCCEEEeeccc
Q 012021 90 EYVKGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGL 155 (472)
Q Consensus 90 E~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILl----d~~g~vkl~DFGl 155 (472)
||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99865 66665531 258899999999999999999999999999999999999 5667899999999
Q ss_pred hhhhhcccCC-CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---------HHHHHHh
Q 012021 156 SALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---------EMYRKIG 225 (472)
Q Consensus 156 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~---------~~~~~i~ 225 (472)
+......... .......||+.|+|||++.+....+.++|||||||++|+|+||..||...... ....++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9865432211 12344578999999999977655568999999999999999999999643211 0000000
Q ss_pred c----------------------------cCC----------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 226 K----------------------------AEF----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 226 ~----------------------------~~~----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
. ... ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 0011134568899999999999999999999999998
No 198
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=3.2e-42 Score=348.66 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=215.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
+.++|++++.||+|+||.||+|.+..+|..||||.+.+... .......+.+|+.+|+.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 56799999999999999999999999999999999865432 2234456889999999999999999999987654
Q ss_pred --EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 84 --KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 468999999 77898888888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------------
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------------ 229 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 229 (472)
. .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+.++.....
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 1 23346789999999987644456889999999999999999999987765544443322111
Q ss_pred -------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 230 -------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 230 -------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
.....+++++.++|.+||..||++|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235788899999999999999999999999999998643
No 199
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-43 Score=359.52 Aligned_cols=249 Identities=30% Similarity=0.528 Sum_probs=216.7
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCc
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGE 96 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 96 (472)
.||+|+||+||.|+|..|....|||.+..... ....-++.||...++|+|.|||+++|.+..++++-++||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 69999999999999999999999999965432 445779999999999999999999999999999999999999999
Q ss_pred ccchhcc--CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCCEEEeeccchhhhhcccCCCccccc
Q 012021 97 LFGKVAK--GKL--KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 97 L~~~i~~--~~l--~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld-~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
|.++++. |++ .|...-.|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||-++....-. ....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 9999975 787 8999999999999999999999999999999999996 57899999999988765432 335677
Q ss_pred cCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCc-HH-HHHH-HHhccCCCCCCCCCHHHHHHHhcc
Q 012021 172 CGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSN-LM-EMYR-KIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 172 ~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~-~~~~-~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
-||..|||||++... +| +.++|||||||++.||.||++||.... +. .+++ -+.+..+++|..++.+++.||.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 899999999999543 44 589999999999999999999997643 22 3332 123456788888999999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCCC
Q 012021 247 LDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
+.+||..||++.++|.+||++.+..
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred cCCCcccCccHHHhccCcccccCCC
Confidence 9999999999999999999987643
No 200
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=3.6e-42 Score=339.45 Aligned_cols=254 Identities=31% Similarity=0.444 Sum_probs=207.9
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCE----
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTK---- 84 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 84 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 5799999999999999999999999999999998654322 233456788999999995 6999999999877665
Q ss_pred -EEEEEEecCCCcccchhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEeeccch
Q 012021 85 -IYFVMEYVKGGELFGKVAK------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLS 156 (472)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~DFGla 156 (472)
.|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 68777642 35899999999999999999999999999999999999998 889999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--------
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------- 228 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------- 228 (472)
....... .......+++.|+|||++.+....+.++||||||+++|+|++|..||...+....+.++....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 7543221 112334678899999998665444689999999999999999999998876655444332210
Q ss_pred ---------CCC-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 229 ---------FKF-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 229 ---------~~~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
... .+.+++++.++|.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 123688899999999999999999999999999985
No 201
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=1.4e-42 Score=336.58 Aligned_cols=252 Identities=29% Similarity=0.504 Sum_probs=217.1
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++.+...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4689999999999999999999999999999998765422 34567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||+.+++|.+++.. ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999999999864 679999999999999999999999 9999999999999999999999999999876543222
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-----cHHHHHHHHhcc-CCCCCCC-CCHHH
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKA-EFKFPNW-FAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s~~l 239 (472)
....|+..|+|||.+.+..+. .++||||||+++|+|++|..||... ........+... ....+.. +++++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 226789999999999777654 8899999999999999999999764 233344443332 2344444 78999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.++|.+||..||.+|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
No 202
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=3.6e-42 Score=337.36 Aligned_cols=251 Identities=32% Similarity=0.503 Sum_probs=210.6
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|++|.||+|.+..+|+.||||.+...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 599999999999999999999999999999998765321 234567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 91 YVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|+.+ +|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9985 77777653 3589999999999999999999999999999999999999999999999999875543221
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------------
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------ 228 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (472)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+.+.++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12345678999999998765555689999999999999999999998876655544432110
Q ss_pred CC-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 FK-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.. +.+..++++.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
No 203
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=5.6e-43 Score=342.51 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=219.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457888999999999999999999999999999875432 234567899999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+++++|.+++..+.+++..++.++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 999999999999888899999999999999999999999999999999999999999999999999876543211 122
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccC
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~ 248 (472)
...|+..|+|||.+.+..+. .++|+||||+++|+|++|..||...........+... ....+..++.++.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34688999999999877654 7899999999999999999999876555444444333 233445578899999999999
Q ss_pred CCCCCcCChhhhhcCcccccC
Q 012021 249 PNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 249 ~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+|.+|||+.++++||||.+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999763
No 204
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=3.4e-42 Score=336.86 Aligned_cols=248 Identities=32% Similarity=0.529 Sum_probs=205.2
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASK--TKIYFV 88 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 88 (472)
|++.+.||+|+||.||+|.+..+++.||+|.+.+..... .. ....+|+.+++++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 789999999999999999999999999999986543211 11 23347888888885 99999999999887 899999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 999975 77777654 56899999999999999999999999999999999999999 9999999999876543221
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------C
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------E 228 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~ 228 (472)
.....+++.|+|||.+...+..+.++|||||||++|+|++|..||...+..+.+..+... .
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 233568899999998766566668999999999999999999999887765544443211 1
Q ss_pred CCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 FKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+.+| ..++.++.++|.+||.++|++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1121 2357899999999999999999999999999997
No 205
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=2.7e-42 Score=341.34 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=219.0
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4699999999999999999999998999999999864432 2346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+||+++++|.+++.+..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 9999999999999888899999999999999999999999999999999999999999999999998775443221 12
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-C--CCCCCCCCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-E--FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~l~~li~~ 245 (472)
....|++.|+|||.+....+ +.++|+||||+++|++++|+.||...+.......+... . ...+..++..++++|.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34568999999999877665 47899999999999999999999876654433333222 1 22334467899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
||..+|.+||++.+++.|+||+...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999998754
No 206
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=6.8e-42 Score=332.35 Aligned_cols=251 Identities=30% Similarity=0.555 Sum_probs=212.5
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987644444455567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 90 EYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999887742 4589999999999999999999999999999999999999999999999999876543221
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHhccCC-CC-CCCCCHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIGKAEF-KF-PNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~-~~~~s~~l~ 240 (472)
......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||.... .......+..... .. +..++..+.
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 12345689999999999877664 78999999999999999999996543 2344444443332 22 234778899
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012021 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|.+||..+|++|||+.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999864
No 207
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=4.1e-42 Score=347.64 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=211.0
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45799999999999999999999999999999999866543 3446788999999999999999999876543
Q ss_pred ---------CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEee
Q 012021 83 ---------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSD 152 (472)
Q Consensus 83 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~D 152 (472)
...|+||||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 36899999997 58888887788999999999999999999999999999999999999974 55789999
Q ss_pred ccchhhhhcccC-CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---
Q 012021 153 FGLSALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--- 228 (472)
Q Consensus 153 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--- 228 (472)
||++........ .+......|+..|+|||.+......+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875532211 1112334688999999987654445589999999999999999999998766544443332110
Q ss_pred ----------------------C-----CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 229 ----------------------F-----KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ----------------------~-----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
. .+.+.++.++.+||.+||.+||.+|||+.+++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 012346788999999999999999999999999999975
No 208
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=4.7e-42 Score=336.00 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=212.1
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
.+..++|++.+.||+|+||.||.|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567899999999999999999998752 457899999864332 123456889999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhccC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEE
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAKG-----------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vk 149 (472)
.++..++||||+.+++|.+++... .++...+..++.|++.||.|||++|++||||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999888541 256788999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC
Q 012021 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~ 228 (472)
|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432211111123356788999999877665 489999999999999999 799998887777666655543
Q ss_pred -CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 229 -FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 229 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
...+...++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45667788999999999999999999999999864
No 209
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=7.3e-42 Score=337.02 Aligned_cols=252 Identities=30% Similarity=0.428 Sum_probs=204.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++|+||+++++++..+...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999998654322 22345678999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+++++|+|||++........ .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence 9996 566655543 5688999999999999999999999999999999999999999999999999875433221 1
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhc---------------cC---
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGK---------------AE--- 228 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~---------------~~--- 228 (472)
.....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.. +...++.. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234467999999999876543457899999999999999999999765432 22221110 00
Q ss_pred -----CCCCC---------CCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 -----FKFPN---------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 -----~~~~~---------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
...+. ..++++.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125689999999999999999999999999998
No 210
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=2.5e-42 Score=340.73 Aligned_cols=254 Identities=33% Similarity=0.447 Sum_probs=212.7
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (472)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999755432 23344667899999999999999999998877 8999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 88887754 358999999999999999999999999999999999999999999999999987654432
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-----------------
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA----------------- 227 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------------- 227 (472)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+.++...
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 12234567899999999876655568899999999999999999999887665554443211
Q ss_pred --------------CCCCCCC-CCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 228 --------------EFKFPNW-FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 228 --------------~~~~~~~-~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
...++.. +++.+.++|.+||+.+|++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 58889999999999999999999999999998
No 211
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=3.1e-42 Score=341.66 Aligned_cols=255 Identities=29% Similarity=0.539 Sum_probs=218.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35566789999999999999999999999999865432 234668899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccc
Q 012021 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|+++++|...+....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ....
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 99999999988778899999999999999999999999999999999999999999999999999875433221 1234
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhccc
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~~L 247 (472)
.+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.... ...+..+++.+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 678999999999977665 489999999999999999999998877666555554332 2233457889999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCCC
Q 012021 248 DPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
..+|.+||++.++++||||.+...
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCCC
Confidence 999999999999999999987543
No 212
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=4.4e-42 Score=332.64 Aligned_cols=246 Identities=33% Similarity=0.616 Sum_probs=208.9
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||+++++++..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433223333445555544 456899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|.+++.. +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999865 6799999999999999999999999999999999999999999999999998875432 134468
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC----CCCCCHHHHHHHhcccCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF----PNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~l~~li~~~L~~ 249 (472)
++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+....... +..+++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999877664 589999999999999999999999888877777766554433 334789999999999999
Q ss_pred CCCCcCC---hhhhhcCccccc
Q 012021 250 NPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rpt---~~eil~h~~f~~ 268 (472)
||++||+ ++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999994 579999999975
No 213
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=1.2e-41 Score=335.18 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=219.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|.-.+.||+|++|.||++.+..+++.+|+|.++.... ...+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 56667899999999999999999999999999864432 234568899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccc
Q 012021 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|+.|++|.+++..+++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 99999999999888899999999999999999999999999999999999999999999999998775433221 1234
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC---CCCCCHHHHHHHhccc
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF---PNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~l~~li~~~L 247 (472)
..|++.|+|||.+.+..+. .++||||+|+++|+|++|..||...+....+..+....... +..+++.+.++|.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 5689999999998776654 78999999999999999999998887776666665543222 2337889999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012021 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..+|++|||+.++++||||++..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999998743
No 214
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=7.3e-42 Score=336.91 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=213.3
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
.+..++|++.+.||+|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3456799999999999999999997652 3558999998654321 23345778999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEE
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAK-----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vk 149 (472)
+.+..|+||||+.+|+|.+++.. ..++...+..++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999999853 1246678899999999999999999999999999999999999999
Q ss_pred EeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-
Q 012021 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA- 227 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~- 227 (472)
|+|||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||......+....+..+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875433221111122345778999999876665 479999999999999998 79999887777766666544
Q ss_pred CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc------Ccccc
Q 012021 228 EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME------NSWFR 267 (472)
Q Consensus 228 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~------h~~f~ 267 (472)
....+...++++.+++.+||+.||++|||+.++++ ||||+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 34556677899999999999999999999999987 77775
No 215
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=1e-41 Score=336.54 Aligned_cols=257 Identities=31% Similarity=0.460 Sum_probs=210.6
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++.+.||+|++|+||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654322 23346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEeeccchhhhhcccC
Q 012021 89 MEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~DFGla~~~~~~~~ 164 (472)
|||+.+ +|.+.+.. . .+++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++.......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 999964 67666643 2 3688999999999999999999999999999999999985 4579999999987543321
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC----------------
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---------------- 228 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------- 228 (472)
.......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+.+.++....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112344678999999998765545589999999999999999999998776554444332100
Q ss_pred -----CC--------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 229 -----FK--------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 -----~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.. ..+.+++++.++|.+||+.+|++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 113467889999999999999999999999999999863
No 216
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=6.2e-42 Score=330.24 Aligned_cols=252 Identities=31% Similarity=0.598 Sum_probs=216.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||++.+..+|..||+|.+...... ....+.+.+|+.+++.++||||+++++.+......|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 699999999999999999999999999999999765332 2334678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-EEEeeccchhhhhcccCCC
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~-vkl~DFGla~~~~~~~~~~ 166 (472)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||++++++. ++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 9999999998864 25899999999999999999999999999999999999998864 69999999876543221
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhc
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~ 245 (472)
......|++.|+|||++....+. .++|+||||+++++|++|..||...+.......+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22344689999999998766554 789999999999999999999988777666665554433 3455678899999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012021 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f 266 (472)
||..+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
No 217
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=4.1e-42 Score=337.83 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=216.0
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||++.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 468999999999999999999999999999999986543 223457789999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+++++|.+++.. +.+++..+..++.+++.||.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999999988865 679999999999999999999997 699999999999999999999999999986543221
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-----------HHHHHHhcc-CCCCCCC
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-----------EMYRKIGKA-EFKFPNW 234 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-----------~~~~~i~~~-~~~~~~~ 234 (472)
....+|+..|+|||++.+..+ +.++|||||||++|+|++|..||...... +....+... ...++..
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred -cCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 234578999999999876655 47899999999999999999999865431 223333322 2233333
Q ss_pred -CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 235 -FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 235 -~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
++.++.+||.+||+.||.+|||+.|+++|+||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999997643
No 218
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=8.1e-42 Score=335.34 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=211.5
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNL----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 467999999999999999999853 456789999986533 22334678899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012021 85 IYFVMEYVKGGELFGKVAK------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g 146 (472)
.|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999988742 2478899999999999999999999999999999999999999
Q ss_pred CEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012021 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
.+||+|||++................++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876543222222234456778999999876665 489999999999999998 999998877666555554
Q ss_pred cc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 226 KA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ....+..+++++.+++.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43 345667789999999999999999999999999865
No 219
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=8e-42 Score=336.63 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=212.0
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457999999999999999999853 345679999986542 234567899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEE
Q 012021 84 KIYFVMEYVKGGELFGKVAK--------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vk 149 (472)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999988853 2489999999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC
Q 012021 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~ 228 (472)
|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998755332211112234467889999998776554 79999999999999998 999998888777777777665
Q ss_pred -CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 229 -FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 229 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
...+..+++++.+++.+||++||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3455668899999999999999999999999964
No 220
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=1.1e-41 Score=330.87 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=215.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+....|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++.+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 34567999999999999999999999999999999986543 22456889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999998854 358999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
... .....+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+.+..+... ....|..+++++.+
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 159 YTA-HAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred eec-cCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 111 1122345679999998776664 78999999999999998 99999988777777776654 45667778999999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012021 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
+|.+||..||++|||+.++++.
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999999999763
No 221
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=1.1e-41 Score=332.80 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=214.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+..++|++.+.||+|+||.||++.+... +..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 5678999999999999999999998644 47899999865432 2334567899999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEE
Q 012021 82 KTKIYFVMEYVKGGELFGKVAK-----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl 150 (472)
....|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999988753 23678899999999999999999999999999999999999999999
Q ss_pred eeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-C
Q 012021 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-E 228 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~ 228 (472)
+|||+++...............++..|+|||.+....+ +.++|||||||++|++++ |..||.+.+.......+... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999876543322122234567889999999876655 488999999999999998 99999887777666666543 3
Q ss_pred CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 229 FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 229 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
...|..++.++.++|.+||..+|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 45677789999999999999999999999999863
No 222
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=3.9e-42 Score=336.40 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=213.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 468899999865432 234578899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCE
Q 012021 84 KIYFVMEYVKGGELFGKVAK---------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~v 148 (472)
..|+||||+++++|.+++.. ..+++..+..++.||+.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999988853 247889999999999999999999999999999999999999999
Q ss_pred EEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc
Q 012021 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 227 (472)
+|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998754322211112334567889999999777664 78999999999999998 99999888877777777665
Q ss_pred CC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 228 EF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 228 ~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.. ..+..++.++.+++.+||..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54 345568899999999999999999999999986
No 223
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=1.1e-41 Score=333.72 Aligned_cols=255 Identities=26% Similarity=0.459 Sum_probs=205.2
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV-MRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653221 12344456554 6778999999999999999999999
Q ss_pred EEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 89 MEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|||++ ++|.+.+.. ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 466555432 4689999999999999999999998 9999999999999999999999999998765322
Q ss_pred cCCCccccccCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHh-ccCCCCC-CCCC
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIG-KAEFKFP-NWFA 236 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~-~~~~~~~-~~~s 236 (472)
. ......|+..|+|||.+.+. ...+.++|+|||||++|+|++|..||... ...+.+..+. .....+| ..++
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1 11235689999999988542 11247899999999999999999999753 2223333332 2333444 3478
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
.++.++|.+||..+|.+|||+.++++||||++..
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998743
No 224
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.6e-41 Score=326.20 Aligned_cols=252 Identities=35% Similarity=0.635 Sum_probs=221.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 699999999999999999999989999999999765432 2445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 91 YVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999988864 569999999999999999999999999999999999999999999999999987654432
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHh
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~ 244 (472)
.......|++.|+|||.+....+. .++|+||+|+++++|++|..||...+.......+.... ..+|..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 123445789999999998776654 78999999999999999999998887777666665543 3456678899999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012021 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+||..+|.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
No 225
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=4.5e-42 Score=347.45 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=216.0
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE--
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK-- 84 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 84 (472)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3677999999999999999999999999999999998654322 2334667789999999999999999998765544
Q ss_pred ----EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 85 ----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 85 ----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.|+|+||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799999888889999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF----------- 229 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (472)
.. .....+++.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+....+..+.....
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 22 23457889999999986644456899999999999999999999988776655554432110
Q ss_pred --------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 230 --------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 --------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.....+++++.++|.+||.+||++|||+.+|+.||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0112358899999999999999999999999999999864
No 226
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=4.9e-42 Score=336.46 Aligned_cols=251 Identities=32% Similarity=0.481 Sum_probs=209.3
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 78899999999999999999999999999999765422 23345678899999999999999999999999999999999
Q ss_pred cCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 92 VKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 92 ~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+. ++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence 95 5888887653 589999999999999999999999999999999999999999999999999875432211 12
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--------------------
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------- 228 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (472)
....+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999988765444578999999999999999999998776544333322110
Q ss_pred ---------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 ---------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ---------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
......+++++.++|.+||++||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
No 227
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=5.9e-42 Score=340.96 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=205.6
Q ss_pred CeEEEeeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIY 86 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (472)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999874422234456778999999999999999999999888 8899
Q ss_pred EEEEecCCCcccchhc-----c-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----CCCEEEeeccch
Q 012021 87 FVMEYVKGGELFGKVA-----K-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE----HGNLKVSDFGLS 156 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~-----~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~----~g~vkl~DFGla 156 (472)
+||||+.+ +|.+.+. . +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 5555442 1 36899999999999999999999999999999999999999 899999999998
Q ss_pred hhhhcccC-CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH---------HHHHH--
Q 012021 157 ALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME---------MYRKI-- 224 (472)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~---------~~~~i-- 224 (472)
........ .......++|+.|+|||++.+....+.++||||||+++++|++|+.||....... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543322 1112345789999999998765544588999999999999999999997543211 00000
Q ss_pred ------------------------hccCCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 225 ------------------------GKAEFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 225 ------------------------~~~~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
......++ ...+.++.++|.+||++||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00001111 1456789999999999999999999999999998
No 228
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=1.5e-41 Score=328.54 Aligned_cols=254 Identities=32% Similarity=0.554 Sum_probs=220.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4699999999999999999999999999999998765421 34577899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+++++|.+++.. +.+++..++.++.||+.|+.|||+ .|++||||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 99999999999975 789999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHHhcc-CCCCCCC-CCHHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKIGKA-EFKFPNW-FAPEVRRL 242 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~l~~l 242 (472)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ........+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999876644 58999999999999999999999776 444555554433 3445555 78999999
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012021 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
|.+||.++|+.|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999975
No 229
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=2e-41 Score=325.19 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=219.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 88 (472)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+|++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999999999999999766532 34567889999999999999999999999988 899999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999876 4899999999999999999999999999999999999999999999999999887655432111
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHh--ccCCCCCCCCCHHHHHHHh
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIG--KAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~l~~li~ 244 (472)
.....++..|+|||.+....+ +.++||||||+++|+|++|..||.... .......+. ......|..++.++.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 344678999999999876654 489999999999999999999998765 333333333 2344567778999999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012021 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+||..||.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
No 230
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=8.1e-42 Score=341.37 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=209.6
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..+|++.+.||+|+||+||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45899999999999999999998766664 8999986432 223456788999999999999999999998765 5
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999875 36899999999999999999999999999999999999999999999999999866433
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
..........++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+....+....+... ....+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221112223456789999999777665 89999999999999997 99999887766554444333 3455667889999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012021 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||..+|.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
No 231
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-45 Score=342.56 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=221.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|.++.+||+|+||.||+|+++.+|+.+|||.+.-+. .+..+.+||.||++++.|++|++|+.+...+.+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3678899999999999999999999999999986553 35778899999999999999999999999999999999
Q ss_pred ecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 91 YVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||..|+..+.++ +.+++|.++..+++..+.||+|||...-+|||||..||||+.+|..||+|||.|......... -
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--R 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--R 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--h
Confidence 999999999886 368999999999999999999999999999999999999999999999999998765433221 3
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~ 245 (472)
.+..|||.|||||++..-+|+ .++||||||++..||..|++||.+..++...--|-... +.-|..+|.++.+||++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 578899999999999999998 68999999999999999999998877765443333322 23345578899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012021 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
||..+|++|.|+-++++|||+++.
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999999863
No 232
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2e-44 Score=390.41 Aligned_cols=259 Identities=32% Similarity=0.573 Sum_probs=226.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.-||+-+.+||.|.||.||-|.+..+|+..|+|-+.-.... ......+.+|..++..++|||+|++|++-...+..||.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44889999999999999999999999999999998766544 45668899999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc--CC
Q 012021 89 MEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH--QD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~--~~ 165 (472)
||||+||+|.+.++.|+ .+|...+.|..|++.|+.|||++||+||||||+||+|+.+|.+|++|||.|..+.... -.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999999998864 7788888899999999999999999999999999999999999999999987665432 23
Q ss_pred CccccccCCCcccChhhhcccCC--CCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGY--DGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
+.+....|||.|||||++.+..- .+.++||||||||+.||+||+.||...+ ...+..++..+ .+++|..+|++.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 45667889999999999976432 2468999999999999999999997643 33444455544 57889999999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
||.+||+.||++|.++.||++|.|-+.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999988754
No 233
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=2.5e-41 Score=324.81 Aligned_cols=252 Identities=33% Similarity=0.601 Sum_probs=221.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999999999999999776532 2456789999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......... ..
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--cc
Confidence 9999999998865 68999999999999999999999999999999999999999999999999998866543221 23
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh-ccCCCCCCCCCHHHHHHHhcccC
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG-KAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...|+..|+|||.+.+..+ +.++||||||+++++|++|..||...+......++. .....++..+++.+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999876664 588999999999999999999998766554444443 34455677789999999999999
Q ss_pred CCCCCcCChhhhhcCccc
Q 012021 249 PNPNTRISMTKIMENSWF 266 (472)
Q Consensus 249 ~dP~~Rpt~~eil~h~~f 266 (472)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
No 234
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=1.5e-41 Score=337.80 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=216.2
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.....+|++.+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 44567899999999999999999999999999999998765444444556788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.| +|.+.+. .+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999999975 5655553 357999999999999999999999999999999999999999999999999988654321
Q ss_pred CCCccccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCC-CCCCCHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKF-PNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~l 239 (472)
....|++.|+|||++.. .+..+.++||||||+++|+|++|..||...+.......+.... ... +..++.++
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 24568899999998742 2334578999999999999999999998877665544444332 222 23467899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.++|.+||..||++||++.+|+.||||...
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999864
No 235
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=1.9e-41 Score=329.51 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=213.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++.+.||+|+||+||+|.+..+ ...||+|.+..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998654 45899999865432 23446688899999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|++|||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999998765221
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+... ....+...++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111123456789999998776654 79999999999999998 99999887777666666554 33455668999999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012021 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
No 236
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=1.3e-41 Score=330.85 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=208.7
Q ss_pred eEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE----
Q 012021 12 YELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK---- 84 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 84 (472)
|++++.||+|+||.||.|....+ +..||+|.+...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987653 478999998754332 2345678999999999999999999998865544
Q ss_pred --EEEEEEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 85 --IYFVMEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 85 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
.+++|||+++++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999887732 3589999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCC
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 233 (472)
+................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 876543222111222345678999999876655 489999999999999999 99999888777777666544 455677
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++++.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999875
No 237
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1e-41 Score=328.53 Aligned_cols=244 Identities=26% Similarity=0.446 Sum_probs=204.1
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2344567899999999999999999999999999999999999999
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999864 3589999999999999999999999999999999999999999999999999875432111100111123
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....+..++..+.+++.+||..+|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999876665 478999999999999997 99999877665555555433 445666788999999999999999
Q ss_pred CCcCChhhhhc
Q 012021 252 NTRISMTKIME 262 (472)
Q Consensus 252 ~~Rpt~~eil~ 262 (472)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
No 238
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=7.3e-42 Score=344.98 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=211.1
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||+|+||+||+|++..+++.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4578999999999999999999999999999999987543222 2345677899999999999999999987544
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...|+|+||+. ++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999995 578877765 6899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (472)
.. .......++..|+|||.+......+.++|||||||++|+|++|+.||...+....+..+...
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 22344578999999999865444568999999999999999999999876543322222100
Q ss_pred --------------CC---CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 228 --------------EF---KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 --------------~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.. ...+.+++++.++|.+||+.+|++|||++++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 112347889999999999999999999999999999975
No 239
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=9.4e-42 Score=337.57 Aligned_cols=259 Identities=28% Similarity=0.511 Sum_probs=213.4
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT- 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 83 (472)
|.+..++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 677889999999999999999999999999999999999754322 123356778999999999999999999986654
Q ss_pred ---------EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEee
Q 012021 84 ---------KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 84 ---------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~D 152 (472)
.+|+|+||+++ +|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999976 56666654 4699999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---
Q 012021 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--- 229 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--- 229 (472)
||++........ .......+++.|+|||.+.+....+.++|||||||++++|++|+.||...+.......+.....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999876543221 1122335688899999886655456899999999999999999999987766555444432100
Q ss_pred ---------------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 ---------------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ---------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.....+++.+.++|.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
No 240
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=1e-41 Score=338.71 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=208.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMS--VAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
+-.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3457899999999999999999999888765 466665432 2223456788999999999 8999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012021 84 KIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g 146 (472)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 99999999999999988853 2478999999999999999999999999999999999999999
Q ss_pred CEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012021 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
.+||+|||++........ .....++..|+|||.+.+..+ +.++|||||||++|+|+| |..||...+..+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999999863321111 111234667999999876654 479999999999999998 999998877777666665
Q ss_pred cc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 226 KA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ....+..+++++.++|.+||+.+|++||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44 234455578999999999999999999999999876
No 241
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=4.2e-42 Score=347.11 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=207.1
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+-.+||++++.||+|+||.||+|++.. +++.||+|++..... ....+.+.+|+.+++++ +||||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 4556799999999999999999997543 457899999865432 23346678899999999 799999999987
Q ss_pred Ee-CCEEEEEEEecCCCcccchhcc-------------------------------------------------------
Q 012021 80 AS-KTKIYFVMEYVKGGELFGKVAK------------------------------------------------------- 103 (472)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------- 103 (472)
.. +..+|++|||+++++|.+++..
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 4678999999999999887742
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCc
Q 012021 104 -------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 104 -------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++................++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578899999999999999999999999999999999999999999999999986543222111223456778
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHH-HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCC
Q 012021 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMY-RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 177 y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+|||++.+..+. .++|||||||++|+|++ |..||.+....+.. ..+... ....|...++++.+++.+||+.+|++
T Consensus 241 y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 241 WMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred ccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 9999999877765 78999999999999998 99999875433322 233322 23445668899999999999999999
Q ss_pred cCChhhhhcC
Q 012021 254 RISMTKIMEN 263 (472)
Q Consensus 254 Rpt~~eil~h 263 (472)
||++.++++|
T Consensus 320 RPs~~ell~~ 329 (337)
T cd05054 320 RPTFSELVEI 329 (337)
T ss_pred CcCHHHHHHH
Confidence 9999999986
No 242
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=6e-42 Score=345.08 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=212.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE----eCC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA----SKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 83 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 34789999999999999999999999999999999875432 2234567788999999999999999999875 345
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999995 578888764 57999999999999999999999999999999999999999999999999998754332
Q ss_pred cC--CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--------------
Q 012021 163 HQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-------------- 226 (472)
Q Consensus 163 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-------------- 226 (472)
.. ........|+..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 11223457899999999986644456899999999999999999999987654332222111
Q ss_pred ----------cC--CCC-----CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 227 ----------AE--FKF-----PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 ----------~~--~~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.. ... .+..++++.++|.+||+.+|.+|||+++++.||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00 001 13368899999999999999999999999999999853
No 243
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=1.6e-41 Score=343.74 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=211.4
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 45899999999999999999999999999999999875432 122346678899999999999999999988543
Q ss_pred -CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 83 -TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...|++++++ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478888887 78898888878899999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------- 228 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (472)
. .....|++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+....
T Consensus 173 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred c-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 1 2345789999999998664444578999999999999999999998765544333321110
Q ss_pred ----------CCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 229 ----------FKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 ----------~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
... ....++++.++|.+||++||.+|||+.++++||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 001 112578899999999999999999999999999998743
No 244
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=4.2e-41 Score=326.92 Aligned_cols=255 Identities=28% Similarity=0.523 Sum_probs=216.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccc--ccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEK--VLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (472)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+++|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999985432 11224456889999999999999999999998664 578
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
++++||+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999998865 6799999999999999999999999999999999999999999999999999876533211
Q ss_pred C-CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHH
Q 012021 165 D-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRR 241 (472)
Q Consensus 165 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~ 241 (472)
. .......|+..|+|||.+.+..++ .++|+|||||++|+|++|..||..........++... ...+|..+++++.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1 112345689999999999776654 7899999999999999999999887666555554432 34567889999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccc
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
No 245
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=1.6e-41 Score=332.47 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=211.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 44689999999999999999999987 778999998864432 22345678899999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CEEEe
Q 012021 83 TKIYFVMEYVKGGELFGKVAKG--------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVS 151 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g---~vkl~ 151 (472)
...|+||||+.|++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999988542 489999999999999999999999999999999999998765 59999
Q ss_pred eccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CC
Q 012021 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EF 229 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~ 229 (472)
|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998865322111111122345679999999776654 89999999999999997 99999987776666555433 44
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..|..++..+.+++.+||..+|++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5667789999999999999999999999999987
No 246
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.8e-41 Score=337.31 Aligned_cols=255 Identities=22% Similarity=0.421 Sum_probs=212.8
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
++..++|.+++.||+|+||.||+|++.. ++..+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566899999999999999999998753 235799999976431 23346788899999999 7999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012021 78 VMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NI 140 (472)
++...+..|+||||+.+++|.+++.. ..+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 99999999999999999999998864 2478899999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012021 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999875532211111122234578999999877665 489999999999999998 899998887777
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.... ...|..++.++.++|.+||..+|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 766665553 35667789999999999999999999999999875
No 247
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=6.5e-42 Score=335.82 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=213.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-..+|++.+.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 355789999999999999999987643 5789999987543 223456788999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012021 83 TKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~ 145 (472)
...++++||+.+++|.+++.. ..+++..+.+++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999888741 347888999999999999999999999999999999999999
Q ss_pred CCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012021 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.+||+|||++................+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+....+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876533222222234456789999999876665 478999999999999998 89999888887777777
Q ss_pred hccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 225 GKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..... ..+..++.++.+++.+||+.+|.+||++++|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66553 4567799999999999999999999999999864
No 248
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=2.8e-41 Score=328.66 Aligned_cols=248 Identities=29% Similarity=0.495 Sum_probs=207.4
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..|+|+||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 44689999999999999999999999999865432 334678899999999999999999999999999999999999
Q ss_pred CCcccchhcc--CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEeeccchhhhhcccCCCcc
Q 012021 94 GGELFGKVAK--GKL--KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 94 gg~L~~~i~~--~~l--~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+++|.+.+.. +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++........ ..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence 9999998865 455 88899999999999999999999999999999999986 67999999999875533221 12
Q ss_pred ccccCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHH--HHHH-HHhccCCCCCCCCCHHHHHHHh
Q 012021 169 HTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLM--EMYR-KIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~s~~l~~li~ 244 (472)
....|++.|+|||.+.... ..+.++|+||||+++|+|++|..||...... .... ........+|..+++++.+++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3346899999999986543 2357899999999999999999999764322 1211 1223344567778999999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012021 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+||+.+|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
No 249
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=1.3e-41 Score=331.88 Aligned_cols=244 Identities=28% Similarity=0.489 Sum_probs=203.6
Q ss_pred cCCeEEEeeE--cccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012021 9 MQRYELGRLL--GQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.+...+ +||||+++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 4577887776 99999999999999999999999987653221 123233322 699999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-~vkl~DFGla~~~~~~~ 163 (472)
|+||||+++++|.+++.. +.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 999999999999999876 4899999999999999999999999999999999999999998 9999999988754321
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH----HHHHhccCCCCCCCCCHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM----YRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~l 239 (472)
....|++.|+|||++.+..+. .++||||||+++|+|++|..||........ ...........++.+++.+
T Consensus 164 -----~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 164 -----SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred -----ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 234689999999999877765 789999999999999999999975433221 1111233345556789999
Q ss_pred HHHHhcccCCCCCCcCC-hhhhhcCcccc
Q 012021 240 RRLLSKILDPNPNTRIS-MTKIMENSWFR 267 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt-~~eil~h~~f~ 267 (472)
.++|.+||+++|.+||+ ++++++||||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999996 69999999996
No 250
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=2.4e-41 Score=325.77 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=213.6
Q ss_pred eeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEec
Q 012021 16 RLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.+++.++|+||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999997654322 4578899999999999999999999999999999999999
Q ss_pred CCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 93 KGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 93 ~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999865 56899999999999999999999999999999999999999999999999998876543
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
..........+++.|+|||.+....+ +.++||||||+++|+|++ |..||...........+... ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122344567889999999877655 489999999999999999 69999998887777777654 3456778899999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012021 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||..+|.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
No 251
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=4.6e-41 Score=331.04 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=210.9
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKIYF 87 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (472)
++|+..+.||.|++|.||++.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999875432 2345678999999999999999999998854 447999
Q ss_pred EEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 88 VMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
||||++|++|.+++. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999999987653 246899999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-----cHHHHHHHHhccC-CCCC----
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKAE-FKFP---- 232 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~~-~~~~---- 232 (472)
. .....++..|+|||.+.+..++ .++||||||+++|+|++|..||... ...+....+.... ..++
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 2 1234678899999998776665 7899999999999999999999865 2233333333311 1111
Q ss_pred --CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 233 --NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 233 --~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..+++++.++|.+||..+|.+|||+.|++.||||++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999997644
No 252
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=2.2e-41 Score=333.72 Aligned_cols=254 Identities=23% Similarity=0.440 Sum_probs=213.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+-.++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4457899999999999999999998644 37899999875432 23346688999999999 7999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld 143 (472)
.+..+|++|||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999988742 4589999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHH
Q 012021 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYR 222 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~ 222 (472)
.++.+||+|||++................++..|+|||++.+..++ .++|||||||++|+|++ |..||......+.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999998865432211111223356789999998766654 78999999999999997 999999888777777
Q ss_pred HHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 223 KIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 223 ~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.... ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665543 34566788999999999999999999999999875
No 253
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=2.3e-41 Score=327.07 Aligned_cols=246 Identities=26% Similarity=0.461 Sum_probs=209.4
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++.+.||+|+||.||++... ++..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999875 4568999998654322 356888999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+++|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence 99999999998864 56899999999999999999999999999999999999999999999999988754321111 0
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....++..|+|||.+.+..+. .++|+||||+++|+|++ |+.||...+..+....+..+. ...|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122345689999998776654 79999999999999999 999999888877777776653 34466678899999999
Q ss_pred ccCCCCCCcCChhhhhc
Q 012021 246 ILDPNPNTRISMTKIME 262 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (472)
||..+|.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
No 254
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=8.1e-42 Score=344.42 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=215.3
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK-- 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 82 (472)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 356789999999999999999999999899999999986543221 2335677899999999 999999999998643
Q ss_pred CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 83 TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
...|+||||+. ++|..++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 47899999997 48988887778899999999999999999999999999999999999999999999999998865433
Q ss_pred cCC---CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-----------
Q 012021 163 HQD---GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE----------- 228 (472)
Q Consensus 163 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------- 228 (472)
... .......||+.|+|||++.+....+.++||||||+++|+|++|+.||......+...++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 221 223345689999999988665555689999999999999999999998765544333321110
Q ss_pred --------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 229 --------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 --------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
....+.++.++.++|.+||+.||++|||+.++++||||++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01112368899999999999999999999999999999873
No 255
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-43 Score=353.37 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=219.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|.=++.||+|+||.||.|++..+.+.||||.+..+.....+--..|.+|+..|+.++|||++.+.++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667899999999999999999999999999987655444445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 91 YVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||-| +-.|++. +.++.|.++..|..+.+.||.|||+++.||||||..||||.+.|.|||+|||.|..... .
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------A 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------A 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------h
Confidence 9965 5566653 57899999999999999999999999999999999999999999999999999886543 3
Q ss_pred ccccCCCcccChhhhcc---cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCC-CCCHHHHHHH
Q 012021 169 HTTCGTPAYVAPEVINR---RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPN-WFAPEVRRLL 243 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~-~~s~~l~~li 243 (472)
.+++|||+|||||++.. ..|+ -++||||||++..+|.-.++|+...+.+.....|..+. +.++. .+|..+++|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 57899999999999853 3455 68999999999999999999999988886666665554 44433 3789999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccCC
Q 012021 244 SKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..||++-|..|||.++++.|+|.....
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCC
Confidence 999999999999999999999997643
No 256
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=1.9e-41 Score=330.14 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=206.6
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CC
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------KT 83 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 83 (472)
|.+++.||+|+||.||+|.+..++. .||+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877775 699999865432 22445778899999999999999999998642 23
Q ss_pred EEEEEEEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 84 KIYFVMEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
..+++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999877631 34899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCC
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNW 234 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 234 (472)
................+++.|+|||.+.+..+. .++||||||+++|+|++ |..||........+..+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 865432211111233467789999998776654 79999999999999999 899998877777777776654 345666
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++..+.++|.+||++||.+|||+.+|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999865
No 257
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1.3e-41 Score=330.26 Aligned_cols=250 Identities=30% Similarity=0.595 Sum_probs=212.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||.|+||.||+|.+..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..|++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999987654444445567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 90 EYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||++|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999988752 4689999999999999999999999999999999999999999999999999876543221
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH--HHHHHHHhccCCC-C-CCCCCHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL--MEMYRKIGKAEFK-F-PNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~l~ 240 (472)
.....+|++.|+|||.+.+..+. .++|+||||+++|+|++|..||..... ......+...... . +..+++++.
T Consensus 162 --~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 162 --AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred --ccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 22345789999999999776654 789999999999999999999975433 3444444333222 2 235788999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||..||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998875
No 258
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-42 Score=349.02 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=209.1
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 87 (472)
...|++++.||.||.++||++... +.+.+|+|.+.... .+...+.-+.+||..|..|+ |.+||+||+|-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 457999999999999999999974 44556666554333 23467888999999999996 9999999999999999999
Q ss_pred EEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||- ..+|..++.++ -++...++.|..|++.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|..+......
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 99986 45899988764 34445899999999999999999999999999999988 4679999999999987766555
Q ss_pred CccccccCCCcccChhhhcccCC----------CCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc--CCCCC
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGY----------DGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA--EFKFP 232 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~----------~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~~~~ 232 (472)
-.-.+.+||+.||+||.+....+ .+.++||||||||||+|+.|+.||.... ...-+..|... .+++|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 55567899999999999854433 2578999999999999999999997643 33333344433 23566
Q ss_pred CCCCHH-HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 233 NWFAPE-VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ~~~s~~-l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
..-+.. +.++++.||..||++|||+.++|+|||++-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 544443 999999999999999999999999999974
No 259
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=3.8e-41 Score=338.80 Aligned_cols=258 Identities=29% Similarity=0.463 Sum_probs=213.1
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 86 (472)
+.++|++++.||.|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46799999999999999999999999999999999865432 22345678899999999999999999999865 56889
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
++|||+ +++|..++..+.+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999998 56888888878899999999999999999999999999999999999999999999999999875422
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--------------------
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-------------------- 226 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-------------------- 226 (472)
......+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+....+..+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 123456788999999876644445899999999999999999999987654322211110
Q ss_pred ------cCCCC-----CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCCC
Q 012021 227 ------AEFKF-----PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK 272 (472)
Q Consensus 227 ------~~~~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~~ 272 (472)
..... .+.+++++.++|.+||+.+|++|||+++++.||||+....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00011 12467899999999999999999999999999999875543
No 260
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=1.8e-41 Score=325.60 Aligned_cols=246 Identities=40% Similarity=0.757 Sum_probs=221.5
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||.|+||.||.+.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+..+..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999887655545667899999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCc
Q 012021 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999876 479999999999999999999999999999999999999999999999999987654322 12345578999
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCC
Q 012021 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRIS 256 (472)
Q Consensus 177 y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt 256 (472)
|+|||...+... +.++|+||||+++|++++|..||...+....+..+......+|..++.++.++|.+||..||+.|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876654 4789999999999999999999988887777888877788888889999999999999999999999
Q ss_pred h---hhhhcCccc
Q 012021 257 M---TKIMENSWF 266 (472)
Q Consensus 257 ~---~eil~h~~f 266 (472)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 899999998
No 261
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=5.8e-41 Score=325.28 Aligned_cols=250 Identities=30% Similarity=0.582 Sum_probs=212.7
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987654444444678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 90 EYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999888742 458999999999999999999999999999999999999999999999999987554322
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHhccCC-CCCC-CCCHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIGKAEF-KFPN-WFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~l~ 240 (472)
.......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||.... .......+..+.. ..|. .++.++.
T Consensus 161 -~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 161 -TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred -cccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 112345789999999999877665 78999999999999999999996543 3344444443332 3343 5788999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
No 262
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=2e-41 Score=370.95 Aligned_cols=253 Identities=27% Similarity=0.457 Sum_probs=206.9
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||.||+|.+..+|+.||+|++...........+++.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765433334557789999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 89 MEYVKGGELFGKVAK------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
|||++|++|.+++.. ..++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999887752 23456778899999999999999999999999999999999999999999999
Q ss_pred hhhhcccCC----------------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH
Q 012021 157 ALAESKHQD----------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM 220 (472)
Q Consensus 157 ~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~ 220 (472)
......... ......+||+.|+|||++.+..++ .++|||||||++|+|+||..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765211100 011234799999999999877664 899999999999999999999987554433
Q ss_pred HHH-HhccCCCC--CCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 221 YRK-IGKAEFKF--PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 221 ~~~-i~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
... ........ ...+++.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222 11111111 1347889999999999999999987665543
No 263
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-42 Score=355.90 Aligned_cols=244 Identities=36% Similarity=0.601 Sum_probs=216.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (472)
..+.|++...+|.|+|+.|..+.+..+++..++|++.+... ...+|+.++... +||||+++++++.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 45689999999999999999999999999999999987732 234677666554 7999999999999999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL-DEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILl-d~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|||.+.|+.|.+.+...+....++..|+.+|+.|+.|||++|++||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999999999999987666558888999999999999999999999999999999 69999999999998865433
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCCCCCCCHHHHHHHh
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
..+.|-|..|+|||++...+|+ .++|+||||++||+||+|+.||...... ++..++..+.+. .++|.++++||+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQ 544 (612)
T ss_pred --hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHH
Confidence 4567889999999999988886 8999999999999999999999875544 777777666555 889999999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012021 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
No 264
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=2.7e-41 Score=333.31 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=209.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCC----------------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTG----------------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (472)
-.++|++++.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999876544 56899998765422 44578899999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccchhccC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012021 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKG------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~N 139 (472)
|+++++++..+...+++|||+.+++|.+++... .+++..++.++.|++.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999999999999999999999999999888542 58999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--CCCCCCCCcH
Q 012021 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--GYLPFHDSNL 217 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--G~~Pf~~~~~ 217 (472)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875543222222234456788999999876555 489999999999999998 7889987666
Q ss_pred HHHHHHHhcc--------CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 218 MEMYRKIGKA--------EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 218 ~~~~~~i~~~--------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
......+... ....+..++.++.++|.+||+.||.+|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5555544322 12334557899999999999999999999999964
No 265
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=6.3e-42 Score=363.27 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=197.5
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCC-CcEEEEEEe--------------ecccccchhhHHHHHHHHHHHHhcCC
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKII--------------DKEKVLKVGMIDQIKREISVMRLVRH 69 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~h 69 (472)
+..+.++|++++.||+|+||+||+|..+.. +..++.|.+ .+...........+.+|+.+|+.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 345678999999999999999999876543 223333311 11111112334568899999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEEEecCCCcccchhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012021 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 70 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld 143 (472)
|||+++++++...+..|+|+|++. ++|..++..+ ......++.++.||+.||.|||++||+||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999985 4666665432 244677889999999999999999999999999999999
Q ss_pred CCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCC--cHHHH
Q 012021 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDS--NLMEM 220 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~--~~~~~ 220 (472)
.++.+||+|||++........ ......+||+.|+|||++.+..+. .++|||||||++|+|++|..+ |... +....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999976543221 112346799999999999887775 789999999999999998754 4332 11122
Q ss_pred HHHHhcc----CCCCC----------------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 221 YRKIGKA----EFKFP----------------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 221 ~~~i~~~----~~~~~----------------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+.++... ...+| ..++.++.++|.+||..||++|||+.|+|+||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 2111110 00011 124567888899999999999999999999999976
Q ss_pred C
Q 012021 269 G 269 (472)
Q Consensus 269 ~ 269 (472)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 3
No 266
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=1.9e-41 Score=349.68 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=207.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 80 (472)
+-.++|++++.||+|+||.||+|.+... +..||||++..... ....+.+.+|+.+|+.++ ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3466889999999999999999987533 35799999965432 234567889999999996 999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc---------------------------------------------------------
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAK--------------------------------------------------------- 103 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------------------------------------------------------- 103 (472)
....+|+||||+++|+|.+++..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999877642
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012021 104 ----------------------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 104 ----------------------------------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld 143 (472)
..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1377888899999999999999999999999999999999
Q ss_pred CCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHH
Q 012021 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMY 221 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~ 221 (472)
.++.+||+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...... ..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999998765432221122334577889999998776654 89999999999999997 99999875443 333
Q ss_pred HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 222 RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 222 ~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..+..+ ....+..+++++.+++.+||..||++|||+.++.+.
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 344333 344566688999999999999999999999998763
No 267
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.8e-42 Score=348.26 Aligned_cols=256 Identities=32% Similarity=0.587 Sum_probs=221.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|..++.||-|+||+|.+++...|...+|+|.+.+..+.....+..++.|-+||..-..+-||+||..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47889999999999999999999999999999999888777778889999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC-----
Q 012021 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ----- 164 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~----- 164 (472)
|++||++..++-+ |-|.|..++.|+..|.+|++++|..|+|||||||+|||||.+|+|||.||||++-+.....
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999999887755 8899999999999999999999999999999999999999999999999999874432110
Q ss_pred -------C----------------------------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC
Q 012021 165 -------D----------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209 (472)
Q Consensus 165 -------~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~ 209 (472)
+ ...+..+||+.|+|||++...+|. ..+|.||.|||||+|+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence 0 011233699999999999999987 7899999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcc----CCCCCCCCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 210 LPFHDSNLMEMYRKIGKA----EFKFPNWFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~~----~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
.||.+....+...++.+- .+.....+|+++.++|.++. -+++.|.. .+++..||||+.
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 999988776665555432 23344568999999998844 46778874 567999999985
No 268
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=2.5e-41 Score=335.43 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=208.6
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK-- 82 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 82 (472)
|-...++|++.+.||.|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 3445789999999999999999999999999999999986543221 2234567899999999999999999987433
Q ss_pred ------CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeecc
Q 012021 83 ------TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 83 ------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFG 154 (472)
..+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+||++++++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 357999999965 56555543 479999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCC---------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh
Q 012021 155 LSALAESKHQD---------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 155 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~ 225 (472)
++......... .......|++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 98765432211 111234578899999998665445588999999999999999999998877665555442
Q ss_pred ccCC-----------------------CCC-------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 226 KAEF-----------------------KFP-------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 226 ~~~~-----------------------~~~-------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.... ..+ ..+++++.++|.+||..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2100 000 1244678899999999999999999999999998
No 269
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=4.6e-41 Score=331.18 Aligned_cols=258 Identities=29% Similarity=0.574 Sum_probs=217.2
Q ss_pred CeEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
.|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999999764332 223346788999999999 599999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999999998865 6799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCccccccCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCCCHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
.......|+..|+|||.+... ...+.++||||||+++|+|++|..||... ........+......+|..+++.+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 122346789999999998643 23357899999999999999999999643 233444455555666777789999
Q ss_pred HHHHhcccCCCCCCcC-----ChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRI-----SMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rp-----t~~eil~h~~f~~~ 269 (472)
.+++.+||..||++|| ++.+++.||||++.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 88999999999763
No 270
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=3.3e-41 Score=326.19 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=208.8
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++.+.||+|+||.||++.+. ++..+|+|++.+.... .+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999885 5678999998654322 246778999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 99999999998864 46899999999999999999999999999999999999999999999999998754321110 0
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~ 245 (472)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+..+....+... ....|...++++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111234579999998776664 78999999999999999 89999887777776666554 345566789999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012021 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
No 271
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=3.6e-41 Score=329.87 Aligned_cols=252 Identities=35% Similarity=0.544 Sum_probs=211.0
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIYFVM 89 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 89 (472)
|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998764 2223446688999999999999999999999888 8999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 78887765 4799999999999999999999999999999999999999999999999999876644321 11
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------------------
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------------------ 229 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (472)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23446788999999876654456899999999999999999999988776555444432100
Q ss_pred -----C--------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 230 -----K--------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 -----~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
. +...+++++.++|.+||..+|.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 011137889999999999999999999999999997
No 272
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=4.2e-41 Score=334.30 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=211.6
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
+..+..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ....+.+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 34566779999999999999999999753 3556899999865432 23456788999999999 7999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeecc
Q 012021 78 VMASKTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFG 154 (472)
++...+..|+||||+.+++|.+++... .+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999999998642 38999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc--CCCC
Q 012021 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA--EFKF 231 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~ 231 (472)
++................+++.|+|||.+....+. .++||||+||++|+|++ |..||........+.+.... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 98755432211111223467789999998776654 79999999999999998 99999876655444333322 2334
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+...++++.+++.+||+++|++|||+.+++..
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 56688999999999999999999999999863
No 273
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=2.5e-41 Score=340.35 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=213.4
Q ss_pred ccCCeEE-EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----------hHHHHHHHHHHHHhcCCCCeeeE
Q 012021 8 LMQRYEL-GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----------MIDQIKREISVMRLVRHPNVVEL 75 (472)
Q Consensus 8 l~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 75 (472)
+.+||.. .+.||.|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 5678875 57799999999999999999999999998654322100 11247789999999999999999
Q ss_pred EEEEEeCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeecc
Q 012021 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFG 154 (472)
++++..++..|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999996 588888765 579999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccc------------CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH
Q 012021 155 LSALAESKH------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 155 la~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~ 222 (472)
++....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987654111 01112334578899999998765555689999999999999999999998877665554
Q ss_pred HHhccC-----C-----------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 223 KIGKAE-----F-----------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 223 ~i~~~~-----~-----------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+.... . ......+.++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 432210 0 0012357889999999999999999999999999999864
No 274
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=5.4e-41 Score=325.20 Aligned_cols=249 Identities=22% Similarity=0.406 Sum_probs=210.1
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999864 667899999865432 2467889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999998854 468999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.. ......++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ....+..++.++.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 1122345678999999876655 478999999999999998 99999887776666666544 23334557899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012021 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||..+|++|||++++++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999975
No 275
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=6.5e-41 Score=328.23 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=210.4
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+...+|++.+.||+|+||+||+|.+..+++ .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345689999999999999999999887776 489999865432 23456788999999999999999999998754
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..++++||+++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999999865 469999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
............+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ....+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 32221111223456789999999777665 79999999999999998 99999877666655555443 34455668999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||..||+.||++.++++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999853
No 276
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=2e-41 Score=327.89 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=213.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
...|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999977 89999999876542 2346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 89 MEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999999864 4689999999999999999999999999999999999999999999999999876533211
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li 243 (472)
......++..|+|||.+....+. .++||||||+++|+|++ |..||...+..+.+..+... ....+..+++++.++|
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 11233456789999998776654 78999999999999998 89999888777777766644 3455667899999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012021 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||..||.+|||+.+|++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
No 277
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=3.7e-41 Score=333.25 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=215.9
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|+-...||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 333468999999999999999999999999985432 23456788999999999999999999999999999999999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccc
Q 012021 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
+++++|.+++..+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .....
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 9999999988888899999999999999999999999999999999999999999999999998765433221 12345
Q ss_pred cCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhcccC
Q 012021 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~~L~ 248 (472)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.... ......+++.+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 68999999999876555 479999999999999999999998876655544443322 22334578999999999999
Q ss_pred CCCCCcCChhhhhcCcccccCCC
Q 012021 249 PNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 249 ~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
.+|.+||++.+++.||||.+...
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999988654
No 278
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=4.9e-41 Score=331.52 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=211.8
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 457999999999999999999864 3456799999864432 23467889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012021 84 KIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g 146 (472)
..++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999998853 2378999999999999999999999999999999999999999
Q ss_pred CEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012021 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
.++|+|||++................+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999998755432221122344578899999998776654 78999999999999998 999998887777777666
Q ss_pred ccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 226 KAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.. ..+..++..+.+++.+||..||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5544 3455678999999999999999999999999763
No 279
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=5.4e-41 Score=326.18 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=208.1
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+..+ ..||+|.+...... .+.+.+|+.+++.++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4567999999999999999999988655 46999998764432 356889999999999999999999875 45689
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999864 358999999999999999999999999999999999999999999999999987554322
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
. .......++..|+|||+..+..++ .++||||||+++|+|++ |..||.+......+..+... ....+..++..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1 111233467789999998766664 89999999999999999 89999887776666666543 23445568899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012021 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
+|.+||.+||++|||+.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999875
No 280
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=5.5e-41 Score=332.29 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=207.5
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (472)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999877765 46888875322 223346788999999998 7999999999999999999
Q ss_pred EEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEE
Q 012021 87 FVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vk 149 (472)
++|||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999999999988854 2488899999999999999999999999999999999999999999
Q ss_pred EeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC
Q 012021 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~ 228 (472)
|+|||++........ ......+..|+|||++....+. .++|||||||++|+|++ |..||..........++....
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999864321111 1112234579999998776654 79999999999999997 999999888777777766543
Q ss_pred -CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 229 -FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 229 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
...|..+++++.+||.+||..+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566689999999999999999999999999765
No 281
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=4.3e-41 Score=330.08 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=211.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+...+|++.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568999999999999999999743 356789999876442 2345678999999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012021 82 KTKIYFVMEYVKGGELFGKVAK----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~ 145 (472)
.+..|++|||+.+++|.+++.. ..+++..++.++.||+.|+.|||++|++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 9999999999999999988754 247899999999999999999999999999999999999999
Q ss_pred CCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012021 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999998754322211112233457889999998877664 78999999999999998 99999887776666666
Q ss_pred hcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 225 GKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 225 ~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
... ....+..+++.+.++|.+||..||.+||++++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 554 34556678999999999999999999999999975
No 282
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=9.4e-41 Score=333.38 Aligned_cols=255 Identities=23% Similarity=0.425 Sum_probs=212.0
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
.+..++|.+++.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456799999999999999999998642 345799999865432 23456788999999999 6999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012021 78 VMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NI 140 (472)
++...+.+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 99999999999999999999988853 2478899999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012021 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999876543221111222334568999999877655 479999999999999999 899998888777
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..+.... ...+..++.++.++|.+||..||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 777665543 34566688999999999999999999999999864
No 283
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=5.3e-41 Score=325.28 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=209.5
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 356789999999999999999999875 6677999998765432 256889999999999999999999885 4568
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999998864 35899999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+....+... ....+...+.++.
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 156 EYT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred ccc-cccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 111 1112235567999999876655 479999999999999999 99999888777777766554 4456667889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||.++|++|||++++.+
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999864
No 284
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=5.7e-41 Score=330.71 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=208.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58999999999999999998754 235799998865432 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012021 86 YFVMEYVKGGELFGKVAK-------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NI 140 (472)
|++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999887643 2478899999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012021 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|+++++.+||+|||++................++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754332211112234567789999998766554 88999999999999998 999998887777
Q ss_pred HHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 220 MYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+... ....|..++.++.+++.+||+++|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 66655543 344566789999999999999999999999999863
No 285
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1.6e-40 Score=317.74 Aligned_cols=248 Identities=34% Similarity=0.575 Sum_probs=214.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976543 345788999999999999999999999999999999999
Q ss_pred ecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 91 YVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|++|++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999988664 799999999999999999999999999999999999999999999999999876654321 2
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCC--CCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNW--FAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~--~s~~l~~li~~ 245 (472)
....|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+.......+... ....+.. ++.++.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45578999999999876654 58899999999999999999999887544433333322 2223322 48899999999
Q ss_pred ccCCCCCCcCChhhhhcCcc
Q 012021 246 ILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h~~ 265 (472)
||+.||++|||+.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
No 286
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=6.6e-41 Score=322.55 Aligned_cols=250 Identities=27% Similarity=0.502 Sum_probs=219.7
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 6999999999999999999999999999999987654332 334567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 91 YVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999988755 46899999999999999999999999999999999999999999999999998876543
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHh
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~ 244 (472)
......|++.|+|||.+.+..+. .++|+||||+++++|++|+.||...+.......+....+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 22345689999999999776654 789999999999999999999998887776666665543 355568899999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012021 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
No 287
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=8.8e-41 Score=323.91 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=210.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 44578999999999999999999974 457899999875432 2356889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999865 259999999999999999999999999999999999999999999999999988664221
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
... .....++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YEA-REGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred ccc-cCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 111 111223457999999876655 478999999999999999 99999888777766666544 23455668899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012021 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||..+|.+||++.+++.
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999875
No 288
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=9.3e-41 Score=327.82 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=202.2
Q ss_pred cCCe-EEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--
Q 012021 9 MQRY-ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-- 81 (472)
Q Consensus 9 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (472)
.+|| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 5677 999999999999998765 335788999999875432 1234667899999999999999999998765
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...+|++|||+.+++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCC-ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH--HHH-------------HHHh
Q 012021 162 KHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM--EMY-------------RKIG 225 (472)
Q Consensus 162 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~--~~~-------------~~i~ 225 (472)
..... ......++..|+|||.+....+ +.++||||||+++|+|++|..||...... +.. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 22111 1122345677999999876655 48999999999999999999998653211 100 0011
Q ss_pred c-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 226 K-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 226 ~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. .....+..++.++.+++.+||.++|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 122345667899999999999999999999999985
No 289
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=8.2e-42 Score=361.71 Aligned_cols=246 Identities=32% Similarity=0.548 Sum_probs=207.1
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEE-EE---eC--
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEV-MA---SK-- 82 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~---~~-- 82 (472)
.+++|.+.|.+|||+.||+|.+...|..||+|.+-.. +....+.+++||++|+.|+ |+|||.+++. .. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4788999999999999999999888899999997543 4466789999999999997 9999999993 21 11
Q ss_pred -CEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 83 -TKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~g--iiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
-.++|.||||.||.|-|++.. .+|+|.++++||.|+++||.+||... |||||||-|||||+.+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 257899999999999998864 56999999999999999999999997 999999999999999999999999988
Q ss_pred hhhhccc-C-CC--c---cccccCCCcccChhhh---cccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc
Q 012021 157 ALAESKH-Q-DG--L---LHTTCGTPAYVAPEVI---NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226 (472)
Q Consensus 157 ~~~~~~~-~-~~--~---~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~ 226 (472)
+-..... . .. . --...-|+.|+|||.+ .+.+. +.|+|||+|||+||-|+...+||++.... .|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe
Confidence 6432211 0 00 0 0113469999999986 34444 48999999999999999999999887543 4678
Q ss_pred cCCCCCC--CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 227 AEFKFPN--WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 ~~~~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+.+|+ .++..+.+||+.||++||.+||++.+++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 8888886 589999999999999999999999999875
No 290
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=7.4e-41 Score=324.14 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=208.6
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||++.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 457999999999999999999874 3456999998654322 35688999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||.||+++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999999998864 46899999999999999999999999999999999999999999999999988754322111
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHh
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLS 244 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~ 244 (472)
......++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+.......+.... ...+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11122345679999999766654 78999999999999998 999998877776666666543 3345557899999999
Q ss_pred cccCCCCCCcCChhhhhcC
Q 012021 245 KILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h 263 (472)
+||.+||.+|||+.+|+++
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
No 291
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=6.6e-41 Score=332.65 Aligned_cols=255 Identities=22% Similarity=0.436 Sum_probs=213.8
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNL-------KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
.+..++|++.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 456779999999999999999999753 234579999986542 123456788999999999 7999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012021 78 VMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NI 140 (472)
++......|++|||+.+++|.+++.. ..++...+..++.||+.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 99999999999999999999988754 2467788999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012021 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999998765432222222334567889999999776664 78999999999999998 889998888877
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.... ...+..++.++.++|.+||.++|.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 777765543 34556688999999999999999999999999875
No 292
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=4.3e-41 Score=330.82 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=206.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 88 (472)
+.|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677889999999999999999999999999998765422 33467889999999986 99999999999999999999
Q ss_pred EEecCCC--cccchhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 89 MEYVKGG--ELFGKVA---KGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 89 ~E~~~gg--~L~~~i~---~~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|||+.+. ++...+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9998642 2333321 35799999999999999999999975 9999999999999999999999999998765432
Q ss_pred cCCCccccccCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhccC-CCC----CCC
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAE-FKF----PNW 234 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~----~~~ 234 (472)
.. .....|++.|+|||++.+. ...+.++|||||||++|+|++|+.||..... .+....+.... ... +..
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 21 2344689999999998765 2345799999999999999999999976542 22223332222 122 223
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
+++++.+||.+||..||++|||+++|+.||||+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 7889999999999999999999999999999976
No 293
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=1.1e-40 Score=327.72 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=219.1
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..+.|++.+.||+|+||.||.+.+..++..||+|++..... ..+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999988999999999976542 34678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
++||+.|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999999774 799999999999999999999999999999999999999999999999998875543221
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCC--CCCCCHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKF--PNWFAPEVRRL 242 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~s~~l~~l 242 (472)
......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.... ... +..++.++.++
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 12344688999999998776654 78999999999999999999998877665544443322 222 23378899999
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012021 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
|.+||+.+|.+|||+.++++|+||.+
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999987
No 294
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=3.2e-41 Score=338.56 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=216.1
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-----KI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (472)
||++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 79999999999999999999998999999999876432 1234567889999999999999999999987765 89
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|++|||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 478888866 5899999999999999999999999999999999999999999999999999886544321
Q ss_pred -CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--------------
Q 012021 165 -DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-------------- 229 (472)
Q Consensus 165 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------------- 229 (472)
........+|+.|+|||++.+....+.++|+||||+++|+|++|..||...+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 01234456899999999998774455899999999999999999999988877665555432110
Q ss_pred -----------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 230 -----------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 -----------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
...+.+++++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0112367889999999999999999999999999999863
No 295
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=5e-41 Score=337.50 Aligned_cols=254 Identities=20% Similarity=0.360 Sum_probs=204.1
Q ss_pred eeEccc--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 16 RLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
..||.| +||+||+|.+..+|+.||+|++...... ....+.+++|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765432 2445789999999999999999999999999999999999999
Q ss_pred CCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC----
Q 012021 94 GGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG---- 166 (472)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~---- 166 (472)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999988865 358999999999999999999999999999999999999999999999998654332211110
Q ss_pred -ccccccCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---------------
Q 012021 167 -LLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--------------- 229 (472)
Q Consensus 167 -~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 229 (472)
......++..|+|||++.+.. ..+.++|||||||++|+|++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011123567799999986542 235789999999999999999999987654433322221110
Q ss_pred --------------------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 230 --------------------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 230 --------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
..+..+++++.+||++||..||++|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01122567899999999999999999999999999998643
No 296
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=9.8e-41 Score=336.24 Aligned_cols=256 Identities=22% Similarity=0.422 Sum_probs=213.3
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT-------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELY 76 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 76 (472)
.++...+|++++.||+|+||.||+|++... +..||+|.+.... .....+.+.+|+.+++++ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 456667899999999999999999987542 2369999886432 223456788999999999 799999999
Q ss_pred EEEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012021 77 EVMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~N 139 (472)
+++...+.+|++|||+.+|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 999999999999999999999998753 136778899999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH
Q 012021 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~ 218 (472)
||++.++.+||+|||+++...............++..|+|||++.+..+. .++||||||+++|+|++ |..||...+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999998755432211112223345679999999776665 78999999999999998 89999988877
Q ss_pred HHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 219 EMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 219 ~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+..+.... ...+..++.++.++|.+||+.+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7777765543 35566688999999999999999999999999987
No 297
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=1.2e-40 Score=326.90 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=207.3
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
-.++|++++.||+|+||+||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 356899999999999999999999887774 6677764322 1233467788888999999999999999875 45
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..++++||+.+|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999864 5789999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHH
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l 239 (472)
...........++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.........+..+. ...+...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 2222222344577889999998766654 89999999999999998 999998877666555554443 34455577899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++.+||..||++|||+.++++.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999763
No 298
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=9.3e-41 Score=323.21 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=204.9
Q ss_pred eeEcccCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 16 RLLGQGTFAKVHYARN--LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||+|.+ ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++. ....++||||+.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999964 45788999999865432 2345678899999999999999999999875 456789999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC-ccccc
Q 012021 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHTT 171 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~~~~~ 171 (472)
+++|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++.......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999998865 579999999999999999999999999999999999999999999999999987654322110 01223
Q ss_pred cCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCC
Q 012021 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~ 249 (472)
.+++.|+|||.+....+ +.++|+|||||++|+|++ |..||.+.+.......+..+. ...|..+++++.++|.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 44678999999866554 478999999999999998 999999887777777666543 466777999999999999999
Q ss_pred CCCCcCChhhhhcC
Q 012021 250 NPNTRISMTKIMEN 263 (472)
Q Consensus 250 dP~~Rpt~~eil~h 263 (472)
||++||++++|...
T Consensus 238 ~p~~Rp~~~~i~~~ 251 (257)
T cd05116 238 GVDERPGFAVVELR 251 (257)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999753
No 299
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=2e-40 Score=331.51 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=216.8
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
...|+..+.||+|+||.||++.+..++..||+|.+.............+.+|+.+++.++|||++++++++.+++..|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34588999999999999999999999999999999765444445567788999999999999999999999999999999
Q ss_pred EEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.| +|.+.+. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999975 6666653 36799999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-C-CCCCCHHHHHH
Q 012021 167 LLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-F-PNWFAPEVRRL 242 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~l~~l 242 (472)
.....|++.|+|||.+.. .+..+.++|||||||++|+|++|..||...+.......+...... . +..+++.+.++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 234578999999999742 233457899999999999999999999887766655555544322 2 23478899999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 243 LSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
|.+||+.+|.+||++.++++|+|+.....
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 99999999999999999999999976443
No 300
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=7.3e-41 Score=338.49 Aligned_cols=254 Identities=31% Similarity=0.479 Sum_probs=208.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 46799999999999999999999999999999999875432 223345678999999999999999999998654
Q ss_pred -CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 83 -TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..+|+|+||+.. +|.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 565544 34699999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (472)
. .....+|+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 234567899999999876444558999999999999999999999887655444433221
Q ss_pred ---------CCCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 ---------EFKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.... .+..++++.+||.+||+.||++|||+++++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 12357789999999999999999999999999999864
No 301
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=4.3e-41 Score=340.35 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=205.7
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARN-----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
..-.+||++++.||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34457999999999999999999985 35678999999975432 23346788999999999 689999999987
Q ss_pred Ee-CCEEEEEEEecCCCcccchhcc-------------------------------------------------------
Q 012021 80 AS-KTKIYFVMEYVKGGELFGKVAK------------------------------------------------------- 103 (472)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------- 103 (472)
.. +..+|++|||+++|+|.+++..
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 54 4578999999999999888743
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccc
Q 012021 104 -------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 104 -------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1367788899999999999999999999999999999999999999999999876532221111123
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHHHHHhc-cCCCCCCCCCHHHHHHHhccc
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMYRKIGK-AEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~-~~~~~~~~~s~~l~~li~~~L 247 (472)
..+++.|+|||++.+..+. .++||||||+++|+|++ |..||...... .....+.. .....|.+.++++.+++.+||
T Consensus 241 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl 319 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 319 (343)
T ss_pred CCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence 3456789999998776664 78999999999999996 99999775433 22333322 234566778899999999999
Q ss_pred CCCCCCcCChhhhhcC
Q 012021 248 DPNPNTRISMTKIMEN 263 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h 263 (472)
..||++|||+.+|++|
T Consensus 320 ~~~p~~Rps~~eil~~ 335 (343)
T cd05103 320 HGEPSQRPTFSELVEH 335 (343)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999987
No 302
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=1.2e-40 Score=364.29 Aligned_cols=149 Identities=33% Similarity=0.656 Sum_probs=139.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||.|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555555667899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
|||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999865 678999999999999999999999999999999999999999999999999875
No 303
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-42 Score=318.17 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=207.3
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-----eC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA-----SK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~ 82 (472)
..+||++.+.||+|||+.||++.+..+++.+|+|.+..... +..+...+|++..++++|||+++++++.. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 35599999999999999999999999999999999977652 44678899999999999999999998752 33
Q ss_pred CEEEEEEEecCCCcccchhcc----C-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 83 TKIYFVMEYVKGGELFGKVAK----G-KLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~i~~ql~~aL~yLH~~g--iiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
...|+++.|...|+|.+.+.. | -++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 459999999999999998853 3 5999999999999999999999998 99999999999999999999999998
Q ss_pred hhhhhcccCCCc-------cccccCCCcccChhhhcccCCC--CCcccchhhhHHHHHHhcCCCCCCCCcH--HHHHHHH
Q 012021 156 SALAESKHQDGL-------LHTTCGTPAYVAPEVINRRGYD--GSKADIWSCGVILYVLLAGYLPFHDSNL--MEMYRKI 224 (472)
Q Consensus 156 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlGvil~~lltG~~Pf~~~~~--~~~~~~i 224 (472)
++...-.-.... -.....|..|+|||.+.-+.+. +.++|||||||+||+|+.|.-||+..-. ..+.-.+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 875543211110 1122468999999998654332 5799999999999999999999964211 0111123
Q ss_pred hccCCCCCC--CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 225 GKAEFKFPN--WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~~~~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..+.+.+|. .+|..+.++|+.||+.||.+||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 344555554 389999999999999999999999999875
No 304
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=1.5e-40 Score=323.64 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=211.0
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+.+|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999887665 69999986542 233457789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999988864 568999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccc---CCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012021 164 QDGLLHTTC---GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 164 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
......... ++..|+|||.+....+. .++|||||||++|++++ |..||...+.......+... ....+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 211111111 24579999999776664 78999999999999886 99999887777666666443 23445567899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+++.+||..+|.+||++.+|+..
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
No 305
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-41 Score=322.91 Aligned_cols=259 Identities=32% Similarity=0.601 Sum_probs=231.4
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
+-.+.|++++.||+|+|++|.+++.+.|.+.+|+|+++++-+...+..+.+..|-.+...- +||.+|-++.+|.++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4567899999999999999999999999999999999999888777888999999988654 799999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
++|.||++||+|.-.+.+ ++++|+.++.|...|+.||.|||++||++||||.+|+|+|..|.+||.|+|+++.-- ..
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~ 404 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GP 404 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--CC
Confidence 999999999999666654 789999999999999999999999999999999999999999999999999987432 23
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-------CcH-HHHHHHHhccCCCCCCCCC
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-------SNL-MEMYRKIGKAEFKFPNWFA 236 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-------~~~-~~~~~~i~~~~~~~~~~~s 236 (472)
.....+.||||.|+|||++.+..| +...|.|+|||+++||++|+.||+- .+. .-+++-|......+|..+|
T Consensus 405 gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls 483 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS 483 (593)
T ss_pred CcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence 345688999999999999998887 4999999999999999999999962 222 3456677788899999999
Q ss_pred HHHHHHHhcccCCCCCCcCC------hhhhhcCccccc
Q 012021 237 PEVRRLLSKILDPNPNTRIS------MTKIMENSWFRK 268 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt------~~eil~h~~f~~ 268 (472)
-.+..+++..|++||.+|.. ..+|..|+||+.
T Consensus 484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999999999999999984 579999999984
No 306
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=1.5e-40 Score=322.25 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=207.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4567899999999999999999988554 4699998865432 2356788999999999999999999885 45689
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999998864 248999999999999999999999999999999999999999999999999987653321
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
. .......++..|+|||...+..+ +.++||||||+++|+|++ |..||.+....+....+... ....+..++..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred c-cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 1 11122345678999999876654 489999999999999999 99999988777766666554 33456668899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012021 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++++||.+||++||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999875
No 307
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=7.6e-41 Score=330.79 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=204.7
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCC--------------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeee
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTG--------------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVE 74 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 74 (472)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .....+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 359999987543 2234567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCcccchhccC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012021 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKG-------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NIL 141 (472)
+++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999998887432 3688899999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--CCCCCCCCcHHH
Q 012021 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--GYLPFHDSNLME 219 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--G~~Pf~~~~~~~ 219 (472)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432221111223345778999999876665 489999999999999988 778888766555
Q ss_pred HHHHHhc--------cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 220 MYRKIGK--------AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 220 ~~~~i~~--------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
....+.. .....++.+++.+.+||.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443321 112334557899999999999999999999999965
No 308
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=1.5e-40 Score=322.13 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=209.6
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++++.||+|+||.||+|.+ .+++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 46678999999999999999999986 46788999998765432 357889999999999999999999874 4578
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+.+++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999998754 46899999999999999999999999999999999999999999999999998755421
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......++..|+|||.+....+ +.++||||||+++|++++ |++||.+.+.......+... ....+...+.++.
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111 1122345678999999876655 478999999999999999 99999988777766666544 2345566889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||..+|++|||++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999875
No 309
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=2.8e-40 Score=330.03 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=213.9
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|...+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34577888999999999999999999999999999766544444556788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.| +|.+.+.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 999964 67666643 578999999999999999999999999999999999999999999999999875422
Q ss_pred ccccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-C-CCCCCCHHHHHH
Q 012021 167 LLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-K-FPNWFAPEVRRL 242 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~s~~l~~l 242 (472)
......|+..|+|||.+.. .+..+.++||||||+++|+|++|..||...+.......+..... . ....++..+.+|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 1234578999999999742 23345789999999999999999999988776555555443322 1 223467889999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 243 LSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
+.+||+.+|.+||++.+++.||||+...
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999998643
No 310
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=1.5e-40 Score=323.55 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=210.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++++.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875544 799999865432 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+++++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999865 468999999999999999999999999999999999999999999999999988654322
Q ss_pred CCCc-cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 164 QDGL-LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
.... .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+... ....+..+++++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1110 111223568999999977665 489999999999999886 99999887776666666544 2344455789999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||+.+|..||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
No 311
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=1.2e-40 Score=327.91 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=211.6
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998753 678999999865432 23456788999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012021 83 TKIYFVMEYVKGGELFGKVAK-----------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~N 139 (472)
...|++|||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 999999999999999888753 137888899999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH
Q 012021 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~ 218 (472)
|+++.++.++|+|||++................++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998754322211111223456779999998776654 79999999999999997 88999887777
Q ss_pred HHHHHHhccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 219 EMYRKIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 219 ~~~~~i~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+....+..+.. ..|..++.++.++|.+||..+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77776665543 456678899999999999999999999999875
No 312
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.6e-40 Score=328.63 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=204.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLK----------------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (472)
..++|++.+.||+|+||+||++++.. ++..||+|++.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999986532 34579999986543 2234567889999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccchhccC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012021 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKG------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~N 139 (472)
|+++++++...+..|+||||+.+++|.+++... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999999999999999999999999999887542 36778899999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--CCCCCCCCcH
Q 012021 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--GYLPFHDSNL 217 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--G~~Pf~~~~~ 217 (472)
||++.++.++|+|||++................+++.|+|||......+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999875533221111222345678999998876655 489999999999999998 7899987665
Q ss_pred HHHHHHHh--------ccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 218 MEMYRKIG--------KAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 218 ~~~~~~i~--------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+...... ......+..+++.+.+|+.+||+.||++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55443321 1123345567899999999999999999999999975
No 313
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=2.7e-40 Score=323.89 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=212.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..++|++++.||+|+||+||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45689999999999999999999877765 589998866542 2345678899999999999999999999987 7
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..++||||+.+|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999998865 4699999999999999999999999999999999999999999999999999886543
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHH
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l 239 (472)
...........++..|+|||.+....+. .++|+||||+++|++++ |..||......+....+..+. ...|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2221111122345689999998766554 79999999999999998 999999888777776666543 45666788999
Q ss_pred HHHHhcccCCCCCCcCChhhhhc
Q 012021 240 RRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+++.+||..||+.|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
No 314
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=1.9e-40 Score=326.51 Aligned_cols=257 Identities=33% Similarity=0.586 Sum_probs=215.0
Q ss_pred CeEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
+|++.+.||+|+||.||++.+. .+++.||||.+.+.... .....+.+.+|+.+++.+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998765432 223456788999999999 599999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+.+++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999999998865 5799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCccccccCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhccCCCCCCCCCHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
......+|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... ..+....+.......|..+++++
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 161 -ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 1123356899999999986543 24578999999999999999999996432 23444455556667777889999
Q ss_pred HHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012021 240 RRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt---~~eil~h~~f~~ 268 (472)
.++|.+||+.||++||| +.++++||||+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 99999999999999998 567799999975
No 315
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=3.1e-40 Score=319.66 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=212.0
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56789999999999999999999975 557899999876543 2356889999999999999999999999989999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||||+++++|.+++.. ..+++..+..++.||+.|+.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999865 368999999999999999999999999999999999999999999999999987654311
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.. ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||.+.+.......+... ....+...+.++.+
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred hh-hhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 0112234568999999876655 488999999999999998 99999888777777776554 34456667899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012021 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||..+|.+||+++++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999874
No 316
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=6.6e-41 Score=327.66 Aligned_cols=251 Identities=32% Similarity=0.511 Sum_probs=211.4
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++..++..|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 92 VKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+.+ +|.+.+.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 77777755 489999999999999999999999999999999999999999999999999987654432 1223
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------CC
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------FK 230 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~ 230 (472)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+.++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34688899999998776445689999999999999999999998877665554442210 00
Q ss_pred -----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 231 -----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 231 -----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112357889999999999999999999999999997
No 317
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=6.3e-41 Score=325.62 Aligned_cols=247 Identities=31% Similarity=0.528 Sum_probs=203.7
Q ss_pred EEEeeEcccCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 13 ELGRLLGQGTFAKVHYARNL----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.+.||.|+||.||.|... ..+..|+||.+.... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999997 356789999995432 223467889999999999999999999999988889999
Q ss_pred EEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 89 MEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||+++|+|.+++... .+++.....++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998764 7999999999999999999999999999999999999999999999999998766322111
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li 243 (472)
.......+...|+|||.+....+ +.++||||||+++||+++ |..||.+.+..+...++.... ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 11233456778999999877665 489999999999999999 789999988888777775543 455667899999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012021 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||..||.+|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
No 318
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=8.9e-42 Score=317.36 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=210.7
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.+..+++...+.++-..+ .|+||+.+|+|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456788999999999999999999999999997664 3355677878888776654 899999999999999999999
Q ss_pred EecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 90 EYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|.+.. -+..++. +++++|..+-++...++.||.||.++ ||+|||+||.|||+|+.|++|+||||++........
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 98843 2333333 37899999999999999999999965 999999999999999999999999999876654332
Q ss_pred ccccccCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhccCCCC-CC--CCCHHH
Q 012021 167 LLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKAEFKF-PN--WFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~~~~~-~~--~~s~~l 239 (472)
.+...|.+.|||||.+... .|+ .++||||||++|+||.||..||...+ ..+...++....++. |. .+|+.+
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred -cccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 2456799999999998543 354 78999999999999999999998844 456777777655433 32 389999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
.+|+..||..|+.+||.+.++|+|||+....
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999999998643
No 319
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=3.3e-40 Score=318.71 Aligned_cols=244 Identities=26% Similarity=0.484 Sum_probs=210.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.+.|++.+.||.|+||.||+|.+ .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 456899999999999999999987 589999999865532 35778899999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 88 VMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 99999999999998652 69999999999999999999999999999999999999999999999999987653211
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~l 242 (472)
....++..|+|||.+....+ +.++||||||+++|++++ |..||...+.......+... ....+..+++++.++
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ----ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 12345667999999876555 478999999999999997 99999888777666665544 345566789999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012021 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||..+|++|||+.++++.
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHhccChhhCcCHHHHHHH
Confidence 999999999999999999863
No 320
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=1.6e-40 Score=342.81 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=209.1
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 79 (472)
.+-.++|.+++.||+|+||.||+|++. .+++.||+|++..... ......+.+|+.+|..+. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 455668999999999999999999964 3457899999975432 233457889999999997 99999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhccC-------------------------------------------------------
Q 012021 80 ASKTKIYFVMEYVKGGELFGKVAKG------------------------------------------------------- 104 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------- 104 (472)
...+..|+||||+.+|+|.+++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999999887431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012021 105 --------------------------------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 105 --------------------------------------------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NI 140 (472)
.+++..++.++.||+.||.|||++|++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677889999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012021 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999876533221111233467889999999977665 478999999999999998 899998755444
Q ss_pred HH-HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 220 MY-RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~-~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ..+..+ ....|..++.++.+++.+||..+|.+||++++|++.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 333333 345667789999999999999999999999999875
No 321
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=3.7e-40 Score=318.67 Aligned_cols=243 Identities=29% Similarity=0.492 Sum_probs=207.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM-ASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~ 85 (472)
+-+.+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++|+|++++++++ ..++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 3456899999999999999999976 58899999985432 245688999999999999999999975 556789
Q ss_pred EEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 86 YFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999999988652 4889999999999999999999999999999999999999999999999988754321
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
. ....++..|+|||++....+. .++|||||||++|+|++ |..||...+.......+... ....+..+++.+.
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1 233456789999998776654 78999999999999997 99999888777776666544 3445667899999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||..+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
No 322
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-41 Score=345.81 Aligned_cols=253 Identities=24% Similarity=0.417 Sum_probs=216.6
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..|..+...++..||+|.||+||+|++-. .||||+++...... +.++.+++|+.+++.-+|.||+-+.|++.....
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 45667778899999999999999999854 49999998776554 578999999999999999999999999988887
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.||+.+|+|.+|+.++.- -+|.....+.|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+.....-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999999864 57999999999999999999999999999999999999999999999999999865544
Q ss_pred cCCCccccccCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-----CCCCC
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-----FPNWF 235 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~ 235 (472)
..+..+...-|...|||||++... ...++.+||||||+++|||+||.+||...+...++-.+.++... .-...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 444456667789999999998543 22358999999999999999999999966666665555555322 12235
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 236 APEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+.++++|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 669999999999999999999999987
No 323
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=4.6e-40 Score=318.18 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=203.3
Q ss_pred eeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEec
Q 012021 16 RLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876655 78999998766532 34567889999999999999999999876 45689999999
Q ss_pred CCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC-cccc
Q 012021 93 KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHT 170 (472)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~~~~ 170 (472)
.+++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 459999999999999999999999999999999999999999999999999987654322110 0111
Q ss_pred ccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccC
Q 012021 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 171 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~ 248 (472)
..++..|+|||.+....+. .++||||||+++|++++ |..||...+.......+.... ...|..+++.+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234679999998776654 79999999999999998 999998877766666665443 35667789999999999999
Q ss_pred CCCCCcCChhhhhc
Q 012021 249 PNPNTRISMTKIME 262 (472)
Q Consensus 249 ~dP~~Rpt~~eil~ 262 (472)
++|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
No 324
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=5.5e-40 Score=319.36 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=211.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999876655 799999865432 233567889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|+||||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999998854 5799999999999999999999999999999999999999999999999999875543
Q ss_pred ccCCCcc-ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012021 162 KHQDGLL-HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 162 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
....... .....++.|+|||.+....++ .++|||||||++|+|++ |..||...+.......+... ....+..++.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2211111 112234579999998776654 89999999999999997 99999887777777766543 22334457899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+++.+||..+|+.||++.++++.
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999863
No 325
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=3e-40 Score=328.94 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=213.5
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...+|...+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999875443333445678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+. |+|.+.+. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999996 46766653 35689999999999999999999999999999999999999999999999998875432
Q ss_pred CccccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-C-CCCCCCHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-K-FPNWFAPEVRR 241 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~s~~l~~ 241 (472)
.....|++.|+|||.+.+ .+..+.++|||||||++|+|++|..||...+.......+..... . .+..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 134568999999999753 22335789999999999999999999987665544444443332 2 23357889999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 242 LLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
+|.+||..+|.+||++.++++|||+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999763
No 326
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-41 Score=299.35 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=214.8
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|.-.++||+|+||+||+|+++.+++.||+|.+....- ..+.-....+||.+|+.++|.|||+++++..++.++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467778899999999999999999999999999976543 2344566789999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||.. +|..+... |.++.+.++.++.|++.||.|||++++.|||+||.|+||+.||.+|++|||+|+.++.+-. -
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 99954 67666654 7899999999999999999999999999999999999999999999999999987654321 2
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-------CC----CCC---
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-------EF----KFP--- 232 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-------~~----~~~--- 232 (472)
....+-|.+|.+|.++.+...++...|+||-|||+.|+.. |++.|.+.+..+...+|-+. .+ .+|
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445679999999999888877789999999999999986 77778888877776666321 00 011
Q ss_pred ------C---------CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 233 ------N---------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ------~---------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
. .++..-++++.++|.-+|.+|+++++.++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 1 12345678999999999999999999999999975
No 327
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=6.4e-40 Score=317.92 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=201.9
Q ss_pred eEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 17 LLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999775 445679999986543 2234567899999999999999999999885 4578999999999
Q ss_pred Ccccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC-ccccc
Q 012021 95 GELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHTT 171 (472)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~~~~~ 171 (472)
++|.+++.. +.+++..+++++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998853 579999999999999999999999999999999999999999999999999987553322111 01112
Q ss_pred cCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCC
Q 012021 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~ 249 (472)
.+++.|+|||.+....+ +.++||||||+++|++++ |..||...........+..+ ...+|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999876665 478999999999999996 99999988777666666554 3566777899999999999999
Q ss_pred CCCCcCChhhhhcC
Q 012021 250 NPNTRISMTKIMEN 263 (472)
Q Consensus 250 dP~~Rpt~~eil~h 263 (472)
+|++||++.+|.+.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999753
No 328
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=4.3e-40 Score=322.56 Aligned_cols=249 Identities=31% Similarity=0.486 Sum_probs=205.6
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCE----
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMASKTK---- 84 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 84 (472)
|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988999999999975432 222334566788887766 59999999999987776
Q ss_pred -EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 85 -IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+|++|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78777754 358999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-----CC-----
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-----FK----- 230 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-----~~----- 230 (472)
... ......+++.|+|||++.+..+. .++|+||+||++|+|++|..||...+..+.+.++.... ..
T Consensus 159 ~~~---~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FEM---ALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CCc---ccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 322 12344578899999999776654 78999999999999999999998877666555543210 00
Q ss_pred ------C-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 231 ------F-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 231 ------~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+ .+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778899999999999999999999999997
No 329
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=1.7e-40 Score=324.55 Aligned_cols=251 Identities=34% Similarity=0.541 Sum_probs=211.4
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 778899999999999999999999999999997654 2223446778899999999999999999999999999999999
Q ss_pred cCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 92 VKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 92 ~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+. ++|.+++... .+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 97 4899988764 799999999999999999999999999999999999999999999999999876543221 223
Q ss_pred cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------CCCC
Q 012021 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------EFKF 231 (472)
Q Consensus 170 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 231 (472)
...++..|+|||.+......+.++||||||++++++++|..||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999876645568999999999999999999999887665554443210 0011
Q ss_pred C-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 232 P-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 232 ~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
+ +.++.++.++|.+||..||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1246789999999999999999999999999998
No 330
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=4.8e-40 Score=330.92 Aligned_cols=257 Identities=30% Similarity=0.428 Sum_probs=205.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----CC
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKT--GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS----KT 83 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 83 (472)
+|++.+.||+|+||.||++.+..+ +..||+|.+..... .......+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 699999999999999999999888 99999999864321 222345678899999998 59999999987532 25
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999985 578887754 67999999999999999999999999999999999999999999999999998755432
Q ss_pred cC--CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012021 163 HQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 163 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
.. ........||+.|+|||++.+....+.++||||||+++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 21 112234578999999998765433458999999999999999999999876543332221110
Q ss_pred ---------------CCC---CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 228 ---------------EFK---FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------------~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
... ..+..+.++.+++.+||+.||.+|||+.+++.||||++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 112257889999999999999999999999999999764
No 331
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=5.3e-40 Score=321.76 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=210.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (472)
+-.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 36889999986432 23445778899999999999999999998755
Q ss_pred CCEEEEEEEecCCCcccchhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEee
Q 012021 82 KTKIYFVMEYVKGGELFGKVAK---------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~D 152 (472)
+...++++||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5788999999999999988754 3588999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CC
Q 012021 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FK 230 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~ 230 (472)
||+++...............++..|+|||++.+..+. .++||||||+++|++++ |+.||...+..+....+..+. +.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9998754322111111223467789999999776654 88999999999999999 999999887777766655442 34
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+..+++++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45567899999999999999999999999985
No 332
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=1.5e-40 Score=321.84 Aligned_cols=252 Identities=30% Similarity=0.538 Sum_probs=212.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
||.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 799999999999999999999888888888877543321 112234567899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 89 MEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999887742 46999999999999999999999999999999999999975 569999999987653321
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
.......|++.|+|||.+.+..++ .++|+||||+++|+|++|..||...........+..+. ...+..++.++.++
T Consensus 160 --~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 160 --DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred --ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 122345688999999998776665 78999999999999999999998877766666665443 34566688999999
Q ss_pred HhcccCCCCCCcCChhhhhcCccc
Q 012021 243 LSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
No 333
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=5.7e-40 Score=315.91 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=205.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|.+++.. ..+++..+..++.+++.||.|||++|++||||||+|||++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999854 4689999999999999999999999999999999999999999999999999875542211111112234
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....|..++.++.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999876655 489999999999999999 89999887766666665543 344566788999999999999999
Q ss_pred CCcCChhhhhcC
Q 012021 252 NTRISMTKIMEN 263 (472)
Q Consensus 252 ~~Rpt~~eil~h 263 (472)
++|||+.++++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
No 334
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=6.2e-40 Score=319.96 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=200.9
Q ss_pred eeEcccCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEec
Q 012021 16 RLLGQGTFAKVHYARNLKTGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988776 46888876432 223446788999999999 7999999999999999999999999
Q ss_pred CCCcccchhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 93 KGGELFGKVAKG-----------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 93 ~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
++++|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999988542 378999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCC
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 233 (472)
+........ ......+..|+|||++....+ +.++||||||+++|+|++ |..||.+.+....+..+... ....+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 753221111 112234567999999876655 479999999999999997 99999887777777666554 234555
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.++.++.+++.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 678999999999999999999999999863
No 335
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=9.6e-40 Score=315.26 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=209.5
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++.+.||.|+||.||++.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999875 4778999998654432 356889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+++|.+++.. +.+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 99999999998864 5689999999999999999999999999999999999999999999999998875432211 11
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+. ...|...+.++.+++.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1122356789999998766654 78999999999999998 999999888777777766543 33455578999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012021 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||..+|++|||+.++++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999864
No 336
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=7.9e-40 Score=323.67 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=208.9
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (472)
+..+-.+.|++.+.||+|+||+||+|.+..+++.||||.+.+.... .....+.+|+.++... .||||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 3455678899999999999999999999988999999999765322 2234556677766666 499999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccchhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGla~~~ 159 (472)
...|++|||+.+ .|.+.+.. +.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999854 56555543 579999999999999999999997 59999999999999999999999999998765
Q ss_pred hcccCCCccccccCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhccC-CCCCC-
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAE-FKFPN- 233 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~~~- 233 (472)
..... .....+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+.+..+.... ...+.
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 33221 12345788999999986542 234789999999999999999999976433 33444443332 22332
Q ss_pred -CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 234 -WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 -~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.++.++.+||.+||..||.+|||+++++.||||+.
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 36889999999999999999999999999999985
No 337
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=3.5e-40 Score=323.06 Aligned_cols=249 Identities=32% Similarity=0.490 Sum_probs=206.7
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 90 (472)
|++.+.||+|+||+||+|.+..+++.||||.+...... .......+|+..++.++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78999999999999999999989999999998654321 11223457899999999 9999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+ +++|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 7788887764 2689999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------C
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------E 228 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~ 228 (472)
.....|+..|+|||++......+.++|+||||+++++|++|+.||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999998865554568999999999999999999999877665544433210 0
Q ss_pred CC-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 229 FK-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
.. .....++++.++|++||..+|++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
No 338
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=8.2e-40 Score=315.92 Aligned_cols=243 Identities=25% Similarity=0.448 Sum_probs=205.4
Q ss_pred eeEcccCCeEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEec
Q 012021 16 RLLGQGTFAKVHYARNLK-TGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+.. +++ .||+|.+...... ...+.+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999776543 556789999999999999999999999988 8999999999
Q ss_pred CCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC-Ccc
Q 012021 93 KGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-GLL 168 (472)
Q Consensus 93 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~-~~~ 168 (472)
++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999865 35899999999999999999999999999999999999999999999999998866432211 111
Q ss_pred ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHHhc
Q 012021 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li~~ 245 (472)
....++..|+|||.+....+. .++|||||||++|+|++ |..||...+..+....+... ....+..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999998776654 78999999999999998 99999887777666665532 233455678999999999
Q ss_pred ccCCCCCCcCChhhhhc
Q 012021 246 ILDPNPNTRISMTKIME 262 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (472)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
No 339
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=2e-41 Score=340.43 Aligned_cols=241 Identities=26% Similarity=0.455 Sum_probs=210.7
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
|-++...-++-||.|+.|.||+++. .++.||||.++.- -..+|.-|+.|+||||+.+.|+|...-.++
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 3344444567799999999999987 6789999987432 235788899999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||||..|.|+..++. +.++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++......
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-- 266 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-- 266 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--
Confidence 99999999999999987 579999999999999999999999999999999999999999999999999988665432
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~l~~li 243 (472)
..-.++||..|||||++...+.. .|+|||||||||||||||..||.+.+...++.-+..+. ...|..++..++-||
T Consensus 267 -TkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 267 -TKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL 344 (904)
T ss_pred -hhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence 23568999999999999877665 89999999999999999999999887776655554443 466788999999999
Q ss_pred hcccCCCCCCcCChhhhhcC
Q 012021 244 SKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h 263 (472)
+.||.-.|..||++.+|+.|
T Consensus 345 Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHhcCCCCCccHHHHHHH
Confidence 99999999999999999988
No 340
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=3.2e-40 Score=328.81 Aligned_cols=247 Identities=23% Similarity=0.422 Sum_probs=198.2
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchh
Q 012021 22 TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV 101 (472)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (472)
++|.||.+++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|++|||+.+++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445666777777999999999976532 2345678999999999999999999999999999999999999999999988
Q ss_pred cc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC-----CCccccccC
Q 012021 102 AK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ-----DGLLHTTCG 173 (472)
Q Consensus 102 ~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~-----~~~~~~~~g 173 (472)
.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 64 4689999999999999999999999999999999999999999999999998764432111 111233457
Q ss_pred CCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH-HHHhccC----------------------
Q 012021 174 TPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY-RKIGKAE---------------------- 228 (472)
Q Consensus 174 t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~-~~i~~~~---------------------- 228 (472)
+..|+|||++... ++ +.++|+||+||++|+|++|..||......... .++....
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 8899999998653 34 47899999999999999999999876543322 2221100
Q ss_pred -----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 229 -----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
...+..+++++.+|+.+||..||++|||++++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112356788999999999999999999999999998643
No 341
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.6e-39 Score=315.08 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=208.5
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||++.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 467889999999999999999999864 56679999886543 234678899999999999999999999887 778
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999999864 35788999999999999999999999999999999999999999999999998755332
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~ 240 (472)
.. .......++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+.... ...+...+.++.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence 11 11122345677999999876554 478999999999999998 999999877766666655442 344566889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012021 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||+++|++||++.++++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999998864
No 342
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=7.8e-40 Score=319.48 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=211.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++|++++.||+|+||+||+|+... +.+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 346799998865432 234577899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-C---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeec
Q 012021 84 KIYFVMEYVKGGELFGKVAK-G---------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDF 153 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DF 153 (472)
..|+||||+++++|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999998864 3 5899999999999999999999999999999999999999999999999
Q ss_pred cchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCC--C
Q 012021 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF--K 230 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~ 230 (472)
|++....... ........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||........+..+..... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9876432211 111233456778999999876655 478999999999999998 8999988777666666664443 3
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..++..+.+++.+||..+|.+|||+.+++..
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455688999999999999999999999999864
No 343
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=1.8e-40 Score=321.59 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=198.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcE-------EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 16 RLLGQGTFAKVHYARNLKTGMS-------VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~-------vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+.||+|+||.||+|.+..++.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4699999999999998765543 8888876443 23456788899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--------EEEeeccchhh
Q 012021 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--------LKVSDFGLSAL 158 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~--------vkl~DFGla~~ 158 (472)
|||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999865 35899999999999999999999999999999999999987765 69999998764
Q ss_pred hhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhccCCCCCCCCCH
Q 012021 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 237 (472)
... .....+++.|+|||++.+....+.++||||||+++|+|++| ..||...+..... .+......+|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 432 13356889999999997655456889999999999999998 5666665544432 233445667777789
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 238 EVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.++|.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
No 344
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=1.2e-39 Score=313.87 Aligned_cols=247 Identities=28% Similarity=0.467 Sum_probs=210.6
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+++.+.||.|+||.||++.+..++ ..||+|.+...... ...+.+..|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 89999999655321 245788999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC-C--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 88 VMEYVKGGELFGKVAKG-K--LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~-~--l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+|||+++++|.+++... . +++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998653 2 99999999999999999999999999999999999999999999999999876543311
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
... ....+++.|+|||.+....+ +.++|+||||+++++|++ |..||...+.......+.... ...+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 110 11236789999999865544 589999999999999998 899998887777777766544 34566689999999
Q ss_pred HhcccCCCCCCcCChhhhhc
Q 012021 243 LSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~ 262 (472)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999975
No 345
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=4.9e-41 Score=343.29 Aligned_cols=254 Identities=25% Similarity=0.532 Sum_probs=221.0
Q ss_pred cCCeE-EEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE--
Q 012021 9 MQRYE-LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK-- 84 (472)
Q Consensus 9 ~~~y~-i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 84 (472)
.+||- ....||+|+|-+||+|.|..+|-.||.-.+....+. .....+++..|+.+|+.|+||||+++|++|.+..+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 45553 457899999999999999999999998766544433 34557899999999999999999999999987765
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEcC-CCCEEEeeccchhhhh
Q 012021 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR--GVCHRDLKPENLLLDE-HGNLKVSDFGLSALAE 160 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~--giiHrDlKp~NILld~-~g~vkl~DFGla~~~~ 160 (472)
+.+|+|.+..|+|+.|+++ ++++...++.|++||+.||.|||++ -|+|||||-+||+|+. .|.|||+|+|||++..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999987 7899999999999999999999998 5999999999999975 4789999999999876
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccCCC--CCCCCCH
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFK--FPNWFAP 237 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~s~ 237 (472)
.... ....|||.|||||.+. ..|+ ..+||||||+.++||+|+..||.. .+...+|+++..+..+ +..--.|
T Consensus 198 ~s~a----ksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 KSHA----KSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cccc----ceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 5443 4578999999999986 5676 899999999999999999999975 6778999999877543 2333468
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
++++||.+||.. .+.|+|+.|+|.||||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 9999999999999999874
No 346
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=2e-39 Score=311.97 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=203.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.. .++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4789999999999986 4788999999865432 233456889999999999999999999999999999999999999
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccC
Q 012021 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|.+++.. ..+++..+..++.|++.||.|+|++|++||||||+||+++.++.++|+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99998864 4689999999999999999999999999999999999999999999999999864332111 11112244
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCC
Q 012021 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 174 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
++.|+|||++....+ +.++||||||+++|++++ |..||...........+... ....+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999876554 478999999999999998 99999887776666666544 335566789999999999999999
Q ss_pred CCcCChhhhhcC
Q 012021 252 NTRISMTKIMEN 263 (472)
Q Consensus 252 ~~Rpt~~eil~h 263 (472)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999753
No 347
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=5.8e-41 Score=362.14 Aligned_cols=255 Identities=31% Similarity=0.531 Sum_probs=209.6
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
....|+.++.||+||||.||+++++-+|..||||.|.... .......+.+|+..|.+|+|||||++|..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4556889999999999999999999999999999997765 33566789999999999999999999842100
Q ss_pred --------------------------------------------------------------------------------
Q 012021 82 -------------------------------------------------------------------------------- 81 (472)
Q Consensus 82 -------------------------------------------------------------------------------- 81 (472)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CEEEEEEEecCCCcccchhccCCCC--HHHHHHHHHHHHHHHHHHH
Q 012021 82 -------------------------K--------TKIYFVMEYVKGGELFGKVAKGKLK--EDAARKYFQQLISAVDYCH 126 (472)
Q Consensus 82 -------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~i~~ql~~aL~yLH 126 (472)
+ ..+||-||||+...|.+++..+.+. ...+|++|++|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1278999999999999999887764 8899999999999999999
Q ss_pred hCCceecCCCCCcEEEcCCCCEEEeeccchhhhh----c------------ccCCCccccccCCCcccChhhhcccC--C
Q 012021 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE----S------------KHQDGLLHTTCGTPAYVAPEVINRRG--Y 188 (472)
Q Consensus 127 ~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~~--~ 188 (472)
++|||||||||.||+||+++.|||+|||+|+... . ...++..+..+||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 0 11122456678999999999998766 2
Q ss_pred CCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhccCCCCCCC----CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 189 DGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKAEFKFPNW----FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 189 ~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~----~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+..|+|+|||||||+||+. ||... ........+.++.++.|.. --+.-..+|++||+.||++|||+.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 3489999999999999994 56543 3334555666666666532 23566789999999999999999999999
Q ss_pred cccc
Q 012021 264 SWFR 267 (472)
Q Consensus 264 ~~f~ 267 (472)
.||.
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 9985
No 348
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=1.9e-39 Score=316.16 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=208.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...+|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 456799999999999999999987644 35799998865432 2345678899999999999999999999875 45
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999999999999865 35899999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......+++.|+|||.+....+. .++||||||+++|++++ |..||......+....+..+ ....|..+++++.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SYY-KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cce-ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 111 01122345689999998766654 88999999999999986 99999888776666666554 3456677899999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012021 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|.+||..+|.+|||+.++++.
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999864
No 349
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=4.1e-40 Score=315.55 Aligned_cols=228 Identities=26% Similarity=0.455 Sum_probs=193.3
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccch
Q 012021 21 GTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK 100 (472)
Q Consensus 21 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 100 (472)
|.||+||+|++..+++.||+|.+.+.. ...+|...+....||||+++++++.+....|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997653 123455555566799999999999999999999999999999998
Q ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccC
Q 012021 101 VAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179 (472)
Q Consensus 101 i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 179 (472)
+.+ +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++...... .....++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 865 57999999999999999999999999999999999999999999999999987654332 223456788999
Q ss_pred hhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCCh--
Q 012021 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISM-- 257 (472)
Q Consensus 180 PE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-- 257 (472)
||.+....+ +.++|+||+|+++|+|++|+.||....... .......+|.++++.++++|.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876655 478999999999999999999876432211 0112345788899999999999999999999986
Q ss_pred ---hhhhcCccc
Q 012021 258 ---TKIMENSWF 266 (472)
Q Consensus 258 ---~eil~h~~f 266 (472)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
No 350
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.5e-39 Score=316.33 Aligned_cols=238 Identities=25% Similarity=0.340 Sum_probs=194.6
Q ss_pred eeEcccCCeEEEEEEEcC------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 16 RLLGQGTFAKVHYARNLK------------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22368899876543 234457888999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-------EEEeecc
Q 012021 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-------LKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~-------vkl~DFG 154 (472)
..++||||+.+++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999887754 56999999999999999999999999999999999999987764 8999999
Q ss_pred chhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHh-cCCCCCCCCcHHHHHHHHhccCCCCCC
Q 012021 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLL-AGYLPFHDSNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll-tG~~Pf~~~~~~~~~~~i~~~~~~~~~ 233 (472)
++...... ....|+..|+|||.+......+.++|||||||++|+|+ +|..||......+.. .+.........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 87654321 23467889999999865454568999999999999997 689998776554432 23333344444
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
No 351
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=1.7e-39 Score=316.35 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=192.1
Q ss_pred eeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 16 RLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996432 44578888875433 12334567889999999999999999999999999999999999
Q ss_pred CCcccchhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 94 GGELFGKVAKG------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+|+|.+++... ..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999988642 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred cccccCCCcccChhhhccc------CCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH-hccCCC-----CCCC
Q 012021 168 LHTTCGTPAYVAPEVINRR------GYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI-GKAEFK-----FPNW 234 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~ 234 (472)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||......+....+ ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233467789999997532 223578999999999999999 88999877665544443 333222 2335
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+.+++..|+ .||++|||+++|++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999976
No 352
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=1.6e-39 Score=316.09 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=203.2
Q ss_pred eeEcccCCeEEEEEEEcCCC------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 16 RLLGQGTFAKVHYARNLKTG------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.||+|+||.||+|.+.... ..+|+|.+.+... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999986544 6899999865421 133467889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----CEEEeeccch
Q 012021 90 EYVKGGELFGKVAK--------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-----NLKVSDFGLS 156 (472)
Q Consensus 90 E~~~gg~L~~~i~~--------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-----~vkl~DFGla 156 (472)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999988853 2478899999999999999999999999999999999999887 8999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCC
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNW 234 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 234 (472)
................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75533221111223356788999999876655 589999999999999998 99999887776666665443 3455667
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++..+.++|.+||..+|.+||+++++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899999999999999999999999975
No 353
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=2.5e-39 Score=321.46 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=206.3
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.++|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4579999999999999999999988876 468888765432 22334678999999999999999999998654 4
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.++++||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999998865 36899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
..........++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+.........+... .+..+...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 221112234467789999998766654 88999999999999997 99999876655544444333 2344556788999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012021 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
No 354
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=2.7e-39 Score=317.80 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=201.4
Q ss_pred CeEEEeeEcccCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CE
Q 012021 11 RYELGRLLGQGTFAKVHYARN----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TK 84 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 84 (472)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368999999999999999974 4578899999986543 223456789999999999999999999998775 67
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999999999999865 35899999999999999999999999999999999999999999999999998865432
Q ss_pred cCC-CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---------------HHHHHHHHhc
Q 012021 163 HQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---------------LMEMYRKIGK 226 (472)
Q Consensus 163 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---------------~~~~~~~i~~ 226 (472)
... .......|+..|+|||++.+..+. .++||||||+++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 211 112234567789999998776554 78999999999999999877653211 0111111111
Q ss_pred -cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 227 -AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 -~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233455688999999999999999999999999864
No 355
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.4e-41 Score=325.23 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=210.0
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--C----CeeeEEE
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--P----NVVELYE 77 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~ 77 (472)
.|.++.+||.++.+||+|+||+|-.+.|..++..||||+++.-. ...+..+-|+.+|+++.+ | -+|.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 47788999999999999999999999999999999999985432 334556779999999842 3 3788999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----------
Q 012021 78 VMASKTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---------- 144 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~---------- 144 (472)
+|+-.+++++|+|.+ |.++++.+..+ +++...++.+++||+.+++|||+.+++|.||||||||+-+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 77999999874 6899999999999999999999999999999999999832
Q ss_pred ----------CCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC
Q 012021 145 ----------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214 (472)
Q Consensus 145 ----------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~ 214 (472)
+..|+|+|||.|+..... -++.+.|..|.|||++.+-+++ .++||||+||||+||.+|...|..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceeccc
Confidence 335899999988864332 2566789999999999999997 899999999999999999999987
Q ss_pred CcHHH---HHHHHhc------------------cCCCCCCCC-------------------------CHHHHHHHhcccC
Q 012021 215 SNLME---MYRKIGK------------------AEFKFPNWF-------------------------APEVRRLLSKILD 248 (472)
Q Consensus 215 ~~~~~---~~~~i~~------------------~~~~~~~~~-------------------------s~~l~~li~~~L~ 248 (472)
.+..+ +.++|.. +...+|... ..++.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 55433 3333321 111111110 1257899999999
Q ss_pred CCCCCcCChhhhhcCccccc
Q 012021 249 PNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~~eil~h~~f~~ 268 (472)
.||.+|+|+.|+|.||||..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 99999999999999999975
No 356
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=1.7e-39 Score=318.13 Aligned_cols=237 Identities=26% Similarity=0.343 Sum_probs=193.9
Q ss_pred eEcccCCeEEEEEEEcCC------------------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe
Q 012021 17 LLGQGTFAKVHYARNLKT------------------------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 72 (472)
+||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358899886543 2334567889999999999999
Q ss_pred eeEEEEEEeCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----
Q 012021 73 VELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---- 146 (472)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g---- 146 (472)
+++++++......|+||||+++|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999888854 5799999999999999999999999999999999999998654
Q ss_pred ---CEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHH-hcCCCCCCCCcHHHHHH
Q 012021 147 ---NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL-LAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 147 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~l-ltG~~Pf~~~~~~~~~~ 222 (472)
.+|++|||++...... ....+++.|+|||.+.+....+.++||||||+++|+| ++|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999987543221 2345788999999886644446899999999999998 47999998765544332
Q ss_pred HHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 223 KIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 223 ~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
........|...++++.++|.+||+.+|++|||+.+|+++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2223344555567899999999999999999999999875
No 357
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.1e-40 Score=335.27 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=214.4
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCc---E-EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM---S-VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+..++-.+.++||+|+||+||+|..+..+. . ||+|....+..........+.+|+++|+.++|||||++||+....
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 444556677999999999999999876433 3 899998764434456678899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.-+|+|||+|.||+|.+++.+. .++..+..+++.+.+.||+|||+++++||||-..|+|++.++.+||+||||++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999999874 49999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccc-CCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCC--CCCCCCC
Q 012021 161 SKHQDGLLHTTC-GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF--KFPNWFA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s 236 (472)
.... ....+ -...|+|||.+...-| +.++||||+||++||+++ |..||.+....+...+|....+ ..|...+
T Consensus 314 ~~~~---~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 314 QYVM---KKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred ceee---ccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 1111 11112 3457999999987755 589999999999999999 8899999999999999966544 4556678
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++..++.+|+..||+.|||+.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 88999999999999999999999965
No 358
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=5.1e-39 Score=315.45 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=200.1
Q ss_pred cCCeEEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Q 012021 9 MQRYELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--K 82 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 82 (472)
..+|++.+.||+|+||.||.+. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 3589999999999999999997 44578999999986543 2345678899999999999999999998743 4
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 578999999999999999864 468999999999999999999999999999999999999999999999999988654
Q ss_pred cccCCCcc-ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH----------------HHHH
Q 012021 161 SKHQDGLL-HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----------------MYRK 223 (472)
Q Consensus 161 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~----------------~~~~ 223 (472)
........ ....++..|+|||.+.+..+ +.++||||||+++|+|++|..|+....... +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32211101 11223456999999876655 479999999999999999987764432110 1111
Q ss_pred Hhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 224 IGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 224 i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.. .....+..++.++.++|.+||..+|++|||+.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 1233455688999999999999999999999999763
No 359
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=3.3e-39 Score=311.61 Aligned_cols=241 Identities=28% Similarity=0.491 Sum_probs=204.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||.+.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 46899999999999999999864 78899999986432 235688999999999999999999998655 47999
Q ss_pred EEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 89 MEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999864 25899999999999999999999999999999999999999999999999988754321
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li 243 (472)
......+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+..+. ...+..+++++.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 122334568999999876655 478999999999999997 999999887777666665542 334556889999999
Q ss_pred hcccCCCCCCcCChhhhhcC
Q 012021 244 SKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h 263 (472)
.+||..+|..||+++++++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999763
No 360
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=4.7e-39 Score=313.38 Aligned_cols=244 Identities=18% Similarity=0.242 Sum_probs=192.9
Q ss_pred eeEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 16 RLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999764 35678999988655321 233568889999999999999999999999999999999999
Q ss_pred CCcccchhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 94 GGELFGKVAK------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 94 gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+|+|.+++.. ...++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999998853 2356778889999999999999999999999999999999999999999999865432211111
Q ss_pred cccccCCCcccChhhhcccC------CCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHH-HhccCCCC-----CCC
Q 012021 168 LHTTCGTPAYVAPEVINRRG------YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRK-IGKAEFKF-----PNW 234 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~-i~~~~~~~-----~~~ 234 (472)
.....|++.|+|||++.+.. ..+.++||||||+++|+|++ |..||......+.... +....... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999985432 12578999999999999996 9999987665544332 22222222 223
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++.+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
No 361
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=5.3e-41 Score=317.01 Aligned_cols=262 Identities=29% Similarity=0.435 Sum_probs=210.9
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 83 (472)
...|++...||+|+||.||+|....++. .+|||.+..++- ..+.....-||+.+++.++|||++.|..+|-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3479999999999999999997665543 689999976643 22444567799999999999999999999866 88
Q ss_pred EEEEEEEecCCCcccchhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CCEEEeec
Q 012021 84 KIYFVMEYVKGGELFGKVAK------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH----GNLKVSDF 153 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~----g~vkl~DF 153 (472)
.+++++||++. +|...|+- ..++...++.+++||++|+.|||++-|+||||||.|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999965 78777742 358999999999999999999999999999999999999877 89999999
Q ss_pred cchhhhhcccCCC-ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---------HHHHHH
Q 012021 154 GLSALAESKHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---------MEMYRK 223 (472)
Q Consensus 154 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---------~~~~~~ 223 (472)
|+++++...-..- .....+-|.+|+|||.+.+...++.+.||||.|||+.||+|-++.|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887653321 234566799999999999988888999999999999999999888865321 122222
Q ss_pred Hhcc--C---------CCCCCC--------------------------CCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 224 IGKA--E---------FKFPNW--------------------------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 224 i~~~--~---------~~~~~~--------------------------~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
|... - ...|.+ -++...+|+.+||+.||.+|+|+++.|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 2110 0 011111 14568899999999999999999999999999
Q ss_pred ccCCCC
Q 012021 267 RKGLVK 272 (472)
Q Consensus 267 ~~~~~~ 272 (472)
.+...+
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 986543
No 362
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=5.2e-39 Score=311.24 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=199.0
Q ss_pred eeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCEEEEEEEe
Q 012021 16 RLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA-SKTKIYFVMEY 91 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 91 (472)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999975432 2234567889999999999999999999764 56678999999
Q ss_pred cCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC--Cc
Q 012021 92 VKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD--GL 167 (472)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~--~~ 167 (472)
+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999865 45778888999999999999999999999999999999999999999999998754321110 01
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....+++.|+|||.+....+. .++|||||||++|+|++ |.+||...+..+....+.... ...+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233467789999998776654 79999999999999999 567787777666666555443 34455678999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012021 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||.++|++||++.+++..
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999864
No 363
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=6.3e-39 Score=317.50 Aligned_cols=255 Identities=14% Similarity=0.192 Sum_probs=192.7
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhh--------HHHHHHHHHHHHhcCCCCee
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGM--------IDQIKREISVMRLVRHPNVV 73 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv 73 (472)
.++..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...++.+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 346678999999999999999999998877 6778888754332110000 01112333445667899999
Q ss_pred eEEEEEEeCC----EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCE
Q 012021 74 ELYEVMASKT----KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 74 ~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~v 148 (472)
++++++.... ..|+++|++.. ++.+.+.. ...++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9999865443 45788887743 45555544 357889999999999999999999999999999999999999999
Q ss_pred EEeeccchhhhhcccC-----CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-H----
Q 012021 149 KVSDFGLSALAESKHQ-----DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-M---- 218 (472)
Q Consensus 149 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~---- 218 (472)
+|+|||+|+....... ........||+.|+|||++.+..+. .++|||||||++|+|++|.+||...+. .
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999876532211 1112334799999999999877764 899999999999999999999987632 1
Q ss_pred ----HHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 219 ----EMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 219 ----~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+...++......++ ..++++.+++..|+..+|++||++++|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 12233333333333 46889999999999999999999999975
No 364
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=4.2e-39 Score=313.79 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=205.4
Q ss_pred eEEEeeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q 012021 12 YELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT----- 83 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (472)
|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 5789999999654422 234567889999999999999999999885432
Q ss_pred -EEEEEEEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 84 -KIYFVMEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
..++++||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 34789999999999776532 2478999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCC
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 233 (472)
+................+++.|++||.+....++ .++|||||||++|+|++ |..||...+..+.+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8865332211112233456789999998776654 78999999999999999 99999888777777666544 344556
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..++.+.+++.+||..+|+.|||+.+++..
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999864
No 365
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=8e-39 Score=311.34 Aligned_cols=249 Identities=28% Similarity=0.561 Sum_probs=209.4
Q ss_pred CeEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccc-------cchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEe
Q 012021 11 RYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKV-------LKVGMIDQIKREISVMRL-VRHPNVVELYEVMAS 81 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 81 (472)
.|++.+.||+|+||.||++.+.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999999864321 122344567788888864 799999999999999
Q ss_pred CCEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 82 KTKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
++..|++|||++|++|.+++. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988763 2469999999999999999999996 7899999999999999999999999999
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CC-C
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FP-N 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~-~ 233 (472)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+ .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87654322 2345678999999999976655 58999999999999999999999888777666666554433 22 2
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++++.++|.+||..||++||++.|+.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
No 366
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-39 Score=325.34 Aligned_cols=246 Identities=29% Similarity=0.449 Sum_probs=195.7
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-EEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-KIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV 88 (472)
+.|.-...||+|+||.||+|.- .+|..||||.+....... ..++.+|+.++.+++|||+|+|+|||.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 4677778999999999999986 455999999876654321 355999999999999999999999999988 59999
Q ss_pred EEecCCCcccchhcc--C-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 89 MEYVKGGELFGKVAK--G-KLKEDAARKYFQQLISAVDYCHSRG---VCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~-~l~e~~~~~i~~ql~~aL~yLH~~g---iiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
+||++.|+|.+.+.. + .+++....+|+.+++.||+|||+.. |+||||||.|||||++.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999865 3 7899999999999999999999863 999999999999999999999999999654431
Q ss_pred cCCCccccc-cCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc------HHHHH-HHHhcc------C
Q 012021 163 HQDGLLHTT-CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN------LMEMY-RKIGKA------E 228 (472)
Q Consensus 163 ~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~------~~~~~-~~i~~~------~ 228 (472)
.....+. .||.+|+|||.+.. +..+.++|||||||+|.||+||+.|.+... ..+.. ..+..+ .
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 1112233 89999999999866 445689999999999999999998887532 11111 111111 1
Q ss_pred CCCC-CCCC--HH---HHHHHhcccCCCCCCcCChhhhhc
Q 012021 229 FKFP-NWFA--PE---VRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 229 ~~~~-~~~s--~~---l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..+. ...+ .+ +..+..+|++.+|..||++.++++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2223 23 456778999999999999999854
No 367
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=6.7e-39 Score=309.40 Aligned_cols=235 Identities=25% Similarity=0.305 Sum_probs=193.3
Q ss_pred eeEcccCCeEEEEEEEcCCC----------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 16 RLLGQGTFAKVHYARNLKTG----------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998776 3588887754431 14678899999999999999999999887 778
Q ss_pred EEEEEecCCCcccchhcc-C-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-------CEEEeeccch
Q 012021 86 YFVMEYVKGGELFGKVAK-G-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-------NLKVSDFGLS 156 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-------~vkl~DFGla 156 (472)
|+||||+.+|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999875 3 689999999999999999999999999999999999999888 7999999998
Q ss_pred hhhhcccCCCccccccCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCCCCCCC
Q 012021 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKFPNW 234 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 234 (472)
..... .....++..|+|||++... ...+.++||||||+++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75433 1234577889999998766 344588999999999999999 688887765433333222 22223333
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999985
No 368
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=1.1e-38 Score=311.97 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=203.6
Q ss_pred CCeEEEeeEcccCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Q 012021 10 QRYELGRLLGQGTFAKVHYARNL----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KT 83 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 83 (472)
..|++.+.||+|+||.||+|... .+++.||+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 57889999999999999999864 34889999999765432 345789999999999999999999999877 56
Q ss_pred EEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 84 KIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|++|||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999998764 499999999999999999999999999999999999999999999999999886642
Q ss_pred ccCC-CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH---------------HHHHHh
Q 012021 162 KHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME---------------MYRKIG 225 (472)
Q Consensus 162 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~---------------~~~~i~ 225 (472)
.... .......++..|+|||.+....+ +.++||||||+++++|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 2111 01112244567999999876655 478999999999999999999986542211 112222
Q ss_pred c-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 226 K-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 226 ~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. .....+..++.++.+++.+||..+|.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 123445567889999999999999999999999986
No 369
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=3.2e-38 Score=307.72 Aligned_cols=244 Identities=17% Similarity=0.271 Sum_probs=192.4
Q ss_pred eeEcccCCeEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012021 16 RLLGQGTFAKVHYARNLKT--GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||++..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 34566777654432 2345678899999999999999999999999999999999999
Q ss_pred CCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 94 GGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 94 gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+|+|.+++.. ..+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999998864 24677788899999999999999999999999999999999999999999987542221111112
Q ss_pred ccccCCCcccChhhhcccC------CCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC------CCCCCCC
Q 012021 169 HTTCGTPAYVAPEVINRRG------YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE------FKFPNWF 235 (472)
Q Consensus 169 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 235 (472)
...+|++.|+|||++.... ..+.++||||||+++|+|++ |..||...+..+.+..+.+.. ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999874321 12468999999999999996 578998777666665543332 2233457
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 236 APEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+.+++..|| .+|.+||++++|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999964
No 370
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=4.6e-39 Score=339.54 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=216.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
...-++.+.||+|+||+||+|+--. ....||||.++... ......+|+||+++|..++|||||+|+|+|..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4456788999999999999998653 33579999987654 3346788999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCE
Q 012021 84 KIYFVMEYVKGGELFGKVAK---------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~v 148 (472)
-+|+|+||+..|+|-.++.. .+|+..+.+.++.||+.|+.||-++.++||||...|.|+.++-.|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999999999877642 127889999999999999999999999999999999999999999
Q ss_pred EEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc
Q 012021 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 227 (472)
||+||||++..-+...........-..+|||||.+....|. .+|||||+||+|||+++ |..||.+....+.+..|..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999866543332222233345689999999888876 79999999999999998 99999999998888888776
Q ss_pred C-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhh
Q 012021 228 E-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 228 ~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
. ...|..++.++.+|+..||+.+|++||++.||-
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 5 688999999999999999999999999999984
No 371
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.1e-40 Score=306.98 Aligned_cols=268 Identities=27% Similarity=0.425 Sum_probs=217.7
Q ss_pred CCCcCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012021 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
|..++-...+.|+-..++|+|.||+||+|+...+|+.||+|++-.+.- +.+.-....+|+.+|..++|+|++.++++|.
T Consensus 8 ~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 8 MYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 445666778899999999999999999999999999999987644321 2234455679999999999999999999874
Q ss_pred e--------CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEE
Q 012021 81 S--------KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 81 ~--------~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl 150 (472)
+ ...+|+|+.+|+. +|+.++.. -+++..++.++++++..||.|+|...|+|||+||+|+||+.+|.+||
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 3 2358999999965 78888865 47999999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhcccC--CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-
Q 012021 151 SDFGLSALAESKHQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA- 227 (472)
Q Consensus 151 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~- 227 (472)
+|||+++.+..... ....+..+-|.+|.+||.+.+...++++.|||+-|||+.+|+|+.+-|.+.........|...
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99999976543322 112344567999999999998887889999999999999999999998877665554444210
Q ss_pred -CC--------------------CCCC-------------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 228 -EF--------------------KFPN-------------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 228 -~~--------------------~~~~-------------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
.+ ++|. .-.+++.+|+.++|..||.+|++++++++|.||.+.-
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 00 0111 1145788999999999999999999999999998743
No 372
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2e-39 Score=317.99 Aligned_cols=264 Identities=29% Similarity=0.466 Sum_probs=219.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV----GMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
.|.+||-++.+||+|||++||+|.|...+++||+|+-...+.++. ...+...+|..|.+.|.||.||++|++|.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 577899999999999999999999999999999999765554432 3345677999999999999999999999654
Q ss_pred -CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEc---CCCCEEEeeccc
Q 012021 83 -TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR--GVCHRDLKPENLLLD---EHGNLKVSDFGL 155 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~--giiHrDlKp~NILld---~~g~vkl~DFGl 155 (472)
+..|-|+|||+|.+|.-+++. .-++|.+++.|+.||+.||.||... .|||.||||.||||- .-|.+||.||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 567889999999999999987 4689999999999999999999976 699999999999994 456899999999
Q ss_pred hhhhhcccCC-----CccccccCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HH--HHHH
Q 012021 156 SALAESKHQD-----GLLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EM--YRKI 224 (472)
Q Consensus 156 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~--~~~i 224 (472)
+........+ .+.....||-+|++||.+.-. +..+.+.||||.|||+|.++.|+.||...... ++ +..|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9987654433 134456799999999987432 33457899999999999999999999765332 22 2223
Q ss_pred hc-cCCCCC--CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 225 GK-AEFKFP--NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 225 ~~-~~~~~~--~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
.+ .+..|| +.+++++++||++||...-+.|.++.++-.||+|....
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 33 345555 45899999999999999999999999999999997644
No 373
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-39 Score=332.88 Aligned_cols=241 Identities=33% Similarity=0.539 Sum_probs=197.5
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT------ 83 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 83 (472)
+-|...+.||+||||.||+++++.+|+.||||.+++.... .-.+..-+|+++|++++|||||+++++=++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 4688889999999999999999999999999999876533 34678899999999999999999999865544
Q ss_pred EEEEEEEecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCCC--EEEeeccc
Q 012021 84 KIYFVMEYVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL--DEHGN--LKVSDFGL 155 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILl--d~~g~--vkl~DFGl 155 (472)
...+|||||.||+|+..+.+ .+|+|.+.+.++..+..||.|||++||+||||||.||++ .++|. .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 56899999999999999975 479999999999999999999999999999999999988 34453 79999999
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc----H-HHHHHHHhc----
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----L-MEMYRKIGK---- 226 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~-~~~~~~i~~---- 226 (472)
|+-...+ ....+..||+.|.+||.+...++++..+|.||+||++|+++||.+||.... . .-++..+.+
T Consensus 171 Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 9976543 357888999999999999865666789999999999999999999996422 1 123332221
Q ss_pred ----------c------CCCCCCCCCHH----HHHHHhcccCCCCCCcC
Q 012021 227 ----------A------EFKFPNWFAPE----VRRLLSKILDPNPNTRI 255 (472)
Q Consensus 227 ----------~------~~~~~~~~s~~----l~~li~~~L~~dP~~Rp 255 (472)
+ .+++|..+++. +..++..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 12233344443 34567778999999998
No 374
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=1e-37 Score=334.00 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=179.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCC----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKT----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV---- 78 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---- 78 (472)
.-.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3457899999999999999999999988 999999987543211 111111 1122222222222211
Q ss_pred --EEeCCEEEEEEEecCCCcccchhccCCC---------------------CHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012021 79 --MASKTKIYFVMEYVKGGELFGKVAKGKL---------------------KEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 79 --~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~i~~ql~~aL~yLH~~giiHrDl 135 (472)
...+..+++||||+.+++|.+++....+ .+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999888764321 23456789999999999999999999999
Q ss_pred CCCcEEEcC-CCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCC---------------------CCcc
Q 012021 136 KPENLLLDE-HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD---------------------GSKA 193 (472)
Q Consensus 136 Kp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~ 193 (472)
||+|||++. ++.+||+|||+|+...... .......+||+.|+|||.+...... ..++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 6799999999997654322 1223567899999999976432211 1356
Q ss_pred cchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC---------------------CCCCCHHHHHHHhcccCCCCC
Q 012021 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF---------------------PNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 194 DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~s~~l~~li~~~L~~dP~ 252 (472)
|||||||+||+|+++..|+... .......+....... .........+||.+||+.||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999988775432 112222222111110 111223456899999999999
Q ss_pred CcCChhhhhcCcccccC
Q 012021 253 TRISMTKIMENSWFRKG 269 (472)
Q Consensus 253 ~Rpt~~eil~h~~f~~~ 269 (472)
+|||+.++|+||||+..
T Consensus 440 kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 440 QRISAKAALAHPYFDRE 456 (566)
T ss_pred cCCCHHHHhCCcCcCCC
Confidence 99999999999999763
No 375
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-37 Score=327.92 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=222.9
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE-----eC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA-----SK 82 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~~ 82 (472)
.+.|++.+.+|.|.+|+||+++++.+++..|+|+.+... ..-+.+..|.+||+.+ .|||++.+|+++. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 457999999999999999999999999999999987654 3347788999999887 5999999999984 35
Q ss_pred CEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~ 159 (472)
+.+|||||||.||+..|+++. +++.|..+..+++.++.|+.+||.+.++|||||=.|||++.+|.|||+|||+++..
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999875 58999999999999999999999999999999999999999999999999999876
Q ss_pred hcccCCCccccccCCCcccChhhhccc-----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC---C
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVINRR-----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK---F 231 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---~ 231 (472)
..... .-.+..|||.|||||++... .|+ ..+|+||||++..||..|.+|+-+..++...-+|.+++++ -
T Consensus 174 dsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DSTVG--RRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ecccc--cccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 65433 34678999999999998543 233 6899999999999999999999999888777777666542 2
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
|..++.++.++|..||..|..+||++.++++|||+..+
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 45578999999999999999999999999999999853
No 376
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-37 Score=336.08 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=212.5
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGM-----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
...-++++.||+|+||.||.|....... .||||.+.+.. +.+....+.+|..+|+.++|||||+++|++-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4467889999999999999998875433 38888876543 4566788999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 84 KIYFVMEYVKGGELFGKVAKG--------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
..++++||+.||+|..+|++. .++......++.||+.|+.||+++++|||||...|+||++...+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999753 488899999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHH-HHhccCCCCCC
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYR-KIGKAEFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~-~i~~~~~~~~~ 233 (472)
|+..-.......-....-...|||||.+....+ +.++|||||||++||++| |..||.+.+..+... -...++...|.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 994322111110001112246999999987655 589999999999999998 999999988877766 44556788889
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 234 WFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++..+.+++..||..+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999987
No 377
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=1.2e-36 Score=288.63 Aligned_cols=239 Identities=47% Similarity=0.849 Sum_probs=207.8
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchh
Q 012021 22 TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV 101 (472)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (472)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..++.++|+||+++++++......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999976543221 578999999999999999999999999999999999999999999998
Q ss_pred ccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccCh
Q 012021 102 AKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180 (472)
Q Consensus 102 ~~~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 180 (472)
... .+++..++.++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 764 48999999999999999999999999999999999999999999999999988654432 23456789999999
Q ss_pred hhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccCCCCCCC---CCHHHHHHHhcccCCCCCCcCC
Q 012021 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKFPNW---FAPEVRRLLSKILDPNPNTRIS 256 (472)
Q Consensus 181 E~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~l~~li~~~L~~dP~~Rpt 256 (472)
|.+....++ .++||||||++++++++|..||.. .+.......+.......... ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999766665 699999999999999999999988 55556666665555443332 7889999999999999999999
Q ss_pred hhhhhcCccc
Q 012021 257 MTKIMENSWF 266 (472)
Q Consensus 257 ~~eil~h~~f 266 (472)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
No 378
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=1.6e-38 Score=316.93 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=215.9
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC------CCCeeeEEE
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR------HPNVVELYE 77 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~ 77 (472)
-|++|.+||.+....|+|-|++|..|.+..-|..||||+|....+ +.+.=.+|+.||+.|+ --|+++|+.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 478999999999999999999999999999999999999976643 3455678999999996 358999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-C---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-EEEee
Q 012021 78 VMASKTKIYFVMEYVKGGELFGKVAK-G---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-LKVSD 152 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~-vkl~D 152 (472)
.|...+++|||+|-+ ..+|.+.+.+ | +|....++.|++||+.||..|...||+|.||||+|||+++..+ +||||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 999999999999988 4578888875 3 5889999999999999999999999999999999999998764 79999
Q ss_pred ccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC
Q 012021 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP 232 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~ 232 (472)
||.|..+... ..+.+.-+..|.|||++.+.+|+ ...|+||.||+||||.||+..|++.....++.........+|
T Consensus 581 fGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 581 FGSASFASEN----EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred Cccccccccc----cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9998766543 23445567789999999999998 889999999999999999999998776666554432222222
Q ss_pred CC-----------------------------------------------------C-------CHHHHHHHhcccCCCCC
Q 012021 233 NW-----------------------------------------------------F-------APEVRRLLSKILDPNPN 252 (472)
Q Consensus 233 ~~-----------------------------------------------------~-------s~~l~~li~~~L~~dP~ 252 (472)
.. + -..+++|+.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 11 1 13588999999999999
Q ss_pred CcCChhhhhcCccccc
Q 012021 253 TRISMTKIMENSWFRK 268 (472)
Q Consensus 253 ~Rpt~~eil~h~~f~~ 268 (472)
+|.|+.++|.||||..
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999964
No 379
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=5.1e-38 Score=285.73 Aligned_cols=251 Identities=27% Similarity=0.512 Sum_probs=205.2
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC--E
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKT--K 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 84 (472)
..++|++.+++|+|.|++||.|++..+++.++||+++.-+ .+.+++|+.||+.|. ||||++++++..+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3568999999999999999999999999999999986543 367999999999997 999999999986653 4
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCEEEeeccchhhhhccc
Q 012021 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~-g~vkl~DFGla~~~~~~~ 163 (472)
..+|+||+++.+...+- ..++.-.++.++.+|+.||+|||+.||+|||+||.|++||.. ..++|+|+|||.+.....
T Consensus 110 paLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred chhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 67999999886654332 458888999999999999999999999999999999999965 469999999998775433
Q ss_pred CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHh-------------ccCC
Q 012021 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIG-------------KAEF 229 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~-------------~~~~ 229 (472)
.....+.+..|--||.+..-......-|+|||||+|..|+..+.||.. .+..+..-+|. +-..
T Consensus 188 ---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 245667888999999997776666899999999999999999999753 33333333331 1011
Q ss_pred CC-------------CCC-----------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 230 KF-------------PNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 ~~-------------~~~-----------~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.+ .+| .++++.+|+.++|..|-.+|+|+.|.+.||||...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 11 111 46999999999999999999999999999999753
No 380
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-38 Score=292.64 Aligned_cols=252 Identities=24% Similarity=0.451 Sum_probs=207.6
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV-MRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.+-+..||.|+||+|++-.++.+|+..|||.|..... .....++..|.+. ++.-+.||||++||..-.++..|+.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445679999999999999999999999999987664 2344667777765 566679999999999999999999999
Q ss_pred ecCCCcc---cchh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 91 YVKGGEL---FGKV---AKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 91 ~~~gg~L---~~~i---~~~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++.- +| +.++ .+..++|..+-.+....+.||+||... .|+|||+||+|||||..|.+||||||++......-
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9954 33 2222 236799999999999999999999965 89999999999999999999999999987554322
Q ss_pred CCCccccccCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhccCCCC---CC---C
Q 012021 164 QDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKAEFKF---PN---W 234 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~~~~~---~~---~ 234 (472)
. .+...|...|||||.+.. .+|+ .++||||||++|||+.||..|+..-+ ..+....+..+.++. +. .
T Consensus 223 A---kT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 223 A---KTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred H---hhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 1 234579999999999854 3566 89999999999999999999998754 456677777666543 22 2
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~ 270 (472)
++..+..+|.-||.+|-+.||.+.+++.+||++...
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 788999999999999999999999999999998643
No 381
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.4e-35 Score=311.00 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=190.1
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEc----------------CCCcEEEEEEeecccccch-----------hhHHHHHH
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNL----------------KTGMSVAIKIIDKEKVLKV-----------GMIDQIKR 59 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~~-----------~~~~~~~~ 59 (472)
+-.++|++.++||+|+||.||+|... ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45679999999999999999999753 2456799999864321100 01122334
Q ss_pred HHHHHHhcCCCCe-----eeEEEEEEe--------CCEEEEEEEecCCCcccchhcc-----------------------
Q 012021 60 EISVMRLVRHPNV-----VELYEVMAS--------KTKIYFVMEYVKGGELFGKVAK----------------------- 103 (472)
Q Consensus 60 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~----------------------- 103 (472)
|+.++..++|.++ +++++++.. ++..|+||||+.+++|.+++..
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766554 677777643 3568999999999999887642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChh
Q 012021 104 --GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181 (472)
Q Consensus 104 --~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 181 (472)
..+++..++.++.|++.+|.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 1235677889999999999999999999999999999999999999999999875433211 1112234589999999
Q ss_pred hhcccCC--------------------C-CCcccchhhhHHHHHHhcCCC-CCCCCcH-----------HHHHHHHhccC
Q 012021 182 VINRRGY--------------------D-GSKADIWSCGVILYVLLAGYL-PFHDSNL-----------MEMYRKIGKAE 228 (472)
Q Consensus 182 ~~~~~~~--------------------~-~~~~DiwSlGvil~~lltG~~-Pf~~~~~-----------~~~~~~i~~~~ 228 (472)
++..... . ..+.||||+||++|+|++|.+ ||.+... ....+.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9754321 1 124699999999999999986 7754211 11122223334
Q ss_pred CCCC--CCCCHHHHHHHhcccCCCC---CCcCChhhhhcCccccc
Q 012021 229 FKFP--NWFAPEVRRLLSKILDPNP---NTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ~~~~--~~~s~~l~~li~~~L~~dP---~~Rpt~~eil~h~~f~~ 268 (472)
+.++ +..++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 4443 4478999999999999766 68999999999999964
No 382
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-35 Score=291.51 Aligned_cols=134 Identities=29% Similarity=0.509 Sum_probs=117.9
Q ss_pred cCCccc-CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-----C---CCeee
Q 012021 4 KGSILM-QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-----H---PNVVE 74 (472)
Q Consensus 4 ~g~~l~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~ 74 (472)
.|.++. +||.+.++||-|-|++||+|.|..+.+.||+|+.+.... ..+....||.+|+.++ | .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 477777 899999999999999999999999999999999876543 3466778999999884 2 47999
Q ss_pred EEEEEE----eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 012021 75 LYEVMA----SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLL 142 (472)
Q Consensus 75 l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILl 142 (472)
|++.|. .+.++++|+|++ |.+|..+|.. +.++...++.|++||+.||+|||.+ ||||.||||+|||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 999995 456999999999 7788888865 5799999999999999999999976 99999999999998
No 383
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.8e-36 Score=306.67 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=217.6
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCC-C--cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKT-G--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++..+.++||+|.||.|+.|.+... | -.||||.+...... ..++.|.+|+.+|..|+|||+++|||+..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 44567789999999999999998753 3 36999999776643 267889999999999999999999999887 678
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc
Q 012021 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|||++++|+|.+.+.+ ..|-......|+.||+.|+.||.++++|||||...||||-....|||+||||.+-....
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999999999999976 46888999999999999999999999999999999999999999999999999877654
Q ss_pred cCCCccc-cccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHH
Q 012021 163 HQDGLLH-TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEV 239 (472)
Q Consensus 163 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l 239 (472)
.....+. ...-...|+|||.+....+. .++|||++||++|||++ |+.||.+.+...+.++|..+ ....|+.++.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 3321111 11224469999999887775 89999999999999998 89999999999888888754 467788899999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
.+++..||..+|.+|||+..|.+.-+.+
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999999997654443
No 384
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-36 Score=286.21 Aligned_cols=253 Identities=29% Similarity=0.481 Sum_probs=210.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
+.-.||.-++.+|.|+- .|..|-|.-+++.||+|.+.... ......++..+|...+..++|+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 77789999999999999987663 3344567888999999999999999999998543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+|||++.. +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 358999999954 6766665 457778899999999999999999999999999999999999999999999998654
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
.. -..+..+.|..|.|||++.+.+|. ..+||||+||++.||++|...|.+.+..+.+.++...
T Consensus 170 ~~---~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 TD---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cc---cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 32 235667899999999999999865 8899999999999999999999887665555544210
Q ss_pred --------------CCC----CCCC-----------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 228 --------------EFK----FPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 228 --------------~~~----~~~~-----------~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
.+. +|++ -+..+++++.+||..||++|.+++++|.|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 011 1221 134688999999999999999999999999997
No 385
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-36 Score=301.14 Aligned_cols=201 Identities=30% Similarity=0.563 Sum_probs=182.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHH-----HHHHHHHHHHhcC---CCCeeeEEEEEEe
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID-----QIKREISVMRLVR---HPNVVELYEVMAS 81 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~-----~~~~Ei~il~~l~---hpnIv~l~~~~~~ 81 (472)
..|..++.||+|+||.|++|.++.+...|+||.|.|+++....+++ .+--||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 3699999999999999999999999999999999998875433332 3557999999998 9999999999999
Q ss_pred CCEEEEEEEec-CCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhh
Q 012021 82 KTKIYFVMEYV-KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 82 ~~~~~lV~E~~-~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~ 159 (472)
++.+|++||-. +|-+||++|+. ..++|.++..+|+|++.|+++||+.||+|||||-+|+.++.+|-+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999965 45699999986 57999999999999999999999999999999999999999999999999998865
Q ss_pred hcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC
Q 012021 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~ 214 (472)
. .+...+.+||..|.|||++.+..|-+..-|||+||++||.++..+.||..
T Consensus 721 k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 K----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred c----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 4 45578899999999999999999999999999999999999999999853
No 386
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-35 Score=296.78 Aligned_cols=241 Identities=26% Similarity=0.466 Sum_probs=212.1
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
..+..+||-|-||+||.+.++...-.||||.++.+. -.++.+..|+.+|+.++|||+|+|+++|..+--.|||+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 345678999999999999999988999999986543 2357889999999999999999999999999999999999
Q ss_pred cCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcc
Q 012021 92 VKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 92 ~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+..|+|.++++. .-++.-....++.||.+|++||..+++|||||...|.|+.++-.+||+||||++++.....
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY---- 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY---- 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce----
Confidence 999999999975 3477778889999999999999999999999999999999999999999999998764332
Q ss_pred ccccC---CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHH
Q 012021 169 HTTCG---TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 169 ~~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li 243 (472)
+...| ..-|.|||-+....+. .++|||+|||+|||+.| |--||.+.+....|..+.++ ...-|..+++.+.+|+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred ecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence 22233 3459999998777665 89999999999999998 88999999999988888776 3567889999999999
Q ss_pred hcccCCCCCCcCChhhhh
Q 012021 244 SKILDPNPNTRISMTKIM 261 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil 261 (472)
+.||+++|..||+++||-
T Consensus 500 raCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHhcCCcccCccHHHHH
Confidence 999999999999999984
No 387
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=8.2e-35 Score=332.18 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=187.7
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..|...+.||+|+||.||+|.+..++..||+|.+...... ...|+.+++.++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466678999999999999999999999999998644321 235688999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCC
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH---SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH---~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||+++|+|.+++. .+++..+.+++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999986 4889999999999999999999 6699999999999999999888775 665443221
Q ss_pred ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-----HHHHHHHhc-c------CCCC---
Q 012021 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-----MEMYRKIGK-A------EFKF--- 231 (472)
Q Consensus 167 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-----~~~~~~i~~-~------~~~~--- 231 (472)
.....||+.|+|||++.+..+. .++|||||||++|||+||+.||+.... ....+.... . ....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1234689999999999877665 899999999999999999999854211 111111000 0 0011
Q ss_pred ---CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 232 ---PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 ---~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.....++.+++.+||+.||++|||+.++++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11112356789999999999999999999875
No 388
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=6.5e-35 Score=294.73 Aligned_cols=255 Identities=21% Similarity=0.356 Sum_probs=210.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-..+..++++||+|-||+|.+++- ..+..||+|.++..... .....+.+||++|.+|+||||++++++|..++-+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 345778999999999999999985 45699999999876543 345789999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 88 VMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~---l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||++.|+|.+++.... +.-....+++.||++|++||.+.+++||||.+.|+|+|.++++||+|||+++..-+...
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999999997652 24456677999999999999999999999999999999999999999999986544333
Q ss_pred CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHh--cCCCCCCCCcHHHHHHHHhc--------cCCCCCCC
Q 012021 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLL--AGYLPFHDSNLMEMYRKIGK--------AEFKFPNW 234 (472)
Q Consensus 165 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll--tG~~Pf~~~~~~~~~~~i~~--------~~~~~~~~ 234 (472)
...-...+-...|||||.+....+. .++|+|++|+++||++ +...||.........+.... .....|.-
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 2222233446789999998877775 7999999999999875 57899988776655554432 12345777
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
++.++.+++.+||..+-++||+++++-. +|++
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~--~lq~ 803 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL--FLQE 803 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH--HHHH
Confidence 8999999999999999999999999943 3543
No 389
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-35 Score=305.18 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=218.0
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
..-.|.+.||.|.||+|+.++.+..| ..||||.++.... +.....+..|+.||-+..||||++|.|+.....-+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 44568899999999999999988766 4699999976543 344567889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC
Q 012021 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+|+||+++|+|..+++. |.++..++.-+++.|+.|++||-+.|++||||...|||++.|-.+|++||||++..+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999999998865 789999999999999999999999999999999999999999999999999999776544
Q ss_pred CCccccccCC--CcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012021 165 DGLLHTTCGT--PAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt--~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
+...++.-|- ..|.|||.+....+. .++||||+|++|||.++ |+.||.+.+..+....|..+ ..+.|..++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 3333343343 469999999888775 78999999999998775 99999999988888888765 3555667899999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012021 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.|+..||++|-.+||.+++|+++
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999875
No 390
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-36 Score=279.82 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=209.3
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-----KIY 86 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 86 (472)
.+-.+.||.|+||.||.+.|..+|+.||+|.+..-. .+--..+++.+|+.+|.-.+|.|++..+++....+ .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345688999999999999999999999999875322 22334578889999999999999999998875544 477
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+++|.+. .+|-..|.. ..++.+.++-+++||++||+|||+.||.||||||.|+|++.|..+||||||+|+..+....
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~- 211 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR- 211 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence 8888884 477776654 7899999999999999999999999999999999999999999999999999987654332
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh--------------------
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG-------------------- 225 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-------------------- 225 (472)
..++..+-|.+|.|||++.+...++.+.||||.|||+.||+..+..|...++.+..+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 234455678999999999988777789999999999999999999998877655544432
Q ss_pred ---ccCCCCCC-----------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 226 ---KAEFKFPN-----------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 226 ---~~~~~~~~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
++...-|. .-..+...++..+|.+||.+|.+.++.+.|++..++..
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 22222221 12346778999999999999999999999999877543
No 391
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-35 Score=295.66 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=206.0
Q ss_pred eEEEeeEcccCCeEEEEEEEcCC--C--cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKT--G--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~--g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.+.+.||+|-||.||.|....- | -.||||..+.+... +..+.+..|..+|+.++||||++++|++.+ .-.|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34567899999999999987542 3 35889988765432 336789999999999999999999999965 45899
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||+++-|+|+.++.. ..++......|..||..||.|||+.+++||||...|||+.....+||+||||++.......
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y- 546 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY- 546 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch-
Confidence 9999999999999975 4689999999999999999999999999999999999999999999999999997764332
Q ss_pred CccccccC--CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012021 166 GLLHTTCG--TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 166 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.+...| ..-|||||-+.-..+. .++|||-|||.+||++. |..||.+-...+..-.+.++ +.++|+.++|.+..
T Consensus 547 --YkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 547 --YKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred --hhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 222333 3359999998777665 78999999999999775 99999987766666666665 47899999999999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012021 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
|+.+||..+|.+||++.+|..
T Consensus 624 lmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHhccCcccCCcHHHHHH
Confidence 999999999999999988754
No 392
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-35 Score=299.67 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=222.7
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.+|.|+||.||+|+|+.+++..|+|+++.+... ...-+..||-+++..+|||||.+++.+-.....++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 56899999999999999999999999999999999876543 346678999999999999999999999999999999
Q ss_pred EEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 89 MEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||||.||+|.+.-. .|.++|.++....+..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+...-. .
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--K 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh--h
Confidence 99999999998765 48999999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccCCCcccChhhhc---ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC-----CCCCHHH
Q 012021 168 LHTTCGTPAYVAPEVIN---RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-----NWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~l 239 (472)
-..+.|||.|||||+.. ..+|. ..+|||++|++..|+---+.|..+...+.....+.+..+..| ...++.+
T Consensus 169 rksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 25678999999999863 34554 899999999999999999999877777666656666655544 3478899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
-+|++.+|..+|++|||++.+|.|||....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999999764
No 393
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=8.7e-35 Score=304.75 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=197.1
Q ss_pred EEeeEcccCCeE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEe
Q 012021 14 LGRLLGQGTFAK-VHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 14 i~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
--+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ..+...+|+..|+..+ |||||++|+.-.+....|+..|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 346789999986 788876 7889999987543 3467889999999884 99999999999999999999999
Q ss_pred cCCCcccchhccC-C----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CC--CEEEeeccchhhhhc
Q 012021 92 VKGGELFGKVAKG-K----LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HG--NLKVSDFGLSALAES 161 (472)
Q Consensus 92 ~~gg~L~~~i~~~-~----l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~---~g--~vkl~DFGla~~~~~ 161 (472)
|. .+|.++++.. . ......+.++.|++.||++||+.+|+||||||.||||+. ++ +++|+|||+++....
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 94 5899999763 1 111446889999999999999999999999999999976 34 689999999987765
Q ss_pred ccCC-CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhccCCCCCCC---CC
Q 012021 162 KHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKAEFKFPNW---FA 236 (472)
Q Consensus 162 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~---~s 236 (472)
.... ....+..||-+|+|||++..... +.++|||||||++|+.++| .+||.+.-.. ..+|.++++.+-.- -.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCch
Confidence 4332 23456779999999999976654 4689999999999998886 9999775332 23555665543211 11
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.++.+||.+||.++|..||++.++|.||+|-..
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 289999999999999999999999999999753
No 394
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-34 Score=284.78 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=198.3
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL--VRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~---- 83 (472)
...++.+.+|+|.||.||+|.. +++.||||++.... ...+..|-+|.+. ++|+||++++++-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 3567889999999999999986 77999999986543 3567788888775 57999999999876555
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEcCCCCEEEeecc
Q 012021 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR---------GVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~---------giiHrDlKp~NILld~~g~vkl~DFG 154 (472)
.++||+||.+.|+|.+++..+.+++....+++..+++||+|||+. .|+|||||..|||+.+|+...|+|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 899999999999999999999999999999999999999999964 59999999999999999999999999
Q ss_pred chhhhhcccCCCccccccCCCcccChhhhcccCCC-----CCcccchhhhHHHHHHhcCC------------CCCC----
Q 012021 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-----GSKADIWSCGVILYVLLAGY------------LPFH---- 213 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlGvil~~lltG~------------~Pf~---- 213 (472)
||..+......+.....+||.+|||||++.+.--. =.+.||||+|.+|||+++.. +||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988877666667778999999999998653211 13689999999999999853 3343
Q ss_pred -CCcHHHHHHHH--hccCCCCCCCC-----CHHHHHHHhcccCCCCCCcCChhhhh
Q 012021 214 -DSNLMEMYRKI--GKAEFKFPNWF-----APEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 214 -~~~~~~~~~~i--~~~~~~~~~~~-----s~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
.....++...+ .+.++.+|..+ ...+.+.+..||+.||+.|.|+.=+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 12333333333 34455565432 34688999999999999999986443
No 395
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-33 Score=278.02 Aligned_cols=248 Identities=25% Similarity=0.476 Sum_probs=197.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH--hcCCCCeeeEEEEEE----
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR--LVRHPNVVELYEVMA---- 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~---- 80 (472)
.+..+-.+.+.||+|-||+||+|++ .|+.||||++.... .....||.+|.+ .|+|+||+.+++.-.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3456788999999999999999988 78999999996543 245678888886 469999999998752
Q ss_pred eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCCEEEee
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR--------GVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~--------giiHrDlKp~NILld~~g~vkl~D 152 (472)
+.+.+|||++|.+.|+|+|++.+..++-+...+++..+++||++||.. .|.|||||..|||+..||...|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 235799999999999999999999999999999999999999999964 499999999999999999999999
Q ss_pred ccchhhhhccc--CCCccccccCCCcccChhhhcccC----CCC-CcccchhhhHHHHHHhcC----------CCCCCC-
Q 012021 153 FGLSALAESKH--QDGLLHTTCGTPAYVAPEVINRRG----YDG-SKADIWSCGVILYVLLAG----------YLPFHD- 214 (472)
Q Consensus 153 FGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~~~-~~~DiwSlGvil~~lltG----------~~Pf~~- 214 (472)
+|||-...... -+-.....+||..|||||++...- +.+ ..+||||||+|+||++.. .+||.+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997655432 223356789999999999985431 222 258999999999999862 578864
Q ss_pred ----CcHHHHHHHH--hccCCCCCCCC-CH----HHHHHHhcccCCCCCCcCChhhhhc
Q 012021 215 ----SNLMEMYRKI--GKAEFKFPNWF-AP----EVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 215 ----~~~~~~~~~i--~~~~~~~~~~~-s~----~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+++..-+ .+..+.+|.+. +. .+..+++.||..||..|.|+--|..
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3344444332 33455566543 32 3557899999999999999877643
No 396
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-34 Score=266.28 Aligned_cols=255 Identities=26% Similarity=0.465 Sum_probs=205.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEE-EEeCCE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEV-MASKTK 84 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~ 84 (472)
-+.+.|.|.+.||+|-||++.+|+++.+++.+++|.+.+.... ...+.+|...--.| .|.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4677899999999999999999999999999999999877533 46778888765445 49999998886 678889
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCCEEEeeccchhhhhcc
Q 012021 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE--HGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~--~g~vkl~DFGla~~~~~~ 162 (472)
+++++||++-|+|...+...++.|....+++.|+++|++|+|+++++|||||.+||||-. .-++||||||+.+..+.
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 999999999999999999999999999999999999999999999999999999999932 33799999998775432
Q ss_pred cCCCccccccCCCcccChhhhcccC----CCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhcc-CCCCCC
Q 012021 163 HQDGLLHTTCGTPAYVAPEVINRRG----YDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 163 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~-~~~~~~ 233 (472)
.....--+..|.+||++.... ...+.+|+|.||+++|.++||.+||..... ...+.++... ....|.
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 223334567899999874321 123578999999999999999999985332 2233333332 334443
Q ss_pred ---CCCHHHHHHHhcccCCCCCCc---CChhhhhcCcccccCC
Q 012021 234 ---WFAPEVRRLLSKILDPNPNTR---ISMTKIMENSWFRKGL 270 (472)
Q Consensus 234 ---~~s~~l~~li~~~L~~dP~~R---pt~~eil~h~~f~~~~ 270 (472)
.+++.+.++.++-|.++|++| .++.......|.....
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 378999999999999999999 6777777778876543
No 397
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-32 Score=295.37 Aligned_cols=252 Identities=25% Similarity=0.472 Sum_probs=210.3
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEV 78 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 78 (472)
+..++..+.+.||+|+||.|++|.-.. ....||||.+...... ...+.+..|+.+|+.+. ||||+.++++
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 344455677899999999999997431 1457999998665433 45678999999999885 9999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhccCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012021 79 MASKTKIYFVMEYVKGGELFGKVAKGK-----------------LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NIL 141 (472)
+...+.+++|+||+..|+|.++++..+ ++......+++||+.|++||++.+++||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 999999999999999999999997755 899999999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccchhhhhcccCCCccccccCCC--cccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCc-H
Q 012021 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP--AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSN-L 217 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~--~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~-~ 217 (472)
+..+..+||+|||+|+........ ......|+. .|||||.+....| +.++||||+|++|||+++ |..||.+.. .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999854332211 011222333 3999999988555 489999999999999998 899998855 5
Q ss_pred HHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 218 MEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 218 ~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+++..+..+. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 56677676665 4788889999999999999999999999999975
No 398
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=100.00 E-value=2.9e-33 Score=274.84 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=203.7
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
..+.+.|.++.+||+|+|+.||+|.+.. .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3466789999999999999999999988 78999999986543 2367999999999885 9999999999999
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEeeccchhhhh
Q 012021 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~DFGla~~~~ 160 (472)
+++..+|+||.+..+..++.. .++..+++.|++.++.||.++|.+||+||||||.|+|.+. .+.-.|+|||||...+
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~--~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR--SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CCeeEEEecccCccCHHHHHh--cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999998877666654 4678899999999999999999999999999999999975 4578999999987221
Q ss_pred ccc------C-------------------------CCcc-----------ccccCCCcccChhhhcccCCCCCcccchhh
Q 012021 161 SKH------Q-------------------------DGLL-----------HTTCGTPAYVAPEVINRRGYDGSKADIWSC 198 (472)
Q Consensus 161 ~~~------~-------------------------~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 198 (472)
... . .+.. ....||++|.|||++.+.+-.++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 110 0 0000 012499999999999998888899999999
Q ss_pred hHHHHHHhcCCCCCCCCc-----HHHHHHHH------------hc---------------------c--------CC---
Q 012021 199 GVILYVLLAGYLPFHDSN-----LMEMYRKI------------GK---------------------A--------EF--- 229 (472)
Q Consensus 199 Gvil~~lltG~~Pf~~~~-----~~~~~~~i------------~~---------------------~--------~~--- 229 (472)
|+|+..++++..||.... ..++..-. .+ . ..
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999985321 11110000 00 0 00
Q ss_pred CC---CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 230 KF---PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 ~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.. ...++..+.+|+.+||+.||.+|.|+++.|.||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 0114568899999999999999999999999999974
No 399
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.98 E-value=2e-31 Score=246.09 Aligned_cols=212 Identities=47% Similarity=0.831 Sum_probs=186.5
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012021 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+.+++.++|++|+++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664321 346789999999999999999999999999999999999999999
Q ss_pred cchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCEEEeeccchhhhhcccCCCccccccCC
Q 012021 98 FGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 98 ~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
.+++... .++...++.++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9998765 7999999999999999999999999999999999999999 89999999999876543221 12345678
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012021 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
..|++||.+......+.++|+|++|++++++ ..+.+++.+|+..||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987653445889999999999999 678999999999999999
Q ss_pred CChhhhhcCc
Q 012021 255 ISMTKIMENS 264 (472)
Q Consensus 255 pt~~eil~h~ 264 (472)
|++.++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
No 400
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.98 E-value=2.1e-32 Score=245.85 Aligned_cols=211 Identities=25% Similarity=0.466 Sum_probs=170.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
...-+..||+|+||.|-+.++..+|...|+|.+...-. ....+++.+|+++..+ ..+|.+|.+||.+..+..+++.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34456789999999999999999999999999965432 3445677788887654 57999999999999999999999
Q ss_pred EecCCCcccch----hcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 90 EYVKGGELFGK----VAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 90 E~~~gg~L~~~----i~~-~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|.+.. +|..+ +.. +.++|..+-+++-.++.||.|||++ .++|||+||.|||++.+|++|+||||++......-
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 99954 55332 233 5799999999999999999999987 89999999999999999999999999987554321
Q ss_pred CCCccccccCCCcccChhhhc----ccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccC
Q 012021 164 QDGLLHTTCGTPAYVAPEVIN----RRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE 228 (472)
Q Consensus 164 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~ 228 (472)
. .+...|...|||||.+. ..+|+ -++||||||++++||.+++.||+. ..+.++..++....
T Consensus 204 A---kt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 204 A---KTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred H---HHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 1 12256889999999874 33665 799999999999999999999976 34556666665543
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.97 E-value=5.9e-31 Score=247.51 Aligned_cols=218 Identities=43% Similarity=0.718 Sum_probs=186.4
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++...+..++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999888999999999765432 2467889999999999999999999999999999999999
Q ss_pred cCCCcccchhccC-C-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccc
Q 012021 92 VKGGELFGKVAKG-K-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 92 ~~gg~L~~~i~~~-~-l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+.+++|.+++... . +++..+..++.+++.++.+||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 9999999998763 4 89999999999999999999999999999999999999999999999999887654321 1224
Q ss_pred cccCCCcccChhhh-cccCCCCCcccchhhhHHHHHHhcCCCCCCC--CcHHHHHHHHhccCCCCCC
Q 012021 170 TTCGTPAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 170 ~~~gt~~y~aPE~~-~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~--~~~~~~~~~i~~~~~~~~~ 233 (472)
...++..|++||.+ ....+. .++|+|+||+++++|++|+.||.. .+...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 45788899999998 444444 689999999999999999999977 3444777777777654443
No 402
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=3.9e-32 Score=283.26 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=210.8
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
.+-++.||.|+||+||++.+...|+ +||||++...... +....+.+|+-+|..++|||+++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456889999999999999987776 5888888655432 34577889999999999999999999997766 889
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCC
Q 012021 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|++|+++|.|.++++. +.+.....+.|..||+.|+.|||.++++||||-..|+|+.+-..+||.|||+|.+.......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999864 67999999999999999999999999999999999999999999999999999987664433
Q ss_pred CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHH
Q 012021 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li 243 (472)
-......-.+.|||=|.+....|. .++||||+||++||++| |..|+.+....++-..+..+ +...|+.++-++.-++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 222222234568999988777765 89999999999999998 99999998888777766655 3678888999999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012021 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||..|+..||+++++.+
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999998754
No 403
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.97 E-value=1.2e-31 Score=286.99 Aligned_cols=260 Identities=29% Similarity=0.505 Sum_probs=211.4
Q ss_pred cCCe-EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecc---cccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 9 MQRY-ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKE---KVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...| .-...+|.|++|.|+.+......+.++.|.+... ..........+..|+.+-..++|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3445 4678899999999999988888887887766421 11111222337778888889999999887777766666
Q ss_pred EEEEEEecCCCcccchhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhccc
Q 012021 85 IYFVMEYVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++.+||||++ +|+..+... .++..++..++.||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+.......
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999875 89999999999999999999999999999999999999999999999999998877665
Q ss_pred CC--CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH--HHHHhc-------cCCCCC
Q 012021 164 QD--GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM--YRKIGK-------AEFKFP 232 (472)
Q Consensus 164 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~--~~~i~~-------~~~~~~ 232 (472)
.. ......+|+..|+|||++.+..|+....||||+|++++.|.+|+.||......+. +..... +...+-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 54 4566789999999999999999999999999999999999999999976543322 111111 111222
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
..++.+.+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 3367788999999999999999999999999999864
No 404
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.96 E-value=1.3e-30 Score=291.17 Aligned_cols=199 Identities=17% Similarity=0.230 Sum_probs=146.8
Q ss_pred hcCC-CCeeeEEEEE-------EeCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012021 66 LVRH-PNVVELYEVM-------ASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 66 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDl 135 (472)
.++| +||++++++| .....+++++||+ +++|++++.. +.+++.+++.+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5778888877 2334677888987 6699999965 46999999999999999999999999999999
Q ss_pred CCCcEEEcC-------------------CCCEEEeeccchhhhhcccC---------C-----CccccccCCCcccChhh
Q 012021 136 KPENLLLDE-------------------HGNLKVSDFGLSALAESKHQ---------D-----GLLHTTCGTPAYVAPEV 182 (472)
Q Consensus 136 Kp~NILld~-------------------~g~vkl~DFGla~~~~~~~~---------~-----~~~~~~~gt~~y~aPE~ 182 (472)
||+||||+. ++.+|++|||+++....... . ......+||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 44566666666653211000 0 00112468999999999
Q ss_pred hcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhh
Q 012021 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 183 ~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
+.+..| +.++|||||||+||||++|..|+..... ....+..... ..+....+...+++.+||.++|.+|||+.|++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988777 4899999999999999999998764321 1111111111 11111245678899999999999999999999
Q ss_pred cCccccc
Q 012021 262 ENSWFRK 268 (472)
Q Consensus 262 ~h~~f~~ 268 (472)
+||||.+
T Consensus 264 ~h~~~~~ 270 (793)
T PLN00181 264 QSEFINE 270 (793)
T ss_pred hchhhhh
Confidence 9999975
No 405
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.96 E-value=3.7e-27 Score=230.34 Aligned_cols=255 Identities=36% Similarity=0.609 Sum_probs=213.0
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCEEEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP-NVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 90 (472)
|.+.+.||.|+||.||.+.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999877655433567899999999999988 79999999988888999999
Q ss_pred ecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CEEEeeccchhhhhcccCC
Q 012021 91 YVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-~vkl~DFGla~~~~~~~~~ 165 (472)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777654 699999999999999999999999999999999999999999 6999999998755433222
Q ss_pred C----ccccccCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCC-CCCC
Q 012021 166 G----LLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFK-FPNW 234 (472)
Q Consensus 166 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 234 (472)
. .....+||+.|+|||.+.+. .......|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34677899999999999774 4556899999999999999999999887663 4555555544433 2222
Q ss_pred CC--------HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 235 FA--------PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 ~s--------~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 478999999999999999999999988766543
No 406
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.95 E-value=8.1e-28 Score=242.70 Aligned_cols=172 Identities=24% Similarity=0.248 Sum_probs=136.8
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhcCCCCeee-EEEEEE
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVRHPNVVE-LYEVMA 80 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~ 80 (472)
-..+.++|++.+.||+|+||+||+|++.. +++.||||.+..... ........+.+|+.+|+.++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 35788999999999999999999999876 678889998753311 12234567999999999999999985 5442
Q ss_pred eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCCEEEeeccchhhh
Q 012021 81 SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL-KPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDl-Kp~NILld~~g~vkl~DFGla~~~ 159 (472)
+..|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++++||+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 458999999999999632 21 11 1468899999999999999999999 999999999999999999999876
Q ss_pred hcccCCCc------cccccCCCcccChhhhccc
Q 012021 160 ESKHQDGL------LHTTCGTPAYVAPEVINRR 186 (472)
Q Consensus 160 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 186 (472)
........ +.+.++++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54332222 2466789999999998543
No 407
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.95 E-value=3.2e-28 Score=236.51 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=208.5
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-E
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM-A 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~ 80 (472)
+-..|+++.-.+-+|+||.||.|++++. .+.|-+|.+.... ..-....+..|-..+..+.|||+..+.++. +
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4456889999999999999999977643 2345566553322 123356677888889999999999999987 4
Q ss_pred eCCEEEEEEEecCCCcccchhc-----c----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEe
Q 012021 81 SKTKIYFVMEYVKGGELFGKVA-----K----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~-----~----~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~ 151 (472)
+.+..++++.+..-|+|..++. . ..++-.+...++.|++.|++|||++||+|.||...|.+||+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 5567888999998899988775 1 246777888999999999999999999999999999999999999999
Q ss_pred eccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-C
Q 012021 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-F 229 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 229 (472)
|=.|++-....+.+.+-........||+||.+....|. .++|+|||||+||||+| |+.|+-+.++.+++..++.+. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99998865544433333333345679999999988886 78999999999999998 999999999999998888774 5
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.-|-.+++++..++.-||..+|++||+.+|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 667789999999999999999999999999864
No 408
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.95 E-value=3.8e-28 Score=221.54 Aligned_cols=158 Identities=22% Similarity=0.264 Sum_probs=127.9
Q ss_pred Ccccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCcccccc
Q 012021 95 GELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
|+|.+++.. +.+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 678888864 46999999999999999999999999 999999999999999 9988765331 236
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCC-------CCCCCH--HHHHH
Q 012021 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKF-------PNWFAP--EVRRL 242 (472)
Q Consensus 173 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~-------~~~~s~--~l~~l 242 (472)
||+.|+|||++.+..+. .++|||||||++|+|++|+.||...... ..+..+....... +..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 7999999999999999999999765432 3333332221111 122333 69999
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012021 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
|.+||..||.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999863
No 409
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.95 E-value=1.1e-26 Score=233.32 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=195.9
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhcCC----CCeeeEEEEE-EeCCE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTG-MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH----PNVVELYEVM-ASKTK 84 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 84 (472)
+|.+.+.||+|+||.||++.+..++ ..+|+|+......... ..++.|..++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998774 6899999866532211 267889999988873 6999999999 58889
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-----CCEEEeeccch
Q 012021 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-----GNLKVSDFGLS 156 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~-----g~vkl~DFGla 156 (472)
.|+||+.+ |.+|.++... +.++...+.+++.|++.+|+++|+.|++||||||+|++++.. ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 8889887642 679999999999999999999999999999999999999865 35999999999
Q ss_pred hhhh--cccC-----CCc-cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--
Q 012021 157 ALAE--SKHQ-----DGL-LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-- 226 (472)
Q Consensus 157 ~~~~--~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-- 226 (472)
+... .... ... .....||..|+++.+..+... +.+.|+||++.++.+++.|.+||..........++..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8332 1111 111 123459999999999887766 4899999999999999999999977553222222222
Q ss_pred -cCCC--CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 227 -AEFK--FPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 -~~~~--~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.... +....+.++..+...+-..+...+|.+..+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 233356778888888888999999999988765
No 410
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.95 E-value=9.4e-29 Score=254.28 Aligned_cols=238 Identities=34% Similarity=0.611 Sum_probs=207.9
Q ss_pred eEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEec
Q 012021 17 LLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
.+|+|+||+|++++.. ..|..+|+|+..+...... ....-+.|..++..++ ||.+|+++..+.++++.|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~-~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR-DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccc-cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999987644 3678899999877654322 1225566888888887 999999999999999999999999
Q ss_pred CCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccc
Q 012021 93 KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
.||+|+..+.. ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|.+++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999988876 568899999999999999999999999999999999999999999999999998664322 22
Q ss_pred cCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCC
Q 012021 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 172 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
|||..|||||++. +.. ..+|.||+|+++|+|+||..||.. +....|.+..+..|..++.++++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 444 689999999999999999999988 677788889999999999999999999999999
Q ss_pred CCcCCh-----hhhhcCccccc
Q 012021 252 NTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 252 ~~Rpt~-----~eil~h~~f~~ 268 (472)
..|... .+|++|+||+.
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 999864 69999999986
No 411
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.95 E-value=6.1e-27 Score=215.07 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=203.8
Q ss_pred cCCcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEeC
Q 012021 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~ 82 (472)
+..+..++|.++++||.|+||.+|+|.+..+|+.||||+-...... .++..|..+.+.|++ ..|..+..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 3457788999999999999999999999999999999997554322 467789999999974 7888888889999
Q ss_pred CEEEEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CEEEeeccchh
Q 012021 83 TKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSA 157 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g---~vkl~DFGla~ 157 (472)
.+-.+||+.. |.+|.++.. ...++..+++-++-|++.-++|+|.++++||||||+|+|..-+- .+.++|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999998 778988875 36899999999999999999999999999999999999986443 58999999999
Q ss_pred hhhcccCCC-----ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCC
Q 012021 158 LAESKHQDG-----LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEF 229 (472)
Q Consensus 158 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~ 229 (472)
.+....... .-....||..|.+-....+... +.+.|+-|+|.+|.++.-|.+||.+.. ...-|++|..-..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 775543321 1233469999999887766554 478999999999999999999998743 3455666765554
Q ss_pred CC-----CCCCCHHHHHHHhcccCCCCCCcCChhhh
Q 012021 230 KF-----PNWFAPEVRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 230 ~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~ei 260 (472)
.. ...+|.|+.-.+.-|-..--++-|+..-+
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 43 35688899999988877777777876544
No 412
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=1.8e-26 Score=220.52 Aligned_cols=247 Identities=20% Similarity=0.347 Sum_probs=205.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (472)
++.-.|+++++||+|+||..+.+.+..++++||||.-.... .+.+++.|....+.|. .++|...|.+...+-+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 44448999999999999999999999999999999865432 3468999999999986 69999999999888899
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----CEEEeeccchhh
Q 012021 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-----NLKVSDFGLSAL 158 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g-----~vkl~DFGla~~ 158 (472)
.||||++ |-+|.|+..- ++|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 7788888764 5799999999999999999999999999999999999997654 489999999998
Q ss_pred hhcccCCC-----ccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---CcHHHHHHHHhccCCC
Q 012021 159 AESKHQDG-----LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEFK 230 (472)
Q Consensus 159 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~ 230 (472)
+....... .-....||..||+-....+...+ .+.|+-|||-+++++|-|.+||.+ .+..+-|++|....-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 76543321 22345699999999888887765 889999999999999999999986 4566788888765433
Q ss_pred C-----CCCCCHHHHHHHhcccCCCCCCcCChhhh
Q 012021 231 F-----PNWFAPEVRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 231 ~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~ei 260 (472)
- ...++.++...++-.-..+-.+-|+++-+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 2 34577788877776666666777777644
No 413
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.92 E-value=5.3e-25 Score=207.79 Aligned_cols=176 Identities=16% Similarity=0.218 Sum_probs=138.4
Q ss_pred CcccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHH------HHHHHHHHHhcCCCCeeeEEEEE
Q 012021 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ------IKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
.++.++|++.+.||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 36889999999999999999999765 57789999997665444443333 68999999999999999999886
Q ss_pred EeC--------CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEe
Q 012021 80 ASK--------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 80 ~~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~ 151 (472)
... +..+++|||++|.+|.+.. .+++. ...+++.++..||++|++|||+||.||+++.+| ++|+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP---EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh---hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 533 3589999999999997763 23332 456999999999999999999999999999998 9999
Q ss_pred eccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHh
Q 012021 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLL 206 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll 206 (472)
|||.......... .........|. .++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a--------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKA--------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhh--------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 9997654322111 01133445566 7899999999987654
No 414
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.91 E-value=3.2e-24 Score=198.95 Aligned_cols=142 Identities=20% Similarity=0.253 Sum_probs=113.3
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----------------------hHHHHHHHHHHHHhcCCCC
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----------------------MIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 71 (472)
...||+|+||.||+|.+. +|+.||||++......... ......+|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998887
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccch-hccCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcCCCCEE
Q 012021 72 VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYC-HSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~i~~ql~~aL~yL-H~~giiHrDlKp~NILld~~g~vk 149 (472)
+.....+.... .|+||||+.|+++... +..+++++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75544433222 3899999999877655 4557899999999999999999999 799999999999999998 57899
Q ss_pred Eeeccchhhhh
Q 012021 150 VSDFGLSALAE 160 (472)
Q Consensus 150 l~DFGla~~~~ 160 (472)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999987543
No 415
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.91 E-value=1.1e-24 Score=234.23 Aligned_cols=220 Identities=32% Similarity=0.640 Sum_probs=175.8
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
.-..|+.++++..|+||.||+++++.+.+.+|+| ++++... +++ |+.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee--------------
Confidence 3457999999999999999999999999999994 4544321 111 44444455544
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC--
Q 012021 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ-- 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~-- 164 (472)
|+-...++. |.++.+. +.+++|||+-||+|||+||+|+||..-|++|+.|||++...-....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 333334433 5565554 7799999999999999999999999999999999999864321110
Q ss_pred -----------CCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC
Q 012021 165 -----------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 165 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 233 (472)
.-.-...||||.|+|||++...+|- ..+|+|++|+|+|+++-|..||.++..++++..+......+|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0112345999999999999999985 8899999999999999999999999999999999888777765
Q ss_pred C---CCHHHHHHHhcccCCCCCCcC---ChhhhhcCccccc
Q 012021 234 W---FAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFRK 268 (472)
Q Consensus 234 ~---~s~~l~~li~~~L~~dP~~Rp---t~~eil~h~~f~~ 268 (472)
. ++++++++|.++|+.+|..|. ..-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 4 789999999999999999996 4568889999985
No 416
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.91 E-value=3.9e-25 Score=236.98 Aligned_cols=259 Identities=32% Similarity=0.561 Sum_probs=220.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (472)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... ......+.+..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999998888754 44567777775543 23345677788999988887 999999999999999999
Q ss_pred EEEEecCCCcccchh-ccC--CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCC-CEEEeeccchhhhhc
Q 012021 87 FVMEYVKGGELFGKV-AKG--KLKEDAARKYFQQLISAVDYCH-SRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAES 161 (472)
Q Consensus 87 lV~E~~~gg~L~~~i-~~~--~l~e~~~~~i~~ql~~aL~yLH-~~giiHrDlKp~NILld~~g-~vkl~DFGla~~~~~ 161 (472)
++++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++ +++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 653 6888899999999999999999 99999999999999999999 999999999998877
Q ss_pred -ccCCCccccccC-CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH-HHHHHhcc--C--CCCCCC
Q 012021 162 -KHQDGLLHTTCG-TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME-MYRKIGKA--E--FKFPNW 234 (472)
Q Consensus 162 -~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~-~~~~i~~~--~--~~~~~~ 234 (472)
..........|| ++.|+|||.+.+..|.+...|+||+|+++..+++|..||....... .+..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 566667788899 9999999999988888899999999999999999999998755432 22222222 2 222334
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
++....+++.++|..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999987
No 417
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.90 E-value=2.2e-23 Score=193.48 Aligned_cols=143 Identities=19% Similarity=0.254 Sum_probs=116.0
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHhcCCC
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----------------------GMIDQIKREISVMRLVRHP 70 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hp 70 (472)
+.+.||+|+||.||+|.+. +|+.||||+++....... .......+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999986531100 0123356899999999999
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccc-hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCE
Q 012021 71 NVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~v 148 (472)
++.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555544333 489999999885543 3556788999999999999999999999 9999999999999999 8899
Q ss_pred EEeeccchhhhh
Q 012021 149 KVSDFGLSALAE 160 (472)
Q Consensus 149 kl~DFGla~~~~ 160 (472)
+|+|||+|....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987654
No 418
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.89 E-value=1.5e-23 Score=203.68 Aligned_cols=234 Identities=26% Similarity=0.360 Sum_probs=151.6
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC----------CCCeeeEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR----------HPNVVELYEVMA 80 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------hpnIv~l~~~~~ 80 (472)
.+..++.||.|+++.||.+.|..||+.+|+|++...........+.+++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3567889999999999999999999999999987655444455677777765544432 223333333321
Q ss_pred ---------eC---CE-----EEEEEEecCCCcccchhcc----CCC----CHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012021 81 ---------SK---TK-----IYFVMEYVKGGELFGKVAK----GKL----KEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 81 ---------~~---~~-----~~lV~E~~~gg~L~~~i~~----~~l----~e~~~~~i~~ql~~aL~yLH~~giiHrDl 135 (472)
.. +. .+++|+-+ .++|.+.+.- ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 12 35677766 4467665431 222 12223445589999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccC-------CCCCcccchhhhHHHHHHhcC
Q 012021 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG-------YDGSKADIWSCGVILYVLLAG 208 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DiwSlGvil~~lltG 208 (472)
+|+|++++.+|.+.|+||+.....+.... ....+..|.+||...... ..+.+.|.|+||+++|.|+||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987665443221 134457899999875431 124788999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012021 209 YLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
.+||.......... ..+.....++..++.||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~----~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE----WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG----GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc----ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99998654432111 0233333688999999999999999988
No 419
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.89 E-value=7e-23 Score=189.78 Aligned_cols=192 Identities=19% Similarity=0.252 Sum_probs=145.1
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhh-HHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM-IDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..+...|+.|+||+||++.. .+..++.+.+.......... ...+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999998876 77888888776555432211 225789999999995 5889999886 4479999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCCEEEeeccchhhhhcccCC---
Q 012021 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL-KPENLLLDEHGNLKVSDFGLSALAESKHQD--- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDl-Kp~NILld~~g~vkl~DFGla~~~~~~~~~--- 165 (472)
||+.|.+|...+..+ ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 78 SYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999999987543221 2357889999999999999999999 799999999999999999999854322210
Q ss_pred -C-------ccccccCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCC
Q 012021 166 -G-------LLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDS 215 (472)
Q Consensus 166 -~-------~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~ 215 (472)
. .......++.|++|+...--. .+-...+.++.|+-+|.++|+..++..+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 011234788999998653321 1224679999999999999999986543
No 420
>PRK10345 hypothetical protein; Provisional
Probab=99.87 E-value=7.4e-22 Score=185.37 Aligned_cols=132 Identities=20% Similarity=0.265 Sum_probs=108.7
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-----CCCCeeeEEEEEEeCC---EEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-----RHPNVVELYEVMASKT---KIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 86 (472)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||++++++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 47899999999995 7777666 6999876432 2346789999999999 5799999999998874 444
Q ss_pred -EEEEe--cCCCcccchhccCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEcCC----CCEEEeecc
Q 012021 87 -FVMEY--VKGGELFGKVAKGKLKEDAARKYFQQLISAV-DYCHSRGVCHRDLKPENLLLDEH----GNLKVSDFG 154 (472)
Q Consensus 87 -lV~E~--~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL-~yLH~~giiHrDlKp~NILld~~----g~vkl~DFG 154 (472)
+|+|| +.+++|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ ++++|+||+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 557999999988777777 35678888777 99999999999999999999743 379999954
No 421
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.87 E-value=1.7e-22 Score=197.42 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=175.7
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCc-----------------------------------EEEEEEeeccccc--c
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGM-----------------------------------SVAIKIIDKEKVL--K 50 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----------------------------------~vAiK~i~~~~~~--~ 50 (472)
-.+.|+|++.||+|..+.||.|+-..+|. +.|||.+-.-... .
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 34679999999999999999987653221 3556654211111 1
Q ss_pred hhhHHHHHHHHH------H--------HHh--------cCCCCeeeEEEEEEe---------------------------
Q 012021 51 VGMIDQIKREIS------V--------MRL--------VRHPNVVELYEVMAS--------------------------- 81 (472)
Q Consensus 51 ~~~~~~~~~Ei~------i--------l~~--------l~hpnIv~l~~~~~~--------------------------- 81 (472)
....+.+.+|.. . .+. -+|||||++.++|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 122233333321 1 111 259999999887632
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCC--CEEEeeccchh
Q 012021 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL--DEHG--NLKVSDFGLSA 157 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILl--d~~g--~vkl~DFGla~ 157 (472)
...+|+||...+ .+|..++-.+..+....+-++.|+++|+.|||.+||.|||+|.+|||+ |+|+ .+.|+|||.+-
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcch-hhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 335899998774 488888888888888999999999999999999999999999999998 4444 48999999754
Q ss_pred hhhcccC----CCccccccCCCcccChhhhcccCC-----CCCcccchhhhHHHHHHhcCCCCCCCCcHHHH--HHHHhc
Q 012021 158 LAESKHQ----DGLLHTTCGTPAYVAPEVINRRGY-----DGSKADIWSCGVILYVLLAGYLPFHDSNLMEM--YRKIGK 226 (472)
Q Consensus 158 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~--~~~i~~ 226 (472)
--....- ....-..-|...-||||+....+- +-.++|.|++|.+.||+++...||.....+.+ ...-..
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~ 473 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES 473 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh
Confidence 2221100 011123457888999999854321 11489999999999999999999987543321 111122
Q ss_pred cCCCCCCCCCHHHHHHHhcccCCCCCCcCChh
Q 012021 227 AEFKFPNWFAPEVRRLLSKILDPNPNTRISMT 258 (472)
Q Consensus 227 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 258 (472)
.-+.+|..+++.+++++..+|++||++|++..
T Consensus 474 qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 474 QLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 33567888999999999999999999999854
No 422
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.87 E-value=2.7e-23 Score=223.69 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=181.8
Q ss_pred CeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccc-ccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012021 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEK-VLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.|...+.||.+-|=+|.+|.+. .| .|+||++-+.. ...-....+..+|++ ...++|||.+.+.-+.+++...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6889999999999999999884 34 49999997654 222222333345555 66779999999999988888999999
Q ss_pred EecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhh--cccCCC
Q 012021 90 EYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE--SKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~--~~~~~~ 166 (472)
+|+.. +|+|++..++ +...+.+.|+.||+.||..||..||+|+|||.|||||..-..+.|+||..-+..- ......
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99955 8999998776 6778889999999999999999999999999999999999999999997533211 111110
Q ss_pred ---ccccccCCCcccChhhhcccC----------CCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC--CC
Q 012021 167 ---LLHTTCGTPAYVAPEVINRRG----------YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE--FK 230 (472)
Q Consensus 167 ---~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~~ 230 (472)
.+.+...-.+|.|||.+...+ .-+++.||||+||+++||++ |++||.-..... |+.-.... .-
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a-Yr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA-YRSGNADDPEQL 258 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh-HhccCccCHHHH
Confidence 122333445799999985422 12467899999999999988 688885322211 11110000 00
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+..--+..++++|..|++.||++|.++++.|+.
T Consensus 259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 001123468999999999999999999999875
No 423
>smart00090 RIO RIO-like kinase.
Probab=99.85 E-value=8.6e-21 Score=181.96 Aligned_cols=143 Identities=18% Similarity=0.197 Sum_probs=115.2
Q ss_pred eEEEeeEcccCCeEEEEEE-EcCCCcEEEEEEeecccccc---------------------hhhHHHHHHHHHHHHhcCC
Q 012021 12 YELGRLLGQGTFAKVHYAR-NLKTGMSVAIKIIDKEKVLK---------------------VGMIDQIKREISVMRLVRH 69 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~h 69 (472)
|++.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++.+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8899999999999999999 66799999999997543110 0012346789999999975
Q ss_pred C--CeeeEEEEEEeCCEEEEEEEecCCCcccchh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCC
Q 012021 70 P--NVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSRG-VCHRDLKPENLLLDEH 145 (472)
Q Consensus 70 p--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~i~~ql~~aL~yLH~~g-iiHrDlKp~NILld~~ 145 (472)
. .+.++++. ...|+||||+.|.+|.... ....+.+..+..++.||+.++.+||++| ++||||||+||+++ +
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3 34455543 2358999999998887665 3456777778899999999999999999 99999999999999 8
Q ss_pred CCEEEeeccchhhh
Q 012021 146 GNLKVSDFGLSALA 159 (472)
Q Consensus 146 g~vkl~DFGla~~~ 159 (472)
+.++|+|||.|...
T Consensus 185 ~~i~LiDFg~a~~~ 198 (237)
T smart00090 185 GKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEEEEChhhhcc
Confidence 89999999987744
No 424
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.84 E-value=1.1e-21 Score=183.17 Aligned_cols=242 Identities=20% Similarity=0.361 Sum_probs=196.5
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-++...+..+|.+.-.|+.|++++ .|..++.|+++-.... ......+..|.-.|+...||||+.+++.|.+..++.+
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred chhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 344556788899999999999988 5667888888655432 2334568889999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCEEEe--eccchhhhh
Q 012021 88 VMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVS--DFGLSALAE 160 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~g--iiHrDlKp~NILld~~g~vkl~--DFGla~~~~ 160 (472)
+..|++-|+|+..+..+ ..+..++.+++.++++|+.|||+.. |.---|....+++|++-+.+|+ |--++
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---- 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---- 340 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee----
Confidence 99999999999999764 3678899999999999999999873 4445688899999999877664 22111
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCC--CcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH--hccCCCCCCCCC
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDG--SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPNWFA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s 236 (472)
.+. ....-.|.||+||.++.++.+. .++|+|||.+++|||.|.+.||.+-++++.--+| ......+|+.++
T Consensus 341 fqe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 341 FQE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred eec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 111 1234578999999998776543 4799999999999999999999998887655444 345678999999
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhh
Q 012021 237 PEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
+.+..|+.-|+..||.+||.++.|+
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999998875
No 425
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.83 E-value=1.7e-20 Score=205.61 Aligned_cols=236 Identities=19% Similarity=0.321 Sum_probs=179.4
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
...|.|-+.||+|+||+||.|.+.. |+.||+|+-.....+..-...+++..+. +. --+.|..+...+.-.+.-++|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcceee
Confidence 4589999999999999999999866 9999999988777665444444444333 11 135666666666777788999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-------CCCCEEEeeccchhhhh
Q 012021 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-------EHGNLKVSDFGLSALAE 160 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld-------~~g~vkl~DFGla~~~~ 160 (472)
+||.+-|+|.+++.. +.+++..+..+..|++..|+.||..||||+||||+|.||. .+--++|+|||-|.-..
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999999999976 5799999999999999999999999999999999999993 22359999999876544
Q ss_pred cccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----CCCCCC
Q 012021 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-----KFPNWF 235 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~ 235 (472)
.-.....+...++|-.+-.+|...++.+. +.+|.|.|..+++.||.|+.- + ...+.. .++..+
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q----~~~g~~~~~~~~~~Ry~ 920 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E----VKNGSSWMVKTNFPRYW 920 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H----hcCCcceeccccchhhh
Confidence 32223356778899999999999999986 999999999999999999642 1 222211 122222
Q ss_pred CHH-HHHHHhcccCCCCCCcCChhhh
Q 012021 236 APE-VRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 236 s~~-l~~li~~~L~~dP~~Rpt~~ei 260 (472)
..+ ..+++..+|.+|-..=|...+|
T Consensus 921 ~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 921 KRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hHHHHHHHHHHHhCcCcccchhHHHH
Confidence 222 3467788888554444555554
No 426
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.82 E-value=1.6e-19 Score=169.77 Aligned_cols=137 Identities=23% Similarity=0.335 Sum_probs=116.1
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----GMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+.||+|++|.||+|.+ +|..|++|+......... .....+.+|+.++..+.|++|+....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 788899998754332211 123467889999999999999888888777888999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhh
Q 012021 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~ 158 (472)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988865322 7889999999999999999999999999999999 78999999998764
No 427
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.80 E-value=2e-19 Score=167.80 Aligned_cols=139 Identities=19% Similarity=0.278 Sum_probs=110.3
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-------------------hhHHHHHHHHHHHHhcCCCC-
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-------------------GMIDQIKREISVMRLVRHPN- 71 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 71 (472)
|.+.+.||+|+||.||++.+. +|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 899999999999999999874 899999999865431000 01123678899999988774
Q ss_pred -eeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEE
Q 012021 72 -VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 72 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl 150 (472)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2345899999999988765431 346678899999999999999999999999999999999999
Q ss_pred eeccchhhhh
Q 012021 151 SDFGLSALAE 160 (472)
Q Consensus 151 ~DFGla~~~~ 160 (472)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999886443
No 428
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.79 E-value=6.1e-19 Score=164.29 Aligned_cols=133 Identities=21% Similarity=0.294 Sum_probs=109.3
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-----VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
.||+|+||+||++.. +|..|++|......... .....++.+|+.+++.+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 77899999965432211 11236678999999999988776666566667778999999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhh
Q 012021 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~ 158 (472)
++|++|.+.+..... .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887754322 7899999999999999999999999999999 88999999998765
No 429
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.77 E-value=1.9e-18 Score=185.19 Aligned_cols=140 Identities=21% Similarity=0.290 Sum_probs=113.6
Q ss_pred CCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012021 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..|...+.||+|+||+||++.+. +..+++|+....... .....+.+.+|+.+++.++|++++.++.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34567899999999999999874 444555543322111 11123568899999999999999988888777778
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhh
Q 012021 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~ 159 (472)
.++||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999988775 457799999999999999999999999999999 6789999999998753
No 430
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.77 E-value=2.4e-18 Score=158.61 Aligned_cols=139 Identities=20% Similarity=0.307 Sum_probs=102.2
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHH---------------------HHHHHHHHHHhcCCC--
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID---------------------QIKREISVMRLVRHP-- 70 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp-- 70 (472)
+++.||+|+||+||.|.+. +|+.||||++............ ....|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 8999999998764322111111 114566777666544
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccc-hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCE
Q 012021 71 NVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~v 148 (472)
.+.+++++ ...++||||++|+.+.. .+...... ..++.++.+++.++.++|. +||+||||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 34555554 23589999999965432 22221111 6788999999999999999 9999999999999999 8999
Q ss_pred EEeeccchhhh
Q 012021 149 KVSDFGLSALA 159 (472)
Q Consensus 149 kl~DFGla~~~ 159 (472)
+|+|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999988644
No 431
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.75 E-value=2.2e-19 Score=182.19 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=166.2
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEE-------E
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE-------V 78 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-------~ 78 (472)
...+.+.+..+..+++.+....-..+ .+.++-+..+..+ ........+++-.+.-..|-+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 34556666677777776665443322 2333333332222 122334455555555444433332222 1
Q ss_pred E-----EeCCEEEEEEEecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEE
Q 012021 79 M-----ASKTKIYFVMEYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 79 ~-----~~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vk 149 (472)
+ ....+.|+.|++|.-.+|.+++... ..+......++.|++.|++| +|.+|||+||.||+...++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 1 1133589999999999999999753 36677889999999999999 9999999999999999999999
Q ss_pred Eeeccchhhhhccc----CCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012021 150 VSDFGLSALAESKH----QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 150 l~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
|.|||+........ .....+...||..||+||.+.+..|. .++||||||+||+||+. =..+|... .....+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFERI---ATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh
Confidence 99999977554332 11123556799999999999988886 89999999999999997 23333221 222233
Q ss_pred hccCCCCCCC-CCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012021 225 GKAEFKFPNW-FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 225 ~~~~~~~~~~-~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f 266 (472)
..+.++..-+ --|+-..|+.++|.+.|.+||++.+.--|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3333321111 12455689999999999999977777666664
No 432
>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs). Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.
Probab=99.75 E-value=7.8e-19 Score=129.58 Aligned_cols=60 Identities=68% Similarity=1.025 Sum_probs=48.4
Q ss_pred CCCCCCchhhhccCCCCCCCCchhhhhh---cccceeeccCCHHHHHHHHHHHHhHcCcEEEE
Q 012021 310 KPCNLNAFDIISFSAGFDLSGLFEEREK---RKEVRFTSNKPVSTIISKLEGIAKLLRLKVKK 369 (472)
Q Consensus 310 ~~~~~~~f~~~~~s~~~~ls~l~~~~~~---~~~~rf~~~~~~~~i~~~l~~~~~~l~~~v~~ 369 (472)
+|..+|||||||||+|||||+||++... ++++||+|++||++|++|||++|+.+||+|+|
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3678999999999999999999986543 57999999999999999999999999999986
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.74 E-value=1.7e-17 Score=159.40 Aligned_cols=137 Identities=18% Similarity=0.301 Sum_probs=107.4
Q ss_pred eeEc-ccCCeEEEEEEEcCCCcEEEEEEeecccc----c------chhhHHHHHHHHHHHHhcCCCCe--eeEEEEEEeC
Q 012021 16 RLLG-QGTFAKVHYARNLKTGMSVAIKIIDKEKV----L------KVGMIDQIKREISVMRLVRHPNV--VELYEVMASK 82 (472)
Q Consensus 16 ~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 82 (472)
..|| .||.|+||.+.. .+..++||.+..... . .......+.+|+.++..+.|++| ++++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888876 478999998864321 1 11223568899999999998875 6777764332
Q ss_pred -C---EEEEEEEecCC-CcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 83 -T---KIYFVMEYVKG-GELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 83 -~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
. ..++|||+++| .+|.+++..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999998 6888888777777654 5689999999999999999999999999999999999999776
Q ss_pred h
Q 012021 158 L 158 (472)
Q Consensus 158 ~ 158 (472)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
No 434
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.73 E-value=1.1e-17 Score=172.64 Aligned_cols=199 Identities=25% Similarity=0.395 Sum_probs=156.3
Q ss_pred HHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcE
Q 012021 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGV-CHRDLKPENL 140 (472)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~yLH~~gi-iHrDlKp~NI 140 (472)
|+.+.|.|+.++++.+.++...+.|.+||.-|+|.+.+... .++.-....++++|+.||.|+|+-.| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45788999999999999999999999999999999999774 57778888899999999999998865 9999999999
Q ss_pred EEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCC------CCCcccchhhhHHHHHHhcCCCCCCC
Q 012021 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY------DGSKADIWSCGVILYVLLAGYLPFHD 214 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlGvil~~lltG~~Pf~~ 214 (472)
++|....+||+|||+..+..........+...-..-|.|||.+..... .+.+.||||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999776542111111112223446899999876422 24679999999999999999999976
Q ss_pred C----cHHHHHHHHhc-cCCCC-CC-----CCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012021 215 S----NLMEMYRKIGK-AEFKF-PN-----WFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 215 ~----~~~~~~~~i~~-~~~~~-~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. ...++..++.+ +...+ |. .+.+++..++.+||..+|..||++++|-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 3 22345555555 22212 21 24557899999999999999999998854
No 435
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.70 E-value=1.8e-16 Score=139.05 Aligned_cols=132 Identities=23% Similarity=0.322 Sum_probs=113.8
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCEEEEEEEe
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (472)
+++.||.|.++.||++.+ .+..+++|.+..... ...+.+|+.+++.++| .++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 468899999999999998 347899999865532 3568899999999976 5899999998888899999999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCCEEEeeccchhh
Q 012021 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR---GVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~---giiHrDlKp~NILld~~g~vkl~DFGla~~ 158 (472)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||++..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5667778899999999999985 799999999999999989999999998763
No 436
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.66 E-value=2.1e-17 Score=178.56 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=210.9
Q ss_pred ccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012021 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.+.+.+.+-+-.|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|-++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45567888899999999999999888888888887654432222223444455555555566777766666667788999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcc----
Q 012021 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK---- 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~---- 162 (472)
+++|+.|++|...+.. +..+++-++.+...+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999999987 66899999999999999999999999999999999999999999999999843221100
Q ss_pred ------------------cCC-------CccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH
Q 012021 163 ------------------HQD-------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL 217 (472)
Q Consensus 163 ------------------~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~ 217 (472)
... ..-....||+.|.+||.+.+... +..+|+|+.|+++++.++|..||.+...
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 000 11223468999999999988765 4789999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC---CCCHHHHHHHhcccCCCCCCcCChh---hhhcCcccccC
Q 012021 218 MEMYRKIGKAEFKFPN---WFAPEVRRLLSKILDPNPNTRISMT---KIMENSWFRKG 269 (472)
Q Consensus 218 ~~~~~~i~~~~~~~~~---~~s~~l~~li~~~L~~dP~~Rpt~~---eil~h~~f~~~ 269 (472)
...++.|.+.....|. ..++++++++.+.|..+|.+|..+. ++-.|+||+..
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999888777664 3789999999999999999999988 89999999864
No 437
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.61 E-value=3.5e-16 Score=161.68 Aligned_cols=257 Identities=19% Similarity=0.221 Sum_probs=196.7
Q ss_pred cccCCeEEEeeEcc--cCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012021 7 ILMQRYELGRLLGQ--GTFAKVHYARN--LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
....++.+...+|. |.+|.||.+.. ..++..+|+|.-+.... .......-.+|+...+.++ |+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCccccc
Confidence 44567888999999 99999999998 88999999998322111 0011122346777777775 9999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-C-CCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEcCC-CCEEEeecc
Q 012021 82 KTKIYFVMEYVKGGELFGKVAK-G-KLKEDAARKYFQQLIS----AVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFG 154 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~----aL~yLH~~giiHrDlKp~NILld~~-g~vkl~DFG 154 (472)
.+..|+-+|++. .+|..+... . -+++..++..+.+... ||.++|+.+++|-|+||+||++..+ ...++.|||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999999995 677777654 3 4899999999999999 9999999999999999999999999 889999999
Q ss_pred chhhhhcccCCCcc---ccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC--cHHHHHHHHhccCC
Q 012021 155 LSALAESKHQDGLL---HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--NLMEMYRKIGKAEF 229 (472)
Q Consensus 155 la~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~--~~~~~~~~i~~~~~ 229 (472)
+...+....-.... ...-|...|++||...+ ..+...|+|++|.+..+..+|..+.... +.....+.+. ...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~ 345 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPL 345 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cch
Confidence 98766554322211 22257788999998754 3467899999999999999887765443 2222111111 122
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.+....+.++...+..|++.+|-.|++.+.+++|+++..
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 233345677888999999999999999999999998874
No 438
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.56 E-value=1.2e-14 Score=151.52 Aligned_cols=141 Identities=22% Similarity=0.311 Sum_probs=98.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-------------------------------hhHH------HHH
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-------------------------------GMID------QIK 58 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------------------~~~~------~~~ 58 (472)
+.||.|++|.||+|+. .+|+.||||+......... +... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 5899999999865321000 0001 133
Q ss_pred HHHHHHHhcC-----CCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 012021 59 REISVMRLVR-----HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLIS-AVDYCHSRGV 130 (472)
Q Consensus 59 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~-aL~yLH~~gi 130 (472)
+|...+.+++ ++++.-..-+....+..++||||++|++|.+..... ..+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555442 344432222233345679999999999998876432 222 2345566655 4788999999
Q ss_pred eecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 131 iHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+|+|+||.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999987654
No 439
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.54 E-value=2.8e-15 Score=158.29 Aligned_cols=144 Identities=22% Similarity=0.409 Sum_probs=99.8
Q ss_pred cCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-----hhhHHHH
Q 012021 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--------------------------K-----VGMIDQI 57 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------------~-----~~~~~~~ 57 (472)
...|+. +.||.|++|.||.|+.+.+|+.||||+..+.... + .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 8899999999999999888999999999754210 0 0122334
Q ss_pred HHHHHHH------HhcC----CCCeeeEEEEE-EeCCEEEEEEEecCCCcccch--hcc-C----CCCHHHHHHHHHHHH
Q 012021 58 KREISVM------RLVR----HPNVVELYEVM-ASKTKIYFVMEYVKGGELFGK--VAK-G----KLKEDAARKYFQQLI 119 (472)
Q Consensus 58 ~~Ei~il------~~l~----hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~i~~ql~ 119 (472)
.+|++.+ .++. +.+.+.+-.++ +-.+..++||||+.|+.+.+. +.. + .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 4444433 3332 33333333333 235567899999999999764 322 3 255555666666665
Q ss_pred HHHHHHHhCCceecCCCCCcEEEcCCC----CEEEeeccchhhhh
Q 012021 120 SAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGLSALAE 160 (472)
Q Consensus 120 ~aL~yLH~~giiHrDlKp~NILld~~g----~vkl~DFGla~~~~ 160 (472)
..|++|+|+||.||+++.+| .++++|||++....
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999988 99999999887554
No 440
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.49 E-value=4e-13 Score=124.36 Aligned_cols=141 Identities=18% Similarity=0.230 Sum_probs=104.3
Q ss_pred EeeEcccCCeEEEEEEEcC------CCcEEEEEEeecccc-------------------cchhhHHH----HHHHHHHHH
Q 012021 15 GRLLGQGTFAKVHYARNLK------TGMSVAIKIIDKEKV-------------------LKVGMIDQ----IKREISVMR 65 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~-------------------~~~~~~~~----~~~Ei~il~ 65 (472)
...||.|--+.||.|.... .+..+|||+...... .+...... .++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998653 357999999742110 01111223 348999999
Q ss_pred hcCC--CCeeeEEEEEEeCCEEEEEEEecCCCcccc-hhccCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEE
Q 012021 66 LVRH--PNVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYC-HSRGVCHRDLKPENLL 141 (472)
Q Consensus 66 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~yL-H~~giiHrDlKp~NIL 141 (472)
++.. -++.+++++ ...++||||+.+..+.. .+....+++..+..++.+++.+|..+ |..|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8863 456677765 45789999997754432 33444566777788899999999999 8999999999999999
Q ss_pred EcCCCCEEEeeccchhhhh
Q 012021 142 LDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~ 160 (472)
++ ++.+.|+|||.|....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 5789999999776543
No 441
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.48 E-value=2.4e-13 Score=122.93 Aligned_cols=127 Identities=20% Similarity=0.320 Sum_probs=97.1
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEecC
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 93 (472)
++.|+.|.++.||.++. .+..|++|+...... ......+|+.+++.+.+.++ .+++.+.. +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999986 478999999755431 11245789999998865554 45555433 33589999999
Q ss_pred CCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 94 GGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGV-----CHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 94 gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~gi-----iHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11123467899999999999985 9999999999999 6789999999765
No 442
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.45 E-value=6.5e-13 Score=138.92 Aligned_cols=171 Identities=18% Similarity=0.331 Sum_probs=131.5
Q ss_pred EEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCC
Q 012021 28 YARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK 107 (472)
Q Consensus 28 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 107 (472)
.|..+.++.+|.|.+.+.+.- ...+.+++-+.-|+.++||||+++++.++.++.+|+|+|.+.. |..+++. ++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hH
Confidence 355677899999999876643 3456788889999999999999999999999999999999865 4444443 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhccc
Q 012021 108 EDAARKYFQQLISAVDYCH-SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186 (472)
Q Consensus 108 e~~~~~i~~ql~~aL~yLH-~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 186 (472)
......-++||+.||.||| ..+++|++|.-..|+++..|..||.+|.++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 7777788999999999998 56899999999999999999999999998764433221 01111122246677765433
Q ss_pred CCCCCcccchhhhHHHHHHhcCCC
Q 012021 187 GYDGSKADIWSCGVILYVLLAGYL 210 (472)
Q Consensus 187 ~~~~~~~DiwSlGvil~~lltG~~ 210 (472)
. -..|.|.|||++++++.|.+
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c---cchhhhhHHHHHHHHhCccc
Confidence 3 24799999999999999943
No 443
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.44 E-value=6.9e-14 Score=144.80 Aligned_cols=253 Identities=19% Similarity=0.177 Sum_probs=189.8
Q ss_pred CCcccCCeEEEeeEcccCCeEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 012021 5 GSILMQRYELGRLLGQGTFAKVHYARNL-KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK 82 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (472)
.....++|.++..||.|.|+.|+..... .++..+++|...+......+... -..|+-+...+ .|.++++++..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccc
Confidence 4566788999999999999999987765 67889999987655433222111 22455555555 499999999999999
Q ss_pred CEEEEEEEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCEEEeeccchhhhh
Q 012021 83 TKIYFVMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~-g~vkl~DFGla~~~~ 160 (472)
...|+-.|||+++++...+. ...+++...+++..|++.++.++|+..++|+|+||.||++..+ +..++.|||.+....
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999999998765553 2568899999999999999999999999999999999999886 788999999886422
Q ss_pred cccCCCccccccCCCccc-ChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCCcHHHHHHHHhccCCCCCCCCCHH
Q 012021 161 SKHQDGLLHTTCGTPAYV-APEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEMYRKIGKAEFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~ 238 (472)
... ....++-.+. .+|++........++|++|||..+.+.++|..- +.... ...|..+.....+....+
T Consensus 419 ~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred eec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCCchHHh
Confidence 211 1122333444 355555444455899999999999999998643 22222 223444545544555588
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012021 239 VRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h~~f~ 267 (472)
+..+...+..+++..|+.+.++..|+-|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 89999999999999999999998876554
No 444
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.33 E-value=1.2e-12 Score=126.24 Aligned_cols=201 Identities=19% Similarity=0.310 Sum_probs=141.3
Q ss_pred HHhcCCCCeeeEEEEEEeC-----CEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC--Cce
Q 012021 64 MRLVRHPNVVELYEVMASK-----TKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSR--GVC 131 (472)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~yLH~~--gii 131 (472)
|-.+-|.|||+++.|+.+. ....++.||+..|++..++++ ..+......+|.-||+.||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455699999999998544 458899999999999888864 3588889999999999999999988 599
Q ss_pred ecCCCCCcEEEcCCCCEEEeeccchhhhhcc--cCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC
Q 012021 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESK--HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209 (472)
Q Consensus 132 HrDlKp~NILld~~g~vkl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~ 209 (472)
|+++..+-|++..+|-+|+.---.......- ..........|-++|.|||.=..... +.++|||++|....+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 9999999999999998887432111110000 00011122346788999996433333 35799999999999999887
Q ss_pred CCCCC-CcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 210 LPFHD-SNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 210 ~Pf~~-~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
.--.. .+....-..+.+.-+.... +--+.+|.+||+..|+.||++.+++.||..-+
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~len---~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGLEN---GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eccCCCcceeehhhhhhhheeeccC---ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 64222 2221222222222222111 12357899999999999999999999997754
No 445
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.30 E-value=2.5e-11 Score=114.26 Aligned_cols=139 Identities=21% Similarity=0.285 Sum_probs=110.1
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC---CEEEEEEE
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASK---TKIYFVME 90 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 90 (472)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999873 4689999997654321 123568899999999976 4467788776654 36789999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 012021 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS------------------------------------------- 127 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~------------------------------------------- 127 (472)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988876654568888888888899999988884
Q ss_pred -------------CCceecCCCCCcEEEcC--CCCEEEeeccchh
Q 012021 128 -------------RGVCHRDLKPENLLLDE--HGNLKVSDFGLSA 157 (472)
Q Consensus 128 -------------~giiHrDlKp~NILld~--~g~vkl~DFGla~ 157 (472)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999998 5668999999765
No 446
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.25 E-value=6.3e-11 Score=106.77 Aligned_cols=134 Identities=21% Similarity=0.298 Sum_probs=101.9
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhh-----HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM-----IDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
..+++|+-+.+|.+.. -|..+++|.=.+........ ..+-.+|+.++..++--.|.-.+=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999865 45556777643333222222 3456789999988876666655556667777889999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhh
Q 012021 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~ 158 (472)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 245677778888899999999999999999997665 99999999874
No 447
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.20 E-value=2e-10 Score=103.17 Aligned_cols=144 Identities=19% Similarity=0.252 Sum_probs=109.5
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----MIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+..|-+|+-+.|+.+.. .|+...||.=.......+. ...+.++|+.+|.++.--.|.-..=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 668899999999999987 8888888864333322222 235678899999888766666656666677777899
Q ss_pred EEecCC-Ccccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---EEEeeccchhhh
Q 012021 89 MEYVKG-GELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALA 159 (472)
Q Consensus 89 ~E~~~g-g~L~~~i~~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~---vkl~DFGla~~~ 159 (472)
|||++| .++.+++.. ..........++++|-+.+.-||.++|+|+||..+||+|..+|. +.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 466666643 22333334789999999999999999999999999999977663 589999997643
No 448
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.16 E-value=4.8e-10 Score=114.39 Aligned_cols=210 Identities=16% Similarity=0.251 Sum_probs=155.9
Q ss_pred CeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCEEEEEEEecCC-Ccc
Q 012021 23 FAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----KTKIYFVMEYVKG-GEL 97 (472)
Q Consensus 23 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L 97 (472)
-.+.|++....+|..|++|.++-.+.... ...-.-+++++.+.|+|+|++.++|.+ +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999954433221 122244678899999999999999863 4579999999987 466
Q ss_pred cchh----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 98 FGKV----------------AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 98 ~~~i----------------~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.++- ...+.+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|+..|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5542 113578999999999999999999999999999999999999999999998887665543
Q ss_pred ccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCCcHHHH-HHHHhccCCCCCCCCCHHH
Q 012021 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEM-YRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~l 239 (472)
.. .+ -+... .+-|.=.||.+++.|.||..- |........ ... +...++.++
T Consensus 446 d~--------------~~--~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D~ 498 (655)
T KOG3741|consen 446 DP--------------TE--PLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTDL 498 (655)
T ss_pred CC--------------Cc--chhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHHH
Confidence 22 01 11111 356888999999999999654 222222222 222 234478899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012021 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++|.-+...++.. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999998887 788888764
No 449
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.14 E-value=2.8e-10 Score=104.94 Aligned_cols=128 Identities=23% Similarity=0.368 Sum_probs=85.6
Q ss_pred EEEEEEEcCCCcEEEEEEeeccc-----------------------ccchhhHHHHHHHHHHHHhcCCC--CeeeEEEEE
Q 012021 25 KVHYARNLKTGMSVAIKIIDKEK-----------------------VLKVGMIDQIKREISVMRLVRHP--NVVELYEVM 79 (472)
Q Consensus 25 ~Vy~a~~~~~g~~vAiK~i~~~~-----------------------~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 79 (472)
.||.|.. .+|..+|+|+..... ....-.....++|..+|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 578899999974310 01111235678999999999865 566777553
Q ss_pred EeCCEEEEEEEecC--CCcccchhccCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 80 ASKTKIYFVMEYVK--GGELFGKVAKGKLKEDAARKYFQQLISAVDY-CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 80 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~y-LH~~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
..++||||+. |..+. .+....++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2379999998 54453 3433333355667788888885555 579999999999999999887 8999999976
Q ss_pred hhh
Q 012021 157 ALA 159 (472)
Q Consensus 157 ~~~ 159 (472)
...
T Consensus 154 v~~ 156 (188)
T PF01163_consen 154 VDS 156 (188)
T ss_dssp EET
T ss_pred eec
Confidence 643
No 450
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.10 E-value=4.5e-11 Score=125.75 Aligned_cols=153 Identities=20% Similarity=0.379 Sum_probs=113.8
Q ss_pred HHHHHHHHHHhC-CceecCCCCCcEEEcCCCCEEEeeccchhhhhcccC------C-CccccccCCCcccChhhhcccCC
Q 012021 117 QLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ------D-GLLHTTCGTPAYVAPEVINRRGY 188 (472)
Q Consensus 117 ql~~aL~yLH~~-giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~------~-~~~~~~~gt~~y~aPE~~~~~~~ 188 (472)
+.++|+.|+|.. +++|+.|.|++|.++.+|.+||+.|+.+........ + ....-..-...|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999966 899999999999999999999999998765433111 0 01111124567999999877 45
Q ss_pred CCCcccchhhhHHHHHHh-cCCCCCCCCcHHHHHHHH----hccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012021 189 DGSKADIWSCGVILYVLL-AGYLPFHDSNLMEMYRKI----GKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 189 ~~~~~DiwSlGvil~~ll-tG~~Pf~~~~~~~~~~~i----~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.++|+||+|+++|.+. .|+.-+...+....+..- ....+.....+++++++-+.++|..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 568999999999999999 455555444333222221 112334456789999999999999999999999999999
Q ss_pred cccccCC
Q 012021 264 SWFRKGL 270 (472)
Q Consensus 264 ~~f~~~~ 270 (472)
|||....
T Consensus 266 ~ff~D~~ 272 (700)
T KOG2137|consen 266 PFFSDPG 272 (700)
T ss_pred cccCCch
Confidence 9998754
No 451
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.04 E-value=4.1e-09 Score=102.80 Aligned_cols=131 Identities=17% Similarity=0.093 Sum_probs=93.6
Q ss_pred EEEEEEEcCCCcEEEEEEeeccccc---ch-----hhHHHHHHHHHHHHhcCCCCe--eeEEEEEEe-----CCEEEEEE
Q 012021 25 KVHYARNLKTGMSVAIKIIDKEKVL---KV-----GMIDQIKREISVMRLVRHPNV--VELYEVMAS-----KTKIYFVM 89 (472)
Q Consensus 25 ~Vy~a~~~~~g~~vAiK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lV~ 89 (472)
.|+.... .|+.|.||........ +. .-.....+|...+..+..-+| +.++.+.+. ....|+||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555433 6778999976432211 00 001136789998888754333 344445433 23578999
Q ss_pred EecCCC-cccchhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------CCCEEEeeccchh
Q 012021 90 EYVKGG-ELFGKVA---KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-------HGNLKVSDFGLSA 157 (472)
Q Consensus 90 E~~~gg-~L~~~i~---~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~-------~g~vkl~DFGla~ 157 (472)
|++++. +|.+++. ....++.....++.+++..+.-||..||+|+|++|.|||++. ++.+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 7888775 345677888899999999999999999999999999999975 4579999999764
No 452
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=99.00 E-value=2.7e-09 Score=101.72 Aligned_cols=137 Identities=23% Similarity=0.319 Sum_probs=103.4
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccc-----------c------cc--hhhHHHHHHHHHHHHhcCCC--
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEK-----------V------LK--VGMIDQIKREISVMRLVRHP-- 70 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-----------~------~~--~~~~~~~~~Ei~il~~l~hp-- 70 (472)
+.++..||.|.-|.||.|.+ ..|..+|||.=.... . .. .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35789999999999999997 478999999742110 0 00 01134567899999999644
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEE
Q 012021 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl 150 (472)
.+.+.+++ +...+||||++|-.|...- ++......++..|++-+.-.-..|++|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 77777765 5678999999998876543 234555566667777776666899999999999999999999999
Q ss_pred eeccchh
Q 012021 151 SDFGLSA 157 (472)
Q Consensus 151 ~DFGla~ 157 (472)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9996443
No 453
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.84 E-value=4.5e-08 Score=97.96 Aligned_cols=232 Identities=20% Similarity=0.251 Sum_probs=149.3
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeee--------EEEEEEeCC
Q 012021 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVE--------LYEVMASKT 83 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~--------l~~~~~~~~ 83 (472)
..++.||+|+-+.+|-.-.. +. .+-|+..+..... +. +....|.. -.||-+-. ++|- ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~-----~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAA-----QA-QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGK 83 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCchH-----HH-HHHHHhccCCCCcchhhhhcccHHHhhCC-Cccc
Confidence 35688999999999865432 22 3447776554211 11 12222322 24554332 1221 1222
Q ss_pred EEEEEEEecCCCcc-cchhc----c---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccc
Q 012021 84 KIYFVMEYVKGGEL-FGKVA----K---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 84 ~~~lV~E~~~gg~L-~~~i~----~---~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGl 155 (472)
.+-+.|..+.|..= ..+.. + ....+..+.+.++.|+.+...||..|..-+|+.++|+|+++++.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 37788998888532 22221 1 2367889999999999999999999999999999999999999999998542
Q ss_pred hhhhhcccCCCccccccCCCcccChhhhcccCCC----CCcccchhhhHHHHHHhcC-CCCCCCC-------cHHHHHHH
Q 012021 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD----GSKADIWSCGVILYVLLAG-YLPFHDS-------NLMEMYRK 223 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~DiwSlGvil~~lltG-~~Pf~~~-------~~~~~~~~ 223 (472)
-.+ ...+......+|.+.|.+||...-..+. +...|.|.||+++|+++.| ++||.+. +..+ ..
T Consensus 164 fqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 164 FQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 211 1223334456799999999986422211 3568999999999998886 9999652 2222 12
Q ss_pred HhccCC-----------CCC---CC--CCHHHHHHHhcccCC--CCCCcCChhh
Q 012021 224 IGKAEF-----------KFP---NW--FAPEVRRLLSKILDP--NPNTRISMTK 259 (472)
Q Consensus 224 i~~~~~-----------~~~---~~--~s~~l~~li~~~L~~--dP~~Rpt~~e 259 (472)
|..+.+ +-| +| +++++..|..+|+.. ++.-|||++.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 221111 111 11 678999999998864 3668998763
No 454
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.79 E-value=8.5e-08 Score=90.07 Aligned_cols=104 Identities=21% Similarity=0.367 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHhcCCCC--eeeEEEEEEeC----CEEEEEEEecCCC-cccchhcc-CCCCHHHHHHHHHHHHHHHHHHH
Q 012021 55 DQIKREISVMRLVRHPN--VVELYEVMASK----TKIYFVMEYVKGG-ELFGKVAK-GKLKEDAARKYFQQLISAVDYCH 126 (472)
Q Consensus 55 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH 126 (472)
....+|...+..|..-+ .++++++.+.. ...|+|+|+++|. +|.+++.. ..++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46788888888775333 34556655442 3568999999885 78888865 34777888899999999999999
Q ss_pred hCCceecCCCCCcEEEcCCC---CEEEeeccchhh
Q 012021 127 SRGVCHRDLKPENLLLDEHG---NLKVSDFGLSAL 158 (472)
Q Consensus 127 ~~giiHrDlKp~NILld~~g---~vkl~DFGla~~ 158 (472)
.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999986553
No 455
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.79 E-value=1.3e-07 Score=88.50 Aligned_cols=141 Identities=20% Similarity=0.290 Sum_probs=96.2
Q ss_pred cccCCeEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHH------HHHHHHHHHHhcC---CCCeeeEEE
Q 012021 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID------QIKREISVMRLVR---HPNVVELYE 77 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~------~~~~Ei~il~~l~---hpnIv~l~~ 77 (472)
++.++|.+.+.+-......|.+..- +|+.+++|.........+.... ...+.+..+..+. -..+..++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 6778999999999988888876654 7899999998654432222111 1233444344432 233333333
Q ss_pred EE-----EeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEee
Q 012021 78 VM-----ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 78 ~~-----~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~D 152 (472)
+. .-....+++|||++|.+|.+... +++ .+...|.+++.-+|+.|++|+|..|.|+++..++ ++++|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 32 22345668999999988866532 333 2446678889999999999999999999998655 99999
Q ss_pred ccchh
Q 012021 153 FGLSA 157 (472)
Q Consensus 153 FGla~ 157 (472)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98543
No 456
>PRK09902 hypothetical protein; Provisional
Probab=98.71 E-value=2e-07 Score=86.96 Aligned_cols=137 Identities=15% Similarity=0.142 Sum_probs=98.9
Q ss_pred cccCCeEEEEEEEcCCCcEEEEEEeecccc--cc-hhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEe----CCEEEEEE
Q 012021 19 GQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LK-VGMIDQIKREISVMRLVRHPN--VVELYEVMAS----KTKIYFVM 89 (472)
Q Consensus 19 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~-~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~----~~~~~lV~ 89 (472)
|.||-+.|+.... .|+.+=+|.-...-. .. ..-...+.+|+..|+.|..-+ +.++...... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5588889988765 455677887531110 00 122467889999998885322 4444422111 23478999
Q ss_pred EecCC-CcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--EEEeeccchh
Q 012021 90 EYVKG-GELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--LKVSDFGLSA 157 (472)
Q Consensus 90 E~~~g-g~L~~~i~~~---~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~--vkl~DFGla~ 157 (472)
|-+.| -+|.+++..+ +.++.....++.+++..+.-||+.|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98865 4788887653 4577888899999999999999999999999999999997777 9999997544
No 457
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.59 E-value=9.8e-07 Score=83.59 Aligned_cols=138 Identities=18% Similarity=0.207 Sum_probs=99.9
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccc---------------------hhhHHHHHHHHHHHHhcC--CCCee
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK---------------------VGMIDQIKREISVMRLVR--HPNVV 73 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~--hpnIv 73 (472)
.|+.|--+.||+|.. .++..+|+|++......- .-......+|+..|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 556677778999985 678999999985422110 011234567888888875 45566
Q ss_pred eEEEEEEeCCEEEEEEEecCCC-cccchhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCEEEe
Q 012021 74 ELYEVMASKTKIYFVMEYVKGG-ELFGKVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 74 ~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~-~giiHrDlKp~NILld~~g~vkl~ 151 (472)
+.+.+.. -.|||||+... .-.-.++.-++...++..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.|+
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 7777653 47999999553 12223333345555788899999999998877 8999999999999999 8899999
Q ss_pred eccchhhhh
Q 012021 152 DFGLSALAE 160 (472)
Q Consensus 152 DFGla~~~~ 160 (472)
|||-|....
T Consensus 209 D~~QaV~~~ 217 (268)
T COG1718 209 DVSQAVTID 217 (268)
T ss_pred ECccccccC
Confidence 999776544
No 458
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.58 E-value=8.4e-07 Score=84.57 Aligned_cols=132 Identities=15% Similarity=0.153 Sum_probs=84.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCEEEEEEEecC
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ 93 (472)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.+++.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 35567889875432 2345789999999986443 4778888888888899999999
Q ss_pred CCc-ccch---------------------hcc---CCCCHHH-HHHHHHHH----------HH-HHHHHH----hCCcee
Q 012021 94 GGE-LFGK---------------------VAK---GKLKEDA-ARKYFQQL----------IS-AVDYCH----SRGVCH 132 (472)
Q Consensus 94 gg~-L~~~---------------------i~~---~~l~e~~-~~~i~~ql----------~~-aL~yLH----~~giiH 132 (472)
|.. +... +.. ...+... ..++..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 1100 111 0011000 00111111 11 111222 124789
Q ss_pred cCCCCCcEEEcCCCCEEEeeccchh
Q 012021 133 RDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 133 rDlKp~NILld~~g~vkl~DFGla~ 157 (472)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999765
No 459
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.56 E-value=8.5e-07 Score=83.71 Aligned_cols=136 Identities=21% Similarity=0.299 Sum_probs=82.6
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC--CeeeEEEEE---EeCCEEEEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP--NVVELYEVM---ASKTKIYFVM 89 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV~ 89 (472)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998743 59999997544 2346788999999888533 355666644 3344689999
Q ss_pred EecCCCcccc----------------hhc---c-----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 012021 90 EYVKGGELFG----------------KVA---K-----GKLKEDA---------ARKY------------FQQLIS-AVD 123 (472)
Q Consensus 90 E~~~gg~L~~----------------~i~---~-----~~l~e~~---------~~~i------------~~ql~~-aL~ 123 (472)
++++|..+.. .+. . ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 110 0 0011000 0000 111222 233
Q ss_pred HHHh-------CCceecCCCCCcEEEc-CCCCEEEeeccchh
Q 012021 124 YCHS-------RGVCHRDLKPENLLLD-EHGNLKVSDFGLSA 157 (472)
Q Consensus 124 yLH~-------~giiHrDlKp~NILld-~~g~vkl~DFGla~ 157 (472)
.+++ ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3699999999999999 66777899998654
No 460
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.54 E-value=4.7e-07 Score=95.65 Aligned_cols=143 Identities=20% Similarity=0.266 Sum_probs=94.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccc---------------------------cch----hhHHH------HH
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV---------------------------LKV----GMIDQ------IK 58 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---------------------------~~~----~~~~~------~~ 58 (472)
+-|+.++-|.||.|+. .+|+.||||+....-. .-. +..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999997 4699999999754210 000 11122 23
Q ss_pred HHHHHHHhc-----CCCCeeeEEEEEEeCCEEEEEEEecCCCcccchh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 012021 59 REISVMRLV-----RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV--AKGKLKEDAARKYFQQLISAVDYCHSRGVC 131 (472)
Q Consensus 59 ~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i--~~~~l~e~~~~~i~~ql~~aL~yLH~~gii 131 (472)
+|...+.++ +.|++.-..=+++-.+.-.++|||+.|-.+.+.. ...+++...+...+.++ -+..+=..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 444444444 2466555555556667789999999999888874 44455533322221111 12222348999
Q ss_pred ecCCCCCcEEEcCCCCEEEeeccchhhhhc
Q 012021 132 HRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 132 HrDlKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
|.|.+|.||+++.+|.+.+.|||+......
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999998765443
No 461
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.42 E-value=5.1e-08 Score=102.09 Aligned_cols=237 Identities=20% Similarity=0.193 Sum_probs=165.5
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEEEEEE
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E 90 (472)
|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+...+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 455667899999999999986665444 6665433 34556889999999999 7777777888889999999
Q ss_pred ecCCC-cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCc
Q 012021 91 YVKGG-ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg-~L~~~i~~--~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
++.++ +-...... -.+.+-+.....+.-..+++++|+.-=+||| ||+..+ +..+..||+......... .
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~ 386 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K 386 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---c
Confidence 99887 33222211 2344445556666778899999998778998 777655 678999999876554332 2
Q ss_pred cccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCC---CCCCCHHHHHH
Q 012021 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKF---PNWFAPEVRRL 242 (472)
Q Consensus 168 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~s~~l~~l 242 (472)
..+..+|+.++|||+.....+. ...|.|++|.--.++.-|.+|-.... .....+..+. +.+ ..|-+.+-+++
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~ 463 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDF 463 (829)
T ss_pred cccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCC
Confidence 3567899999999998888777 68999999988778888877743311 0000011110 001 11222222347
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012021 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
...|+..-|..|+.....+-|.+|..
T Consensus 464 ~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 464 PAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccccCCCCCCCcchhhHHHHHHhcc
Confidence 78899999999999999988888764
No 462
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.30 E-value=6e-06 Score=79.35 Aligned_cols=74 Identities=16% Similarity=0.174 Sum_probs=53.6
Q ss_pred eEcccCC-eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEecCC
Q 012021 17 LLGQGTF-AKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 17 ~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
.|-.|.. +.||.+.. .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4455555 78898865 34788889875432 235678999998884 44466788887777788999999999
Q ss_pred Cccc
Q 012021 95 GELF 98 (472)
Q Consensus 95 g~L~ 98 (472)
.+|.
T Consensus 77 ~~l~ 80 (244)
T cd05150 77 VPAA 80 (244)
T ss_pred ccHh
Confidence 7664
No 463
>PLN02876 acyl-CoA dehydrogenase
Probab=98.29 E-value=1.1e-05 Score=90.97 Aligned_cols=82 Identities=20% Similarity=0.342 Sum_probs=59.2
Q ss_pred EEeeEcccCCeEEEEEEEcCCC--cEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCe--eeEEEEEEeC---CEE
Q 012021 14 LGRLLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNV--VELYEVMASK---TKI 85 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 85 (472)
-++.|+.|.++.+|+......+ ..+++|+....... .....+.+|+.+|+.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3678899999999998764332 46778876543321 12356889999999995 6665 7788877654 468
Q ss_pred EEEEEecCCCcc
Q 012021 86 YFVMEYVKGGEL 97 (472)
Q Consensus 86 ~lV~E~~~gg~L 97 (472)
|+||||++|..+
T Consensus 120 flVME~v~G~~~ 131 (822)
T PLN02876 120 FYIMEYLEGRIF 131 (822)
T ss_pred eEEEEecCCccc
Confidence 999999998643
No 464
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.24 E-value=2.1e-05 Score=73.21 Aligned_cols=130 Identities=19% Similarity=0.295 Sum_probs=96.8
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-------------cchhhHHHHHHHHHHHHhcC------CCCeeeEE
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-------------LKVGMIDQIKREISVMRLVR------HPNVVELY 76 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~ 76 (472)
..||+|+.=.||. + .......||+...... ......++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999984 3 3456688999876650 01122466777877766665 78999999
Q ss_pred EEEEeCCEEEEEEEecCCC------cccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----
Q 012021 77 EVMASKTKIYFVMEYVKGG------ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---- 146 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg------~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g---- 146 (472)
|+.+++.-.-+|+|.+... +|.+++..+.+++ .. ...+-+-.+||-+++|+.+|++|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9999999999999987642 5777887777877 33 34455566788899999999999999996433
Q ss_pred CEEEee
Q 012021 147 NLKVSD 152 (472)
Q Consensus 147 ~vkl~D 152 (472)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 477777
No 465
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.20 E-value=5.8e-06 Score=92.28 Aligned_cols=202 Identities=19% Similarity=0.243 Sum_probs=139.7
Q ss_pred HHHHHHHHHHhcCCCCeeeEEEEEEeCC----EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 012021 56 QIKREISVMRLVRHPNVVELYEVMASKT----KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGV 130 (472)
Q Consensus 56 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yLH~~gi 130 (472)
....|+..+....|+|++.++.+-.... ...+..|++..-++...+.. +..+...++.+..+++.|+.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 3445666677889999999999864432 23355688888888888866 789999999999999999999999965
Q ss_pred eecCCCCC---cEEEcCCCCEEEe--eccchhhhhcccCCCccccccCCCcccChhhhcccCCC-CCcccchhhhHHHHH
Q 012021 131 CHRDLKPE---NLLLDEHGNLKVS--DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-GSKADIWSCGVILYV 204 (472)
Q Consensus 131 iHrDlKp~---NILld~~g~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DiwSlGvil~~ 204 (472)
.|.-+... +-..+..+.+.++ ||+.+......... ....-+..+.+||....+.+. +...|+|.+|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 55544444 3334455566666 88876655433221 223345667888877655443 224699999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012021 205 LLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~ 269 (472)
+..|..+-....... .+ .+.....+..++..+|+..++++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~~~~~~~---~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPV---SL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccccchh---hh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 988865521111100 00 111112267889999999999999999999999998753
No 466
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.17 E-value=1.2e-05 Score=72.46 Aligned_cols=129 Identities=21% Similarity=0.316 Sum_probs=93.8
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCee-eEEEEEEeCCEEEEEEEe
Q 012021 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV-ELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~ 91 (472)
++.+.||+|++|.||++.. .|..+|+|+-..+. ....+..|+.+|..+.--++. ++|.+.. .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 3567899999999999998 67799999865443 346789999999999876664 5665543 3455999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEcCCCCEEEeeccchhh
Q 012021 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK-PENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlK-p~NILld~~g~vkl~DFGla~~ 158 (472)
+.|-+|......+ + ++-+..+++.-.-|-..||-|..|. |..++|-.++.+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998876554332 2 2334456666556667799999987 5555555566999999997774
No 467
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.16 E-value=3.7e-05 Score=71.28 Aligned_cols=128 Identities=20% Similarity=0.254 Sum_probs=90.3
Q ss_pred CCeEEEeeEcccCC-eEEEEEEEcCCCcEEEEEEeec---c-------cccch--------hhHHHHHHHHHHHHhc---
Q 012021 10 QRYELGRLLGQGTF-AKVHYARNLKTGMSVAIKIIDK---E-------KVLKV--------GMIDQIKREISVMRLV--- 67 (472)
Q Consensus 10 ~~y~i~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~-------~~~~~--------~~~~~~~~Ei~il~~l--- 67 (472)
..++.++.||.|+- |.||+++- .|+.+|+|++.. . ..... ...+-+..|.+..-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999987 788999999421 0 00000 1234567777776555
Q ss_pred CCCCe--eeEEEEEEeC------------------CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh
Q 012021 68 RHPNV--VELYEVMASK------------------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS 127 (472)
Q Consensus 68 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~ 127 (472)
.+.++ |+.+|++.-. ....||.||++... .+ ..+-+.+|.+-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~----~~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PL----QIRDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------cc----chhHHHHHHHHHHHHHH
Confidence 46667 9999997221 12356777765543 12 23345678888899999
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccch
Q 012021 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 128 ~giiHrDlKp~NILld~~g~vkl~DFGla 156 (472)
.||+-+|+++.|.. + =+|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999985 3 389999853
No 468
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=98.06 E-value=2.8e-05 Score=74.42 Aligned_cols=73 Identities=10% Similarity=0.073 Sum_probs=47.0
Q ss_pred eeEcccCCe-EEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC---CeeeEEEEEEeC---CEEEEE
Q 012021 16 RLLGQGTFA-KVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP---NVVELYEVMASK---TKIYFV 88 (472)
Q Consensus 16 ~~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~lV 88 (472)
+.|+.|+.. .||... ..+++|+..... ....+.+|..+|+.+... -+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567777776 488652 357778754321 235788999999888532 344555544332 245899
Q ss_pred EEecCCCccc
Q 012021 89 MEYVKGGELF 98 (472)
Q Consensus 89 ~E~~~gg~L~ 98 (472)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997663
No 469
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.06 E-value=2.3e-05 Score=82.76 Aligned_cols=141 Identities=21% Similarity=0.276 Sum_probs=89.8
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc----------------------------hhhHHHHHHHHHHH---
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK----------------------------VGMIDQIKREISVM--- 64 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------------------~~~~~~~~~Ei~il--- 64 (472)
+.||.-+.|.||.|+-+ +|+.||||+-++.-... .+..+.+..|++.+
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 67899999999999975 59999999964321000 01122222333222
Q ss_pred -------HhcCCCC------eeeEEEEEEeCCEEEEEEEecCCCcccch--hccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012021 65 -------RLVRHPN------VVELYEVMASKTKIYFVMEYVKGGELFGK--VAKGKLKEDAARKYFQQLISAVDYCHSRG 129 (472)
Q Consensus 65 -------~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~~~~i~~ql~~aL~yLH~~g 129 (472)
+.+.|-+ |.++|- .-.+...|+|||++|..+.|. +.+.+++...+...+.+... .-+-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 2223444 333333 334567899999999877654 45566766654433333222 2223468
Q ss_pred ceecCCCCCcEEEcC----CCCEEEeeccchhhhhc
Q 012021 130 VCHRDLKPENLLLDE----HGNLKVSDFGLSALAES 161 (472)
Q Consensus 130 iiHrDlKp~NILld~----~g~vkl~DFGla~~~~~ 161 (472)
++|.|-+|.||++.. ++.+.+-|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 66899999998775543
No 470
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=97.92 E-value=5.5e-05 Score=69.97 Aligned_cols=99 Identities=20% Similarity=0.293 Sum_probs=81.5
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEeCCEEEEEEEecCCCcccch----hccCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 012021 58 KREISVMRLVRH-PNVVELYEVMASKTKIYFVMEYVKGGELFGK----VAKGKLKEDAARKYFQQLISAVDYCHS---RG 129 (472)
Q Consensus 58 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----i~~~~l~e~~~~~i~~ql~~aL~yLH~---~g 129 (472)
..|.-+|+.+.+ +++++++|+|- .++|.||...+++... ..-...++....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 69999999984 3678899987766532 122357899999999999999999997 45
Q ss_pred ceecCCCCCcEEEcCCCCEEEeeccchhhhh
Q 012021 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 130 iiHrDlKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+.-.|++|+|+-++++|++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8899999999999999999999998765543
No 471
>PRK10593 hypothetical protein; Provisional
Probab=97.84 E-value=0.00041 Score=68.94 Aligned_cols=78 Identities=9% Similarity=0.085 Sum_probs=56.5
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEe---CCEEE
Q 012021 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH---PNVVELYEVMAS---KTKIY 86 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~ 86 (472)
.-.+.||.|..+.||.... .+..+.+|... ... ....+.+|...|+.+.. -.+.++++++.. .+..|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMAR-SFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEec-ccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 4457899999999998864 23356777743 211 12578899999998853 367888887754 36789
Q ss_pred EEEEecCCCcc
Q 012021 87 FVMEYVKGGEL 97 (472)
Q Consensus 87 lV~E~~~gg~L 97 (472)
+|||+++|.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998755
No 472
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=97.83 E-value=0.0003 Score=72.46 Aligned_cols=79 Identities=19% Similarity=0.212 Sum_probs=55.6
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--c--hhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--K--VGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (472)
.+.||.|.+..||.+.+...++.|+||.-...... . .-..++...|...|+.+. -.++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 47899999999999998544468999985422110 0 123467788888888763 3457777777 4455789
Q ss_pred EEEecCCC
Q 012021 88 VMEYVKGG 95 (472)
Q Consensus 88 V~E~~~gg 95 (472)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999874
No 473
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=97.81 E-value=0.00021 Score=68.07 Aligned_cols=75 Identities=19% Similarity=0.314 Sum_probs=49.2
Q ss_pred EeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEEEEEEec
Q 012021 15 GRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~ 92 (472)
++.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...+ .++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4677888888999987532 3678999987543211 122357899998885433 345554432 2 3799999
Q ss_pred CCCcc
Q 012021 93 KGGEL 97 (472)
Q Consensus 93 ~gg~L 97 (472)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 99655
No 474
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=97.80 E-value=8.5e-07 Score=100.54 Aligned_cols=208 Identities=17% Similarity=0.100 Sum_probs=145.6
Q ss_pred HHHHHHHHhcCCCCeeeEEEEEE--eCCEEEEEEEecCCCcccchhccC-----CCCHHHHHHHHHHHHHHHHHHHhC--
Q 012021 58 KREISVMRLVRHPNVVELYEVMA--SKTKIYFVMEYVKGGELFGKVAKG-----KLKEDAARKYFQQLISAVDYCHSR-- 128 (472)
Q Consensus 58 ~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~aL~yLH~~-- 128 (472)
..|.+-++...|+++...+.-.. +....|..++|+.+|.+++.|-+| .+.+.-+.....+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34445556678999887766553 345678999999999999998654 344555555555657888888865
Q ss_pred ---CceecCCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHH
Q 012021 129 ---GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL 205 (472)
Q Consensus 129 ---giiHrDlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~l 205 (472)
-.+|+++|+-|.+|..+-++++.++|+.+..... ........+++.|++|++...-.+. .++|+|..|+-+|++
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHH
Confidence 2789999999999999999999999998832221 1223456788999999998777765 559999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012021 206 LAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 206 ltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~ 268 (472)
..|..+|.......+...+... .+..+...|.++-.....+|-..-..||.-..++.-+.|.-
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9998877433322222222222 23344444555555566666666778888887777666654
No 475
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=97.78 E-value=0.00015 Score=70.29 Aligned_cols=131 Identities=16% Similarity=0.218 Sum_probs=78.0
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEecCCC
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 95 (472)
.+..|-.+.+|+.. .+++.+++|+...... ...-...+|..+++.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45668888999887 3677888998644321 110124689999998864333 34444432 36899999986
Q ss_pred cccch-----------------hccC-----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceecCC
Q 012021 96 ELFGK-----------------VAKG-----KLKE-DAARKYFQQL---------ISAVDYCHS--------RGVCHRDL 135 (472)
Q Consensus 96 ~L~~~-----------------i~~~-----~l~e-~~~~~i~~ql---------~~aL~yLH~--------~giiHrDl 135 (472)
.+... +..- +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 1111 1111 1222322222 111222211 25899999
Q ss_pred CCCcEEEcCCCCEEEeeccchh
Q 012021 136 KPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~ 157 (472)
.|.||++++++ +.|+||..|.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999877 7899998765
No 476
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=97.77 E-value=0.00026 Score=69.94 Aligned_cols=135 Identities=16% Similarity=0.144 Sum_probs=83.9
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEV------MASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 86 (472)
.+.|..|....+|+... ++..+++|+.... ....+..|+.+++.+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56778888889998864 4457899987541 1256778888888875332 4454442 23456789
Q ss_pred EEEEecCCCcccch--------------hcc--CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 012021 87 FVMEYVKGGELFGK--------------VAK--GKLKE--------DAAR------------KYFQQLISAVDYCHS--- 127 (472)
Q Consensus 87 lV~E~~~gg~L~~~--------------i~~--~~l~e--------~~~~------------~i~~ql~~aL~yLH~--- 127 (472)
+|++|++|..+... +.. ..+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999999765320 000 00000 0000 011112333444443
Q ss_pred ----CCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 128 ----RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 ----~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899998654
No 477
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.77 E-value=2.6e-05 Score=76.58 Aligned_cols=134 Identities=16% Similarity=0.247 Sum_probs=96.6
Q ss_pred eEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-----------------cchhhHH--HHHHHHHHHHhcCC--C
Q 012021 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-----------------LKVGMID--QIKREISVMRLVRH--P 70 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----------------~~~~~~~--~~~~Ei~il~~l~h--p 70 (472)
|.++..||-|.-+.||.+.+ ..|+..++|.-..... ..+-.+. ...+|+..|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56899999999999999987 5788999996422110 0011112 24578888888853 2
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCEEE
Q 012021 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHrDlKp~NILld~~g~vkl 150 (472)
-+.+.+++ +..++|||++.|-.|...-. ...+..+...++.-+--|-.+|+||+|..--||++++++.+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 34455544 46789999999988765432 1123345566777777888999999999999999999999999
Q ss_pred eeccc
Q 012021 151 SDFGL 155 (472)
Q Consensus 151 ~DFGl 155 (472)
+||--
T Consensus 244 IDFPQ 248 (465)
T KOG2268|consen 244 IDFPQ 248 (465)
T ss_pred eechH
Confidence 99964
No 478
>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.
Probab=97.77 E-value=6.3e-05 Score=52.74 Aligned_cols=42 Identities=24% Similarity=0.390 Sum_probs=35.9
Q ss_pred ceEEEEEEEEEEc-CceEEEEEEccCCCcHHHHHHHHHhhhhcc
Q 012021 386 GVLGMDAEIFEIT-PFFHLVEVKKSSGDTLEYQKVMNQEIRPAL 428 (472)
Q Consensus 386 ~~l~~~~~v~e~~-~~~~lve~~~~~Gd~le~~~~~~~~l~~~l 428 (472)
..+.|.+||+.+. ++++.|+||+.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 4588999999997 899999999999999999999998 55544
No 479
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.68 E-value=0.00042 Score=69.06 Aligned_cols=136 Identities=17% Similarity=0.201 Sum_probs=81.6
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEV------MASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 86 (472)
.+.++.|....+|++.. .+ ..+++|+..... ..+.+..|+.++..|...+ +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DV-GRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CC-CcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677787789998864 34 467789875432 1244566777777774222 3444432 12346789
Q ss_pred EEEEecCCCcccch--------------hcc--CCCC--------HHH-----HH----------HHHHHHHHHHHHHHh
Q 012021 87 FVMEYVKGGELFGK--------------VAK--GKLK--------EDA-----AR----------KYFQQLISAVDYCHS 127 (472)
Q Consensus 87 lV~E~~~gg~L~~~--------------i~~--~~l~--------e~~-----~~----------~i~~ql~~aL~yLH~ 127 (472)
+++||++|..+... +.. ..++ ... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 99999998543210 110 0110 000 00 011123334555542
Q ss_pred -------CCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 128 -------RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 -------~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
.+++|+|+.+.||+++.++...|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899998654
No 480
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.61 E-value=0.00068 Score=67.54 Aligned_cols=139 Identities=21% Similarity=0.291 Sum_probs=90.2
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCC--EEEEE
Q 012021 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEVMASKT--KIYFV 88 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~--~~~lV 88 (472)
.+++....|.--.+|...+ +++.+++. ... ...........++|+.+|+.+.--- +...++++.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444554444445666665 37888888 332 2223345677889999998875423 344555565554 67999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHH-HHHHHHHHHHh----------------------------------------
Q 012021 89 MEYVKGGELFGKVAKGKLKEDAARKYFQ-QLISAVDYCHS---------------------------------------- 127 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~-ql~~aL~yLH~---------------------------------------- 127 (472)
|+|++|..+.+.......+ .+++. .+++.|..||+
T Consensus 104 ~~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 104 MEWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EEEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 9999996444333222222 22222 56666666664
Q ss_pred ----------C--------CceecCCCCCcEEEcCCCCEEEeeccchhhh
Q 012021 128 ----------R--------GVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 128 ----------~--------giiHrDlKp~NILld~~g~vkl~DFGla~~~ 159 (472)
+ .++|+|+.+.||+++.++-+-|.||+++.+-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1 4799999999999999999999999988753
No 481
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.47 E-value=0.001 Score=65.99 Aligned_cols=75 Identities=15% Similarity=0.195 Sum_probs=49.3
Q ss_pred EeeEcccCCeEEEEEEEcC------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEE
Q 012021 15 GRLLGQGTFAKVHYARNLK------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYF 87 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 87 (472)
++.|..|--..+|++.... +++.+++|+...... ......+|..+++.+...++ .++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556667777899887533 258899999755421 12346789889888864333 455655542 35
Q ss_pred EEEecCCCcc
Q 012021 88 VMEYVKGGEL 97 (472)
Q Consensus 88 V~E~~~gg~L 97 (472)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999998765
No 482
>PRK05231 homoserine kinase; Provisional
Probab=97.47 E-value=0.0025 Score=63.69 Aligned_cols=135 Identities=13% Similarity=0.160 Sum_probs=75.7
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEE------EEEeCCEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYE------VMASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 86 (472)
.+.|+.|....+|.... ++..+++|++. . .. .+.+..|+.+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~-~-~~----~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFE-R-LT----AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEec-c-CC----hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35567777789998875 33478999875 1 11 234445666666653212 333332 123356789
Q ss_pred EEEEecCCCcccc-----------h---hcc--CCC--------C--H-HH-HH-----------HHHHH-HHHHHHHHH
Q 012021 87 FVMEYVKGGELFG-----------K---VAK--GKL--------K--E-DA-AR-----------KYFQQ-LISAVDYCH 126 (472)
Q Consensus 87 lV~E~~~gg~L~~-----------~---i~~--~~l--------~--e-~~-~~-----------~i~~q-l~~aL~yLH 126 (472)
++++|++|..+.. . +.. ..+ . . .. .. ..+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 9999999974421 0 000 001 0 0 00 00 11111 111122222
Q ss_pred -------hCCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 127 -------SRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 127 -------~~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
..|++|+|+.|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999966556899999754
No 483
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.32 E-value=0.003 Score=65.00 Aligned_cols=77 Identities=18% Similarity=0.080 Sum_probs=54.2
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-ch---hhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEE
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-KV---GMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 86 (472)
..+.||.|....||+..+ .+..++||.-...... .. -..++...|...|+.+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999887 3567999986532221 11 13456667788887764 247888888877 4467
Q ss_pred EEEEecCC
Q 012021 87 FVMEYVKG 94 (472)
Q Consensus 87 lV~E~~~g 94 (472)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
No 484
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.17 E-value=0.0035 Score=62.90 Aligned_cols=141 Identities=22% Similarity=0.272 Sum_probs=98.9
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc----------------------cchhhH-HHHHHHHHHHHhcCCC
Q 012021 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV----------------------LKVGMI-DQIKREISVMRLVRHP 70 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----------------------~~~~~~-~~~~~Ei~il~~l~hp 70 (472)
|-..|..|.-+.||.|.. .+|..+|||++..+-. ....++ -+...|+.-|++++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445678899999999985 6888899999743210 011122 3456788889988765
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCC-CcccchhccCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCCE
Q 012021 71 NVVELYEVMASKTKIYFVMEYVKG-GELFGKVAKGKLKEDAARKYFQQLISAVDYCH-SRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH-~~giiHrDlKp~NILld~~g~v 148 (472)
.|.-.--+... ...|||+|+.. |--.-.++.-.++...+..+-+|++.-+.-|- ..+++|.||.--|+|+- +|.+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 55432222221 24699999953 22233445557888899999999998888774 56999999999999984 5689
Q ss_pred EEeeccchhh
Q 012021 149 KVSDFGLSAL 158 (472)
Q Consensus 149 kl~DFGla~~ 158 (472)
.|+|-+-+.-
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999986543
No 485
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=97.11 E-value=0.0061 Score=59.88 Aligned_cols=30 Identities=27% Similarity=0.494 Sum_probs=25.0
Q ss_pred CceecCCCCCcEEEcCCCC-EEEeeccchhh
Q 012021 129 GVCHRDLKPENLLLDEHGN-LKVSDFGLSAL 158 (472)
Q Consensus 129 giiHrDlKp~NILld~~g~-vkl~DFGla~~ 158 (472)
.++|+|++|.|||++.+++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999997653
No 486
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=97.09 E-value=0.0012 Score=68.69 Aligned_cols=163 Identities=23% Similarity=0.258 Sum_probs=104.4
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeC-CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 012021 55 DQIKREISVMRLVRHPNVVELYEVMASK-TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133 (472)
Q Consensus 55 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~giiHr 133 (472)
.++.-...+++.+.|+|...++++.... ....+|||++ +.+|.+.+..+.+-..... .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------cccccee
Confidence 4456678899999999999999987554 3477899999 6688888776543222111 2222221
Q ss_pred CCCCCcEEEcCCCCEEEeeccchhhhhcccCCCccccccCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC
Q 012021 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213 (472)
Q Consensus 134 DlKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltG~~Pf~ 213 (472)
|+ ++++| .... . | |- ..++++||||+|.++.++.-|...|.
T Consensus 92 -----~~-------~~~td----~~~t----------~-----~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----NI-------IYITD----HFLT----------K-----Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----hh-------hhccc----cccc----------c-----C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 22 22333 0000 0 0 00 11248999999999999999987776
Q ss_pred CCcHHHHHHHHhccCCCC------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012021 214 DSNLMEMYRKIGKAEFKF------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h~~f~~~~~ 271 (472)
.....+....+.+-.... -..++..+..+..+|+-..|..||...++++++-|.++..
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 554444333332211110 0113455678899999999999999999999999987654
No 487
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.06 E-value=0.0037 Score=63.25 Aligned_cols=77 Identities=16% Similarity=0.100 Sum_probs=50.6
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-c---hhhHHHHHHHHHHHHhcC--CC-CeeeEEEEEEeCCEEEEEE
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-K---VGMIDQIKREISVMRLVR--HP-NVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 89 (472)
.+|.|....||++.+...++.|+||.-..--.. . .-..++..-|...|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998544478999985422111 1 123456678888887764 34 45555544 445566999
Q ss_pred EecCCC
Q 012021 90 EYVKGG 95 (472)
Q Consensus 90 E~~~gg 95 (472)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
No 488
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=96.83 E-value=0.014 Score=57.93 Aligned_cols=29 Identities=38% Similarity=0.746 Sum_probs=25.2
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 ~giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999998543
No 489
>PRK12396 5-methylribose kinase; Reviewed
Probab=96.76 E-value=0.0057 Score=62.69 Aligned_cols=79 Identities=20% Similarity=0.248 Sum_probs=53.8
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc---hhhHHHHHHHHHHHHhcC--CC-CeeeEEEEEEeCCEEEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK---VGMIDQIKREISVMRLVR--HP-NVVELYEVMASKTKIYFV 88 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 88 (472)
.+.||.|.-.-||++.+...++.|+||.-..--... .-..++..-|..+|+... -| +++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999984346789999753221111 123577788999998774 35 45556654 44556788
Q ss_pred EEecCCC
Q 012021 89 MEYVKGG 95 (472)
Q Consensus 89 ~E~~~gg 95 (472)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9988653
No 490
>PLN02236 choline kinase
Probab=96.73 E-value=0.014 Score=59.25 Aligned_cols=136 Identities=18% Similarity=0.247 Sum_probs=81.1
Q ss_pred EEeeEcccCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEE
Q 012021 14 LGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFV 88 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV 88 (472)
-++.|-.|-...+|++.... .++.|++|+..... ....++ .+|..+++.+..-++ .++++.+... .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34455558888999986432 34789999875542 122233 679999988865444 3566665432 57
Q ss_pred EEecCCCcccch-----------------hccCC-------CCHHHHHHHHHHHH-----------------HHHHHH--
Q 012021 89 MEYVKGGELFGK-----------------VAKGK-------LKEDAARKYFQQLI-----------------SAVDYC-- 125 (472)
Q Consensus 89 ~E~~~gg~L~~~-----------------i~~~~-------l~e~~~~~i~~ql~-----------------~aL~yL-- 125 (472)
.||++|.+|... ++... .....+..++.++. ..+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987655311 11101 11223333432221 111111
Q ss_pred --H----hCCceecCCCCCcEEEcC-CCCEEEeeccchh
Q 012021 126 --H----SRGVCHRDLKPENLLLDE-HGNLKVSDFGLSA 157 (472)
Q Consensus 126 --H----~~giiHrDlKp~NILld~-~g~vkl~DFGla~ 157 (472)
. ...++|+|+++.|||+++ ++.+.++||..|.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 226899999999999986 4689999998655
No 491
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=96.38 E-value=0.034 Score=56.11 Aligned_cols=135 Identities=17% Similarity=0.266 Sum_probs=78.1
Q ss_pred EeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEE
Q 012021 15 GRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVME 90 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E 90 (472)
++.|..|=-..+|++..... +..|.+|+...... ...+ -.+|..+++.+..-++ .++++++. .+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 34554477778998865432 34899998754321 1112 2578899988875555 45666653 22 5889
Q ss_pred ecCCCcccc-----------------hhccCC------C-CHHHHHHHHHHHH----------------------HHHHH
Q 012021 91 YVKGGELFG-----------------KVAKGK------L-KEDAARKYFQQLI----------------------SAVDY 124 (472)
Q Consensus 91 ~~~gg~L~~-----------------~i~~~~------l-~e~~~~~i~~ql~----------------------~aL~y 124 (472)
|++|..|.. .++... . -...+..|+.++- .-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998765421 011111 1 1223333332221 11111
Q ss_pred ----HHhC----CceecCCCCCcEEEcC-CCCEEEeeccchh
Q 012021 125 ----CHSR----GVCHRDLKPENLLLDE-HGNLKVSDFGLSA 157 (472)
Q Consensus 125 ----LH~~----giiHrDlKp~NILld~-~g~vkl~DFGla~ 157 (472)
+... -++|.|+.|.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1112 2799999999999975 5789999998765
No 492
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=96.24 E-value=0.063 Score=53.04 Aligned_cols=75 Identities=12% Similarity=0.144 Sum_probs=49.0
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEEEE
Q 012021 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+-.+.+|.|....+|... .+++.+-||+-.... ...+..|..-|+.|. --.+++++.+....+..||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345778989999999877 588899999876222 245778888888884 445778999988877789999
Q ss_pred EecCCC
Q 012021 90 EYVKGG 95 (472)
Q Consensus 90 E~~~gg 95 (472)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
No 493
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=96.20 E-value=0.015 Score=54.47 Aligned_cols=29 Identities=38% Similarity=0.840 Sum_probs=20.8
Q ss_pred CceecCCCCCcEEE-cCCCCEEEeeccchh
Q 012021 129 GVCHRDLKPENLLL-DEHGNLKVSDFGLSA 157 (472)
Q Consensus 129 giiHrDlKp~NILl-d~~g~vkl~DFGla~ 157 (472)
.++|.|+.|.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 889999999998765
No 494
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=96.07 E-value=0.024 Score=57.00 Aligned_cols=86 Identities=24% Similarity=0.331 Sum_probs=61.4
Q ss_pred CCCeeeEEEEE-EeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCC
Q 012021 69 HPNVVELYEVM-ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 69 hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~-giiHrDlKp~NILld~~g 146 (472)
.++..+++-+- .+....|++|++- |++|... . --..+++..++++.+..++-+..+ ..-|||+...||||+ +|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i-k--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISII-K--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeeee-e--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 44444444443 3344667788876 5555322 1 234567788889888888777755 688999999999999 99
Q ss_pred CEEEeeccchhhh
Q 012021 147 NLKVSDFGLSALA 159 (472)
Q Consensus 147 ~vkl~DFGla~~~ 159 (472)
++.|+||-++++-
T Consensus 359 nvtLIDfklsRl~ 371 (488)
T COG5072 359 NVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEeeeeecc
Confidence 9999999999843
No 495
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=96.00 E-value=0.12 Score=51.61 Aligned_cols=29 Identities=21% Similarity=0.242 Sum_probs=26.8
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccchh
Q 012021 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 129 giiHrDlKp~NILld~~g~vkl~DFGla~ 157 (472)
+++|+|+.++|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998655
No 496
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=95.87 E-value=0.093 Score=52.83 Aligned_cols=133 Identities=20% Similarity=0.291 Sum_probs=80.3
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC------eeeEEE----EEEeCCEEE
Q 012021 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN------VVELYE----VMASKTKIY 86 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~----~~~~~~~~~ 86 (472)
.|.+ .-..||+... .+|.. ++|+.... .. ...+.-|+..|..|.-.. +..+-| ......+.+
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEe-cCCCe-EEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 4556888876 34444 99998776 22 256778888888774221 222222 222224888
Q ss_pred EEEEecCCCcccc-h--------------h----------ccC---CCCHH----H---------HHHHHHHHHHHHHHH
Q 012021 87 FVMEYVKGGELFG-K--------------V----------AKG---KLKED----A---------ARKYFQQLISAVDYC 125 (472)
Q Consensus 87 lV~E~~~gg~L~~-~--------------i----------~~~---~l~e~----~---------~~~i~~ql~~aL~yL 125 (472)
-+.+|++|..+.. . + ..+ ...+. . -.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 9999999987762 1 0 000 01111 0 111233444555555
Q ss_pred HhC--------C--ceecCCCCCcEEEcCCCC-EEEeeccchh
Q 012021 126 HSR--------G--VCHRDLKPENLLLDEHGN-LKVSDFGLSA 157 (472)
Q Consensus 126 H~~--------g--iiHrDlKp~NILld~~g~-vkl~DFGla~ 157 (472)
.+. + +||+|+.|.||+++.+.. +.++|||-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 543 4 999999999999999885 8999999654
No 497
>PRK11768 serine/threonine protein kinase; Provisional
Probab=95.59 E-value=0.34 Score=48.74 Aligned_cols=71 Identities=15% Similarity=0.071 Sum_probs=44.1
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEE---E--EEEeCCEEEEEEEecC
Q 012021 21 GTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELY---E--VMASKTKIYFVMEYVK 93 (472)
Q Consensus 21 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lV~E~~~ 93 (472)
+.-..||.... .+|..+++|+...... ....+..|...+..|.... ++... + ....++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34456888864 4677899999864432 2356777888877664211 22211 1 2233567889999998
Q ss_pred CCc
Q 012021 94 GGE 96 (472)
Q Consensus 94 gg~ 96 (472)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 864
No 498
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=95.44 E-value=0.058 Score=50.80 Aligned_cols=84 Identities=19% Similarity=0.235 Sum_probs=57.8
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--Ccee
Q 012021 55 DQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR--GVCH 132 (472)
Q Consensus 55 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yLH~~--giiH 132 (472)
..++.+.+++.++. .|+++..- +...+-++.|+|..-.. ... .++..=+.+|.-.|+. +.+|
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~~-N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NFS-NFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------chh-HHHHHhHHHHHHhhccCCCeec
Confidence 44678888888763 56777632 44567789999844211 001 1111124567778843 7999
Q ss_pred cCCCCCcEEEcCCCCEEEeecc
Q 012021 133 RDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 133 rDlKp~NILld~~g~vkl~DFG 154 (472)
+|..|+||+-|..|.+||.|=+
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred CCCChhheeecCCCCEEecChh
Confidence 9999999999999999999976
No 499
>PTZ00384 choline kinase; Provisional
Probab=95.25 E-value=0.12 Score=53.21 Aligned_cols=76 Identities=14% Similarity=0.204 Sum_probs=46.0
Q ss_pred EEeeEcccCCeEEEEEEEcCC-CcE-----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEE
Q 012021 14 LGRLLGQGTFAKVHYARNLKT-GMS-----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIY 86 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~-g~~-----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 86 (472)
.++.|..|--..+|++..... +.. |.+++..... ...-.-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345565588889999875332 122 4444421111 111122578999999976555 566666643 6
Q ss_pred EEEEecCCCcc
Q 012021 87 FVMEYVKGGEL 97 (472)
Q Consensus 87 lV~E~~~gg~L 97 (472)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999999765
No 500
>PRK06148 hypothetical protein; Provisional
Probab=94.65 E-value=0.28 Score=56.99 Aligned_cols=135 Identities=14% Similarity=0.230 Sum_probs=75.9
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-------CCCeeeE-----EEEEEe-C
Q 012021 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-------HPNVVEL-----YEVMAS-K 82 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-------hpnIv~l-----~~~~~~-~ 82 (472)
+.|+ |..-.+|+... .+|..+++|+.+.... ...+..|..+|..|. -|.+++- +..... +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~-----~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEP-----RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccc-----hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 5675 45677888864 5677899999876421 133444555665442 2333321 111211 2
Q ss_pred C--EEEEEEEecCCCcccch-----------------h----cc-------CCCCH-----------------HHHHHHH
Q 012021 83 T--KIYFVMEYVKGGELFGK-----------------V----AK-------GKLKE-----------------DAARKYF 115 (472)
Q Consensus 83 ~--~~~lV~E~~~gg~L~~~-----------------i----~~-------~~l~e-----------------~~~~~i~ 115 (472)
+ +.+.+++|++|..+.+. + .. ..+.+ ...+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 56788999999766431 0 00 00111 1112223
Q ss_pred HHHHHHHHH-----HH--hCCceecCCCCCcEEEcCCC--CEE-Eeeccchh
Q 012021 116 QQLISAVDY-----CH--SRGVCHRDLKPENLLLDEHG--NLK-VSDFGLSA 157 (472)
Q Consensus 116 ~ql~~aL~y-----LH--~~giiHrDlKp~NILld~~g--~vk-l~DFGla~ 157 (472)
.+++....- +. .+++||.|+.+.|||++.++ .+. |+|||.+.
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 333333221 11 24799999999999999875 555 99999765
Done!